"","NGenes","Direction","PValue","FDR"
"REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES",16,"Up",0.00173521723676452,0.999827083089274
"MATZUK_POST-IMPLANTATION_AND_POST-PARTUM",10,"Up",0.00181373856430894,0.999827083089274
"REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE",1,"Up",0.00197812475763609,0.999827083089274
"BIOCARTA_PLATELETAPP_PATHWAY",12,"Down",0.00327665365643669,0.999827083089274
"REACTOME_ACTIVATED_POINT_MUTANTS_OF_FGFR2",13,"Down",0.00588435256128021,0.999827083089274
"VISALA_AGING_LYMPHOCYTE_UP",5,"Up",0.00625815526339435,0.999827083089274
"REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION",10,"Down",0.00637046142885408,0.999827083089274
"PID_INTEGRIN4_PATHWAY",9,"Up",0.00645502385070705,0.999827083089274
"REACTOME_TRAF6_MEDIATED_NFKB_ACTIVATION",16,"Up",0.00791915693320677,0.999827083089274
"REACTOME_SIGNALING_BY_FGFR3_MUTANTS",9,"Down",0.00810103006798004,0.999827083089274
"REACTOME_FGFR_LIGAND_BINDING_AND_ACTIVATION",18,"Down",0.00845684397401783,0.999827083089274
"DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP",25,"Up",0.00870529505045983,0.999827083089274
"JIANG_CORE_DUPLICON_GENES",1,"Up",0.00912992309269833,0.999827083089274
"WANG_ESOPHAGUS_CANCER_PROGRESSION_UP",6,"Up",0.010402557483072,0.999827083089274
"OHASHI_AURKA_TARGETS",4,"Up",0.0110576813970408,0.999827083089274
"REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION",11,"Down",0.0118478198953597,0.999827083089274
"SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN",8,"Up",0.012645635390857,0.999827083089274
"REACTOME_NEGATIVE_REGULATION_OF_FGFR_SIGNALING",27,"Down",0.0134820181396236,0.999827083089274
"REACTOME_FRS2_MEDIATED_CASCADE",28,"Down",0.0138020587981174,0.999827083089274
"REACTOME_SIGNALING_BY_ACTIVATED_POINT_MUTANTS_OF_FGFR1",9,"Down",0.0148418098277598,0.999827083089274
"REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX",16,"Up",0.0149348727684691,0.999827083089274
"REACTOME_SHC_MEDIATED_CASCADE",24,"Down",0.015006914072455,0.999827083089274
"REACTOME_IRAK1_RECRUITS_IKK_COMPLEX",5,"Up",0.0173384792816856,0.999827083089274
"WANG_RECURRENT_LIVER_CANCER_UP",6,"Up",0.0183472083824191,0.999827083089274
"MIKKELSEN_ES_LCP_WITH_H3K27ME3",6,"Down",0.0191958009308251,0.999827083089274
"ZEMBUTSU_SENSITIVITY_TO_MITOMYCIN",6,"Up",0.0194612209451092,0.999827083089274
"CHESLER_BRAIN_D6MIT150_QTL_CIS",4,"Up",0.0197986147057272,0.999827083089274
"SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A",16,"Up",0.0199090319291907,0.999827083089274
"WILLIAMS_ESR2_TARGETS_UP",8,"Up",0.0200798000662814,0.999827083089274
"REACTOME_FGFR4_LIGAND_BINDING_AND_ACTIVATION",10,"Down",0.0204949274716179,0.999827083089274
"RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_UP",1,"Up",0.0205467398015152,0.999827083089274
"REACTOME_PERK_REGULATED_GENE_EXPRESSION",14,"Up",0.0218555335149767,0.999827083089274
"ABBUD_LIF_SIGNALING_2_DN",5,"Up",0.0222893369387408,0.999827083089274
"IRITANI_MAD1_TARGETS_UP",8,"Up",0.0236337179159666,0.999827083089274
"REACTOME_ACTIVATION_OF_CHAPERONES_BY_ATF6_ALPHA",8,"Up",0.0256658800914167,0.999827083089274
"REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_ATF6_ALPHA",8,"Up",0.0256658800914167,0.999827083089274
"ZIRN_TRETINOIN_RESPONSE_UP",11,"Up",0.0256933721556314,0.999827083089274
"YANG_BREAST_CANCER_ESR1_LASER_UP",15,"Down",0.0258718421870438,0.999827083089274
"SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_DN",7,"Up",0.0262322454884383,0.999827083089274
"BIOCARTA_VITCB_PATHWAY",9,"Down",0.0269707596880639,0.999827083089274
"BIOCARTA_FIBRINOLYSIS_PATHWAY",8,"Down",0.0271898406694839,0.999827083089274
"REACTOME_PI3K_CASCADE",41,"Down",0.0272361418625638,0.999827083089274
"SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN",17,"Up",0.0275404102067791,0.999827083089274
"CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY",10,"Up",0.0287294104461093,0.999827083089274
"LANDIS_ERBB2_BREAST_TUMORS_65_UP",15,"Down",0.0292862645248767,0.999827083089274
"LINDGREN_BLADDER_CANCER_CLUSTER_2A_UP",5,"Up",0.0299962936065707,0.999827083089274
"REACTOME_PLATELET_CALCIUM_HOMEOSTASIS",11,"Up",0.0312261955359626,0.999827083089274
"BIOCARTA_TFF_PATHWAY",19,"Down",0.031521838171463,0.999827083089274
"KONDO_HYPOXIA",8,"Down",0.0322849081606116,0.999827083089274
"BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN",5,"Down",0.0326710087391829,0.999827083089274
"TOMIDA_LUNG_CANCER_POOR_SURVIVAL",3,"Up",0.0331345754686483,0.999827083089274
"REACTOME_CD28_DEPENDENT_VAV1_PATHWAY",10,"Down",0.0331705383137557,0.999827083089274
"REACTOME_DEFENSINS",10,"Down",0.0338307512693963,0.999827083089274
"MAINA_VHL_TARGETS_DN",13,"Up",0.0340142355250131,0.999827083089274
"KANG_CISPLATIN_RESISTANCE_DN",3,"Down",0.0359796145009232,0.999827083089274
"MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_DN",6,"Up",0.0387465273150448,0.999827083089274
"COLLIS_PRKDC_REGULATORS",10,"Up",0.0400625288499236,0.999827083089274
"YANAGISAWA_LUNG_CANCER_RECURRENCE",4,"Up",0.0404736358234603,0.999827083089274
"ZERBINI_RESPONSE_TO_SULINDAC_DN",4,"Up",0.0414585946775406,0.999827083089274
"IKEDA_MIR133_TARGETS_DN",3,"Down",0.0417387585277134,0.999827083089274
"MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN",15,"Down",0.0451335674331744,0.999827083089274
"SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP",26,"Up",0.0469113028630371,0.999827083089274
"ABBUD_LIF_SIGNALING_2_UP",11,"Up",0.0475891481731896,0.999827083089274
"PID_RXR_VDR_PATHWAY",23,"Up",0.0508708867914502,0.999827083089274
"WONG_IFNA2_RESISTANCE_UP",7,"Up",0.0513657609059937,0.999827083089274
"BUSA_SAM68_TARGETS_UP",6,"Up",0.0535095390833232,0.999827083089274
"GHO_ATF5_TARGETS_UP",5,"Up",0.0537335459841467,0.999827083089274
"BIOCARTA_BIOPEPTIDES_PATHWAY",39,"Down",0.0539506004040246,0.999827083089274
"MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_13",1,"Up",0.0547177270909018,0.999827083089274
"MATZUK_OVULATION",9,"Up",0.0548535459734388,0.999827083089274
"MATZUK_SPERMATID_DIFFERENTIATION",19,"Down",0.055476420512342,0.999827083089274
"MCCABE_HOXC6_TARGETS_DN",8,"Down",0.0559920201968073,0.999827083089274
"KIM_ALL_DISORDERS_DURATION_CORR_UP",3,"Up",0.0560424842169443,0.999827083089274
"MAYBURD_RESPONSE_TO_L663536_UP",10,"Up",0.0565593246885582,0.999827083089274
"MALIK_REPRESSED_BY_ESTROGEN",9,"Up",0.0573440902801078,0.999827083089274
"REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE",54,"Down",0.0579393047177181,0.999827083089274
"PID_TOLL_ENDOGENOUS_PATHWAY",21,"Up",0.0580222744870672,0.999827083089274
"BIOCARTA_SPRY_PATHWAY",15,"Down",0.0585082639424093,0.999827083089274
"MCBRYAN_TERMINAL_END_BUD_UP",11,"Up",0.0586867058247916,0.999827083089274
"HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP",16,"Up",0.0586895523190393,0.999827083089274
"REACTOME_BETA_DEFENSINS",6,"Down",0.0626253839361812,0.999827083089274
"PETRETTO_HEART_MASS_QTL_CIS_DN",12,"Down",0.0631324710888885,0.999827083089274
"DEMAGALHAES_AGING_UP",36,"Up",0.0632819776301812,0.999827083089274
"BARIS_THYROID_CANCER_UP",12,"Up",0.0646398331698731,0.999827083089274
"SESTO_RESPONSE_TO_UV_C4",12,"Down",0.0647265411514606,0.999827083089274
"PIEPOLI_LGI1_TARGETS_UP",12,"Up",0.0647482985763343,0.999827083089274
"REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING",11,"Down",0.0648031115441745,0.999827083089274
"REACTOME_SIGNALING_BY_FGFR_MUTANTS",33,"Down",0.0654180339618299,0.999827083089274
"WONG_ENDOMETRIAL_CANCER_LATE",11,"Up",0.0660040888569484,0.999827083089274
"REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_DAI",14,"Up",0.0661685866278613,0.999827083089274
"LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN",26,"Down",0.0672909271673458,0.999827083089274
"BIOCARTA_EPHA4_PATHWAY",7,"Down",0.0672932532481832,0.999827083089274
"TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN",6,"Up",0.0683200556618274,0.999827083089274
"TERAMOTO_OPN_TARGETS_CLUSTER_6",13,"Up",0.070003470998818,0.999827083089274
"REACTOME_ACTIVATION_OF_GENES_BY_ATF4",11,"Up",0.0709906628851677,0.999827083089274
"IM_SREBF1A_TARGETS",2,"Up",0.0714477407831026,0.999827083089274
"CHEOK_RESPONSE_TO_HD_MTX_UP",12,"Up",0.0717376116417111,0.999827083089274
"MANTOVANI_NFKB_TARGETS_UP",22,"Up",0.0718856494543342,0.999827083089274
"OHM_EMBRYONIC_CARCINOMA_DN",6,"Up",0.0730993541685217,0.999827083089274
"CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP",42,"Down",0.0734005420576232,0.999827083089274
"REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH",57,"Down",0.0740633547945514,0.999827083089274
"BIOCARTA_IL22BP_PATHWAY",12,"Down",0.074242513534327,0.999827083089274
"BIOCARTA_PTDINS_PATHWAY",17,"Up",0.0744067819299122,0.999827083089274
"WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP",7,"Down",0.0744980207837945,0.999827083089274
"HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN",8,"Up",0.0748196164062103,0.999827083089274
"KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS",9,"Down",0.0760112006059229,0.999827083089274
"MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_1",2,"Down",0.0761618695884132,0.999827083089274
"BIOCARTA_ACE2_PATHWAY",11,"Down",0.0776516704138241,0.999827083089274
"LEE_INTRATHYMIC_T_PROGENITOR",11,"Up",0.0777671447987787,0.999827083089274
"WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_DN",3,"Up",0.0778418021015207,0.999827083089274
"TOMIDA_METASTASIS_DN",13,"Up",0.0784474364158438,0.999827083089274
"BIOCARTA_CBL_PATHWAY",10,"Down",0.0784708668669562,0.999827083089274
"BIOCARTA_SALMONELLA_PATHWAY",4,"Down",0.0791724560462896,0.999827083089274
"KONG_E2F1_TARGETS",6,"Down",0.0801362021303732,0.999827083089274
"VERNELL_RETINOBLASTOMA_PATHWAY_DN",4,"Down",0.080652446332838,0.999827083089274
"WESTON_VEGFA_TARGETS_12HR",29,"Up",0.0817480396388699,0.999827083089274
"BIOCARTA_ASBCELL_PATHWAY",10,"Down",0.0819619618543758,0.999827083089274
"SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_UP",8,"Down",0.0829686250286514,0.999827083089274
"REACTOME_DEADENYLATION_OF_MRNA",5,"Down",0.0843055135003924,0.999827083089274
"WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53",6,"Up",0.0855226322025033,0.999827083089274
"POS_RESPONSE_TO_HISTAMINE_DN",4,"Up",0.0857798621068598,0.999827083089274
"REACTOME_PEROXISOMAL_LIPID_METABOLISM",11,"Up",0.0859711470343463,0.999827083089274
"BIOCARTA_RAB_PATHWAY",8,"Down",0.085982259390833,0.999827083089274
"SUMI_HNF4A_TARGETS",9,"Up",0.0869113262163018,0.999827083089274
"REACTOME_ALPHA_LINOLENIC_ACID_ALA_METABOLISM",5,"Up",0.0875583767151045,0.999827083089274
"REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE",42,"Down",0.0883290647639331,0.999827083089274
"NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON",13,"Up",0.0883776167326765,0.999827083089274
"BIOCARTA_CD40_PATHWAY",13,"Up",0.0896119382621171,0.999827083089274
"MOTAMED_RESPONSE_TO_ANDROGEN_UP",3,"Up",0.090263832974651,0.999827083089274
"TURJANSKI_MAPK14_TARGETS",10,"Down",0.090395993209524,0.999827083089274
"ROSS_AML_WITH_AML1_ETO_FUSION",32,"Up",0.0905855485750722,0.999827083089274
"REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING",13,"Down",0.0914649821582614,0.999827083089274
"BIOCARTA_AT1R_PATHWAY",31,"Down",0.0916557116606814,0.999827083089274
"PENG_RAPAMYCIN_RESPONSE_DN",118,"Up",0.0926029114061143,0.999827083089274
"HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP",7,"Up",0.093194828673951,0.999827083089274
"PLASARI_TGFB1_TARGETS_1HR_DN",4,"Down",0.0934210423782569,0.999827083089274
"BIOCARTA_SPPA_PATHWAY",20,"Down",0.0936527922698474,0.999827083089274
"REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION",8,"Down",0.0936646595989444,0.999827083089274
"REACTOME_SIGNALING_BY_FGFR1_MUTANTS",21,"Down",0.0950543017372191,0.999827083089274
"REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS",21,"Down",0.0951848312885611,0.999827083089274
"BARRIER_COLON_CANCER_RECURRENCE_UP",12,"Up",0.0952497927492752,0.999827083089274
"MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP",43,"Up",0.0959727611244138,0.999827083089274
"MOOTHA_PYR",4,"Down",0.0968316235785525,0.999827083089274
"MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_5",1,"Down",0.0974377774749169,0.999827083089274
"REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES",35,"Down",0.0980474306324054,0.999827083089274
"REACTOME_ION_CHANNEL_TRANSPORT",31,"Up",0.0985800903191131,0.999827083089274
"REACTOME_ACTIVATION_OF_RAC",9,"Down",0.0986932890259517,0.999827083089274
"INGA_TP53_TARGETS",11,"Down",0.0987884865980801,0.999827083089274
"GERHOLD_RESPONSE_TO_TZD_UP",5,"Down",0.0997589261080178,0.999827083089274
"SHIRAISHI_PLZF_TARGETS_UP",4,"Up",0.100191937685871,0.999827083089274
"REACTOME_SIGNALING_BY_INSULIN_RECEPTOR",62,"Down",0.101547546821959,0.999827083089274
"MEISSNER_NPC_ICP_WITH_H3K4ME3",4,"Down",0.102031779574204,0.999827083089274
"TESAR_ALK_TARGETS_HUMAN_ES_5D_UP",5,"Down",0.102244209178781,0.999827083089274
"KEGG_RNA_POLYMERASE",8,"Up",0.104445121893077,0.999827083089274
"DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_DN",7,"Down",0.10475011495044,0.999827083089274
"REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS",7,"Up",0.104805927994808,0.999827083089274
"SEMBA_FHIT_TARGETS_UP",7,"Up",0.105477128876238,0.999827083089274
"SASSON_FSH_RESPONSE",9,"Up",0.105711629024095,0.999827083089274
"STONER_ESOPHAGEAL_CARCINOGENESIS_DN",3,"Down",0.107148866749115,0.999827083089274
"PID_RHOA_REG_PATHWAY",14,"Up",0.107185439067332,0.999827083089274
"BIOCARTA_IL10_PATHWAY",15,"Down",0.107219410505902,0.999827083089274
"BIOCARTA_INTRINSIC_PATHWAY",18,"Down",0.108209967871061,0.999827083089274
"MACLACHLAN_BRCA1_TARGETS_UP",19,"Down",0.108485948077456,0.999827083089274
"NIKOLSKY_BREAST_CANCER_5P15_AMPLICON",7,"Down",0.109081331296123,0.999827083089274
"SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES",27,"Up",0.110558617237904,0.999827083089274
"LOPES_METHYLATED_IN_COLON_CANCER_DN",26,"Up",0.110738486812399,0.999827083089274
"LI_WILMS_TUMOR_ANAPLASTIC_DN",4,"Down",0.110848013713174,0.999827083089274
"PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3",7,"Up",0.111213118562507,0.999827083089274
"TRAYNOR_RETT_SYNDROM_UP",16,"Down",0.11124425260642,0.999827083089274
"RAFFEL_VEGFA_TARGETS_UP",9,"Down",0.111318423585903,0.999827083089274
"ZEILSTRA_CD44_TARGETS_DN",6,"Up",0.111429433090067,0.999827083089274
"STAEGE_EWING_FAMILY_TUMOR",16,"Up",0.111800953906033,0.999827083089274
"MA_PITUITARY_FETAL_VS_ADULT_DN",9,"Down",0.111895635296733,0.999827083089274
"CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_UP",3,"Up",0.11231481623854,0.999827083089274
"KEGG_HOMOLOGOUS_RECOMBINATION",16,"Down",0.112375846308022,0.999827083089274
"REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY",9,"Down",0.112381055142802,0.999827083089274
"TURJANSKI_MAPK7_TARGETS",8,"Down",0.113392027337138,0.999827083089274
"VALK_AML_CLUSTER_4",13,"Down",0.113688190754062,0.999827083089274
"KONDO_COLON_CANCER_HCP_WITH_H3K27ME3",1,"Up",0.113792337226025,0.999827083089274
"REACTOME_CGMP_EFFECTS",11,"Down",0.114787862690851,0.999827083089274
"GROSS_HYPOXIA_VIA_ELK3_ONLY_DN",27,"Up",0.115243395722633,0.999827083089274
"REACTOME_REGULATION_OF_KIT_SIGNALING",15,"Down",0.115970613931837,0.999827083089274
"KYNG_NORMAL_AGING_UP",8,"Up",0.116191507669771,0.999827083089274
"PID_INTEGRIN_CS_PATHWAY",18,"Down",0.11626951337764,0.999827083089274
"KYNG_WERNER_SYNDROM_UP",9,"Up",0.116315034021259,0.999827083089274
"REACTOME_PYRIMIDINE_CATABOLISM",2,"Down",0.116909305692675,0.999827083089274
"HU_ANGIOGENESIS_UP",10,"Down",0.11782862433759,0.999827083089274
"MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN",7,"Up",0.117904192335053,0.999827083089274
"NOUSHMEHR_GBM_GERMLINE_MUTATED",4,"Down",0.11854308928313,0.999827083089274
"DAVIES_MULTIPLE_MYELOMA_VS_MGUS_UP",8,"Up",0.118625844105744,0.999827083089274
"KEGG_MELANOMA",58,"Down",0.118872879594659,0.999827083089274
"BIOCARTA_AMI_PATHWAY",16,"Down",0.119273570681499,0.999827083089274
"LIU_IL13_MEMORY_MODEL_DN",4,"Up",0.119283259325625,0.999827083089274
"REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR",5,"Up",0.119609497613454,0.999827083089274
"MCCOLLUM_GELDANAMYCIN_RESISTANCE_DN",4,"Down",0.11970894803332,0.999827083089274
"KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES",12,"Up",0.120989079387354,0.999827083089274
"REACTOME_HOMOLOGOUS_RECOMBINATION_REPAIR_OF_REPLICATION_INDEPENDENT_DOUBLE_STRAND_BREAKS",12,"Down",0.12105538465842,0.999827083089274
"REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT",6,"Down",0.121465948659251,0.999827083089274
"LIM_MAMMARY_LUMINAL_PROGENITOR_DN",5,"Up",0.121573186337711,0.999827083089274
"VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN",6,"Up",0.121752392845775,0.999827083089274
"MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN",10,"Up",0.121812784654953,0.999827083089274
"GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN",6,"Up",0.122003466081419,0.999827083089274
"REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS",24,"Down",0.122087974003884,0.999827083089274
"REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX_UPON_TLR7_8_OR_9_STIMULATION",2,"Up",0.122190106355069,0.999827083089274
"PID_IL12_STAT4_PATHWAY",29,"Down",0.122456746527753,0.999827083089274
"REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX",5,"Up",0.122472352724833,0.999827083089274
"SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN",11,"Down",0.122934310480135,0.999827083089274
"YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN",40,"Down",0.123015333902654,0.999827083089274
"MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_3",4,"Up",0.123057909478289,0.999827083089274
"DER_IFN_ALPHA_RESPONSE_UP",51,"Down",0.123194395233938,0.999827083089274
"BIOCARTA_CDK5_PATHWAY",10,"Down",0.123559579009408,0.999827083089274
"TESAR_ALK_TARGETS_EPISC_3D_UP",7,"Down",0.123600925230534,0.999827083089274
"GUILLAUMOND_KLF10_TARGETS_DN",13,"Down",0.124245748275355,0.999827083089274
"PID_S1P_S1P2_PATHWAY",24,"Down",0.126941139913938,0.999827083089274
"PID_ERBB1_INTERNALIZATION_PATHWAY",26,"Down",0.126986302177303,0.999827083089274
"LE_SKI_TARGETS_DN",6,"Up",0.127171572243585,0.999827083089274
"HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN",5,"Up",0.127586398573621,0.999827083089274
"GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_DN",3,"Down",0.127853923537245,0.999827083089274
"REACTOME_HYALURONAN_METABOLISM",11,"Down",0.128526192242269,0.999827083089274
"KEGG_BASE_EXCISION_REPAIR",19,"Down",0.129099360453622,0.999827083089274
"WESTON_VEGFA_TARGETS_6HR",52,"Up",0.129557990164018,0.999827083089274
"BIOCARTA_TCRA_PATHWAY",10,"Down",0.129745467734554,0.999827083089274
"BIOCARTA_IL3_PATHWAY",15,"Down",0.13012959191601,0.999827083089274
"PID_THROMBIN_PAR4_PATHWAY",15,"Down",0.130317887958286,0.999827083089274
"RADAEVA_RESPONSE_TO_IFNA1_UP",44,"Up",0.130435922615547,0.999827083089274
"SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B",12,"Up",0.13071082902582,0.999827083089274
"HEIDENBLAD_AMPLICON_12P11_12_DN",9,"Up",0.130755373485359,0.999827083089274
"KAPOSI_LIVER_CANCER_MET_UP",12,"Down",0.130789027286262,0.999827083089274
"WEBER_METHYLATED_LCP_IN_SPERM_UP",4,"Up",0.130815531380138,0.999827083089274
"BIOCARTA_ERK5_PATHWAY",16,"Down",0.131837536327651,0.999827083089274
"MOOTHA_ROS",4,"Up",0.132250999273764,0.999827083089274
"SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN",7,"Down",0.132592472934599,0.999827083089274
"PRAMOONJAGO_SOX4_TARGETS_DN",25,"Down",0.13260036458638,0.999827083089274
"BALDWIN_PRKCI_TARGETS_UP",17,"Up",0.133087410570889,0.999827083089274
"BIOCARTA_IL2RB_PATHWAY",33,"Down",0.133129345022987,0.999827083089274
"REACTOME_E2F_ENABLED_INHIBITION_OF_PRE_REPLICATION_COMPLEX_FORMATION",6,"Down",0.133300053731008,0.999827083089274
"REACTOME_DOUBLE_STRAND_BREAK_REPAIR",15,"Down",0.13348784381882,0.999827083089274
"CLIMENT_BREAST_CANCER_COPY_NUMBER_DN",3,"Down",0.134770870128576,0.999827083089274
"SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN",12,"Up",0.134829014115341,0.999827083089274
"REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_",68,"Down",0.13501138876407,0.999827083089274
"BIOCARTA_CYTOKINE_PATHWAY",20,"Down",0.13517096632838,0.999827083089274
"SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_UP",3,"Down",0.136343115943035,0.999827083089274
"REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS",7,"Down",0.13684839064919,0.999827083089274
"MATHEW_FANCONI_ANEMIA_GENES",3,"Down",0.136940122814515,0.999827083089274
"HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN",7,"Up",0.137753432646205,0.999827083089274
"SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_UP",6,"Down",0.138537429650342,0.999827083089274
"ZHANG_INTERFERON_RESPONSE",11,"Down",0.13858038234583,0.999827083089274
"KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS",21,"Down",0.138786199872122,0.999827083089274
"REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE",23,"Down",0.139187286054346,0.999827083089274
"ROZANOV_MMP14_CORRELATED",8,"Up",0.139958919277572,0.999827083089274
"MARSON_FOXP3_TARGETS_UP",42,"Up",0.141204731313133,0.999827083089274
"REACTOME_SOS_MEDIATED_SIGNALLING",11,"Down",0.141956037930004,0.999827083089274
"CASTELLANO_HRAS_AND_NRAS_TARGETS_UP",5,"Up",0.142339036685398,0.999827083089274
"BENPORATH_NOS_TARGETS",80,"Down",0.14267223568672,0.999827083089274
"BIOCARTA_MAL_PATHWAY",18,"Down",0.142932070188343,0.999827083089274
"GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_DN",2,"Down",0.143039223832667,0.999827083089274
"REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION",39,"Up",0.143368136856061,0.999827083089274
"REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION",7,"Up",0.144101996238172,0.999827083089274
"PID_TCPTP_PATHWAY",37,"Down",0.144558114162776,0.999827083089274
"SPIRA_SMOKERS_LUNG_CANCER_UP",25,"Down",0.145201449148223,0.999827083089274
"WANG_RESPONSE_TO_ANDROGEN_UP",21,"Up",0.145366323088686,0.999827083089274
"MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP",27,"Up",0.14552683574282,0.999827083089274
"KIM_TIAL1_TARGETS",12,"Down",0.14596070057151,0.999827083089274
"IWANAGA_E2F1_TARGETS_NOT_INDUCED_BY_SERUM",3,"Up",0.146186191178241,0.999827083089274
"KEGG_ENDOMETRIAL_CANCER",44,"Down",0.146846163406801,0.999827083089274
"GALI_TP53_TARGETS_APOPTOTIC_DN",4,"Down",0.147275387427604,0.999827083089274
"STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP",34,"Down",0.147690450110898,0.999827083089274
"HENDRICKS_SMARCA4_TARGETS_DN",33,"Up",0.148786615186585,0.999827083089274
"LEE_AGING_CEREBELLUM_UP",65,"Up",0.149572941189896,0.999827083089274
"KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY",28,"Up",0.150000122881838,0.999827083089274
"MATZUK_FERTILIZATION",8,"Down",0.150299307921144,0.999827083089274
"BIOCARTA_TNFR2_PATHWAY",16,"Up",0.150778386364239,0.999827083089274
"PID_FGF_PATHWAY",51,"Down",0.151214818991938,0.999827083089274
"REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE",9,"Down",0.151483318114591,0.999827083089274
"REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION",10,"Up",0.151969245398611,0.999827083089274
"REACTOME_PYRIMIDINE_METABOLISM",7,"Down",0.152351244068085,0.999827083089274
"SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP",10,"Up",0.152553142438983,0.999827083089274
"GROSS_ELK3_TARGETS_DN",16,"Down",0.153354936978001,0.999827083089274
"MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_8",8,"Up",0.154392660078361,0.999827083089274
"GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN",6,"Down",0.154488897862135,0.999827083089274
"TSUNODA_CISPLATIN_RESISTANCE_UP",8,"Down",0.15480750571672,0.999827083089274
"REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S",17,"Down",0.155149227821434,0.999827083089274
"MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_UP",6,"Down",0.155670483169464,0.999827083089274
"PIONTEK_PKD1_TARGETS_DN",15,"Down",0.155936948974905,0.999827083089274
"HUMMEL_BURKITTS_LYMPHOMA_UP",19,"Down",0.156077893019593,0.999827083089274
"REACTOME_TRANSLOCATION_OF_ZAP_70_TO_IMMUNOLOGICAL_SYNAPSE",10,"Down",0.156846504106641,0.999827083089274
"CHUANG_OXIDATIVE_STRESS_RESPONSE_DN",7,"Down",0.157720900223951,0.999827083089274
"ZHAN_MULTIPLE_MYELOMA_LB_DN",16,"Down",0.15779623445641,0.999827083089274
"REACTOME_ACTIVATION_OF_NMDA_RECEPTOR_UPON_GLUTAMATE_BINDING_AND_POSTSYNAPTIC_EVENTS",27,"Down",0.158302208690264,0.999827083089274
"FARMER_BREAST_CANCER_CLUSTER_4",7,"Down",0.1583309713139,0.999827083089274
"TIAN_BHLHA15_TARGETS",6,"Down",0.158634908222487,0.999827083089274
"REACTOME_OXYGEN_DEPENDENT_PROLINE_HYDROXYLATION_OF_HYPOXIA_INDUCIBLE_FACTOR_ALPHA",3,"Down",0.158898806207492,0.999827083089274
"CHANGOLKAR_H2AFY_TARGETS_UP",10,"Up",0.159298986144701,0.999827083089274
"REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING",11,"Up",0.159587558627329,0.999827083089274
"LEE_AGING_NEOCORTEX_DN",63,"Up",0.15971387877905,0.999827083089274
"VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP",15,"Down",0.15989202002545,0.999827083089274
"LIU_LIVER_CANCER",19,"Down",0.160625588396015,0.999827083089274
"CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP",27,"Up",0.160888063013866,0.999827083089274
"KEGG_FOLATE_BIOSYNTHESIS",9,"Up",0.161027093248703,0.999827083089274
"REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN1_SIGNALING",9,"Up",0.161226150411031,0.999827083089274
"BIOCARTA_TCAPOPTOSIS_PATHWAY",10,"Down",0.161583234457145,0.999827083089274
"REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES",3,"Down",0.163121382623479,0.999827083089274
"REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES",22,"Down",0.163929030569073,0.999827083089274
"OHM_METHYLATED_IN_ADULT_CANCERS",22,"Up",0.163969624890041,0.999827083089274
"PID_AR_NONGENOMIC_PATHWAY",28,"Down",0.164267685770436,0.999827083089274
"MAINA_HYPOXIA_VHL_TARGETS_UP",5,"Up",0.164567723442039,0.999827083089274
"DER_IFN_GAMMA_RESPONSE_UP",57,"Down",0.164817391050899,0.999827083089274
"BIOCARTA_AHSP_PATHWAY",10,"Down",0.164941639278886,0.999827083089274
"HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN",10,"Up",0.16497630733422,0.999827083089274
"REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX",5,"Down",0.165318633011294,0.999827083089274
"KEGG_REGULATION_OF_ACTIN_CYTOSKELETON",133,"Down",0.166425088700155,0.999827083089274
"HESSON_TUMOR_SUPPRESSOR_CLUSTER_3P21_3",1,"Down",0.16698469952159,0.999827083089274
"BIOCARTA_PYK2_PATHWAY",27,"Down",0.167585909338251,0.999827083089274
"MATZUK_PREOVULATORY_FOLLICLE",8,"Down",0.167775006452879,0.999827083089274
"CHANDRAN_METASTASIS_TOP50_DN",17,"Down",0.168146651754682,0.999827083089274
"GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN",8,"Down",0.168212195929595,0.999827083089274
"REACTOME_G_ALPHA_I_SIGNALLING_EVENTS",124,"Up",0.16837662190746,0.999827083089274
"TERAMOTO_OPN_TARGETS_CLUSTER_1",4,"Up",0.168490912685774,0.999827083089274
"REACTOME_IL_2_SIGNALING",39,"Down",0.170075326497929,0.999827083089274
"KEGG_ARGININE_AND_PROLINE_METABOLISM",29,"Up",0.170211883013045,0.999827083089274
"ABDULRAHMAN_KIDNEY_CANCER_VHL_DN",3,"Down",0.171656742126036,0.999827083089274
"KANNAN_TP53_TARGETS_UP",38,"Down",0.171661780083773,0.999827083089274
"FRASOR_RESPONSE_TO_ESTRADIOL_UP",24,"Up",0.171930948267844,0.999827083089274
"REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING",9,"Up",0.172457207907023,0.999827083089274
"VARELA_ZMPSTE24_TARGETS_DN",23,"Down",0.172492260758034,0.999827083089274
"BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN",11,"Down",0.173126334898729,0.999827083089274
"BIOCARTA_INFLAM_PATHWAY",26,"Down",0.173564956550792,0.999827083089274
"WESTON_VEGFA_TARGETS",82,"Up",0.173924664954339,0.999827083089274
"PID_IL12_2PATHWAY",62,"Down",0.174769404323724,0.999827083089274
"PASTURAL_RIZ1_TARGETS_DN",4,"Up",0.17508214760634,0.999827083089274
"REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_ACETYLCHOLINE",10,"Down",0.175240250255393,0.999827083089274
"SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES",37,"Down",0.175290208682085,0.999827083089274
"CHANDRAN_METASTASIS_TOP50_UP",16,"Down",0.175303130233507,0.999827083089274
"OSADA_ASCL1_TARGETS_UP",42,"Up",0.175316626913373,0.999827083089274
"LI_WILMS_TUMOR",18,"Up",0.175449253896792,0.999827083089274
"BASSO_HAIRY_CELL_LEUKEMIA_UP",2,"Up",0.175642904416027,0.999827083089274
"SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP",6,"Up",0.177139877481476,0.999827083089274
"WANG_THOC1_TARGETS_UP",7,"Down",0.177369380979859,0.999827083089274
"BIOCARTA_CCR3_PATHWAY",20,"Down",0.177492994061322,0.999827083089274
"BIOCARTA_IL4_PATHWAY",10,"Down",0.178182891845829,0.999827083089274
"CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN",9,"Up",0.178355209341337,0.999827083089274
"SIG_CHEMOTAXIS",27,"Up",0.178483537389765,0.999827083089274
"LIU_CDX2_TARGETS_DN",7,"Down",0.178603846671019,0.999827083089274
"NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP",52,"Down",0.178634942237844,0.999827083089274
"XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR",13,"Up",0.179056459876983,0.999827083089274
"REACTOME_MTORC1_MEDIATED_SIGNALLING",5,"Down",0.179397885178867,0.999827083089274
"BIOCARTA_GH_PATHWAY",25,"Down",0.179669114384415,0.999827083089274
"REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING",17,"Down",0.180490360424084,0.999827083089274
"REN_BOUND_BY_E2F",46,"Down",0.18201628176395,0.999827083089274
"CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN",11,"Down",0.182528475368093,0.999827083089274
"BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP",16,"Up",0.18255518136878,0.999827083089274
"SA_G2_AND_M_PHASES",8,"Down",0.182877689711633,0.999827083089274
"ZHAN_MULTIPLE_MYELOMA_SPIKED",18,"Down",0.183432910740185,0.999827083089274
"SIMBULAN_UV_RESPONSE_NORMAL_UP",8,"Up",0.183703268540777,0.999827083089274
"ABDULRAHMAN_KIDNEY_CANCER_VHL_UP",1,"Down",0.183761289355568,0.999827083089274
"DORN_ADENOVIRUS_INFECTION_48HR_DN",31,"Up",0.183794474206592,0.999827083089274
"YANG_BREAST_CANCER_ESR1_BULK_UP",9,"Up",0.183906992531511,0.999827083089274
"LIU_TARGETS_OF_VMYB_VS_CMYB_UP",4,"Down",0.18438832302491,0.999827083089274
"PID_FRA_PATHWAY",35,"Up",0.184633980672302,0.999827083089274
"RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_DN",5,"Up",0.184769025719452,0.999827083089274
"BIOCARTA_MET_PATHWAY",29,"Down",0.184933062211858,0.999827083089274
"REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1",7,"Up",0.185604471529237,0.999827083089274
"DASU_IL6_SIGNALING_SCAR_DN",11,"Down",0.186318940053295,0.999827083089274
"TANG_SENESCENCE_TP53_TARGETS_UP",19,"Down",0.187480374297042,0.999827083089274
"SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP",11,"Down",0.187527895389267,0.999827083089274
"KEGG_ALLOGRAFT_REJECTION",36,"Down",0.187690814367392,0.999827083089274
"WANG_RESPONSE_TO_FORSKOLIN_UP",21,"Up",0.187710640947542,0.999827083089274
"BIOCARTA_NFAT_PATHWAY",42,"Down",0.187913428055332,0.999827083089274
"REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT",81,"Down",0.18851987316443,0.999827083089274
"KEGG_ABC_TRANSPORTERS",26,"Down",0.188905566811089,0.999827083089274
"REACTOME_PECAM1_INTERACTIONS",10,"Down",0.18930031582913,0.999827083089274
"MIKKELSEN_MEF_LCP_WITH_H3K27ME3",22,"Down",0.189632295985824,0.999827083089274
"WILCOX_RESPONSE_TO_PROGESTERONE_DN",36,"Up",0.189927735110481,0.999827083089274
"BIOCARTA_DNAFRAGMENT_PATHWAY",9,"Down",0.191593103818297,0.999827083089274
"BIOCARTA_INTEGRIN_PATHWAY",30,"Down",0.191682321222453,0.999827083089274
"FIGUEROA_AML_METHYLATION_CLUSTER_2_UP",13,"Up",0.191764070823399,0.999827083089274
"REACTOME_PYRUVATE_METABOLISM",9,"Down",0.191764671585832,0.999827083089274
"DIERICK_SEROTONIN_FUNCTION_GENES",6,"Down",0.192901936622406,0.999827083089274
"GHO_ATF5_TARGETS_DN",9,"Down",0.193518101385841,0.999827083089274
"DAUER_STAT3_TARGETS_UP",31,"Up",0.193542279116426,0.999827083089274
"REACTOME_SHC_RELATED_EVENTS",14,"Down",0.193747932007148,0.999827083089274
"KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN",43,"Down",0.193845783878467,0.999827083089274
"REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK",4,"Up",0.193859993038325,0.999827083089274
"MEDINA_SMARCA4_TARGETS",18,"Up",0.194045810286756,0.999827083089274
"WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1",14,"Down",0.194748448508495,0.999827083089274
"HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP",42,"Up",0.194780991933094,0.999827083089274
"MURAKAMI_UV_RESPONSE_1HR_DN",9,"Down",0.194943771544871,0.999827083089274
"REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI",6,"Up",0.195365804850201,0.999827083089274
"KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_OLD",8,"Down",0.19562651427136,0.999827083089274
"DORN_ADENOVIRUS_INFECTION_32HR_DN",29,"Up",0.195919525092731,0.999827083089274
"TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN",7,"Down",0.196210339887082,0.999827083089274
"KEGG_SMALL_CELL_LUNG_CANCER",72,"Up",0.196339443815293,0.999827083089274
"MILI_PSEUDOPODIA_CHEMOTAXIS_UP",20,"Down",0.197161902589063,0.999827083089274
"BIOCARTA_TH1TH2_PATHWAY",17,"Down",0.197176137699162,0.999827083089274
"SCHUHMACHER_MYC_TARGETS_DN",4,"Down",0.197485172564018,0.999827083089274
"MOOTHA_GLYCOGEN_METABOLISM",8,"Down",0.198247145150251,0.999827083089274
"ZHAN_EARLY_DIFFERENTIATION_GENES_UP",4,"Down",0.198935213072677,0.999827083089274
"PID_FANCONI_PATHWAY",19,"Down",0.198938437068516,0.999827083089274
"REACTOME_PD1_SIGNALING",12,"Down",0.199015209107414,0.999827083089274
"DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN",36,"Down",0.199126077072807,0.999827083089274
"REACTOME_TRANSPORT_OF_RIBONUCLEOPROTEINS_INTO_THE_HOST_NUCLEUS",5,"Down",0.199228729431925,0.999827083089274
"ZEMBUTSU_SENSITIVITY_TO_FLUOROURACIL",3,"Up",0.199506668477939,0.999827083089274
"CAFFAREL_RESPONSE_TO_THC_24HR_3_DN",6,"Up",0.199888011850743,0.999827083089274
"ST_G_ALPHA_S_PATHWAY",9,"Down",0.200165259357736,0.999827083089274
"REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA",3,"Up",0.200366162038212,0.999827083089274
"BIOCARTA_CTCF_PATHWAY",20,"Up",0.20065411297365,0.999827083089274
"KEGG_PROPANOATE_METABOLISM",9,"Down",0.200806227259755,0.999827083089274
"REACTOME_NCAM1_INTERACTIONS",37,"Down",0.200946009652151,0.999827083089274
"FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN",46,"Up",0.202671507174854,0.999827083089274
"KYNG_DNA_DAMAGE_BY_4NQO",19,"Down",0.202944819977043,0.999827083089274
"THILLAINADESAN_ZNF217_TARGETS_DN",3,"Up",0.204498404885148,0.999827083089274
"SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER",19,"Up",0.204673965299403,0.999827083089274
"OZEN_MIR125B1_TARGETS",9,"Up",0.204837693832887,0.999827083089274
"BIOCARTA_HSP27_PATHWAY",13,"Down",0.20495313789299,0.999827083089274
"LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_DN",4,"Down",0.204967097399163,0.999827083089274
"BIOCARTA_EGF_PATHWAY",29,"Down",0.205259636469661,0.999827083089274
"REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR",6,"Up",0.205565960336118,0.999827083089274
"HE_PTEN_TARGETS_DN",6,"Up",0.205925655745614,0.999827083089274
"YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN",16,"Down",0.206309968232839,0.999827083089274
"REACTOME_IL_3_5_AND_GM_CSF_SIGNALING",42,"Down",0.206761122183357,0.999827083089274
"ITO_PTTG1_TARGETS_DN",5,"Down",0.207013065698891,0.999827083089274
"SHIN_B_CELL_LYMPHOMA_CLUSTER_6",11,"Up",0.207159025485203,0.999827083089274
"MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_9",4,"Down",0.207274819562614,0.999827083089274
"SA_CASPASE_CASCADE",17,"Down",0.207349337109769,0.999827083089274
"FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP",40,"Up",0.207533500863703,0.999827083089274
"NIKOLSKY_BREAST_CANCER_17P11_AMPLICON",6,"Down",0.207537447217221,0.999827083089274
"PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN",53,"Up",0.20757074855927,0.999827083089274
"PID_IL1_PATHWAY",25,"Up",0.207935915520439,0.999827083089274
"BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX",12,"Down",0.20804056099041,0.999827083089274
"REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS",121,"Up",0.20819119151532,0.999827083089274
"PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_DN",4,"Up",0.208399655353125,0.999827083089274
"CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN",30,"Up",0.208788054251154,0.999827083089274
"MIKKELSEN_IPS_LCP_WITH_H3K27ME3",5,"Down",0.208796775130967,0.999827083089274
"MENSSEN_MYC_TARGETS",36,"Up",0.208824858177693,0.999827083089274
"PID_ALK1_PATHWAY",24,"Down",0.209034896215793,0.999827083089274
"ZEMBUTSU_SENSITIVITY_TO_NIMUSTINE",11,"Up",0.209278713056701,0.999827083089274
"FOURNIER_ACINAR_DEVELOPMENT_EARLY_DN",5,"Down",0.209482142739832,0.999827083089274
"KAUFFMANN_MELANOMA_RELAPSE_UP",32,"Down",0.209513210075086,0.999827083089274
"REACTOME_REGULATION_OF_RHEB_GTPASE_ACTIVITY_BY_AMPK",4,"Down",0.209585551195488,0.999827083089274
"CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN",59,"Up",0.209739194238463,0.999827083089274
"GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN",42,"Down",0.210101905150048,0.999827083089274
"BIOCARTA_ARF_PATHWAY",16,"Up",0.210272039563635,0.999827083089274
"JIANG_TIP30_TARGETS_DN",18,"Up",0.210333505005684,0.999827083089274
"FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN",9,"Down",0.210546582038859,0.999827083089274
"ASTON_MAJOR_DEPRESSIVE_DISORDER_UP",21,"Up",0.210687312344319,0.999827083089274
"STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN",17,"Down",0.210690322002019,0.999827083089274
"KIM_MYCL1_AMPLIFICATION_TARGETS_UP",7,"Up",0.211115862536415,0.999827083089274
"ST_WNT_CA2_CYCLIC_GMP_PATHWAY",13,"Up",0.211288391248241,0.999827083089274
"REACTOME_IL_RECEPTOR_SHC_SIGNALING",27,"Down",0.211811116370062,0.999827083089274
"STEINER_ERYTHROCYTE_MEMBRANE_GENES",12,"Down",0.212255390465193,0.999827083089274
"HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN",42,"Up",0.212335425510148,0.999827083089274
"WIERENGA_PML_INTERACTOME",25,"Up",0.21256882601721,0.999827083089274
"REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL",5,"Up",0.212649267197504,0.999827083089274
"DE_YY1_TARGETS_UP",9,"Up",0.212954489000496,0.999827083089274
"REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS",4,"Up",0.213091093950697,0.999827083089274
"GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP",6,"Up",0.213122184906672,0.999827083089274
"BIOCARTA_MCALPAIN_PATHWAY",21,"Down",0.21335014165214,0.999827083089274
"CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP",21,"Up",0.213397302271971,0.999827083089274
"MA_PITUITARY_FETAL_VS_ADULT_UP",16,"Down",0.213713696544403,0.999827083089274
"MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA",7,"Up",0.214023402093504,0.999827083089274
"REACTOME_RAP1_SIGNALLING",7,"Up",0.214521341598906,0.999827083089274
"REACTOME_GLYCOSPHINGOLIPID_METABOLISM",18,"Down",0.214573250253947,0.999827083089274
"BROWNE_HCMV_INFECTION_8HR_DN",24,"Down",0.214742545849618,0.999827083089274
"PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN",35,"Down",0.215016837986483,0.999827083089274
"REACTOME_G0_AND_EARLY_G1",17,"Up",0.215476341928802,0.999827083089274
"KOHOUTEK_CCNT1_TARGETS",23,"Up",0.215649202848309,0.999827083089274
"FERRANDO_HOX11_NEIGHBORS",17,"Down",0.21674967660934,0.999827083089274
"DOANE_BREAST_CANCER_CLASSES_UP",32,"Down",0.216935602228329,0.999827083089274
"REACTOME_RIG_I_MDA5_MEDIATED_INDUCTION_OF_IFN_ALPHA_BETA_PATHWAYS",38,"Up",0.217194756114873,0.999827083089274
"PID_HEDGEHOG_GLI_PATHWAY",30,"Up",0.217575500854622,0.999827083089274
"PID_CDC42_REG_PATHWAY",11,"Up",0.218809013011021,0.999827083089274
"BIOCARTA_EDG1_PATHWAY",24,"Down",0.218809260531708,0.999827083089274
"TAKAYAMA_BOUND_BY_AR",4,"Down",0.218815743716543,0.999827083089274
"YAMASHITA_LIVER_CANCER_STEM_CELL_DN",54,"Up",0.219004601655623,0.999827083089274
"HUANG_FOXA2_TARGETS_DN",24,"Up",0.219223955516383,0.999827083089274
"LI_CISPLATIN_RESISTANCE_DN",18,"Up",0.219440842925343,0.999827083089274
"VERRECCHIA_RESPONSE_TO_TGFB1_C6",4,"Up",0.220036660280922,0.999827083089274
"DUAN_PRDM5_TARGETS",41,"Up",0.22150484469269,0.999827083089274
"BIOCARTA_CACAM_PATHWAY",8,"Down",0.221578247214597,0.999827083089274
"GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN",22,"Up",0.221955779621113,0.999827083089274
"BIOCARTA_PDGF_PATHWAY",29,"Down",0.22255821058779,0.999827083089274
"XU_GH1_AUTOCRINE_TARGETS_DN",57,"Up",0.222793724583707,0.999827083089274
"YANG_BREAST_CANCER_ESR1_UP",16,"Down",0.222936812690823,0.999827083089274
"KRISHNAN_FURIN_TARGETS_UP",9,"Up",0.22298177742947,0.999827083089274
"XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR",9,"Up",0.223019744161279,0.999827083089274
"DURCHDEWALD_SKIN_CARCINOGENESIS_DN",119,"Down",0.223076994356417,0.999827083089274
"BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE",20,"Up",0.223367043540006,0.999827083089274
"BIOCARTA_CHEMICAL_PATHWAY",22,"Down",0.223519950130729,0.999827083089274
"TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP",36,"Down",0.223557658317564,0.999827083089274
"RAMALHO_STEMNESS_UP",85,"Down",0.223767407289814,0.999827083089274
"MIKKELSEN_MCV6_LCP_WITH_H3K27ME3",11,"Down",0.223800482823039,0.999827083089274
"ZHENG_FOXP3_TARGETS_IN_THYMUS_DN",6,"Up",0.22402142781187,0.999827083089274
"PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP",18,"Up",0.224465472579207,0.999827083089274
"PID_IL27_PATHWAY",21,"Down",0.224960655871046,0.999827083089274
"CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN",8,"Up",0.225064417320373,0.999827083089274
"MELLMAN_TUT1_TARGETS_UP",6,"Up",0.225282184478257,0.999827083089274
"JI_METASTASIS_REPRESSED_BY_STK11",15,"Down",0.225614898555548,0.999827083089274
"REACTOME_ERK_MAPK_TARGETS",13,"Down",0.225702053013128,0.999827083089274
"HOFFMAN_CLOCK_TARGETS_DN",8,"Up",0.225850538837567,0.999827083089274
"REACTOME_SIGNAL_ATTENUATION",11,"Down",0.22606700382373,0.999827083089274
"GOUYER_TATI_TARGETS_DN",10,"Up",0.226794177320862,0.999827083089274
"BIOCARTA_FMLP_PATHWAY",31,"Down",0.226928322368471,0.999827083089274
"PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_UP",2,"Down",0.227127645119274,0.999827083089274
"ABBUD_LIF_SIGNALING_1_DN",18,"Down",0.227239146408271,0.999827083089274
"ONO_AML1_TARGETS_UP",18,"Down",0.227994841278642,0.999827083089274
"KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN",10,"Down",0.228380288140052,0.999827083089274
"PASTURAL_RIZ1_TARGETS_UP",4,"Down",0.228501789829212,0.999827083089274
"REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING",9,"Down",0.229262874826306,0.999827083089274
"NIKOLSKY_BREAST_CANCER_7P15_AMPLICON",11,"Up",0.229297671442704,0.999827083089274
"BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN",5,"Down",0.229471533191199,0.999827083089274
"WESTON_VEGFA_TARGETS_3HR",53,"Up",0.230066698757631,0.999827083089274
"CHESLER_BRAIN_QTL_CIS",39,"Down",0.230409983010779,0.999827083089274
"REACTOME_IL1_SIGNALING",22,"Up",0.230550457643279,0.999827083089274
"REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN",12,"Down",0.230561809532893,0.999827083089274
"REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING",15,"Down",0.231051471880513,0.999827083089274
"SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2",28,"Up",0.231550087765289,0.999827083089274
"WANG_RECURRENT_LIVER_CANCER_DN",8,"Up",0.231618603153275,0.999827083089274
"BIOCARTA_ATRBRCA_PATHWAY",15,"Down",0.231770602872081,0.999827083089274
"ODONNELL_METASTASIS_DN",12,"Up",0.231980835717577,0.999827083089274
"SASAI_TARGETS_OF_CXCR6_AND_PTCH1_UP",7,"Down",0.232123404167745,0.999827083089274
"REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS",25,"Up",0.232629649396483,0.999827083089274
"REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION",15,"Up",0.232815663943975,0.999827083089274
"HAHTOLA_MYCOSIS_FUNGOIDES_UP",9,"Down",0.233057843344343,0.999827083089274
"PID_S1P_S1P4_PATHWAY",13,"Down",0.233400066489504,0.999827083089274
"LINDVALL_IMMORTALIZED_BY_TERT_UP",37,"Down",0.234445434415763,0.999827083089274
"ST_GA12_PATHWAY",22,"Down",0.235018985425475,0.999827083089274
"REACTOME_GLUCOSE_TRANSPORT",12,"Down",0.235045430859727,0.999827083089274
"HOUSTIS_ROS",28,"Up",0.235163062742539,0.999827083089274
"PID_MAPK_TRK_PATHWAY",26,"Down",0.235279337215815,0.999827083089274
"YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7",38,"Down",0.235390036157357,0.999827083089274
"NEBEN_AML_WITH_FLT3_OR_NRAS_DN",9,"Down",0.235612469506604,0.999827083089274
"REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT",20,"Down",0.236209101547413,0.999827083089274
"REACTOME_P2Y_RECEPTORS",2,"Up",0.236396352713475,0.999827083089274
"BOWIE_RESPONSE_TO_TAMOXIFEN",11,"Down",0.236569675714906,0.999827083089274
"TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN",8,"Down",0.237139151797755,0.999827083089274
"LIU_CMYB_TARGETS_DN",3,"Up",0.237712029785016,0.999827083089274
"ST_FAS_SIGNALING_PATHWAY",50,"Down",0.237881433786017,0.999827083089274
"FINETTI_BREAST_CANCER_KINOME_RED",14,"Down",0.237885778758738,0.999827083089274
"REACTOME_MICRORNA_MIRNA_BIOGENESIS",7,"Up",0.237908886584427,0.999827083089274
"REACTOME_REGULATORY_RNA_PATHWAYS",7,"Up",0.237908886584427,0.999827083089274
"BIOCARTA_CLASSIC_PATHWAY",9,"Up",0.23807879456694,0.999827083089274
"BIOCARTA_CDC42RAC_PATHWAY",8,"Down",0.238143012398161,0.999827083089274
"BIOCARTA_IL2_PATHWAY",21,"Down",0.239270393536037,0.999827083089274
"MEISSNER_ES_ICP_WITH_H3K4ME3",8,"Down",0.239372367937599,0.999827083089274
"BONCI_TARGETS_OF_MIR15A_AND_MIR16_1",56,"Down",0.239785633699444,0.999827083089274
"ZHAN_MULTIPLE_MYELOMA_MS_DN",6,"Up",0.240308739943693,0.999827083089274
"TSUTSUMI_FBXW8_TARGETS",4,"Up",0.240490709979887,0.999827083089274
"IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP",14,"Down",0.240947208392681,0.999827083089274
"SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP",14,"Down",0.241182147412394,0.999827083089274
"WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION",3,"Up",0.24120035437441,0.999827083089274
"DER_IFN_BETA_RESPONSE_UP",70,"Down",0.241200604393717,0.999827083089274
"PID_TCR_JNK_PATHWAY",14,"Up",0.241361718883023,0.999827083089274
"PODAR_RESPONSE_TO_ADAPHOSTIN_DN",13,"Up",0.241478801099383,0.999827083089274
"LIU_PROSTATE_CANCER_UP",39,"Down",0.2417603935945,0.999827083089274
"DAZARD_UV_RESPONSE_CLUSTER_G4",16,"Up",0.241908961225106,0.999827083089274
"WEBER_METHYLATED_ICP_IN_SPERM_UP",3,"Down",0.24259937599863,0.999827083089274
"KEGG_OTHER_GLYCAN_DEGRADATION",9,"Down",0.243076970210375,0.999827083089274
"KEGG_CITRATE_CYCLE_TCA_CYCLE",16,"Down",0.243121537626217,0.999827083089274
"LE_SKI_TARGETS_UP",12,"Up",0.243196472603009,0.999827083089274
"HOWLIN_CITED1_TARGETS_1_DN",19,"Down",0.243248671514673,0.999827083089274
"WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN",35,"Up",0.243646678959901,0.999827083089274
"KEGG_SPHINGOLIPID_METABOLISM",17,"Down",0.243764990185496,0.999827083089274
"BIOCARTA_ACTINY_PATHWAY",6,"Down",0.244039185353904,0.999827083089274
"BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER",20,"Down",0.244095831240113,0.999827083089274
"REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND",10,"Down",0.244374743469327,0.999827083089274
"REACTOME_DESTABILIZATION_OF_MRNA_BY_KSRP",6,"Down",0.245353871227806,0.999827083089274
"CHEN_LIVER_METABOLISM_QTL_CIS",35,"Down",0.245860281277642,0.999827083089274
"LU_EZH2_TARGETS_UP",81,"Up",0.24592538917299,0.999827083089274
"GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP",14,"Up",0.246073410605006,0.999827083089274
"KEGG_STEROID_HORMONE_BIOSYNTHESIS",29,"Up",0.246284811661897,0.999827083089274
"CHUNG_BLISTER_CYTOTOXICITY_DN",16,"Down",0.246332307116617,0.999827083089274
"BURTON_ADIPOGENESIS_8",57,"Down",0.246559038779103,0.999827083089274
"KORKOLA_EMBRYONAL_CARCINOMA",3,"Down",0.246769509997923,0.999827083089274
"NIELSEN_LEIOMYOSARCOMA_CNN1_UP",11,"Up",0.247552971347079,0.999827083089274
"BIOCARTA_CTL_PATHWAY",21,"Down",0.247640093597377,0.999827083089274
"PID_UPA_UPAR_PATHWAY",34,"Down",0.24854979504069,0.999827083089274
"WENG_POR_TARGETS_LIVER_DN",11,"Down",0.248568911940883,0.999827083089274
"SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER",31,"Up",0.248608370741066,0.999827083089274
"DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN",10,"Down",0.248686442293664,0.999827083089274
"HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN",39,"Up",0.249675649596133,0.999827083089274
"CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN",8,"Down",0.250146801738076,0.999827083089274
"SHIN_B_CELL_LYMPHOMA_CLUSTER_7",23,"Up",0.250169559523354,0.999827083089274
"KEGG_DRUG_METABOLISM_OTHER_ENZYMES",19,"Down",0.25052040191929,0.999827083089274
"CAFFAREL_RESPONSE_TO_THC_UP",11,"Up",0.250844248283152,0.999827083089274
"FIGUEROA_AML_METHYLATION_CLUSTER_5_UP",3,"Up",0.251354413175614,0.999827083089274
"MATZUK_MATERNAL_EFFECT",5,"Up",0.251576092375931,0.999827083089274
"RAHMAN_TP53_TARGETS_PHOSPHORYLATED",14,"Up",0.251706701382329,0.999827083089274
"FRASOR_TAMOXIFEN_RESPONSE_DN",3,"Down",0.252004542883657,0.999827083089274
"REACTOME_INFLAMMASOMES",8,"Up",0.252249201079276,0.999827083089274
"LUI_THYROID_CANCER_PAX8_PPARG_UP",25,"Down",0.253257450611393,0.999827083089274
"REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND",5,"Down",0.2534066267928,0.999827083089274
"SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP",12,"Down",0.253666952222626,0.999827083089274
"HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN",7,"Up",0.253744611849691,0.999827083089274
"FURUKAWA_DUSP6_TARGETS_PCI35_DN",29,"Up",0.254776594251909,0.999827083089274
"PID_PI3K_PLC_TRK_PATHWAY",30,"Down",0.255609440912497,0.999827083089274
"KAAB_FAILED_HEART_ATRIUM_UP",23,"Up",0.255668741566178,0.999827083089274
"HUNSBERGER_EXERCISE_REGULATED_GENES",21,"Down",0.256802536255038,0.999827083089274
"ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP",9,"Up",0.256949721600644,0.999827083089274
"REACTOME_RAF_MAP_KINASE_CASCADE",8,"Down",0.257442464285945,0.999827083089274
"MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_25",4,"Up",0.257543775856671,0.999827083089274
"TURJANSKI_MAPK11_TARGETS",5,"Down",0.257571997364367,0.999827083089274
"REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE",8,"Down",0.257812440408613,0.999827083089274
"POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN",24,"Up",0.258130423155676,0.999827083089274
"WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP",74,"Up",0.258294885485084,0.999827083089274
"KEGG_STEROID_BIOSYNTHESIS",12,"Up",0.258549051232054,0.999827083089274
"HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2",87,"Down",0.259683402381362,0.999827083089274
"KEGG_GRAFT_VERSUS_HOST_DISEASE",34,"Down",0.259954986503639,0.999827083089274
"WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP",15,"Up",0.260091512590712,0.999827083089274
"ZHU_CMV_8_HR_UP",35,"Down",0.260225843947199,0.999827083089274
"KYNG_DNA_DAMAGE_BY_4NQO_OR_UV",40,"Down",0.260345730767578,0.999827083089274
"REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING",13,"Up",0.260472845591842,0.999827083089274
"KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM",16,"Down",0.260637602343383,0.999827083089274
"REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING",5,"Up",0.26071128576004,0.999827083089274
"DORN_ADENOVIRUS_INFECTION_12HR_UP",19,"Up",0.261002276216505,0.999827083089274
"RAFFEL_VEGFA_TARGETS_DN",5,"Down",0.26117521785496,0.999827083089274
"LIU_NASOPHARYNGEAL_CARCINOMA",37,"Down",0.261307372802356,0.999827083089274
"PID_P38_MKK3_6PATHWAY",18,"Up",0.261545708284507,0.999827083089274
"KEGG_LINOLEIC_ACID_METABOLISM",20,"Up",0.262007209049095,0.999827083089274
"STEGMEIER_PRE-MITOTIC_CELL_CYCLE_REGULATORS",2,"Down",0.262296555181296,0.999827083089274
"REACTOME_RECYCLING_PATHWAY_OF_L1",18,"Up",0.262329480208495,0.999827083089274
"HO_LIVER_CANCER_VASCULAR_INVASION",6,"Up",0.262784163006717,0.999827083089274
"SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP",20,"Down",0.263602713112837,0.999827083089274
"NIKOLSKY_BREAST_CANCER_19P13_AMPLICON",2,"Down",0.264085166814295,0.999827083089274
"VALK_AML_CLUSTER_7",18,"Down",0.264257229344376,0.999827083089274
"REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS",13,"Up",0.264507589036826,0.999827083089274
"WAGNER_APO2_SENSITIVITY",6,"Up",0.26471617091675,0.999827083089274
"REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE",10,"Down",0.26480593336567,0.999827083089274
"PID_RET_PATHWAY",30,"Down",0.265288459490084,0.999827083089274
"MIKKELSEN_DEDIFFERENTIATED_STATE_UP",6,"Down",0.265598003597088,0.999827083089274
"REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS",187,"Up",0.265676225635351,0.999827083089274
"NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON",9,"Up",0.265782125760597,0.999827083089274
"FOURNIER_ACINAR_DEVELOPMENT_LATE_DN",11,"Down",0.265845504291307,0.999827083089274
"REACTOME_PURINE_SALVAGE",8,"Up",0.266198883525879,0.999827083089274
"HOFFMAN_CLOCK_TARGETS_UP",6,"Up",0.266458609998798,0.999827083089274
"KOMMAGANI_TP63_GAMMA_TARGETS",7,"Down",0.266732062503715,0.999827083089274
"LANDIS_BREAST_CANCER_PROGRESSION_UP",27,"Down",0.266782679266944,0.999827083089274
"PID_FAK_PATHWAY",42,"Down",0.266806305241656,0.999827083089274
"SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP",8,"Up",0.266888284368669,0.999827083089274
"REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS",19,"Down",0.267235294418077,0.999827083089274
"GLINSKY_CANCER_DEATH_UP",5,"Down",0.267920811473502,0.999827083089274
"VALK_AML_CLUSTER_16",9,"Down",0.268476979746036,0.999827083089274
"ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS",38,"Down",0.269103849128599,0.999827083089274
"FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP",6,"Up",0.26916378456067,0.999827083089274
"BOYERINAS_ONCOFETAL_TARGETS_OF_LET7A1",3,"Down",0.269981053098141,0.999827083089274
"CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB",9,"Up",0.269983032929978,0.999827083089274
"ITO_PTTG1_TARGETS_UP",6,"Down",0.27128703002303,0.999827083089274
"XU_RESPONSE_TO_TRETINOIN_UP",11,"Down",0.27196881727474,0.999827083089274
"BIOCARTA_NKT_PATHWAY",28,"Down",0.271992891279583,0.999827083089274
"VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN",43,"Down",0.272343836703287,0.999827083089274
"REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION",7,"Down",0.272576793850517,0.999827083089274
"BIOCARTA_NTHI_PATHWAY",22,"Up",0.272997397600223,0.999827083089274
"CASTELLANO_HRAS_TARGETS_DN",3,"Down",0.273048973722043,0.999827083089274
"LU_TUMOR_ENDOTHELIAL_MARKERS_DN",3,"Down",0.273391526810245,0.999827083089274
"AKL_HTLV1_INFECTION_UP",20,"Up",0.274566732586037,0.999827083089274
"YU_MYC_TARGETS_UP",19,"Down",0.274735707862297,0.999827083089274
"PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY",31,"Down",0.275514042096358,0.999827083089274
"KEGG_PROTEASOME",32,"Down",0.275567290132593,0.999827083089274
"GOERING_BLOOD_HDL_CHOLESTEROL_QTL_TRANS",19,"Up",0.27572105042518,0.999827083089274
"WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_DN",11,"Up",0.275825584614408,0.999827083089274
"NAKAJIMA_MAST_CELL",36,"Up",0.276809307958731,0.999827083089274
"REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV1_INFECTION",2,"Up",0.276812389347876,0.999827083089274
"PID_ENDOTHELIN_PATHWAY",53,"Down",0.276876120864395,0.999827083089274
"LANDIS_ERBB2_BREAST_TUMORS_324_UP",91,"Down",0.277121475797731,0.999827083089274
"REACTOME_SIGNALLING_TO_RAS",20,"Down",0.277217034691603,0.999827083089274
"RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_DN",9,"Down",0.277319873073167,0.999827083089274
"REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR",15,"Down",0.277497851078237,0.999827083089274
"REACTOME_EGFR_DOWNREGULATION",17,"Down",0.277722456091498,0.999827083089274
"BIOCARTA_41BB_PATHWAY",16,"Up",0.278000859291933,0.999827083089274
"ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP",28,"Down",0.278145714774745,0.999827083089274
"PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION",23,"Up",0.27842733276643,0.999827083089274
"NGO_MALIGNANT_GLIOMA_1P_LOH",12,"Up",0.278514123260605,0.999827083089274
"PID_IL3_PATHWAY",25,"Down",0.278706790691452,0.999827083089274
"VANLOO_SP3_TARGETS_UP",4,"Down",0.278851000918292,0.999827083089274
"REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION",16,"Down",0.278980338310969,0.999827083089274
"BIOCARTA_PGC1A_PATHWAY",19,"Down",0.27946915913384,0.999827083089274
"GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN",16,"Up",0.279675263231312,0.999827083089274
"ST_GRANULE_CELL_SURVIVAL_PATHWAY",21,"Down",0.279916326062399,0.999827083089274
"CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP",35,"Up",0.280039372462495,0.999827083089274
"YEMELYANOV_GR_TARGETS_DN",9,"Up",0.280395526515042,0.999827083089274
"RADAEVA_RESPONSE_TO_IFNA1_DN",8,"Down",0.280795648172376,0.999827083089274
"LEE_METASTASIS_AND_RNA_PROCESSING_UP",7,"Up",0.281078769538978,0.999827083089274
"LANG_MYB_FAMILY_TARGETS",18,"Down",0.281129659635827,0.999827083089274
"LIANG_SILENCED_BY_METHYLATION_DN",7,"Down",0.281356818594217,0.999827083089274
"MOSERLE_IFNA_RESPONSE",12,"Down",0.281723049702827,0.999827083089274
"AMIT_DELAYED_EARLY_GENES",16,"Up",0.282121768561082,0.999827083089274
"ALONSO_METASTASIS_EMT_DN",3,"Down",0.282442453071338,0.999827083089274
"REACTOME_SPHINGOLIPID_METABOLISM",24,"Down",0.282465155190619,0.999827083089274
"BURTON_ADIPOGENESIS_PEAK_AT_24HR",25,"Down",0.282477095029229,0.999827083089274
"KEGG_CIRCADIAN_RHYTHM_MAMMAL",10,"Up",0.283113963725203,0.999827083089274
"URS_ADIPOCYTE_DIFFERENTIATION_DN",22,"Down",0.283168346942481,0.999827083089274
"ST_GAQ_PATHWAY",20,"Up",0.284105155969312,0.999827083089274
"GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN",9,"Up",0.284300927268953,0.999827083089274
"PID_NEPHRIN_NEPH1_PATHWAY",24,"Down",0.284645609153307,0.999827083089274
"REACTOME_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRONLESS_TRANSCRIPT",5,"Down",0.285338972785618,0.999827083089274
"HOWLIN_CITED1_TARGETS_2_UP",9,"Up",0.285389918541952,0.999827083089274
"MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_8",5,"Down",0.285418360164563,0.999827083089274
"PID_P73PATHWAY",60,"Down",0.285766762123007,0.999827083089274
"REACTOME_PI_3K_CASCADE",36,"Down",0.285885824083566,0.999827083089274
"WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_DN",5,"Up",0.285927371334509,0.999827083089274
"LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT",39,"Down",0.286154831959587,0.999827083089274
"REACTOME_CA_DEPENDENT_EVENTS",22,"Down",0.28617908594038,0.999827083089274
"REACTOME_RNA_POL_I_RNA_POL_III_AND_MITOCHONDRIAL_TRANSCRIPTION",34,"Down",0.286329622682557,0.999827083089274
"LE_NEURONAL_DIFFERENTIATION_DN",9,"Up",0.286357009991872,0.999827083089274
"CROONQUIST_IL6_DEPRIVATION_UP",10,"Down",0.286455031525994,0.999827083089274
"RODRIGUES_NTN1_TARGETS_UP",7,"Down",0.28670199253431,0.999827083089274
"REACTOME_METABOLISM_OF_PORPHYRINS",11,"Down",0.286811116264244,0.999827083089274
"APRELIKOVA_BRCA1_TARGETS",43,"Down",0.287648572780597,0.999827083089274
"GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN",24,"Down",0.287673952644781,0.999827083089274
"ROLEF_GLIS3_TARGETS",28,"Down",0.287700904772104,0.999827083089274
"HUMMERICH_BENIGN_SKIN_TUMOR_UP",13,"Up",0.287999052534901,0.999827083089274
"REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA",20,"Up",0.288297158633125,0.999827083089274
"ZEMBUTSU_SENSITIVITY_TO_VINCRISTINE",9,"Up",0.288918435149794,0.999827083089274
"KEGG_PYRUVATE_METABOLISM",17,"Down",0.289132857586853,0.999827083089274
"ROSS_ACUTE_MYELOID_LEUKEMIA_CBF",36,"Up",0.28919144835934,0.999827083089274
"REACTOME_SIGNALING_BY_FGFR_IN_DISEASE",83,"Down",0.289343893873074,0.999827083089274
"KYNG_DNA_DAMAGE_DN",130,"Down",0.289672381063118,0.999827083089274
"REACTOME_THE_NLRP3_INFLAMMASOME",6,"Up",0.289928385610812,0.999827083089274
"BURTON_ADIPOGENESIS_7",32,"Up",0.289990345776379,0.999827083089274
"WILLIAMS_ESR1_TARGETS_UP",13,"Down",0.290391165957438,0.999827083089274
"MCBRYAN_TERMINAL_END_BUD_DN",4,"Down",0.290815328059714,0.999827083089274
"BIOCARTA_ECM_PATHWAY",19,"Down",0.291258741265122,0.999827083089274
"PID_TAP63_PATHWAY",37,"Up",0.291594202525513,0.999827083089274
"SA_REG_CASCADE_OF_CYCLIN_EXPR",10,"Up",0.291702065647348,0.999827083089274
"FIGUEROA_AML_METHYLATION_CLUSTER_4_UP",35,"Up",0.292153396935884,0.999827083089274
"YANG_MUC2_TARGETS_COLON_3MO_DN",4,"Down",0.292556272615035,0.999827083089274
"INGRAM_SHH_TARGETS",7,"Down",0.292640966322251,0.999827083089274
"XU_CREBBP_TARGETS_DN",28,"Up",0.292710605108835,0.999827083089274
"KRIEG_KDM3A_TARGETS_NOT_HYPOXIA",54,"Up",0.292814219335385,0.999827083089274
"PID_IL2_1PATHWAY",50,"Down",0.293666433684985,0.999827083089274
"REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES",38,"Up",0.293834697786078,0.999827083089274
"WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP",10,"Up",0.295203247195854,0.999827083089274
"ZEILSTRA_CD44_TARGETS_UP",2,"Down",0.295532644857798,0.999827083089274
"VERNELL_RETINOBLASTOMA_PATHWAY_UP",33,"Down",0.295647648882669,0.999827083089274
"REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES",22,"Down",0.296394003925125,0.999827083089274
"WEBER_METHYLATED_LCP_IN_FIBROBLAST_UP",3,"Up",0.29693966762877,0.999827083089274
"NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON",1,"Up",0.297701191868044,0.999827083089274
"MURAKAMI_UV_RESPONSE_6HR_DN",18,"Down",0.298690534484917,0.999827083089274
"VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN",24,"Up",0.299020106627004,0.999827083089274
"KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION",51,"Up",0.29943202673386,0.999827083089274
"ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN",43,"Up",0.299839367130861,0.999827083089274
"FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN",17,"Up",0.299953619429495,0.999827083089274
"JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP",24,"Down",0.299957221520206,0.999827083089274
"OKAWA_NEUROBLASTOMA_1P36_31_DELETION",4,"Up",0.300659468290982,0.999827083089274
"LUDWICZEK_TREATING_IRON_OVERLOAD",5,"Up",0.300689787351778,0.999827083089274
"REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTERGRINS_",10,"Down",0.300707241865189,0.999827083089274
"FIGUEROA_AML_METHYLATION_CLUSTER_2_DN",3,"Down",0.300739269150151,0.999827083089274
"GOUYER_TUMOR_INVASIVENESS",6,"Down",0.302119211050811,0.999827083089274
"PID_VEGFR1_PATHWAY",24,"Up",0.302267368580528,0.999827083089274
"REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION",13,"Up",0.303304207632526,0.999827083089274
"REACTOME_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS",2,"Up",0.303342768540513,0.999827083089274
"MATZUK_EMBRYONIC_GERM_CELL",16,"Down",0.303375037273359,0.999827083089274
"IKEDA_MIR30_TARGETS_DN",9,"Up",0.303907812928269,0.999827083089274
"BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN",15,"Up",0.304433880314378,0.999827083089274
"BIOCARTA_NFKB_PATHWAY",20,"Up",0.305057341222542,0.999827083089274
"KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION",18,"Down",0.305114267586637,0.999827083089274
"LEE_AGING_NEOCORTEX_UP",64,"Up",0.305512143331844,0.999827083089274
"KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION",7,"Down",0.305546205279456,0.999827083089274
"BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN",21,"Down",0.306202985219529,0.999827083089274
"PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4",48,"Up",0.306536146356616,0.999827083089274
"TESAR_ALK_TARGETS_EPISC_4D_UP",7,"Down",0.306787455788625,0.999827083089274
"FIGUEROA_AML_METHYLATION_CLUSTER_6_UP",45,"Up",0.306922739348611,0.999827083089274
"CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN",23,"Down",0.306984415511361,0.999827083089274
"IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_DN",7,"Up",0.307020717896049,0.999827083089274
"GERHOLD_RESPONSE_TO_TZD_DN",13,"Down",0.307982531029755,0.999827083089274
"HAMAI_APOPTOSIS_VIA_TRAIL_DN",75,"Up",0.308557007454187,0.999827083089274
"REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR",69,"Down",0.308593789557442,0.999827083089274
"PID_RHODOPSIN_PATHWAY",14,"Up",0.308932139754923,0.999827083089274
"MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_2",3,"Up",0.309021877148969,0.999827083089274
"TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP",12,"Up",0.309286980656192,0.999827083089274
"BUDHU_LIVER_CANCER_METASTASIS_DN",7,"Down",0.309837164400183,0.999827083089274
"STREICHER_LSM1_TARGETS_DN",15,"Down",0.309856060691361,0.999827083089274
"DASU_IL6_SIGNALING_SCAR_UP",18,"Down",0.309959657216122,0.999827083089274
"REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS",8,"Up",0.309996138730375,0.999827083089274
"NAKAMURA_BRONCHIAL_AND_BRONCHIOLAR_EPITHELIA",2,"Down",0.310248998989192,0.999827083089274
"SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_DN",2,"Down",0.310500695195542,0.999827083089274
"GENTILE_RESPONSE_CLUSTER_D3",30,"Up",0.310713082544211,0.999827083089274
"VANTVEER_BREAST_CANCER_METASTASIS_UP",19,"Down",0.310990751952382,0.999827083089274
"KALMA_E2F1_TARGETS",9,"Down",0.311141930513562,0.999827083089274
"TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN",9,"Up",0.311203379941195,0.999827083089274
"PHESSE_TARGETS_OF_APC_AND_MBD2_UP",5,"Up",0.311514075344942,0.999827083089274
"BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP",12,"Down",0.311850265776931,0.999827083089274
"SCHEIDEREIT_IKK_TARGETS",13,"Down",0.311866681241643,0.999827083089274
"REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS",22,"Down",0.312010553703797,0.999827083089274
"HEDENFALK_BREAST_CANCER_BRACX_DN",5,"Up",0.312383318742801,0.999827083089274
"REACTOME_STEROID_HORMONES",22,"Up",0.312576639617688,0.999827083089274
"REACTOME_SIGNALING_BY_FGFR",75,"Down",0.312697058270088,0.999827083089274
"VANDESLUIS_NORMAL_EMBRYOS_DN",13,"Down",0.313023284237651,0.999827083089274
"MARKEY_RB1_CHRONIC_LOF_DN",80,"Down",0.313374519821474,0.999827083089274
"BYSTRYKH_HEMATOPOIESIS_STEM_CELL_IL3RA",7,"Down",0.313575699613481,0.999827083089274
"SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY",8,"Up",0.313832933289408,0.999827083089274
"ZHANG_RESPONSE_TO_CANTHARIDIN_DN",33,"Up",0.314051209182362,0.999827083089274
"BIOCARTA_HDAC_PATHWAY",24,"Down",0.314070250135188,0.999827083089274
"PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP",46,"Down",0.314490262329254,0.999827083089274
"BERNARD_PPAPDC1B_TARGETS_DN",27,"Down",0.314513614920503,0.999827083089274
"REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION",9,"Up",0.314814782019143,0.999827083089274
"BIOCARTA_RANKL_PATHWAY",14,"Up",0.314860951012538,0.999827083089274
"POS_RESPONSE_TO_HISTAMINE_UP",6,"Up",0.315764089430819,0.999827083089274
"BIOCARTA_IL12_PATHWAY",20,"Down",0.316139938739033,0.999827083089274
"DAIRKEE_CANCER_PRONE_RESPONSE_E2",18,"Up",0.316789814249788,0.999827083089274
"DAZARD_UV_RESPONSE_CLUSTER_G28",13,"Up",0.317145205223367,0.999827083089274
"SESTO_RESPONSE_TO_UV_C1",43,"Down",0.317207991967502,0.999827083089274
"REACTOME_GAP_JUNCTION_ASSEMBLY",14,"Down",0.31750937116049,0.999827083089274
"TRACEY_RESISTANCE_TO_IFNA2_DN",16,"Up",0.317661713307515,0.999827083089274
"REACTOME_NOD1_2_SIGNALING_PATHWAY",18,"Up",0.317686769243266,0.999827083089274
"REACTOME_MRNA_CAPPING",13,"Up",0.317702906406964,0.999827083089274
"PID_ERBB2_ERBB3_PATHWAY",35,"Down",0.317870929767641,0.999827083089274
"SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN",18,"Down",0.318304041367064,0.999827083089274
"PID_INSULIN_GLUCOSE_PATHWAY",16,"Down",0.318682567073606,0.999827083089274
"BIOCARTA_UCALPAIN_PATHWAY",15,"Down",0.318744178824465,0.999827083089274
"LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN",27,"Up",0.318811302078533,0.999827083089274
"BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN",4,"Up",0.31899341265297,0.999827083089274
"KORKOLA_CORRELATED_WITH_POU5F1",10,"Up",0.319693354619376,0.999827083089274
"MEISSNER_NPC_HCP_WITH_H3K27ME3",49,"Up",0.319847777586539,0.999827083089274
"ELVIDGE_HYPOXIA_BY_DMOG_DN",20,"Down",0.320392369645511,0.999827083089274
"YAMANAKA_GLIOBLASTOMA_SURVIVAL_UP",5,"Up",0.320711948742549,0.999827083089274
"REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY",11,"Down",0.321452383276197,0.999827083089274
"SA_FAS_SIGNALING",9,"Down",0.321763304347321,0.999827083089274
"REACTOME_LAGGING_STRAND_SYNTHESIS",11,"Down",0.322160845045639,0.999827083089274
"WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN",14,"Up",0.322308796113937,0.999827083089274
"BROWNE_HCMV_INFECTION_16HR_UP",81,"Up",0.322543183397403,0.999827083089274
"PID_HNF3B_PATHWAY",39,"Down",0.322742823156325,0.999827083089274
"CASTELLANO_HRAS_AND_NRAS_TARGETS_DN",5,"Down",0.32301585626705,0.999827083089274
"RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN",11,"Up",0.323055487054526,0.999827083089274
"ZHOU_TNF_SIGNALING_30MIN",30,"Up",0.323134417154654,0.999827083089274
"NIKOLSKY_BREAST_CANCER_14Q22_AMPLICON",4,"Up",0.323780662934517,0.999827083089274
"FIRESTEIN_CTNNB1_PATHWAY_AND_PROLIFERATION",2,"Up",0.32387833314249,0.999827083089274
"NADLER_OBESITY_DN",36,"Down",0.323963822715612,0.999827083089274
"REACTOME_GLYCOPROTEIN_HORMONES",9,"Up",0.32397138635388,0.999827083089274
"REACTOME_SIGNALING_BY_PDGF",91,"Down",0.324570072028384,0.999827083089274
"DORN_ADENOVIRUS_INFECTION_32HR_UP",7,"Down",0.324666659496073,0.999827083089274
"REACTOME_BASE_EXCISION_REPAIR",13,"Down",0.324931377132596,0.999827083089274
"HU_ANGIOGENESIS_DN",16,"Up",0.324937469636175,0.999827083089274
"LEONARD_HYPOXIA",36,"Up",0.325183760817326,0.999827083089274
"KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN",16,"Down",0.325497857152983,0.999827083089274
"CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN",12,"Up",0.325792750490977,0.999827083089274
"REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING",8,"Down",0.325974255619569,0.999827083089274
"HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP",8,"Down",0.326330843700665,0.999827083089274
"ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN",25,"Down",0.326958999808231,0.999827083089274
"DALESSIO_TSA_RESPONSE",14,"Up",0.327479076750204,0.999827083089274
"JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN",63,"Up",0.327717889640768,0.999827083089274
"KEGG_HEDGEHOG_SIGNALING_PATHWAY",43,"Up",0.328083997118101,0.999827083089274
"REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION",14,"Down",0.329065264966648,0.999827083089274
"REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION",23,"Up",0.329239023459983,0.999827083089274
"BIOCARTA_FREE_PATHWAY",9,"Up",0.32943949940374,0.999827083089274
"MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22",5,"Down",0.329458499309945,0.999827083089274
"BILD_CTNNB1_ONCOGENIC_SIGNATURE",31,"Down",0.329464655373512,0.999827083089274
"WANG_RESPONSE_TO_BEXAROTENE_DN",20,"Down",0.3298056590925,0.999827083089274
"CHEN_HOXA5_TARGETS_9HR_DN",19,"Down",0.330019393805243,0.999827083089274
"NAKAMURA_LUNG_CANCER",6,"Up",0.330189292062813,0.999827083089274
"KAMMINGA_SENESCENCE",14,"Down",0.331145863000003,0.999827083089274
"SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN",99,"Up",0.331339725211603,0.999827083089274
"PID_ERBB4_PATHWAY",31,"Down",0.331415529333623,0.999827083089274
"KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS",4,"Down",0.331451546576197,0.999827083089274
"HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP",16,"Up",0.331611527600577,0.999827083089274
"SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_DN",5,"Up",0.331738919086642,0.999827083089274
"SANSOM_APC_TARGETS",70,"Down",0.331764302924476,0.999827083089274
"ULE_SPLICING_VIA_NOVA2",25,"Up",0.3318294573888,0.999827083089274
"SEIKE_LUNG_CANCER_POOR_SURVIVAL",10,"Down",0.331889759056325,0.999827083089274
"REACTOME_SIGNALING_BY_NODAL",14,"Down",0.332585514147293,0.999827083089274
"ONGUSAHA_BRCA1_TARGETS_UP",10,"Down",0.332656679981596,0.999827083089274
"REACTOME_FANCONI_ANEMIA_PATHWAY",5,"Down",0.333397404938236,0.999827083089274
"BIOCARTA_PARKIN_PATHWAY",6,"Up",0.333820777719578,0.999827083089274
"REACTOME_ACTIVATION_OF_THE_AP1_FAMILY_OF_TRANSCRIPTION_FACTORS",10,"Down",0.334294227916619,0.999827083089274
"GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_2",7,"Up",0.334320553769337,0.999827083089274
"BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN",46,"Up",0.334379393483743,0.999827083089274
"ROSS_AML_WITH_CBFB_MYH11_FUSION",30,"Up",0.334526509317044,0.999827083089274
"KIM_LRRC3B_TARGETS",31,"Down",0.335346755108839,0.999827083089274
"SHIN_B_CELL_LYMPHOMA_CLUSTER_3",24,"Down",0.335473911162812,0.999827083089274
"JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP",23,"Up",0.335554613353635,0.999827083089274
"REACTOME_ROLE_OF_DCC_IN_REGULATING_APOPTOSIS",5,"Down",0.335755226241326,0.999827083089274
"KEGG_COLORECTAL_CANCER",54,"Down",0.33581233971729,0.999827083089274
"HAHTOLA_MYCOSIS_FUNGOIDES_DN",9,"Down",0.335921576543097,0.999827083089274
"SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN",29,"Down",0.33596157870032,0.999827083089274
"GEORGES_CELL_CYCLE_MIR192_TARGETS",33,"Down",0.336091041349238,0.999827083089274
"WU_HBX_TARGETS_3_DN",11,"Down",0.336358816508819,0.999827083089274
"KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM",6,"Down",0.336376811057788,0.999827083089274
"REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS",3,"Up",0.336429041564819,0.999827083089274
"PID_HDAC_CLASSI_PATHWAY",37,"Up",0.336633268158774,0.999827083089274
"CHANGOLKAR_H2AFY_TARGETS_DN",17,"Down",0.33668790828622,0.999827083089274
"LI_CISPLATIN_RESISTANCE_UP",11,"Up",0.336865848423307,0.999827083089274
"QI_PLASMACYTOMA_DN",57,"Down",0.33735532487676,0.999827083089274
"MAHADEVAN_RESPONSE_TO_MP470_UP",11,"Up",0.337709536079905,0.999827083089274
"CHANG_IMMORTALIZED_BY_HPV31_DN",38,"Down",0.337824700508706,0.999827083089274
"IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM",12,"Down",0.337996408128202,0.999827083089274
"WEINMANN_ADAPTATION_TO_HYPOXIA_UP",23,"Down",0.338173927121822,0.999827083089274
"BIOCARTA_TALL1_PATHWAY",11,"Up",0.338340156510223,0.999827083089274
"JOHNSTONE_PARVB_TARGETS_2_DN",103,"Down",0.338692404608923,0.999827083089274
"REACTOME_PKB_MEDIATED_EVENTS",13,"Down",0.338754810234055,0.999827083089274
"BAKKER_FOXO3_TARGETS_UP",29,"Up",0.338894280945572,0.999827083089274
"REACTOME_PHOSPHORYLATION_OF_THE_APC_C",4,"Down",0.339595506711659,0.999827083089274
"GENTILE_UV_RESPONSE_CLUSTER_D9",13,"Down",0.340039374836223,0.999827083089274
"KEGG_FATTY_ACID_METABOLISM",20,"Down",0.340344228789569,0.999827083089274
"FIGUEROA_AML_METHYLATION_CLUSTER_1_DN",12,"Up",0.341024852891184,0.999827083089274
"COLLER_MYC_TARGETS_DN",7,"Down",0.341728469003266,0.999827083089274
"HOEGERKORP_CD44_TARGETS_DIRECT_UP",16,"Down",0.342028028752351,0.999827083089274
"CHEN_HOXA5_TARGETS_6HR_UP",9,"Up",0.342067219123083,0.999827083089274
"ZHAN_MULTIPLE_MYELOMA_CD1_UP",18,"Down",0.34293956777112,0.999827083089274
"DARWICHE_SKIN_TUMOR_PROMOTER_UP",66,"Down",0.343243873821999,0.999827083089274
"TOMLINS_METASTASIS_UP",5,"Down",0.343387899223158,0.999827083089274
"PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP",59,"Up",0.343769555546881,0.999827083089274
"REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES",32,"Down",0.343859079579376,0.999827083089274
"ZHAN_MULTIPLE_MYELOMA_MF_DN",13,"Down",0.344180071668153,0.999827083089274
"BIOCARTA_RNA_PATHWAY",7,"Up",0.344793608854398,0.999827083089274
"DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP",29,"Down",0.34516855675484,0.999827083089274
"ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN",20,"Down",0.345299966793618,0.999827083089274
"NAKAMURA_ALVEOLAR_EPITHELIUM",2,"Down",0.345453678627364,0.999827083089274
"BERNARD_PPAPDC1B_TARGETS_UP",13,"Down",0.346341404095744,0.999827083089274
"ZEMBUTSU_SENSITIVITY_TO_DOXORUBICIN",8,"Up",0.348013692752255,0.999827083089274
"ABE_VEGFA_TARGETS",12,"Up",0.3483512330223,0.999827083089274
"REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1",35,"Down",0.348361580845414,0.999827083089274
"SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN",16,"Down",0.34853405018205,0.999827083089274
"MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_24",6,"Down",0.348855846940295,0.999827083089274
"SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN",26,"Down",0.348926447342736,0.999827083089274
"IGARASHI_ATF4_TARGETS_UP",1,"Down",0.348943940962002,0.999827083089274
"KEGG_ASCORBATE_AND_ALDARATE_METABOLISM",5,"Down",0.349038704396152,0.999827083089274
"MOOTHA_VOXPHOS",30,"Up",0.349221303900877,0.999827083089274
"BROWNE_HCMV_INFECTION_6HR_UP",48,"Down",0.349224415907155,0.999827083089274
"CROMER_METASTASIS_DN",45,"Up",0.349494001182375,0.999827083089274
"REACTOME_CRMPS_IN_SEMA3A_SIGNALING",13,"Up",0.349610698149673,0.999827083089274
"KENNY_CTNNB1_TARGETS_UP",28,"Up",0.349648854281677,0.999827083089274
"PID_LYMPH_ANGIOGENESIS_PATHWAY",24,"Down",0.350046295941894,0.999827083089274
"LUI_THYROID_CANCER_CLUSTER_2",17,"Up",0.350064032072728,0.999827083089274
"SCHLESINGER_METHYLATED_IN_COLON_CANCER",9,"Up",0.350086809609249,0.999827083089274
"ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN",19,"Up",0.350634048686629,0.999827083089274
"ZHAN_MULTIPLE_MYELOMA_MS_UP",17,"Down",0.351034530909191,0.999827083089274
"CROONQUIST_STROMAL_STIMULATION_DN",7,"Up",0.351206383831634,0.999827083089274
"JIANG_AGING_CEREBRAL_CORTEX_UP",31,"Down",0.351375682860878,0.999827083089274
"BOYLAN_MULTIPLE_MYELOMA_C_D_UP",47,"Down",0.351694340050124,0.999827083089274
"KEGG_GLYCOSAMINOGLYCAN_DEGRADATION",12,"Down",0.351754863224061,0.999827083089274
"REACTOME_DNA_REPAIR",52,"Down",0.351920505281416,0.999827083089274
"REACTOME_IL_7_SIGNALING",11,"Down",0.352023992827003,0.999827083089274
"EHLERS_ANEUPLOIDY_DN",5,"Down",0.352133787796524,0.999827083089274
"FRIDMAN_IMMORTALIZATION_DN",20,"Down",0.352651582619197,0.999827083089274
"RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP",46,"Up",0.353013022988726,0.999827083089274
"REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT",32,"Down",0.353056315246387,0.999827083089274
"REACTOME_PURINE_CATABOLISM",6,"Up",0.353264737336039,0.999827083089274
"WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_DN",3,"Up",0.3533539923777,0.999827083089274
"KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP",24,"Down",0.353543703430713,0.999827083089274
"SANSOM_WNT_PATHWAY_REQUIRE_MYC",50,"Down",0.353940950486989,0.999827083089274
"MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP",5,"Up",0.354051622080008,0.999827083089274
"MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3",34,"Up",0.354118070401612,0.999827083089274
"MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP",82,"Down",0.354368934443044,0.999827083089274
"REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE",15,"Down",0.354628631806421,0.999827083089274
"BIOCARTA_GLEEVEC_PATHWAY",20,"Down",0.354804597467993,0.999827083089274
"LIAO_HAVE_SOX4_BINDING_SITES",20,"Up",0.354861681154306,0.999827083089274
"BIOCARTA_RARRXR_PATHWAY",11,"Up",0.355152874602772,0.999827083089274
"SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP",14,"Up",0.355326710315257,0.999827083089274
"CAFFAREL_RESPONSE_TO_THC_8HR_3_UP",2,"Up",0.355349827487449,0.999827083089274
"REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING",14,"Up",0.355853164902051,0.999827083089274
"WANG_RESPONSE_TO_FORSKOLIN_DN",1,"Up",0.356117531181536,0.999827083089274
"ZHANG_TLX_TARGETS_UP",39,"Down",0.356294686041511,0.999827083089274
"LOPES_METHYLATED_IN_COLON_CANCER_UP",18,"Down",0.356382667678091,0.999827083089274
"REACTOME_REGULATION_OF_APOPTOSIS",34,"Down",0.35654634267525,0.999827083089274
"FARMER_BREAST_CANCER_CLUSTER_2",15,"Down",0.356705435021473,0.999827083089274
"VANHARANTA_UTERINE_FIBROID_UP",29,"Down",0.356848991820426,0.999827083089274
"REACTOME_SIGNALING_BY_SCF_KIT",58,"Down",0.356857772850204,0.999827083089274
"GYORFFY_DOXORUBICIN_RESISTANCE",23,"Up",0.356931552842289,0.999827083089274
"REACTOME_PLC_BETA_MEDIATED_EVENTS",35,"Down",0.357381270553677,0.999827083089274
"REACTOME_RNA_POL_III_TRANSCRIPTION",9,"Down",0.357642134218083,0.999827083089274
"KEGG_CARDIAC_MUSCLE_CONTRACTION",46,"Up",0.358205927214162,0.999827083089274
"DORSEY_GAB2_TARGETS",24,"Up",0.359216155248272,0.999827083089274
"MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4",10,"Up",0.359242611417274,0.999827083089274
"SHIN_B_CELL_LYMPHOMA_CLUSTER_9",18,"Up",0.35992130877215,0.999827083089274
"MCCABE_HOXC6_TARGETS_CANCER_UP",16,"Down",0.359968406957319,0.999827083089274
"ALONSO_METASTASIS_DN",14,"Down",0.359968623293796,0.999827083089274
"WU_ALZHEIMER_DISEASE_UP",5,"Down",0.360027977175211,0.999827083089274
"CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN",120,"Down",0.360356007434116,0.999827083089274
"ZHANG_BREAST_CANCER_PROGENITORS_DN",58,"Up",0.360467597500119,0.999827083089274
"SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN",23,"Down",0.360968598100625,0.999827083089274
"REACTOME_CHOLESTEROL_BIOSYNTHESIS",11,"Up",0.361412283738722,0.999827083089274
"KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM",8,"Up",0.361586756368817,0.999827083089274
"YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15",23,"Down",0.36162791379533,0.999827083089274
"GAUTSCHI_SRC_SIGNALING",8,"Down",0.361797968792766,0.999827083089274
"JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN",23,"Up",0.362398544721204,0.999827083089274
"LOPEZ_MESOTELIOMA_SURVIVAL_TIME_DN",6,"Down",0.363547009317257,0.999827083089274
"REACTOME_SHC_MEDIATED_SIGNALLING",12,"Down",0.363607359519588,0.999827083089274
"MARSON_FOXP3_TARGETS_DN",30,"Down",0.363701636246932,0.999827083089274
"TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP",12,"Down",0.363735552732307,0.999827083089274
"REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING",23,"Up",0.364410155494051,0.999827083089274
"LAIHO_COLORECTAL_CANCER_SERRATED_DN",28,"Down",0.36450231615868,0.999827083089274
"FUJIWARA_PARK2_IN_LIVER_CANCER_DN",3,"Down",0.364531732040892,0.999827083089274
"PID_NFKAPPAB_CANONICAL_PATHWAY",15,"Up",0.364534296376358,0.999827083089274
"REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL",10,"Up",0.364904010711735,0.999827083089274
"REACTOME_GPCR_LIGAND_BINDING",258,"Up",0.364936861855814,0.999827083089274
"QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2",23,"Down",0.365054013985473,0.999827083089274
"PID_NFAT_3PATHWAY",42,"Down",0.365235321787168,0.999827083089274
"REACTOME_PROSTANOID_LIGAND_RECEPTORS",9,"Up",0.365553697687381,0.999827083089274
"ONO_AML1_TARGETS_DN",34,"Down",0.366002329772728,0.999827083089274
"REACTOME_METAL_ION_SLC_TRANSPORTERS",7,"Down",0.366283551481838,0.999827083089274
"IIZUKA_LIVER_CANCER_EARLY_RECURRENCE",8,"Down",0.367037819300222,0.999827083089274
"WENDT_COHESIN_TARGETS_UP",12,"Down",0.36719284748143,0.999827083089274
"PID_HEDGEHOG_2PATHWAY",16,"Up",0.367332892313064,0.999827083089274
"GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP",16,"Down",0.368025393595604,0.999827083089274
"REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS",13,"Up",0.368234595814091,0.999827083089274
"WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN",16,"Up",0.368659448560614,0.999827083089274
"GRADE_COLON_CANCER_DN",12,"Down",0.368942266895937,0.999827083089274
"VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_DN",9,"Up",0.370688853632788,0.999827083089274
"PID_MYC_PATHWAY",12,"Up",0.370811752993392,0.999827083089274
"GOLDRATH_HOMEOSTATIC_PROLIFERATION",79,"Down",0.37084132695156,0.999827083089274
"SESTO_RESPONSE_TO_UV_C0",69,"Up",0.370881433590317,0.999827083089274
"VALK_AML_WITH_EVI1",13,"Down",0.371364452022749,0.999827083089274
"CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP",49,"Up",0.371472612625707,0.999827083089274
"ZHANG_TLX_TARGETS_36HR_DN",68,"Down",0.371783457753289,0.999827083089274
"RUAN_RESPONSE_TO_TNF_DN",77,"Down",0.371816656698143,0.999827083089274
"ST_MYOCYTE_AD_PATHWAY",25,"Up",0.372360243608266,0.999827083089274
"MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_11",2,"Up",0.372893213944003,0.999827083089274
"WAKASUGI_HAVE_ZNF143_BINDING_SITES",34,"Down",0.372911410477842,0.999827083089274
"MEISSNER_BRAIN_ICP_WITH_H3K4ME3",7,"Down",0.372939634047311,0.999827083089274
"SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_DN",4,"Down",0.373204911308667,0.999827083089274
"BIOCARTA_DC_PATHWAY",19,"Down",0.373853550163387,0.999827083089274
"REACTOME_SIGNALING_BY_ROBO_RECEPTOR",20,"Down",0.374167160289343,0.999827083089274
"VALK_AML_CLUSTER_3",16,"Up",0.374504374231598,0.999827083089274
"SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN",11,"Up",0.374558942319091,0.999827083089274
"BIOCARTA_CELL2CELL_PATHWAY",12,"Down",0.374620742953061,0.999827083089274
"KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS",25,"Down",0.374626229566148,0.999827083089274
"CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_DN",3,"Up",0.37513228694512,0.999827083089274
"BILANGES_SERUM_RESPONSE_TRANSLATION",19,"Down",0.376043858545541,0.999827083089274
"KEGG_RENIN_ANGIOTENSIN_SYSTEM",13,"Down",0.376073907192034,0.999827083089274
"LABBE_TGFB1_TARGETS_UP",85,"Down",0.376179040757147,0.999827083089274
"HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP",23,"Up",0.376367111927602,0.999827083089274
"GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP",23,"Down",0.376682856048396,0.999827083089274
"ONGUSAHA_BRCA1_TARGETS_DN",7,"Up",0.376745660604908,0.999827083089274
"REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION",7,"Down",0.377318677890935,0.999827083089274
"VANTVEER_BREAST_CANCER_BRCA1_UP",18,"Up",0.377624834098731,0.999827083089274
"SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP",24,"Up",0.377691361326657,0.999827083089274
"BIOCARTA_AKAP95_PATHWAY",8,"Up",0.377881340381308,0.999827083089274
"LIU_VMYB_TARGETS_UP",36,"Down",0.378042146053754,0.999827083089274
"DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER",29,"Up",0.378623967203398,0.999827083089274
"KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY",42,"Up",0.37882559392145,0.999827083089274
"YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4",10,"Up",0.378944438610158,0.999827083089274
"HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP",10,"Down",0.379044250060281,0.999827083089274
"REACTOME_MEIOSIS",36,"Up",0.379324845760584,0.999827083089274
"ZHU_SKIL_TARGETS_DN",8,"Down",0.379391755880975,0.999827083089274
"OXFORD_RALA_AND_RALB_TARGETS_UP",4,"Up",0.379627985634876,0.999827083089274
"LU_TUMOR_ENDOTHELIAL_MARKERS_UP",8,"Down",0.379652583970816,0.999827083089274
"KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP",38,"Down",0.380123856023087,0.999827083089274
"TURJANSKI_MAPK1_AND_MAPK2_TARGETS",11,"Up",0.380270399488791,0.999827083089274
"BURTON_ADIPOGENESIS_11",31,"Down",0.38054198008666,0.999827083089274
"ELLWOOD_MYC_TARGETS_UP",3,"Up",0.380981537611849,0.999827083089274
"BIOCARTA_ACH_PATHWAY",14,"Down",0.381030427385231,0.999827083089274
"LEE_LIVER_CANCER_MYC_DN",40,"Up",0.38116908130721,0.999827083089274
"MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP",10,"Up",0.381210717198785,0.999827083089274
"REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS",34,"Down",0.381972765215264,0.999827083089274
"BIOCARTA_NOS1_PATHWAY",20,"Down",0.382767491601698,0.999827083089274
"REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS",10,"Up",0.383004804378929,0.999827083089274
"SABATES_COLORECTAL_ADENOMA_DN",114,"Up",0.383034088764765,0.999827083089274
"REACTOME_GLOBAL_GENOMIC_NER_GG_NER",21,"Down",0.383066411861638,0.999827083089274
"KEGG_TYPE_I_DIABETES_MELLITUS",42,"Down",0.383262557446144,0.999827083089274
"REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS",47,"Down",0.383571024370292,0.999827083089274
"NEMETH_INFLAMMATORY_RESPONSE_LPS_DN",29,"Up",0.383678332395573,0.999827083089274
"RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP",71,"Up",0.38370825430959,0.999827083089274
"ROSS_AML_WITH_PML_RARA_FUSION",45,"Down",0.383723273815188,0.999827083089274
"HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN",23,"Up",0.384421130506378,0.999827083089274
"BIOCARTA_TCR_PATHWAY",40,"Down",0.384551643376245,0.999827083089274
"GENTILE_UV_RESPONSE_CLUSTER_D7",19,"Up",0.384878921744176,0.999827083089274
"REACTOME_EARLY_PHASE_OF_HIV_LIFE_CYCLE",9,"Down",0.385186351140719,0.999827083089274
"LU_TUMOR_ANGIOGENESIS_UP",24,"Down",0.385226529049282,0.999827083089274
"REACTOME_METABOLISM_OF_POLYAMINES",6,"Up",0.385494075161681,0.999827083089274
"WANG_NFKB_TARGETS",22,"Up",0.385503339430404,0.999827083089274
"BASSO_CD40_SIGNALING_DN",41,"Up",0.385555818870259,0.999827083089274
"HOQUE_METHYLATED_IN_CANCER",45,"Up",0.385580003633459,0.999827083089274
"NUTT_GBM_VS_AO_GLIOMA_DN",20,"Down",0.385799814824882,0.999827083089274
"DAWSON_METHYLATED_IN_LYMPHOMA_TCL1",28,"Up",0.386092295066553,0.999827083089274
"REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER",22,"Up",0.386210654629366,0.999827083089274
"PARK_HSC_AND_MULTIPOTENT_PROGENITORS",35,"Down",0.386470769740021,0.999827083089274
"SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN",9,"Down",0.386494167234258,0.999827083089274
"HENDRICKS_SMARCA4_TARGETS_UP",28,"Up",0.386527900700017,0.999827083089274
"PID_CXCR4_PATHWAY",76,"Down",0.386819397130006,0.999827083089274
"PID_GMCSF_PATHWAY",36,"Down",0.387664939072936,0.999827083089274
"LEE_LIVER_CANCER_ACOX1_DN",52,"Down",0.387809239549073,0.999827083089274
"BIOCARTA_MPR_PATHWAY",22,"Down",0.388062253033631,0.999827083089274
"MARSON_FOXP3_TARGETS_STIMULATED_UP",12,"Down",0.388144191844959,0.999827083089274
"DELPUECH_FOXO3_TARGETS_UP",46,"Up",0.388199180050307,0.999827083089274
"NABA_BASEMENT_MEMBRANES",27,"Up",0.388305321894968,0.999827083089274
"BORCZUK_MALIGNANT_MESOTHELIOMA_DN",62,"Up",0.388440304389435,0.999827083089274
"CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_DN",5,"Up",0.388617598832231,0.999827083089274
"CHOW_RASSF1_TARGETS_UP",11,"Down",0.388669688263662,0.999827083089274
"GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP",5,"Down",0.388736974707443,0.999827083089274
"REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION",28,"Up",0.388743733647173,0.999827083089274
"RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_DN",5,"Up",0.389284880648326,0.999827083089274
"REACTOME_DSCAM_INTERACTIONS",9,"Down",0.389673451684761,0.999827083089274
"REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A",5,"Down",0.389891173368753,0.999827083089274
"SHARMA_ASTROCYTOMA_WITH_NF1_SYNDROM",3,"Down",0.389923287507573,0.999827083089274
"BIOCARTA_CREB_PATHWAY",23,"Down",0.390809040010799,0.999827083089274
"REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE",1,"Down",0.391562774384744,0.999827083089274
"REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX",22,"Up",0.391847581168036,0.999827083089274
"BYSTRYKH_SCP2_QTL",3,"Down",0.392132451793571,0.999827083089274
"REACTOME_REGULATION_OF_THE_FANCONI_ANEMIA_PATHWAY",1,"Up",0.392799759313294,0.999827083089274
"REACTOME_REGULATION_OF_COMPLEMENT_CASCADE",12,"Up",0.393022103885886,0.999827083089274
"REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY",11,"Down",0.393343644741615,0.999827083089274
"HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP",36,"Up",0.393558948652796,0.999827083089274
"REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY",39,"Up",0.393707828625987,0.999827083089274
"TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP",29,"Down",0.393871727088414,0.999827083089274
"REACTOME_BINDING_AND_ENTRY_OF_HIV_VIRION",3,"Down",0.39390482254657,0.999827083089274
"TRACEY_RESISTANCE_TO_IFNA2_UP",4,"Down",0.394233683580972,0.999827083089274
"NIELSEN_GIST",36,"Down",0.394353722810022,0.999827083089274
"SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5",19,"Up",0.394570148234994,0.999827083089274
"TAKADA_GASTRIC_CANCER_COPY_NUMBER_UP",7,"Down",0.394601221045061,0.999827083089274
"YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17",76,"Down",0.394998895039182,0.999827083089274
"PID_TNF_PATHWAY",36,"Up",0.395065704625384,0.999827083089274
"MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_DN",8,"Down",0.395132811538341,0.999827083089274
"HOEGERKORP_CD44_TARGETS_DIRECT_DN",11,"Down",0.395454499578791,0.999827083089274
"HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP",12,"Down",0.395538696478215,0.999827083089274
"TESAR_JAK_TARGETS_MOUSE_ES_D3_DN",6,"Up",0.395556615161819,0.999827083089274
"AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G",50,"Up",0.395582155991473,0.999827083089274
"REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE",44,"Down",0.395584511996466,0.999827083089274
"PENG_GLUCOSE_DEPRIVATION_UP",28,"Up",0.395845103272666,0.999827083089274
"PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP",11,"Up",0.396211821350119,0.999827083089274
"GRANDVAUX_IRF3_TARGETS_DN",11,"Down",0.397380022283376,0.999827083089274
"OZANNE_AP1_TARGETS_UP",14,"Down",0.397966587945851,0.999827083089274
"MONTERO_THYROID_CANCER_POOR_SURVIVAL_DN",4,"Up",0.397994261490851,0.999827083089274
"PID_HDAC_CLASSII_PATHWAY",23,"Down",0.398023014616539,0.999827083089274
"HUANG_DASATINIB_RESISTANCE_DN",30,"Down",0.398306421307395,0.999827083089274
"GENTILE_UV_HIGH_DOSE_UP",13,"Up",0.39835433623591,0.999827083089274
"HANSON_HRAS_SIGNALING_VIA_NFKB",13,"Up",0.398781425844304,0.999827083089274
"MATZUK_MEIOTIC_AND_DNA_REPAIR",25,"Up",0.399139418059712,0.999827083089274
"PID_RAS_PATHWAY",20,"Down",0.399265087075571,0.999827083089274
"SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP",24,"Down",0.399529537303755,0.999827083089274
"CHOW_RASSF1_TARGETS_DN",12,"Down",0.400025251142483,0.999827083089274
"BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN",24,"Down",0.400949102054219,0.999827083089274
"REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS",10,"Down",0.401785937265333,0.999827083089274
"CHESLER_BRAIN_D6MIT150_QTL_TRANS",6,"Down",0.401797577598122,0.999827083089274
"REACTOME_NEP_NS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY",4,"Down",0.401888926994349,0.999827083089274
"REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0",33,"Down",0.402504651344256,0.999827083089274
"YAGI_AML_SURVIVAL",55,"Up",0.402624682896307,0.999827083089274
"REACTOME_APOPTOSIS",99,"Down",0.402650494804425,0.999827083089274
"REACTOME_POL_SWITCHING",8,"Down",0.402979676485587,0.999827083089274
"LAU_APOPTOSIS_CDKN2A_UP",38,"Up",0.403359651882205,0.999827083089274
"PID_ANGIOPOIETIN_RECEPTOR_PATHWAY",44,"Down",0.403423096451059,0.999827083089274
"ZHAN_MULTIPLE_MYELOMA_CD2_DN",19,"Up",0.403629308459702,0.999827083089274
"GENTILE_UV_RESPONSE_CLUSTER_D4",21,"Up",0.403640097359725,0.999827083089274
"HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN",47,"Down",0.403873017399727,0.999827083089274
"ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN",70,"Down",0.403889033100382,0.999827083089274
"REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS",1,"Up",0.404002390649203,0.999827083089274
"BIOCARTA_EPO_PATHWAY",18,"Down",0.404038705719315,0.999827083089274
"PID_TCR_RAS_PATHWAY",11,"Down",0.404515839526237,0.999827083089274
"PID_NETRIN_PATHWAY",24,"Down",0.405030619115974,0.999827083089274
"REACTOME_REPAIR_SYNTHESIS_FOR_GAP_FILLING_BY_DNA_POL_IN_TC_NER",7,"Down",0.405358381910074,0.999827083089274
"LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP",60,"Down",0.405399042107115,0.999827083089274
"WEINMANN_ADAPTATION_TO_HYPOXIA_DN",34,"Down",0.405410607108379,0.999827083089274
"MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN",12,"Up",0.405451173423357,0.999827083089274
"REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING",19,"Down",0.405838500911086,0.999827083089274
"REACTOME_PIP3_ACTIVATES_AKT_SIGNALING",14,"Up",0.406301624867337,0.999827083089274
"NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP",52,"Up",0.406383285308031,0.999827083089274
"BROWNE_HCMV_INFECTION_16HR_DN",49,"Up",0.406498223180179,0.999827083089274
"REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_EPSILON",4,"Up",0.407056373702966,0.999827083089274
"SMID_BREAST_CANCER_RELAPSE_IN_LIVER_UP",2,"Up",0.407189849369322,0.999827083089274
"BIOCARTA_P38MAPK_PATHWAY",34,"Down",0.407325291386979,0.999827083089274
"BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN",31,"Down",0.407541723870643,0.999827083089274
"FAELT_B_CLL_WITH_VH3_21_UP",22,"Up",0.407672406465613,0.999827083089274
"LUCAS_HNF4A_TARGETS_UP",33,"Up",0.408080814144237,0.999827083089274
"FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP",21,"Up",0.408243046715084,0.999827083089274
"TERAMOTO_OPN_TARGETS_CLUSTER_4",7,"Down",0.40833501139678,0.999827083089274
"BIOCARTA_CDMAC_PATHWAY",15,"Down",0.408976149078409,0.999827083089274
"KEGG_O_GLYCAN_BIOSYNTHESIS",7,"Up",0.409341059149027,0.999827083089274
"REACTOME_PROLACTIN_RECEPTOR_SIGNALING",10,"Down",0.409384728795984,0.999827083089274
"PALOMERO_GSI_SENSITIVITY_UP",4,"Up",0.409594022531372,0.999827083089274
"ALONSO_METASTASIS_NEURAL_UP",12,"Up",0.410028786995399,0.999827083089274
"REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES",10,"Down",0.410236875138018,0.999827083089274
"ALCALAY_AML_BY_NPM1_LOCALIZATION_UP",75,"Up",0.410262491642597,0.999827083089274
"MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5",12,"Down",0.410496663646571,0.999827083089274
"KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS",7,"Up",0.410940242181573,0.999827083089274
"KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG",22,"Down",0.410998955990258,0.999827083089274
"BIOCARTA_RAC1_PATHWAY",15,"Down",0.411623048851189,0.999827083089274
"REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C",31,"Down",0.412233918171242,0.999827083089274
"PID_P53_REGULATION_PATHWAY",29,"Up",0.41249628009003,0.999827083089274
"REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII",13,"Down",0.412826938047839,0.999827083089274
"RAMASWAMY_METASTASIS_UP",33,"Up",0.413469453138013,0.999827083089274
"DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP",41,"Up",0.414117846887789,0.999827083089274
"REACTOME_HDL_MEDIATED_LIPID_TRANSPORT",11,"Down",0.414303575926614,0.999827083089274
"MATZUK_SPERMATOGONIA",15,"Down",0.414323373956322,0.999827083089274
"LEI_HOXC8_TARGETS_UP",8,"Up",0.414393032581221,0.999827083089274
"TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP",50,"Down",0.414957089410952,0.999827083089274
"REACTOME_GAP_JUNCTION_DEGRADATION",7,"Up",0.415334484736512,0.999827083089274
"BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE",73,"Down",0.415555081258556,0.999827083089274
"REACTOME_TIGHT_JUNCTION_INTERACTIONS",9,"Down",0.415762136625836,0.999827083089274
"CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP",4,"Down",0.416072576488161,0.999827083089274
"GROSS_HYPOXIA_VIA_ELK3_ONLY_UP",17,"Down",0.416387863141625,0.999827083089274
"NAGASHIMA_NRG1_SIGNALING_DN",16,"Up",0.417146031971966,0.999827083089274
"MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN",98,"Down",0.417162338410958,0.999827083089274
"WANG_TNF_TARGETS",23,"Down",0.4172083866679,0.999827083089274
"PID_GLYPICAN_1PATHWAY",26,"Down",0.417735820807172,0.999827083089274
"REACTOME_ARMS_MEDIATED_ACTIVATION",11,"Down",0.417849081681336,0.999827083089274
"YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14",62,"Down",0.417849594077807,0.999827083089274
"WILLIAMS_ESR1_TARGETS_DN",5,"Up",0.417994207573715,0.999827083089274
"REACTOME_SULFUR_AMINO_ACID_METABOLISM",9,"Down",0.418001916774372,0.999827083089274
"PASINI_SUZ12_TARGETS_UP",43,"Down",0.418087408395139,0.999827083089274
"PID_P38_GAMMA_DELTA_PATHWAY",8,"Down",0.418200318672863,0.999827083089274
"REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS",31,"Down",0.418201034075149,0.999827083089274
"HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER",10,"Up",0.418337771031279,0.999827083089274
"KLEIN_TARGETS_OF_BCR_ABL1_FUSION",36,"Down",0.418447454912025,0.999827083089274
"REACTOME_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS",9,"Down",0.418920427436988,0.999827083089274
"RAMASWAMY_METASTASIS_DN",32,"Down",0.419030119784936,0.999827083089274
"ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP",100,"Up",0.41919073673001,0.999827083089274
"WHITEFORD_PEDIATRIC_CANCER_MARKERS",59,"Down",0.419713001936564,0.999827083089274
"REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION",55,"Down",0.419773221269849,0.999827083089274
"ST_WNT_BETA_CATENIN_PATHWAY",20,"Up",0.420252310813586,0.999827083089274
"BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN",22,"Down",0.420351566223335,0.999827083089274
"BHAT_ESR1_TARGETS_VIA_AKT1_DN",38,"Up",0.420529993164368,0.999827083089274
"REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS",6,"Down",0.420707633386632,0.999827083089274
"OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN",25,"Up",0.420711177966993,0.999827083089274
"CHICAS_RB1_TARGETS_GROWING",104,"Up",0.420713680670432,0.999827083089274
"MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP",8,"Up",0.420843393507541,0.999827083089274
"MCCLUNG_COCAIN_REWARD_4WK",48,"Up",0.422935938581536,0.999827083089274
"PID_TCR_CALCIUM_PATHWAY",23,"Down",0.423435899261706,0.999827083089274
"JIANG_AGING_HYPOTHALAMUS_DN",31,"Up",0.423802916314134,0.999827083089274
"CHENG_TAF7L_TARGETS",1,"Down",0.424095585626484,0.999827083089274
"BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP",32,"Down",0.424989767683273,0.999827083089274
"SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP",13,"Up",0.425054401260734,0.999827083089274
"BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE",24,"Down",0.425090355860076,0.999827083089274
"ZEMBUTSU_SENSITIVITY_TO_CYCLOPHOSPHAMIDE",8,"Up",0.425425368806205,0.999827083089274
"PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7",149,"Down",0.425629580884235,0.999827083089274
"NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON",16,"Up",0.425757980400515,0.999827083089274
"BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN",17,"Up",0.425780578840071,0.999827083089274
"BIOCARTA_ERYTH_PATHWAY",14,"Down",0.426034670215248,0.999827083089274
"DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS",23,"Down",0.42613874674237,0.999827083089274
"BROWNE_HCMV_INFECTION_24HR_DN",95,"Down",0.426421417873017,0.999827083089274
"JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP",7,"Up",0.426517312734728,0.999827083089274
"GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN",29,"Down",0.426536571214431,0.999827083089274
"KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY",40,"Up",0.426755570936151,0.999827083089274
"REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION",14,"Down",0.426834929522472,0.999827083089274
"KORKOLA_CHORIOCARCINOMA_UP",5,"Down",0.427081448005975,0.999827083089274
"BORCZUK_MALIGNANT_MESOTHELIOMA_UP",140,"Down",0.427571440350991,0.999827083089274
"AMIT_EGF_RESPONSE_240_HELA",32,"Up",0.427584184912493,0.999827083089274
"YU_BAP1_TARGETS",19,"Down",0.427865517382188,0.999827083089274
"HAMAI_APOPTOSIS_VIA_TRAIL_UP",208,"Down",0.428065508606344,0.999827083089274
"REACTOME_PHOSPHORYLATION_OF_CD3_AND_TCR_ZETA_CHAINS",11,"Down",0.428195361041146,0.999827083089274
"LEI_MYB_TARGETS",204,"Up",0.428387518390692,0.999827083089274
"CORRE_MULTIPLE_MYELOMA_DN",33,"Up",0.428682711276283,0.999827083089274
"GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP",12,"Down",0.428825312999685,0.999827083089274
"KEGG_CELL_ADHESION_MOLECULES_CAMS",88,"Down",0.429083610958765,0.999827083089274
"FAELT_B_CLL_WITH_VH3_21_DN",19,"Up",0.429263276107962,0.999827083089274
"SABATES_COLORECTAL_ADENOMA_UP",64,"Up",0.429600424339168,0.999827083089274
"CHANG_IMMORTALIZED_BY_HPV31_UP",30,"Down",0.431088127989889,0.999827083089274
"LY_AGING_OLD_UP",5,"Up",0.432022723088494,0.999827083089274
"SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN",6,"Down",0.43212574079213,0.999827083089274
"STREICHER_LSM1_TARGETS_UP",32,"Up",0.432413043862165,0.999827083089274
"REACTOME_UNWINDING_OF_DNA",7,"Up",0.432659244298233,0.999827083089274
"KANG_FLUOROURACIL_RESISTANCE_DN",7,"Up",0.432844670369164,0.999827083089274
"REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC",33,"Down",0.433014355087726,0.999827083089274
"REACTOME_TELOMERE_MAINTENANCE",20,"Down",0.433623734065567,0.999827083089274
"KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP",7,"Down",0.433672571352909,0.999827083089274
"LEE_AGING_MUSCLE_UP",32,"Down",0.433818232646989,0.999827083089274
"BIOCARTA_CTLA4_PATHWAY",16,"Down",0.434313370692834,0.999827083089274
"REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI",5,"Up",0.434331762582028,0.999827083089274
"REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS",9,"Down",0.434455343381733,0.999827083089274
"BIOCARTA_BARRESTIN_SRC_PATHWAY",12,"Down",0.43460768024849,0.999827083089274
"MANTOVANI_NFKB_TARGETS_DN",3,"Up",0.434696082738746,0.999827083089274
"KEGG_COMPLEMENT_AND_COAGULATION_CASCADES",57,"Down",0.435109136864074,0.999827083089274
"IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP",8,"Up",0.435726960552004,0.999827083089274
"THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP",55,"Up",0.435928281676332,0.999827083089274
"AZARE_STAT3_TARGETS",16,"Down",0.435974902661195,0.999827083089274
"DIRMEIER_LMP1_RESPONSE_EARLY",53,"Up",0.436008140388261,0.999827083089274
"XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP",21,"Down",0.436231114853501,0.999827083089274
"GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN",103,"Up",0.436240370066622,0.999827083089274
"JU_AGING_TERC_TARGETS_DN",4,"Up",0.436455309880467,0.999827083089274
"MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS",6,"Up",0.436798788843717,0.999827083089274
"MILI_PSEUDOPODIA",14,"Down",0.436843547307606,0.999827083089274
"JEPSEN_SMRT_TARGETS",16,"Down",0.436994566532835,0.999827083089274
"KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM",16,"Down",0.437279689380001,0.999827083089274
"BERGER_MBD2_TARGETS",7,"Up",0.43795178205766,0.999827083089274
"BAFNA_MUC4_TARGETS_DN",3,"Up",0.437956488858604,0.999827083089274
"HAEGERSTRAND_RESPONSE_TO_IMATINIB",7,"Down",0.438387242048759,0.999827083089274
"KEGG_LIMONENE_AND_PINENE_DEGRADATION",2,"Down",0.438692433108446,0.999827083089274
"PID_CONE_PATHWAY",11,"Up",0.438718686388707,0.999827083089274
"BIOCARTA_BARR_MAPK_PATHWAY",9,"Down",0.438773969982041,0.999827083089274
"AIYAR_COBRA1_TARGETS_DN",18,"Down",0.438891701168822,0.999827083089274
"GHANDHI_BYSTANDER_IRRADIATION_UP",42,"Up",0.439046481377538,0.999827083089274
"KEGG_PENTOSE_PHOSPHATE_PATHWAY",12,"Down",0.439181659804684,0.999827083089274
"WALLACE_PROSTATE_CANCER_RACE_DN",26,"Down",0.439502588806631,0.999827083089274
"MATZUK_MALE_REPRODUCTION_SERTOLI",23,"Down",0.439857474255622,0.999827083089274
"PID_IFNG_PATHWAY",30,"Up",0.440143575877778,0.999827083089274
"KRISHNAN_FURIN_TARGETS_DN",1,"Up",0.440296868496944,0.999827083089274
"KIM_MYCN_AMPLIFICATION_TARGETS_DN",26,"Down",0.440502151004032,0.999827083089274
"BRIDEAU_IMPRINTED_GENES",47,"Down",0.44058400613292,0.999827083089274
"SUZUKI_RESPONSE_TO_TSA",10,"Down",0.440999867924805,0.999827083089274
"YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN",20,"Down",0.441152582301033,0.999827083089274
"CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP",29,"Down",0.441213362838883,0.999827083089274
"MOOTHA_FFA_OXYDATION",13,"Down",0.441521539629381,0.999827083089274
"REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS",4,"Down",0.441704661055903,0.999827083089274
"KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD",10,"Down",0.441752522444901,0.999827083089274
"LY_AGING_PREMATURE_DN",23,"Up",0.441773324353081,0.999827083089274
"NATSUME_RESPONSE_TO_INTERFERON_BETA_DN",43,"Up",0.442442110918585,0.999827083089274
"APPEL_IMATINIB_RESPONSE",28,"Up",0.442738486506657,0.999827083089274
"REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_",46,"Down",0.442977692785917,0.999827083089274
"DANG_MYC_TARGETS_DN",23,"Down",0.443302945438435,0.999827083089274
"LIM_MAMMARY_STEM_CELL_DN",135,"Down",0.443576186328427,0.999827083089274
"ABBUD_LIF_SIGNALING_1_UP",33,"Down",0.443604188462026,0.999827083089274
"SMID_BREAST_CANCER_NORMAL_LIKE_DN",3,"Down",0.443671105922135,0.999827083089274
"REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G",29,"Down",0.443677741552214,0.999827083089274
"PEART_HDAC_PROLIFERATION_CLUSTER_UP",34,"Up",0.443695372864575,0.999827083089274
"REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING",10,"Up",0.443726067517678,0.999827083089274
"VALK_AML_CLUSTER_13",16,"Up",0.443920576010936,0.999827083089274
"FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN",23,"Up",0.444041646905329,0.999827083089274
"CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_UP",5,"Up",0.444233279343961,0.999827083089274
"JONES_TCOF1_TARGETS",2,"Down",0.444441117376167,0.999827083089274
"PID_FOXO_PATHWAY",31,"Down",0.444684396395028,0.999827083089274
"MCCABE_HOXC6_TARGETS_UP",3,"Up",0.444766320073393,0.999827083089274
"REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING",10,"Up",0.444799003892288,0.999827083089274
"PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_DN",4,"Up",0.444853996865161,0.999827083089274
"BUSA_SAM68_TARGETS_DN",5,"Up",0.445124195012503,0.999827083089274
"GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION",6,"Down",0.44516273418882,0.999827083089274
"BIOCARTA_VDR_PATHWAY",9,"Up",0.445318074903781,0.999827083089274
"REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY",8,"Up",0.445329370083783,0.999827083089274
"KIM_ALL_DISORDERS_DURATION_CORR_DN",61,"Down",0.445843083510284,0.999827083089274
"NABA_COLLAGENS",29,"Down",0.445988832862233,0.999827083089274
"REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK",7,"Down",0.446485024540906,0.999827083089274
"CROSBY_E2F4_TARGETS",3,"Up",0.446568619366705,0.999827083089274
"REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D",24,"Up",0.446802878178948,0.999827083089274
"HEIDENBLAD_AMPLICON_8Q24_UP",15,"Up",0.447109289886639,0.999827083089274
"REACTOME_GLYCOSAMINOGLYCAN_METABOLISM",50,"Down",0.447449405755943,0.999827083089274
"PLASARI_NFIC_TARGETS_BASAL_UP",20,"Up",0.447539880826708,0.999827083089274
"REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION",11,"Up",0.447649759699513,0.999827083089274
"BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN",20,"Down",0.447739825976921,0.999827083089274
"REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL",9,"Up",0.447859048794853,0.999827083089274
"REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION",11,"Down",0.448187857409546,0.999827083089274
"FARMER_BREAST_CANCER_CLUSTER_5",15,"Up",0.448420479191524,0.999827083089274
"KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD",18,"Down",0.448443353715977,0.999827083089274
"MANTOVANI_VIRAL_GPCR_SIGNALING_UP",38,"Up",0.448483416700911,0.999827083089274
"MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3",57,"Up",0.448657072327827,0.999827083089274
"BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP",13,"Down",0.449322184606309,0.999827083089274
"WHITFIELD_CELL_CYCLE_LITERATURE",36,"Up",0.449529680104858,0.999827083089274
"PID_EPO_PATHWAY",30,"Down",0.449639143536837,0.999827083089274
"BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS",65,"Down",0.449935028888877,0.999827083089274
"SEIDEN_MET_SIGNALING",7,"Down",0.450646641421073,0.999827083089274
"LU_TUMOR_VASCULATURE_DN",7,"Down",0.450964759173635,0.999827083089274
"MIKKELSEN_ES_LCP_WITH_H3K4ME3_AND_H3K27ME3",2,"Down",0.451374954524972,0.999827083089274
"NIELSEN_LEIOMYOSARCOMA_UP",12,"Down",0.451534232281657,0.999827083089274
"NAKAMURA_ADIPOGENESIS_LATE_UP",53,"Up",0.451976067438855,0.999827083089274
"KEGG_CALCIUM_SIGNALING_PATHWAY",131,"Up",0.452389796465018,0.999827083089274
"PID_SMAD2_3PATHWAY",10,"Down",0.452470421608089,0.999827083089274
"REACTOME_ER_PHAGOSOME_PATHWAY",44,"Down",0.45255872966773,0.999827083089274
"JISON_SICKLE_CELL_DISEASE_UP",117,"Down",0.452646969155704,0.999827083089274
"REACTOME_HORMONE_LIGAND_BINDING_RECEPTORS",9,"Up",0.452955069042613,0.999827083089274
"YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10",29,"Down",0.45324559288117,0.999827083089274
"PID_REELIN_PATHWAY",26,"Down",0.45347363532793,0.999827083089274
"REACTOME_PI_METABOLISM",18,"Down",0.453531500634689,0.999827083089274
"KOINUMA_COLON_CANCER_MSI_DN",4,"Down",0.453557319511744,0.999827083089274
"TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP",18,"Up",0.453590131584092,0.999827083089274
"CADWELL_ATG16L1_TARGETS_UP",46,"Up",0.453641217410091,0.999827083089274
"CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE",16,"Down",0.453642986934755,0.999827083089274
"FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES_T1",7,"Down",0.453722587096019,0.999827083089274
"REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT",21,"Up",0.453952470375254,0.999827083089274
"HASLINGER_B_CLL_WITH_6Q21_DELETION",4,"Up",0.454193861420471,0.999827083089274
"BIOCARTA_NEUROTRANSMITTERS_PATHWAY",6,"Down",0.454450717480089,0.999827083089274
"WELCH_GATA1_TARGETS",21,"Down",0.454644089478257,0.999827083089274
"NOUZOVA_METHYLATED_IN_APL",18,"Down",0.455287782054621,0.999827083089274
"YAGUE_PRETUMOR_DRUG_RESISTANCE_UP",3,"Up",0.455386274900822,0.999827083089274
"LUI_THYROID_CANCER_CLUSTER_3",14,"Up",0.455569420780503,0.999827083089274
"KEGG_BASAL_TRANSCRIPTION_FACTORS",8,"Up",0.455746315553032,0.999827083089274
"MCBRYAN_PUBERTAL_BREAST_3_4WK_UP",118,"Up",0.456599534144369,0.999827083089274
"EHRLICH_ICF_SYNDROM_DN",11,"Down",0.456844691917092,0.999827083089274
"ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN",13,"Down",0.457011372949196,0.999827083089274
"KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN",10,"Down",0.457191167061962,0.999827083089274
"KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM",36,"Down",0.457209167139346,0.999827083089274
"COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN",65,"Down",0.457624835763637,0.999827083089274
"PHONG_TNF_TARGETS_DN",6,"Down",0.458167848297741,0.999827083089274
"MARSON_FOXP3_TARGETS_STIMULATED_DN",5,"Down",0.458430411305541,0.999827083089274
"GEISS_RESPONSE_TO_DSRNA_UP",24,"Up",0.458478189957325,0.999827083089274
"REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR",15,"Down",0.459335802654882,0.999827083089274
"MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP",42,"Up",0.45952008217595,0.999827083089274
"STAMBOLSKY_BOUND_BY_MUTATED_TP53",10,"Down",0.460863353538504,0.999827083089274
"WU_HBX_TARGETS_3_UP",13,"Up",0.46113057377822,0.999827083089274
"REACTOME_INTERFERON_ALPHA_BETA_SIGNALING",44,"Down",0.461303112818267,0.999827083089274
"REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE",33,"Up",0.461347819327546,0.999827083089274
"PID_S1P_S1P1_PATHWAY",21,"Down",0.461392355118477,0.999827083089274
"MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED",28,"Down",0.461417758331248,0.999827083089274
"STOSSI_RESPONSE_TO_ESTRADIOL",32,"Down",0.461594548345565,0.999827083089274
"LEIN_OLIGODENDROCYTE_MARKERS",34,"Down",0.461689497287428,0.999827083089274
"RICKMAN_HEAD_AND_NECK_CANCER_A",40,"Up",0.462178581906133,0.999827083089274
"BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP",42,"Up",0.462187400910354,0.999827083089274
"BIOCARTA_TID_PATHWAY",14,"Down",0.462463619395706,0.999827083089274
"PHONG_TNF_RESPONSE_VIA_P38_COMPLETE",111,"Up",0.463322672504109,0.999827083089274
"BIOCARTA_PROTEASOME_PATHWAY",21,"Down",0.463382926590327,0.999827083089274
"REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY",7,"Down",0.464009199809324,0.999827083089274
"PID_PS1_PATHWAY",33,"Down",0.464369905379456,0.999827083089274
"TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP",32,"Down",0.464383160211045,0.999827083089274
"KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION",187,"Up",0.464568039205871,0.999827083089274
"KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN",2,"Down",0.464628334163533,0.999827083089274
"REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS",11,"Up",0.464649751093695,0.999827083089274
"WANG_TARGETS_OF_MLL_CBP_FUSION_UP",24,"Up",0.464761191520424,0.999827083089274
"REICHERT_MITOSIS_LIN9_TARGETS",11,"Down",0.464823002574416,0.999827083089274
"BROWN_MYELOID_CELL_DEVELOPMENT_DN",65,"Up",0.464903653541217,0.999827083089274
"HOEGERKORP_CD44_TARGETS_TEMPORAL_UP",6,"Down",0.465296088276047,0.999827083089274
"MIZUSHIMA_AUTOPHAGOSOME_FORMATION",4,"Down",0.465315502376783,0.999827083089274
"BROWNE_HCMV_INFECTION_30MIN_UP",34,"Up",0.465613103888486,0.999827083089274
"DORN_ADENOVIRUS_INFECTION_48HR_UP",9,"Down",0.465617203115272,0.999827083089274
"REACTOME_SEROTONIN_RECEPTORS",11,"Up",0.465947951728534,0.999827083089274
"WEBER_METHYLATED_HCP_IN_SPERM_UP",4,"Up",0.465958748693148,0.999827083089274
"REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS",7,"Down",0.466108430407041,0.999827083089274
"PID_INTEGRIN_A4B1_PATHWAY",28,"Down",0.466195908400764,0.999827083089274
"LAIHO_COLORECTAL_CANCER_SERRATED_UP",54,"Up",0.466533759661823,0.999827083089274
"UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN",33,"Up",0.466711177668222,0.999827083089274
"GEISS_RESPONSE_TO_DSRNA_DN",10,"Down",0.466810895269737,0.999827083089274
"SA_TRKA_RECEPTOR",17,"Down",0.46686016363344,0.999827083089274
"KOBAYASHI_EGFR_SIGNALING_6HR_UP",3,"Down",0.466879369107327,0.999827083089274
"TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_UP",5,"Down",0.467056557361677,0.999827083089274
"JACKSON_DNMT1_TARGETS_UP",68,"Up",0.467115212542257,0.999827083089274
"RASHI_RESPONSE_TO_IONIZING_RADIATION_3",24,"Down",0.467608248160419,0.999827083089274
"REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1",32,"Down",0.46779504833902,0.999827083089274
"ISHIDA_E2F_TARGETS",30,"Down",0.468086538662342,0.999827083089274
"REACTOME_MEIOTIC_SYNAPSIS",18,"Up",0.468131815008199,0.999827083089274
"WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER",39,"Up",0.468327041662027,0.999827083089274
"BIOCARTA_VIP_PATHWAY",25,"Up",0.468805397156212,0.999827083089274
"HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN",65,"Up",0.468871794161134,0.999827083089274
"MANALO_HYPOXIA_DN",97,"Down",0.469562352958071,0.999827083089274
"SOUCEK_MYC_TARGETS",6,"Up",0.469730006824701,0.999827083089274
"PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP",21,"Up",0.469730943274372,0.999827083089274
"GAJATE_RESPONSE_TO_TRABECTEDIN_DN",6,"Down",0.469742770295929,0.999827083089274
"ONGUSAHA_TP53_TARGETS",30,"Down",0.469799127896028,0.999827083089274
"MARSHALL_VIRAL_INFECTION_RESPONSE_UP",4,"Down",0.470036917871661,0.999827083089274
"WANG_BARRETTS_ESOPHAGUS_UP",24,"Up",0.470055870937328,0.999827083089274
"SIG_IL4RECEPTOR_IN_B_LYPHOCYTES",22,"Down",0.470992715330087,0.999827083089274
"BOYLAN_MULTIPLE_MYELOMA_PCA3_UP",32,"Up",0.471224059528254,0.999827083089274
"JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP",60,"Up",0.471992572022791,0.999827083089274
"SANSOM_APC_TARGETS_UP",65,"Down",0.472083440895799,0.999827083089274
"GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN",34,"Up",0.472207474242772,0.999827083089274
"FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN",31,"Down",0.472223023705854,0.999827083089274
"HOFMANN_CELL_LYMPHOMA_UP",45,"Up",0.472301794390486,0.999827083089274
"LIU_IL13_PRIMING_MODEL",9,"Down",0.472392395353043,0.999827083089274
"WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP",8,"Down",0.472547893854214,0.999827083089274
"REACTOME_REGULATION_OF_SIGNALING_BY_CBL",16,"Down",0.473025150654482,0.999827083089274
"REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS",16,"Up",0.473708851033826,0.999827083089274
"BIOCARTA_INSULIN_PATHWAY",19,"Down",0.473734499805612,0.999827083089274
"TOOKER_GEMCITABINE_RESISTANCE_UP",38,"Down",0.474115393672851,0.999827083089274
"SASAKI_TARGETS_OF_TP73_AND_TP63",8,"Down",0.474271143263598,0.999827083089274
"ZHANG_TLX_TARGETS_60HR_DN",127,"Down",0.474405683885444,0.999827083089274
"COLINA_TARGETS_OF_4EBP1_AND_4EBP2",172,"Down",0.474544892402683,0.999827083089274
"LINDSTEDT_DENDRITIC_CELL_MATURATION_C",44,"Down",0.474597212730301,0.999827083089274
"GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN",6,"Down",0.474813357626009,0.999827083089274
"PID_LKB1_PATHWAY",26,"Down",0.474989710468699,0.999827083089274
"BROWNE_HCMV_INFECTION_14HR_UP",67,"Down",0.475035630253547,0.999827083089274
"NAKAMURA_METASTASIS_MODEL_UP",18,"Down",0.475124569889771,0.999827083089274
"KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES",62,"Up",0.475980882662826,0.999827083089274
"ISHIDA_TARGETS_OF_SYT_SSX_FUSIONS",5,"Down",0.476170198165511,0.999827083089274
"IWANAGA_CARCINOGENESIS_BY_KRAS_UP",74,"Down",0.476240568189898,0.999827083089274
"REACTOME_AMINE_COMPOUND_SLC_TRANSPORTERS",9,"Down",0.476284573288768,0.999827083089274
"GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN",47,"Down",0.476344534551572,0.999827083089274
"BAKER_HEMATOPOESIS_STAT1_TARGETS",10,"Up",0.476386307106504,0.999827083089274
"GABRIELY_MIR21_TARGETS",86,"Down",0.47661084500105,0.999827083089274
"BIOCARTA_FEEDER_PATHWAY",4,"Down",0.476820569526893,0.999827083089274
"LEIN_MIDBRAIN_MARKERS",34,"Down",0.476987015389038,0.999827083089274
"JAIN_NFKB_SIGNALING",27,"Down",0.47700251079893,0.999827083089274
"FRASOR_RESPONSE_TO_ESTRADIOL_DN",48,"Up",0.477027685529871,0.999827083089274
"MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP",83,"Down",0.477041306038562,0.999827083089274
"HOWLIN_CITED1_TARGETS_1_UP",16,"Up",0.477198228201205,0.999827083089274
"LUI_THYROID_CANCER_CLUSTER_1",30,"Down",0.477982503520243,0.999827083089274
"THEODOROU_MAMMARY_TUMORIGENESIS",18,"Down",0.478049171749667,0.999827083089274
"PID_AR_TF_PATHWAY",46,"Up",0.478374769718004,0.999827083089274
"MELLMAN_TUT1_TARGETS_DN",21,"Down",0.478510938462577,0.999827083089274
"KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD",17,"Down",0.478562609143047,0.999827083089274
"GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP",43,"Up",0.478783151549843,0.999827083089274
"KEGG_GLIOMA",51,"Down",0.478966090899575,0.999827083089274
"KAUFFMANN_DNA_REPAIR_GENES",125,"Down",0.479282422776275,0.999827083089274
"MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN",13,"Up",0.479392553413862,0.999827083089274
"REACTOME_FACILITATIVE_NA_INDEPENDENT_GLUCOSE_TRANSPORTERS",4,"Down",0.479835972140658,0.999827083089274
"NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN",10,"Down",0.480079488742221,0.999827083089274
"SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3",45,"Up",0.480225563519373,0.999827083089274
"PID_ARF_3PATHWAY",11,"Up",0.480260064846761,0.999827083089274
"PROVENZANI_METASTASIS_UP",85,"Up",0.480469504336438,0.999827083089274
"LE_NEURONAL_DIFFERENTIATION_UP",10,"Up",0.480780145871535,0.999827083089274
"PID_ERBB_NETWORK_PATHWAY",12,"Down",0.480923212918686,0.999827083089274
"HARRIS_BRAIN_CANCER_PROGENITORS",23,"Up",0.481032758458952,0.999827083089274
"REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE",19,"Down",0.481349181623905,0.999827083089274
"GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN",9,"Down",0.481432952867655,0.999827083089274
"ZHAN_MULTIPLE_MYELOMA_UP",32,"Up",0.481530260988851,0.999827083089274
"DORN_ADENOVIRUS_INFECTION_24HR_DN",33,"Up",0.481702701760203,0.999827083089274
"RUAN_RESPONSE_TO_TROGLITAZONE_UP",24,"Down",0.48180427647646,0.999827083089274
"HSIAO_LIVER_SPECIFIC_GENES",160,"Down",0.482391200071204,0.999827083089274
"WANG_HCP_PROSTATE_CANCER",50,"Up",0.482637179778899,0.999827083089274
"REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE",14,"Down",0.48271574271514,0.999827083089274
"GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION",19,"Down",0.482728731326574,0.999827083089274
"PARK_APL_PATHOGENESIS_DN",36,"Up",0.483029768537018,0.999827083089274
"ELVIDGE_HIF1A_TARGETS_UP",24,"Down",0.483293437886077,0.999827083089274
"OSADA_ASCL1_TARGETS_DN",18,"Up",0.483579392727586,0.999827083089274
"ROSS_AML_WITH_MLL_FUSIONS",37,"Down",0.483612408694879,0.999827083089274
"MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED",23,"Up",0.483831419365158,0.999827083089274
"BOYLAN_MULTIPLE_MYELOMA_D_DN",37,"Up",0.483870605471033,0.999827083089274
"ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP",26,"Up",0.483996657283085,0.999827083089274
"MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17",10,"Down",0.484341425624885,0.999827083089274
"KEGG_MISMATCH_REPAIR",13,"Down",0.484588426409726,0.999827083089274
"PID_P38_ALPHA_BETA_PATHWAY",24,"Down",0.484683537368269,0.999827083089274
"KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN",50,"Down",0.484828670959865,0.999827083089274
"NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_DN",16,"Down",0.484916564553154,0.999827083089274
"WENG_POR_TARGETS_GLOBAL_DN",12,"Down",0.485241058400995,0.999827083089274
"REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION",52,"Up",0.485595990339294,0.999827083089274
"YIH_RESPONSE_TO_ARSENITE_C1",19,"Down",0.48575963819191,0.999827083089274
"MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3",19,"Up",0.485800614027417,0.999827083089274
"LIU_COMMON_CANCER_GENES",24,"Up",0.485986069805915,0.999827083089274
"BIOCARTA_NKCELLS_PATHWAY",25,"Down",0.485988270100443,0.999827083089274
"BIOCARTA_ERK_PATHWAY",26,"Down",0.486163371925768,0.999827083089274
"GESERICK_TERT_TARGETS_DN",18,"Up",0.48625829277749,0.999827083089274
"BIOCARTA_ALK_PATHWAY",35,"Up",0.486275590026656,0.999827083089274
"IGARASHI_ATF4_TARGETS_DN",40,"Up",0.486370290559643,0.999827083089274
"BIOCARTA_CSK_PATHWAY",19,"Down",0.486423045891095,0.999827083089274
"AGARWAL_AKT_PATHWAY_TARGETS",10,"Down",0.486470986596664,0.999827083089274
"KAMIKUBO_MYELOID_CEBPA_NETWORK",21,"Up",0.486667137508671,0.999827083089274
"MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP",15,"Down",0.486939553917339,0.999827083089274
"CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN",43,"Down",0.48710470702493,0.999827083089274
"REACTOME_RNA_POL_III_TRANSCRIPTION_TERMINATION",6,"Down",0.487448835700513,0.999827083089274
"PECE_MAMMARY_STEM_CELL_UP",74,"Up",0.487528040672263,0.999827083089274
"REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM",7,"Down",0.487701461060514,0.999827083089274
"KEGG_DORSO_VENTRAL_AXIS_FORMATION",16,"Down",0.487977175957905,0.999827083089274
"ROME_INSULIN_TARGETS_IN_MUSCLE_DN",61,"Down",0.488098205102535,0.999827083089274
"PID_BMP_PATHWAY",25,"Up",0.48824355291849,0.999827083089274
"BIOCARTA_MCM_PATHWAY",15,"Up",0.488443983037688,0.999827083089274
"AMIT_EGF_RESPONSE_120_HELA",38,"Up",0.488469536581087,0.999827083089274
"PIONTEK_PKD1_TARGETS_UP",21,"Up",0.488481109334285,0.999827083089274
"BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP",17,"Up",0.488700877122692,0.999827083089274
"KORKOLA_TERATOMA_UP",10,"Up",0.489118016068781,0.999827083089274
"HAHTOLA_CTCL_PATHOGENESIS",8,"Up",0.489161195282962,0.999827083089274
"KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS",4,"Up",0.489393653439947,0.999827083089274
"ZHU_CMV_ALL_UP",77,"Down",0.489905678354936,0.999827083089274
"COLDREN_GEFITINIB_RESISTANCE_UP",22,"Down",0.489931021850063,0.999827083089274
"MIZUKAMI_HYPOXIA_DN",5,"Down",0.489938430751119,0.999827083089274
"BIOCARTA_CARDIACEGF_PATHWAY",18,"Down",0.490056367118245,0.999827083089274
"BIOCARTA_CERAMIDE_PATHWAY",20,"Down",0.490300904406714,0.999827083089274
"YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2",44,"Down",0.490340803581187,0.999827083089274
"LI_DCP2_BOUND_MRNA",30,"Up",0.490655834711454,0.999827083089274
"COURTOIS_SENESCENCE_TRIGGERS",5,"Down",0.490748856327237,0.999827083089274
"GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_UP",6,"Down",0.491115403679464,0.999827083089274
"REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX",34,"Down",0.491227744873432,0.999827083089274
"WHITFIELD_CELL_CYCLE_S",52,"Down",0.491227749005022,0.999827083089274
"REACTOME_GLYCOLYSIS",20,"Up",0.4914327620036,0.999827083089274
"ZUCCHI_METASTASIS_UP",23,"Down",0.492356922166985,0.999827083089274
"WATANABE_COLON_CANCER_MSI_VS_MSS_DN",31,"Down",0.492541506939839,0.999827083089274
"REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PLC_BETA",18,"Up",0.492613707168666,0.999827083089274
"REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1",32,"Down",0.493140785309305,0.999827083089274
"KOHOUTEK_CCNT2_TARGETS",21,"Down",0.493166697921965,0.999827083089274
"VANASSE_BCL2_TARGETS_UP",22,"Up",0.493332491945166,0.999827083089274
"TCGA_GLIOBLASTOMA_COPY_NUMBER_UP",27,"Up",0.493613725121105,0.999827083089274
"ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN",31,"Down",0.493664892057213,0.999827083089274
"TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP",78,"Down",0.493720355005013,0.999827083089274
"HEDVAT_ELF4_TARGETS_UP",8,"Up",0.493975263146608,0.999827083089274
"RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_UP",5,"Down",0.493996761263603,0.999827083089274
"SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE",37,"Up",0.494035109990674,0.999827083089274
"KEGG_TYROSINE_METABOLISM",25,"Down",0.494177863787971,0.999827083089274
"ST_INTERLEUKIN_4_PATHWAY",21,"Down",0.494826002500426,0.999827083089274
"MATZUK_SPERMATOZOA",65,"Down",0.49483658059464,0.999827083089274
"TERAO_AOX4_TARGETS_HG_UP",9,"Down",0.494931188349232,0.999827083089274
"BIOCARTA_EIF2_PATHWAY",7,"Up",0.4952200075223,0.999827083089274
"KREPPEL_CD99_TARGETS_UP",2,"Up",0.495862752036399,0.999827083089274
"SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM",25,"Up",0.495896555436744,0.999827083089274
"FIGUEROA_AML_METHYLATION_CLUSTER_7_DN",1,"Up",0.496037299983356,0.999827083089274
"DELPUECH_FOXO3_TARGETS_DN",20,"Up",0.4968913244427,0.999827083089274
"REACTOME_MEMBRANE_BINDING_AND_TARGETTING_OF_GAG_PROTEINS",2,"Down",0.496947533317701,0.999827083089274
"TIEN_INTESTINE_PROBIOTICS_2HR_DN",25,"Up",0.497231163998235,0.999827083089274
"CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP",16,"Up",0.497800603818776,0.999827083089274
"BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_DN",5,"Down",0.49791027869248,0.999827083089274
"MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP",11,"Up",0.497979604168829,0.999827083089274
"REACTOME_XENOBIOTICS",13,"Up",0.497984998916572,0.999827083089274
"WENG_POR_TARGETS_LIVER_UP",23,"Up",0.498249448636242,0.999827083089274
"HUTTMANN_B_CLL_POOR_SURVIVAL_UP",136,"Up",0.498605297400798,0.999827083089274
"BIOCARTA_BLYMPHOCYTE_PATHWAY",8,"Up",0.498746551358849,0.999827083089274
"PID_ERBB1_DOWNSTREAM_PATHWAY",71,"Down",0.498885343563383,0.999827083089274
"REACTOME_PLATELET_HOMEOSTASIS",53,"Up",0.499150157926222,0.999827083089274
"KERLEY_RESPONSE_TO_CISPLATIN_DN",4,"Down",0.499241078974537,0.999827083089274
"REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX",42,"Down",0.499423617190639,0.999827083089274
"PID_BETA_CATENIN_DEG_PATHWAY",13,"Down",0.499460738916949,0.999827083089274
"PID_VEGF_VEGFR_PATHWAY",10,"Up",0.499562259056911,0.999827083089274
"HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_DN",7,"Up",0.499693190106493,0.999827083089274
"KEGG_LYSINE_DEGRADATION",11,"Down",0.500056480604326,0.999827083089274
"CASTELLANO_HRAS_TARGETS_UP",5,"Down",0.500197125859421,0.999827083089274
"REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION",59,"Up",0.500310981477912,0.999827083089274
"ZHENG_RESPONSE_TO_ARSENITE_UP",8,"Up",0.500389617874203,0.999827083089274
"WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP",22,"Down",0.500517376616532,0.999827083089274
"TCGA_GLIOBLASTOMA_COPY_NUMBER_DN",11,"Down",0.500737396153434,0.999827083089274
"VERRECCHIA_RESPONSE_TO_TGFB1_C2",21,"Up",0.500817790355323,0.999827083089274
"PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN",14,"Up",0.500981917760833,0.999827083089274
"ROSS_LEUKEMIA_WITH_MLL_FUSIONS",43,"Down",0.501118243270304,0.999827083089274
"TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP",44,"Down",0.501460240211101,0.999827083089274
"RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN",25,"Up",0.501525237858889,0.999827083089274
"KEGG_GLYCOLYSIS_GLUCONEOGENESIS",36,"Down",0.501645359543608,0.999827083089274
"ZHAN_MULTIPLE_MYELOMA_PR_DN",15,"Down",0.501688389050787,0.999827083089274
"REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE",8,"Down",0.501779965226875,0.999827083089274
"BIOCARTA_BCR_PATHWAY",32,"Down",0.502066751228489,0.999827083089274
"VALK_AML_CLUSTER_12",21,"Down",0.50225106907719,0.999827083089274
"BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN",87,"Down",0.502404516344604,0.999827083089274
"MIKKELSEN_PLURIPOTENT_STATE_UP",3,"Down",0.502409755379878,0.999827083089274
"XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN",13,"Up",0.502456697897543,0.999827083089274
"WEBER_METHYLATED_LCP_IN_SPERM_DN",2,"Down",0.502587109061817,0.999827083089274
"BAKER_HEMATOPOIESIS_STAT3_TARGETS",16,"Down",0.502597419853293,0.999827083089274
"GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN",29,"Down",0.502622515225618,0.999827083089274
"RODRIGUES_THYROID_CARCINOMA_DN",34,"Down",0.502816170503597,0.999827083089274
"PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP",60,"Up",0.503206136725355,0.999827083089274
"KAN_RESPONSE_TO_ARSENIC_TRIOXIDE",72,"Up",0.503210033557542,0.999827083089274
"STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP",54,"Down",0.50332763781518,0.999827083089274
"TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP",6,"Down",0.503563830810307,0.999827083089274
"PID_DELTA_NP63_PATHWAY",34,"Up",0.503609577947315,0.999827083089274
"ST_JNK_MAPK_PATHWAY",31,"Up",0.503657093073589,0.999827083089274
"OXFORD_RALB_TARGETS_DN",2,"Down",0.503672947123473,0.999827083089274
"KEGG_ALPHA_LINOLENIC_ACID_METABOLISM",10,"Up",0.503740580256417,0.999827083089274
"SWEET_KRAS_TARGETS_UP",52,"Down",0.50395327489125,0.999827083089274
"GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP",12,"Down",0.504284464766064,0.999827083089274
"FIRESTEIN_CTNNB1_PATHWAY",15,"Up",0.504411238056675,0.999827083089274
"REACTOME_SIGNALLING_TO_ERKS",24,"Down",0.505037701450258,0.999827083089274
"REACTOME_RESPIRATORY_ELECTRON_TRANSPORT",25,"Down",0.505555947439916,0.999827083089274
"VIETOR_IFRD1_TARGETS",8,"Down",0.50561214975597,0.999827083089274
"MASSARWEH_RESPONSE_TO_ESTRADIOL",26,"Up",0.505767593708081,0.999827083089274
"CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP",12,"Up",0.505881075663601,0.999827083089274
"FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN",17,"Down",0.505912598148999,0.999827083089274
"REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION",66,"Down",0.506114471618929,0.999827083089274
"FIGUEROA_AML_METHYLATION_CLUSTER_3_DN",7,"Up",0.506213397905795,0.999827083089274
"DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP",143,"Down",0.506262166503355,0.999827083089274
"ZHANG_GATA6_TARGETS_DN",25,"Down",0.506304524724389,0.999827083089274
"REACTOME_COLLAGEN_FORMATION",39,"Down",0.506456658448315,0.999827083089274
"REACTOME_P38MAPK_EVENTS",9,"Down",0.506555152453683,0.999827083089274
"REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION",7,"Up",0.506579422437761,0.999827083089274
"REACTOME_TRNA_AMINOACYLATION",7,"Up",0.506579422437761,0.999827083089274
"MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_DN",6,"Down",0.506636227974058,0.999827083089274
"PID_ANTHRAX_PATHWAY",14,"Down",0.50679707734263,0.999827083089274
"DELACROIX_RAR_TARGETS_UP",34,"Up",0.506908853591717,0.999827083089274
"HOLLEMAN_DAUNORUBICIN_B_ALL_DN",4,"Down",0.507158777015964,0.999827083089274
"ST_T_CELL_SIGNAL_TRANSDUCTION",33,"Down",0.50717905357364,0.999827083089274
"SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP",37,"Down",0.507188648558714,0.999827083089274
"MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3",52,"Up",0.507205421626649,0.999827083089274
"RIGGINS_TAMOXIFEN_RESISTANCE_DN",104,"Up",0.507685210519168,0.999827083089274
"PID_CIRCADIAN_PATHWAY",11,"Up",0.507948117005174,0.999827083089274
"BILANGES_SERUM_SENSITIVE_VIA_TSC2",13,"Down",0.508074631659389,0.999827083089274
"LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE",30,"Down",0.508931999156885,0.999827083089274
"CAFFAREL_RESPONSE_TO_THC_8HR_3_DN",5,"Up",0.50911709799193,0.999827083089274
"REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING",20,"Up",0.509507826966258,0.999827083089274
"BIOCARTA_RAS_PATHWAY",19,"Down",0.509645948128179,0.999827083089274
"WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP",80,"Up",0.509666755463738,0.999827083089274
"REACTOME_RNA_POL_I_PROMOTER_OPENING",8,"Down",0.509693674256691,0.999827083089274
"BIOCARTA_IGF1R_PATHWAY",20,"Down",0.51002186081893,0.999827083089274
"REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_GLUCAGON_LIKE_PEPTIDE1",29,"Up",0.51011237856458,0.999827083089274
"SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN",15,"Down",0.510370551169823,0.999827083089274
"CHOI_ATL_ACUTE_STAGE",4,"Down",0.510370752142451,0.999827083089274
"RIZ_ERYTHROID_DIFFERENTIATION_HEMGN",27,"Up",0.510427392785177,0.999827083089274
"KORKOLA_CHORIOCARCINOMA",7,"Up",0.510621771638095,0.999827083089274
"REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS",28,"Down",0.510627664198211,0.999827083089274
"PID_SYNDECAN_4_PATHWAY",27,"Down",0.510687334554036,0.999827083089274
"PID_MTOR_4PATHWAY",42,"Down",0.511203008197153,0.999827083089274
"MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_18",2,"Up",0.511434505508829,0.999827083089274
"REACTOME_EXTENSION_OF_TELOMERES",15,"Down",0.511660076616803,0.999827083089274
"KEGG_RENAL_CELL_CARCINOMA",49,"Down",0.511841804454026,0.999827083089274
"DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN",38,"Down",0.512144696868939,0.999827083089274
"FUKUSHIMA_TNFSF11_TARGETS",15,"Down",0.51220774340858,0.999827083089274
"VANLOO_SP3_TARGETS_DN",37,"Down",0.512240777383722,0.999827083089274
"DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP",30,"Down",0.512459474263731,0.999827083089274
"BURTON_ADIPOGENESIS_PEAK_AT_16HR",31,"Down",0.51251337070886,0.999827083089274
"FERRANDO_LYL1_NEIGHBORS",13,"Up",0.512536513003321,0.999827083089274
"REACTOME_CALNEXIN_CALRETICULIN_CYCLE",5,"Up",0.512615616397414,0.999827083089274
"REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE",5,"Up",0.512615616397414,0.999827083089274
"SHIN_B_CELL_LYMPHOMA_CLUSTER_1",12,"Down",0.512901597989941,0.999827083089274
"VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN",15,"Up",0.513199219579659,0.999827083089274
"BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN",17,"Down",0.513329454317184,0.999827083089274
"BIOCARTA_TRKA_PATHWAY",12,"Down",0.513662022466385,0.999827083089274
"PID_NCADHERIN_PATHWAY",30,"Down",0.513781836609754,0.999827083089274
"BIOCARTA_GPCR_PATHWAY",29,"Down",0.513887415800381,0.999827083089274
"BIOCARTA_PML_PATHWAY",15,"Down",0.513919401285025,0.999827083089274
"WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN",13,"Down",0.513970977227835,0.999827083089274
"LEIN_CHOROID_PLEXUS_MARKERS",47,"Down",0.514222335205993,0.999827083089274
"HONMA_DOCETAXEL_RESISTANCE",22,"Up",0.514566617851077,0.999827083089274
"ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP",41,"Up",0.514578512764315,0.999827083089274
"APPIERTO_RESPONSE_TO_FENRETINIDE_DN",23,"Up",0.514582994876796,0.999827083089274
"HASLINGER_B_CLL_WITH_13Q14_DELETION",14,"Up",0.514757283073738,0.999827083089274
"LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL",10,"Down",0.514988562913236,0.999827083089274
"PID_AVB3_INTEGRIN_PATHWAY",66,"Down",0.515331112900172,0.999827083089274
"ROVERSI_GLIOMA_COPY_NUMBER_DN",21,"Up",0.515490023837502,0.999827083089274
"SUZUKI_CTCFL_TARGETS_UP",6,"Down",0.515689011664298,0.999827083089274
"BIOCARTA_PITX2_PATHWAY",11,"Down",0.515803732129975,0.999827083089274
"KEGG_TYPE_II_DIABETES_MELLITUS",37,"Down",0.515819418360435,0.999827083089274
"CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_UP",3,"Up",0.51592406270803,0.999827083089274
"DORMOY_ELAVL1_TARGETS",9,"Down",0.51635666357933,0.999827083089274
"MATZUK_LUTEAL_GENES",8,"Up",0.516565060696576,0.999827083089274
"SMID_BREAST_CANCER_LUMINAL_A_DN",8,"Up",0.517085885231088,0.999827083089274
"REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS",12,"Down",0.517170587792544,0.999827083089274
"ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF",24,"Up",0.517297450861701,0.999827083089274
"BIOCARTA_EIF4_PATHWAY",20,"Down",0.517716291225895,0.999827083089274
"JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP",39,"Down",0.517767392435972,0.999827083089274
"KEGG_BETA_ALANINE_METABOLISM",8,"Down",0.51798959632576,0.999827083089274
"MAINA_VHL_TARGETS_UP",8,"Up",0.518136821358834,0.999827083089274
"REACTOME_TOLL_RECEPTOR_CASCADES",68,"Up",0.518809616017331,0.999827083089274
"RICKMAN_METASTASIS_UP",73,"Down",0.518910962387455,0.999827083089274
"PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN",23,"Down",0.518997773548072,0.999827083089274
"REACTOME_GLUCURONIDATION",3,"Down",0.519003324277752,0.999827083089274
"JIANG_VHL_TARGETS",49,"Down",0.519290967894113,0.999827083089274
"XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP",10,"Down",0.519432591158448,0.999827083089274
"KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS",4,"Up",0.519574423851499,0.999827083089274
"KEGG_NUCLEOTIDE_EXCISION_REPAIR",24,"Down",0.51974707544286,0.999827083089274
"REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION",53,"Up",0.519837456367443,0.999827083089274
"REACTOME_PACKAGING_OF_TELOMERE_ENDS",5,"Down",0.520285301813028,0.999827083089274
"LEE_DOUBLE_POLAR_THYMOCYTE",12,"Up",0.520660775382962,0.999827083089274
"GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN",54,"Down",0.520993472015234,0.999827083089274
"BROWNE_HCMV_INFECTION_1HR_UP",39,"Up",0.521181537771931,0.999827083089274
"WEI_MYCN_TARGETS_WITH_E_BOX",244,"Down",0.521237095966611,0.999827083089274
"MODY_HIPPOCAMPUS_PRENATAL",27,"Up",0.521281622855674,0.999827083089274
"KEGG_AUTOIMMUNE_THYROID_DISEASE",47,"Down",0.521347883405298,0.999827083089274
"SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN",17,"Up",0.52136926543773,0.999827083089274
"GERHOLD_ADIPOGENESIS_DN",60,"Down",0.521378864894246,0.999827083089274
"CHANG_CYCLING_GENES",58,"Down",0.521478043735689,0.999827083089274
"PID_IL6_7_PATHWAY",41,"Up",0.522006892154503,0.999827083089274
"TSAI_RESPONSE_TO_RADIATION_THERAPY",25,"Down",0.522224693442005,0.999827083089274
"ZIRN_TRETINOIN_RESPONSE_WT1_UP",11,"Up",0.522268395713999,0.999827083089274
"SENESE_HDAC2_TARGETS_UP",51,"Down",0.522334295336187,0.999827083089274
"PID_AMB2_NEUTROPHILS_PATHWAY",35,"Down",0.522548915718972,0.999827083089274
"BIOCARTA_RELA_PATHWAY",14,"Up",0.522609939529817,0.999827083089274
"SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM",66,"Down",0.522817269123726,0.999827083089274
"MARKS_HDAC_TARGETS_DN",15,"Down",0.523236055158482,0.999827083089274
"COLLIS_PRKDC_SUBSTRATES",14,"Up",0.523355022572289,0.999827083089274
"BOYLAN_MULTIPLE_MYELOMA_D_UP",30,"Down",0.523358493853048,0.999827083089274
"MORI_SMALL_PRE_BII_LYMPHOCYTE_DN",40,"Up",0.523710996525135,0.999827083089274
"REACTOME_NFKB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL",8,"Up",0.524057536888967,0.999827083089274
"MORI_SMALL_PRE_BII_LYMPHOCYTE_UP",48,"Up",0.524145373111518,0.999827083089274
"VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP",8,"Up",0.524727458607446,0.999827083089274
"ROESSLER_LIVER_CANCER_METASTASIS_DN",6,"Down",0.524837793409797,0.999827083089274
"GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP",31,"Up",0.524863445898712,0.999827083089274
"SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP",7,"Up",0.525025753864052,0.999827083089274
"BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP",20,"Up",0.525027743214273,0.999827083089274
"WINNEPENNINCKX_MELANOMA_METASTASIS_DN",18,"Up",0.525233224450587,0.999827083089274
"BIOCARTA_IL17_PATHWAY",15,"Down",0.525284313118541,0.999827083089274
"REACTOME_INTEGRIN_ALPHAIIB_BETA3_SIGNALING",20,"Up",0.525772727607129,0.999827083089274
"TSAI_DNAJB4_TARGETS_DN",4,"Up",0.525817289137076,0.999827083089274
"FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_DN",4,"Down",0.526363283384172,0.999827083089274
"REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT",12,"Down",0.526367391707024,0.999827083089274
"JACKSON_DNMT1_TARGETS_DN",23,"Up",0.52640664630433,0.999827083089274
"PID_P38_MK2_PATHWAY",17,"Down",0.526502605301846,0.999827083089274
"BIOCARTA_MEF2D_PATHWAY",15,"Down",0.52700895663239,0.999827083089274
"BILD_SRC_ONCOGENIC_SIGNATURE",23,"Down",0.527194173837212,0.999827083089274
"GERHOLD_ADIPOGENESIS_UP",47,"Down",0.527250521179603,0.999827083089274
"GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP",33,"Up",0.527526866514307,0.999827083089274
"OHASHI_AURKB_TARGETS",6,"Up",0.527542161225232,0.999827083089274
"BIOCARTA_VEGF_PATHWAY",23,"Down",0.527584086423361,0.999827083089274
"CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN",23,"Up",0.527802210948797,0.999827083089274
"BURTON_ADIPOGENESIS_9",59,"Up",0.527958019182699,0.999827083089274
"MORI_PLASMA_CELL_UP",11,"Up",0.528067666656087,0.999827083089274
"KIM_PTEN_TARGETS_UP",9,"Down",0.52816305796559,0.999827083089274
"SHIN_B_CELL_LYMPHOMA_CLUSTER_2",23,"Down",0.528321632053458,0.999827083089274
"YANG_MUC2_TARGETS_DUODENUM_3MO_DN",15,"Up",0.528342891367419,0.999827083089274
"SESTO_RESPONSE_TO_UV_C2",34,"Up",0.52870119059756,0.999827083089274
"TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN",12,"Up",0.528951167045986,0.999827083089274
"GENTILE_UV_RESPONSE_CLUSTER_D8",21,"Down",0.529156442476249,0.999827083089274
"LEE_LIVER_CANCER_E2F1_UP",52,"Up",0.529602435015561,0.999827083089274
"GHANDHI_DIRECT_IRRADIATION_DN",11,"Up",0.529639752201523,0.999827083089274
"SCHMAHL_PDGF_SIGNALING",2,"Down",0.52974677102015,0.999827083089274
"SCHRAMM_INHBA_TARGETS_DN",18,"Up",0.529814966781129,0.999827083089274
"GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP",4,"Up",0.529822947258175,0.999827083089274
"XU_CREBBP_TARGETS_UP",14,"Down",0.529875257953397,0.999827083089274
"BRUNEAU_SEPTATION_ATRIAL",4,"Up",0.529930719123135,0.999827083089274
"BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP",18,"Up",0.529969928770387,0.999827083089274
"ZHAN_LATE_DIFFERENTIATION_GENES_UP",22,"Up",0.530151913167945,0.999827083089274
"BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP",14,"Up",0.530443277664267,0.999827083089274
"LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP",46,"Up",0.530649405206158,0.999827083089274
"REACTOME_PURINE_METABOLISM",19,"Up",0.531979034342075,0.999827083089274
"WENG_POR_TARGETS_GLOBAL_UP",10,"Up",0.532097139697465,0.999827083089274
"BIOCARTA_HER2_PATHWAY",17,"Down",0.532405333432041,0.999827083089274
"FIGUEROA_AML_METHYLATION_CLUSTER_6_DN",11,"Down",0.532432077035513,0.999827083089274
"DISTECHE_ESCAPED_FROM_X_INACTIVATION",12,"Down",0.532549537771339,0.999827083089274
"REACTOME_NUCLEOTIDE_EXCISION_REPAIR",26,"Down",0.532633290102745,0.999827083089274
"AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53",50,"Down",0.532833592893251,0.999827083089274
"GRANDVAUX_IRF3_TARGETS_UP",5,"Down",0.533080474638702,0.999827083089274
"BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP",11,"Up",0.533140952582565,0.999827083089274
"BIOCARTA_STRESS_PATHWAY",23,"Up",0.533333890847345,0.999827083089274
"WEBER_METHYLATED_HCP_IN_SPERM_DN",7,"Down",0.533409011065009,0.999827083089274
"KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM",7,"Up",0.533640330762358,0.999827083089274
"NADLER_OBESITY_UP",51,"Up",0.533729012713526,0.999827083089274
"REACTOME_TRANSCRIPTION",59,"Down",0.533845843023884,0.999827083089274
"ONO_FOXP3_TARGETS_UP",19,"Down",0.53409020705529,0.999827083089274
"KEGG_THYROID_CANCER",25,"Down",0.534180073891916,0.999827083089274
"BIOCARTA_G2_PATHWAY",19,"Down",0.534187407816742,0.999827083089274
"AIGNER_ZEB1_TARGETS",18,"Down",0.534641046854797,0.999827083089274
"KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP",45,"Down",0.535069619552382,0.999827083089274
"NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN",66,"Up",0.535181386853529,0.999827083089274
"GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP",61,"Down",0.535210261362247,0.999827083089274
"REACTOME_METABOLISM_OF_RNA",107,"Down",0.535324008783195,0.999827083089274
"GUILLAUMOND_KLF10_TARGETS_UP",29,"Up",0.535606688138417,0.999827083089274
"PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN",59,"Up",0.535606955794643,0.999827083089274
"MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_27",7,"Down",0.535933494626267,0.999827083089274
"REACTOME_KINESINS",14,"Down",0.537245130668759,0.999827083089274
"BEIER_GLIOMA_STEM_CELL_DN",27,"Down",0.537328018953199,0.999827083089274
"REACTOME_SIGNALING_BY_NOTCH2",7,"Down",0.537556746700722,0.999827083089274
"BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP",42,"Up",0.537693330391108,0.999827083089274
"ZAMORA_NOS2_TARGETS_DN",73,"Up",0.537883451683214,0.999827083089274
"VALK_AML_CLUSTER_10",13,"Down",0.538065695192181,0.999827083089274
"GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN",14,"Down",0.538099257106458,0.999827083089274
"GROSS_HYPOXIA_VIA_HIF1A_ONLY",6,"Up",0.538220393492112,0.999827083089274
"PID_ARF6_DOWNSTREAM_PATHWAY",12,"Up",0.538407626917718,0.999827083089274
"REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY",5,"Up",0.538548061288709,0.999827083089274
"NAKAYAMA_FRA2_TARGETS",18,"Down",0.538655790998256,0.999827083089274
"LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN",10,"Down",0.539351108321547,0.999827083089274
"BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN",30,"Down",0.539839886688917,0.999827083089274
"OUILLETTE_CLL_13Q14_DELETION_UP",13,"Down",0.539885736248828,0.999827083089274
"LEI_HOXC8_TARGETS_DN",14,"Down",0.540365100634883,0.999827083089274
"HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP",11,"Up",0.540483199336597,0.999827083089274
"REACTOME_SYNTHESIS_OF_PA",14,"Up",0.54086288880738,0.999827083089274
"BIOCARTA_SHH_PATHWAY",13,"Up",0.541042500160984,0.999827083089274
"ZHU_SKIL_TARGETS_UP",17,"Down",0.541143005312682,0.999827083089274
"ZUCCHI_METASTASIS_DN",29,"Up",0.54126371018635,0.999827083089274
"KANG_FLUOROURACIL_RESISTANCE_UP",15,"Up",0.541611851454767,0.999827083089274
"NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_UP",14,"Up",0.541883320672604,0.999827083089274
"KEGG_LONG_TERM_DEPRESSION",54,"Up",0.542465248271514,0.999827083089274
"HUMMERICH_MALIGNANT_SKIN_TUMOR_DN",13,"Up",0.542661016505995,0.999827083089274
"WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN",26,"Up",0.542958700589335,0.999827083089274
"NABA_ECM_AFFILIATED",74,"Up",0.543151480295517,0.999827083089274
"KATSANOU_ELAVL1_TARGETS_DN",70,"Up",0.543335855869059,0.999827083089274
"IRITANI_MAD1_TARGETS_DN",25,"Up",0.543420158983731,0.999827083089274
"CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2",79,"Down",0.544004684243602,0.999827083089274
"VANHARANTA_UTERINE_FIBROID_DN",38,"Up",0.544295269341364,0.999827083089274
"REACTOME_S_PHASE",74,"Down",0.544329212028063,0.999827083089274
"PID_LIS1_PATHWAY",25,"Down",0.544417799498464,0.999827083089274
"OXFORD_RALB_TARGETS_UP",5,"Up",0.544835225419943,0.999827083089274
"DING_LUNG_CANCER_MUTATED_FREQUENTLY",10,"Down",0.544844657540445,0.999827083089274
"KERLEY_RESPONSE_TO_CISPLATIN_UP",26,"Down",0.545687243988209,0.999827083089274
"BIOCARTA_ARAP_PATHWAY",6,"Up",0.546181988058824,0.999827083089274
"SANA_TNF_SIGNALING_DN",45,"Up",0.546424778832817,0.999827083089274
"BOUDOUKHA_BOUND_BY_IGF2BP2",53,"Up",0.546703889967655,0.999827083089274
"LUI_THYROID_CANCER_CLUSTER_5",10,"Down",0.546793324339698,0.999827083089274
"NAGY_STAGA_COMPONENTS_HUMAN",3,"Up",0.546878322500703,0.999827083089274
"GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP",13,"Up",0.547357685994962,0.999827083089274
"HOWLIN_PUBERTAL_MAMMARY_GLAND",57,"Up",0.547411335093853,0.999827083089274
"LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP",15,"Down",0.547815785678158,0.999827083089274
"FERRARI_RESPONSE_TO_FENRETINIDE_DN",4,"Up",0.548164902705972,0.999827083089274
"NIELSEN_LIPOSARCOMA_UP",11,"Up",0.548479764406362,0.999827083089274
"REACTOME_AMINE_DERIVED_HORMONES",11,"Down",0.548637680329854,0.999827083089274
"BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN",19,"Down",0.548871927785479,0.999827083089274
"BIOCARTA_LYM_PATHWAY",11,"Down",0.549297128390256,0.999827083089274
"MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3",174,"Up",0.549362906544174,0.999827083089274
"PID_REG_GR_PATHWAY",70,"Down",0.549711356793555,0.999827083089274
"EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION",36,"Down",0.549740071697402,0.999827083089274
"BIOCARTA_TGFB_PATHWAY",16,"Up",0.549887512951486,0.999827083089274
"REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS",8,"Up",0.549990569291272,0.999827083089274
"KYNG_DNA_DAMAGE_UP",121,"Up",0.550014409799297,0.999827083089274
"KIM_MYCN_AMPLIFICATION_TARGETS_UP",42,"Up",0.55014485658324,0.999827083089274
"BRACHAT_RESPONSE_TO_METHOTREXATE_UP",11,"Down",0.550208606548756,0.999827083089274
"KEGG_TRYPTOPHAN_METABOLISM",18,"Down",0.550262671887838,0.999827083089274
"BENPORATH_CYCLING_GENES",257,"Down",0.550660721603618,0.999827083089274
"SONG_TARGETS_OF_IE86_CMV_PROTEIN",34,"Down",0.550697985565414,0.999827083089274
"YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11",41,"Up",0.550781087147707,0.999827083089274
"REACTOME_CD28_CO_STIMULATION",23,"Down",0.550895167885015,0.999827083089274
"LEIN_NEURON_MARKERS",39,"Down",0.551017669769498,0.999827083089274
"REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B",3,"Down",0.551277031905111,0.999827083089274
"NIKOLSKY_BREAST_CANCER_19Q13.1_AMPLICON",4,"Down",0.551478128205118,0.999827083089274
"REACTOME_L1CAM_INTERACTIONS",59,"Up",0.551609270805929,0.999827083089274
"MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_15",7,"Down",0.552169923575616,0.999827083089274
"REACTOME_METABOLISM_OF_MRNA",99,"Down",0.552556764176631,0.999827083089274
"JIANG_AGING_CEREBRAL_CORTEX_DN",41,"Up",0.552607461407986,0.999827083089274
"LIU_VAV3_PROSTATE_CARCINOGENESIS_UP",101,"Up",0.552785968488834,0.999827083089274
"YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16",46,"Up",0.553020454891218,0.999827083089274
"SA_G1_AND_S_PHASES",12,"Up",0.553089417495313,0.999827083089274
"REACTOME_ZINC_TRANSPORTERS",3,"Down",0.55382476296073,0.999827083089274
"MITSIADES_RESPONSE_TO_APLIDIN_UP",179,"Up",0.553888802498405,0.999827083089274
"REACTOME_MUSCLE_CONTRACTION",35,"Down",0.554017690979842,0.999827083089274
"MARTIN_INTERACT_WITH_HDAC",32,"Down",0.554031292250043,0.999827083089274
"OSAWA_TNF_TARGETS",7,"Down",0.554373870936966,0.999827083089274
"PID_CDC42_PATHWAY",45,"Down",0.554706474547903,0.999827083089274
"NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON",3,"Down",0.554712344165451,0.999827083089274
"REACTOME_MRNA_SPLICING_MINOR_PATHWAY",11,"Up",0.555026541345408,0.999827083089274
"KONG_E2F3_TARGETS",47,"Down",0.555699259253243,0.999827083089274
"KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY",47,"Up",0.555761153784057,0.999827083089274
"FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP",66,"Up",0.556005572832566,0.999827083089274
"MORI_PRE_BI_LYMPHOCYTE_DN",42,"Up",0.556218721521398,0.999827083089274
"REACTOME_HIV_INFECTION",103,"Down",0.556428336302101,0.999827083089274
"FREDERICK_PRKCI_TARGETS",4,"Down",0.556447041058985,0.999827083089274
"VICENT_METASTASIS_UP",5,"Down",0.557005330876262,0.999827083089274
"PID_INTEGRIN_A9B1_PATHWAY",22,"Down",0.557197928023819,0.999827083089274
"UDAYAKUMAR_MED1_TARGETS_UP",54,"Up",0.557256182805347,0.999827083089274
"IVANOVSKA_MIR106B_TARGETS",27,"Down",0.557411223063356,0.999827083089274
"SA_PTEN_PATHWAY",15,"Down",0.557920887219536,0.999827083089274
"JEON_SMAD6_TARGETS_UP",16,"Up",0.558623559434457,0.999827083089274
"BENPORATH_ES_CORE_NINE",9,"Up",0.559174543631227,0.999827083089274
"DARWICHE_PAPILLOMA_PROGRESSION_RISK",33,"Up",0.559447819259096,0.999827083089274
"REACTOME_DNA_REPLICATION",92,"Down",0.559511059313172,0.999827083089274
"ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_UP",2,"Up",0.559610082377708,0.999827083089274
"LIU_CMYB_TARGETS_UP",63,"Down",0.560141168225789,0.999827083089274
"REACTOME_UNFOLDED_PROTEIN_RESPONSE",33,"Up",0.5604253750375,0.999827083089274
"SANCHEZ_MDM2_TARGETS",10,"Down",0.560654758081784,0.999827083089274
"SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER",29,"Up",0.56082159789885,0.999827083089274
"PID_MYC_REPRESS_PATHWAY",51,"Up",0.561161280154657,0.999827083089274
"OHM_EMBRYONIC_CARCINOMA_UP",6,"Up",0.561596075414969,0.999827083089274
"OSMAN_BLADDER_CANCER_DN",126,"Up",0.561880722232965,0.999827083089274
"BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP",7,"Up",0.56249958477943,0.999827083089274
"NUYTTEN_NIPP1_TARGETS_UP",215,"Up",0.562642455309448,0.999827083089274
"REACTOME_SIGNALING_BY_HIPPO",8,"Down",0.562841887789018,0.999827083089274
"KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM",15,"Down",0.56305171203711,0.999827083089274
"TERAMOTO_OPN_TARGETS_CLUSTER_8",4,"Down",0.563234720862015,0.999827083089274
"REACTOME_LIPOPROTEIN_METABOLISM",19,"Down",0.563281365037906,0.999827083089274
"ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN",6,"Up",0.563797289248787,0.999827083089274
"BENPORATH_OCT4_TARGETS",119,"Down",0.563830591906885,0.999827083089274
"RASHI_RESPONSE_TO_IONIZING_RADIATION_5",88,"Up",0.563843494460852,0.999827083089274
"TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP",104,"Down",0.56407529756123,0.999827083089274
"PID_MYC_ACTIV_PATHWAY",48,"Down",0.564263545406266,0.999827083089274
"RUIZ_TNC_TARGETS_UP",75,"Down",0.564361940807709,0.999827083089274
"SAGIV_CD24_TARGETS_DN",27,"Up",0.564376594373285,0.999827083089274
"BIOCARTA_BAD_PATHWAY",24,"Down",0.564445110402922,0.999827083089274
"BURTON_ADIPOGENESIS_5",60,"Up",0.564627820549808,0.999827083089274
"CROONQUIST_NRAS_SIGNALING_UP",26,"Up",0.564964945961245,0.999827083089274
"DAUER_STAT3_TARGETS_DN",13,"Down",0.565072283770446,0.999827083089274
"DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP",9,"Up",0.565172059881061,0.999827083089274
"XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN",8,"Down",0.565318872159202,0.999827083089274
"TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_DN",6,"Up",0.565448957301825,0.999827083089274
"TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN",32,"Up",0.565481653248145,0.999827083089274
"REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN",7,"Down",0.565685242440405,0.999827083089274
"VERHAAK_AML_WITH_NPM1_MUTATED_DN",132,"Down",0.565845315559727,0.999827083089274
"REACTOME_MRNA_PROCESSING",48,"Up",0.565981710488693,0.999827083089274
"BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP",76,"Down",0.566231179384078,0.999827083089274
"HAN_JNK_SINGALING_DN",29,"Up",0.566368179029844,0.999827083089274
"REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS",71,"Down",0.566836481744721,0.999827083089274
"JOHNSTONE_PARVB_TARGETS_1_DN",21,"Down",0.566932988740104,0.999827083089274
"DAZARD_UV_RESPONSE_CLUSTER_G2",21,"Up",0.567235527063062,0.999827083089274
"YAGI_AML_WITH_11Q23_REARRANGED",181,"Down",0.567445520581366,0.999827083089274
"VALK_AML_CLUSTER_8",13,"Down",0.56744783477661,0.999827083089274
"BROWNE_INTERFERON_RESPONSIVE_GENES",32,"Down",0.567471474998897,0.999827083089274
"CHEN_ETV5_TARGETS_SERTOLI",14,"Up",0.567525401600591,0.999827083089274
"REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN",3,"Down",0.567756572253041,0.999827083089274
"YAGI_AML_RELAPSE_PROGNOSIS",19,"Up",0.567831380434087,0.999827083089274
"DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN",136,"Down",0.568149058746336,0.999827083089274
"RIZKI_TUMOR_INVASIVENESS_3D_DN",140,"Down",0.568158397287851,0.999827083089274
"REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE",2,"Down",0.568233395763698,0.999827083089274
"WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK",50,"Up",0.568234699672912,0.999827083089274
"WINTER_HYPOXIA_DN",25,"Up",0.568487243720737,0.999827083089274
"BIOCARTA_PTC1_PATHWAY",8,"Up",0.568605460791724,0.999827083089274
"YANG_BREAST_CANCER_ESR1_BULK_DN",13,"Down",0.568613417852574,0.999827083089274
"KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN",53,"Up",0.568961274768051,0.999827083089274
"GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN",15,"Down",0.569019001248643,0.999827083089274
"KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS",44,"Up",0.569034477083034,0.999827083089274
"REACTOME_COMMON_PATHWAY",9,"Down",0.569147205598259,0.999827083089274
"KEGG_GAP_JUNCTION",67,"Down",0.569167435839606,0.999827083089274
"REACTOME_NEPHRIN_INTERACTIONS",10,"Down",0.569172304910241,0.999827083089274
"REACTOME_NEURONAL_SYSTEM",180,"Down",0.569563735748864,0.999827083089274
"BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN",24,"Up",0.569747295547953,0.999827083089274
"GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION",23,"Up",0.569948046676023,0.999827083089274
"REACTOME_DAG_AND_IP3_SIGNALING",24,"Down",0.570036194663296,0.999827083089274
"GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_DN",4,"Down",0.570213105241941,0.999827083089274
"RICKMAN_HEAD_AND_NECK_CANCER_C",41,"Up",0.570235328886183,0.999827083089274
"SMID_BREAST_CANCER_ERBB2_UP",71,"Up",0.570302980833789,0.999827083089274
"STEGER_ADIPOGENESIS_UP",17,"Up",0.57085059916344,0.999827083089274
"CLAUS_PGR_POSITIVE_MENINGIOMA_DN",8,"Up",0.571167815623718,0.999827083089274
"GILDEA_METASTASIS",16,"Down",0.57133853355545,0.999827083089274
"KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM",17,"Up",0.571341672704789,0.999827083089274
"HOSHIDA_LIVER_CANCER_SURVIVAL_UP",46,"Up",0.571604767261727,0.999827083089274
"PID_ARF6_PATHWAY",23,"Down",0.572147548044483,0.999827083089274
"MIKKELSEN_MEF_HCP_WITH_H3K27ME3",277,"Up",0.572192010140815,0.999827083089274
"HASLINGER_B_CLL_WITH_11Q23_DELETION",8,"Up",0.572217162303613,0.999827083089274
"KEGG_CHEMOKINE_SIGNALING_PATHWAY",132,"Up",0.57235394317435,0.999827083089274
"SABATES_COLORECTAL_ADENOMA_SIZE_UP",8,"Up",0.572641055776319,0.999827083089274
"MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_1",7,"Up",0.572667643869633,0.999827083089274
"WHITFIELD_CELL_CYCLE_M_G1",58,"Down",0.57270358285666,0.999827083089274
"FUNG_IL2_SIGNALING_2",8,"Down",0.572741555010132,0.999827083089274
"SESTO_RESPONSE_TO_UV_C3",15,"Up",0.572789851276135,0.999827083089274
"BIOCARTA_MITOCHONDRIA_PATHWAY",20,"Down",0.572819371041785,0.999827083089274
"THUM_SYSTOLIC_HEART_FAILURE_DN",67,"Up",0.573024139276482,0.999827083089274
"PID_EPHA_FWDPATHWAY",28,"Down",0.573113385874652,0.999827083089274
"MIKKELSEN_PLURIPOTENT_STATE_DN",7,"Down",0.573222729242846,0.999827083089274
"IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR",171,"Up",0.573788241579664,0.999827083089274
"RAO_BOUND_BY_SALL4_ISOFORM_B",194,"Up",0.574185070588825,0.999827083089274
"REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING",3,"Up",0.574318595991184,0.999827083089274
"TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP",93,"Down",0.574359112455702,0.999827083089274
"NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON",25,"Up",0.574460144209429,0.999827083089274
"LEE_SP4_THYMOCYTE",8,"Down",0.574801322156655,0.999827083089274
"MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN",87,"Up",0.575141867108174,0.999827083089274
"GUTIERREZ_MULTIPLE_MYELOMA_DN",16,"Up",0.57523241067801,0.999827083089274
"BIOCARTA_BCELLSURVIVAL_PATHWAY",13,"Down",0.575293333858372,0.999827083089274
"ROETH_TERT_TARGETS_DN",5,"Down",0.575907995631662,0.999827083089274
"WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP",50,"Up",0.575929789173865,0.999827083089274
"BRUNEAU_SEPTATION_VENTRICULAR",7,"Up",0.575985355153021,0.999827083089274
"SANDERSON_PPARA_TARGETS",10,"Down",0.576057176519692,0.999827083089274
"WONG_EMBRYONIC_STEM_CELL_CORE",178,"Down",0.576296414725942,0.999827083089274
"DELASERNA_TARGETS_OF_MYOD_AND_SMARCA4",10,"Down",0.576366607907055,0.999827083089274
"PECE_MAMMARY_STEM_CELL_DN",52,"Down",0.576685518106972,0.999827083089274
"BURTON_ADIPOGENESIS_10",15,"Down",0.576718782198614,0.999827083089274
"CHIN_BREAST_CANCER_COPY_NUMBER_DN",10,"Up",0.576750989003338,0.999827083089274
"REACTOME_SIGNALING_BY_NOTCH3",7,"Down",0.577557828922199,0.999827083089274
"WHITFIELD_CELL_CYCLE_G1_S",45,"Down",0.577793566899718,0.999827083089274
"REACTOME_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX",14,"Up",0.578192449778298,0.999827083089274
"PARK_APL_PATHOGENESIS_UP",12,"Up",0.578911439096372,0.999827083089274
"SYED_ESTRADIOL_RESPONSE",13,"Down",0.579015074237753,0.999827083089274
"NEWMAN_ERCC6_TARGETS_DN",18,"Down",0.579410379521853,0.999827083089274
"REACTOME_ADP_SIGNALLING_THROUGH_P2RY12",18,"Up",0.579840064822817,0.999827083089274
"WEBER_METHYLATED_HCP_IN_FIBROBLAST_UP",2,"Down",0.580177073009388,0.999827083089274
"REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR",17,"Up",0.580226142157274,0.999827083089274
"COLDREN_GEFITINIB_RESISTANCE_DN",67,"Down",0.580230750585972,0.999827083089274
"DAZARD_UV_RESPONSE_CLUSTER_G24",19,"Down",0.580246720129051,0.999827083089274
"NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN",45,"Down",0.580371127467467,0.999827083089274
"PARENT_MTOR_SIGNALING_UP",229,"Down",0.580476141499078,0.999827083089274
"CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN",9,"Up",0.580658078249029,0.999827083089274
"ZEMBUTSU_SENSITIVITY_TO_CISPLATIN",7,"Down",0.580788830575012,0.999827083089274
"ZHANG_GATA6_TARGETS_UP",8,"Up",0.580874845446803,0.999827083089274
"PID_S1P_S1P3_PATHWAY",29,"Down",0.581029584672215,0.999827083089274
"PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP",33,"Down",0.581779486756373,0.999827083089274
"HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN",33,"Up",0.58187506918734,0.999827083089274
"KEGG_HISTIDINE_METABOLISM",9,"Down",0.582171832994955,0.999827083089274
"REACTOME_EXTRINSIC_PATHWAY_FOR_APOPTOSIS",10,"Down",0.582232517256502,0.999827083089274
"REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS",5,"Down",0.58227482992778,0.999827083089274
"REACTOME_GPCR_DOWNSTREAM_SIGNALING",312,"Up",0.582463817730912,0.999827083089274
"PID_EPHRINB_REV_PATHWAY",26,"Down",0.582679390798675,0.999827083089274
"KEGG_NON_HOMOLOGOUS_END_JOINING",7,"Down",0.582698814860448,0.999827083089274
"MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN",57,"Up",0.583177451597106,0.999827083089274
"HE_PTEN_TARGETS_UP",16,"Down",0.583281576639933,0.999827083089274
"TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN",51,"Up",0.583288481155289,0.999827083089274
"GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11",22,"Up",0.5833828414143,0.999827083089274
"ZHENG_GLIOBLASTOMA_PLASTICITY_DN",39,"Up",0.583475564601611,0.999827083089274
"SINGH_NFE2L2_TARGETS",13,"Down",0.584278312009947,0.999827083089274
"REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC",18,"Up",0.584637308426224,0.999827083089274
"REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION",11,"Up",0.584966439475822,0.999827083089274
"STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN",18,"Down",0.58503773124229,0.999827083089274
"DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_UP",3,"Up",0.585197959997407,0.999827083089274
"FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP",27,"Up",0.585266928299518,0.999827083089274
"NOJIMA_SFRP2_TARGETS_UP",22,"Up",0.585320561560508,0.999827083089274
"OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_UP",12,"Down",0.585355405268031,0.999827083089274
"GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3",6,"Down",0.585410850236962,0.999827083089274
"WARTERS_IR_RESPONSE_5GY",19,"Down",0.585541428055014,0.999827083089274
"PID_BCR_5PATHWAY",59,"Up",0.585755249856613,0.999827083089274
"LEE_LIVER_CANCER_DENA_UP",52,"Up",0.585825276838814,0.999827083089274
"REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC",15,"Up",0.585848809383487,0.999827083089274
"HOLLMANN_APOPTOSIS_VIA_CD40_UP",95,"Down",0.585994271295739,0.999827083089274
"DARWICHE_SKIN_TUMOR_PROMOTER_DN",78,"Up",0.586272569333707,0.999827083089274
"REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE",6,"Up",0.586314584013126,0.999827083089274
"LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS",20,"Up",0.586634216729349,0.999827083089274
"YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1",42,"Up",0.586724693975572,0.999827083089274
"OLSSON_E2F3_TARGETS_UP",9,"Up",0.586746818335084,0.999827083089274
"PID_CXCR3_PATHWAY",33,"Down",0.587231041615942,0.999827083089274
"SWEET_KRAS_TARGETS_DN",33,"Down",0.587721210132686,0.999827083089274
"KEGG_LEISHMANIA_INFECTION",59,"Down",0.58790799037112,0.999827083089274
"PID_IL2_STAT5_PATHWAY",30,"Down",0.587936672779584,0.999827083089274
"PLASARI_TGFB1_TARGETS_1HR_UP",26,"Down",0.588206807183912,0.999827083089274
"WEIGEL_OXIDATIVE_STRESS_RESPONSE",30,"Down",0.588408946572426,0.999827083089274
"SMID_BREAST_CANCER_ERBB2_DN",3,"Down",0.588654265421118,0.999827083089274
"TESAR_ALK_TARGETS_HUMAN_ES_4D_DN",4,"Down",0.588781084893049,0.999827083089274
"KONDO_PROSTATE_CANCER_WITH_H3K27ME3",71,"Down",0.58924561639296,0.999827083089274
"MAHADEVAN_RESPONSE_TO_MP470_DN",15,"Up",0.589486884506075,0.999827083089274
"FIGUEROA_AML_METHYLATION_CLUSTER_3_UP",53,"Up",0.589523688800939,0.999827083089274
"KEGG_INOSITOL_PHOSPHATE_METABOLISM",24,"Down",0.589698651080819,0.999827083089274
"JIANG_HYPOXIA_VIA_VHL",15,"Down",0.58971611235249,0.999827083089274
"SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN",6,"Up",0.590080737034867,0.999827083089274
"BIOCARTA_TOLL_PATHWAY",28,"Up",0.590219960360967,0.999827083089274
"LIM_MAMMARY_LUMINAL_MATURE_UP",39,"Down",0.590321450658712,0.999827083089274
"SMIRNOV_RESPONSE_TO_IR_2HR_UP",32,"Down",0.59041273727857,0.999827083089274
"RIZ_ERYTHROID_DIFFERENTIATION_6HR",35,"Down",0.590493810223912,0.999827083089274
"MARKS_HDAC_TARGETS_UP",16,"Down",0.590662339202684,0.999827083089274
"KEGG_LYSOSOME",75,"Down",0.590927189546175,0.999827083089274
"FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES",5,"Down",0.591027268833312,0.999827083089274
"CHICAS_RB1_TARGETS_LOW_SERUM",30,"Down",0.591053575729541,0.999827083089274
"PID_ALPHA_SYNUCLEIN_PATHWAY",27,"Down",0.591094335136507,0.999827083089274
"INAMURA_LUNG_CANCER_SCC_DN",7,"Up",0.591195798948767,0.999827083089274
"CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY",21,"Up",0.591466959412885,0.999827083089274
"LABBE_WNT3A_TARGETS_UP",92,"Down",0.591605108067232,0.999827083089274
"MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_7",6,"Up",0.591605807990823,0.999827083089274
"WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_UP",10,"Down",0.591623386881447,0.999827083089274
"KIM_WT1_TARGETS_12HR_DN",98,"Down",0.591834322444952,0.999827083089274
"REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS",30,"Up",0.591900358953186,0.999827083089274
"REACTOME_LYSOSOME_VESICLE_BIOGENESIS",16,"Up",0.592199414370337,0.999827083089274
"PATTERSON_DOCETAXEL_RESISTANCE",17,"Up",0.592796290589101,0.999827083089274
"DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2",69,"Down",0.593049469452947,0.999827083089274
"PID_WNT_SIGNALING_PATHWAY",21,"Down",0.593191768082197,0.999827083089274
"MIKKELSEN_NPC_HCP_WITH_H3K27ME3",181,"Up",0.593217796230093,0.999827083089274
"PENG_GLUTAMINE_DEPRIVATION_DN",161,"Up",0.593231734471616,0.999827083089274
"KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION",35,"Down",0.593691506372461,0.999827083089274
"RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP",53,"Up",0.594282238742903,0.999827083089274
"MATTIOLI_MGUS_VS_PCL",55,"Up",0.594417431220549,0.999827083089274
"ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN",109,"Down",0.594842480734314,0.999827083089274
"AMIT_SERUM_RESPONSE_40_MCF10A",25,"Up",0.595115809051143,0.999827083089274
"SCHAVOLT_TARGETS_OF_TP53_AND_TP63",11,"Down",0.595356214031174,0.999827083089274
"REACTOME_CS_DS_DEGRADATION",11,"Down",0.595400979896149,0.999827083089274
"MATZUK_EARLY_ANTRAL_FOLLICLE",11,"Down",0.595756748302314,0.999827083089274
"HEIDENBLAD_AMPLIFIED_IN_BONE_CANCER",5,"Down",0.595899875606862,0.999827083089274
"ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP",80,"Up",0.595966576954396,0.999827083089274
"BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN",9,"Down",0.596274564497619,0.999827083089274
"REACTOME_CELL_JUNCTION_ORGANIZATION",36,"Up",0.596423401583732,0.999827083089274
"SU_THYMUS",13,"Up",0.597049649884442,0.999827083089274
"TING_SILENCED_BY_DICER",15,"Down",0.597137133891267,0.999827083089274
"LY_AGING_MIDDLE_DN",10,"Down",0.597219229866018,0.999827083089274
"VALK_AML_WITH_11Q23_REARRANGED",9,"Down",0.597440056895851,0.999827083089274
"REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS",28,"Up",0.597479423833531,0.999827083089274
"MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY",7,"Down",0.597563262579355,0.999827083089274
"TERAO_AOX4_TARGETS_SKIN_DN",7,"Up",0.597599533979451,0.999827083089274
"BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN",20,"Down",0.597935814146241,0.999827083089274
"GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN",17,"Down",0.598236624059899,0.999827083089274
"REACTOME_METABOLISM_OF_NON_CODING_RNA",8,"Down",0.598387994821855,0.999827083089274
"SEKI_INFLAMMATORY_RESPONSE_LPS_DN",12,"Down",0.598632532080965,0.999827083089274
"YAGI_AML_WITH_T_9_11_TRANSLOCATION",59,"Down",0.5986867174661,0.999827083089274
"REACTOME_SIGNALING_BY_WNT",41,"Down",0.598885391534121,0.999827083089274
"REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS",13,"Down",0.598903594064017,0.999827083089274
"REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION",156,"Down",0.59899360652314,0.999827083089274
"KEGG_VIRAL_MYOCARDITIS",61,"Down",0.59907425086613,0.999827083089274
"CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN",20,"Down",0.599157336753344,0.999827083089274
"REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS",5,"Down",0.599199452741552,0.999827083089274
"KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS",60,"Up",0.599272406808065,0.999827083089274
"LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP",6,"Down",0.59936939223686,0.999827083089274
"GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP",252,"Down",0.599733799961999,0.999827083089274
"KIM_GERMINAL_CENTER_T_HELPER_UP",21,"Down",0.599804762985802,0.999827083089274
"ST_B_CELL_ANTIGEN_RECEPTOR",31,"Down",0.599918465454073,0.999827083089274
"HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP",46,"Down",0.600287145633976,0.999827083089274
"ENK_UV_RESPONSE_EPIDERMIS_UP",145,"Down",0.600491441661295,0.999827083089274
"REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS",110,"Up",0.600774208209456,0.999827083089274
"BIOCARTA_PTEN_PATHWAY",17,"Down",0.601042530088999,0.999827083089274
"TOMLINS_PROSTATE_CANCER_UP",19,"Down",0.60162096967059,0.999827083089274
"BIOCARTA_FAS_PATHWAY",27,"Down",0.60179107711903,0.999827083089274
"IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR",35,"Up",0.601802854600217,0.999827083089274
"REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE",3,"Up",0.601909657382212,0.999827083089274
"REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE",3,"Up",0.601909657382212,0.999827083089274
"PEART_HDAC_PROLIFERATION_CLUSTER_DN",52,"Down",0.6023213307288,0.999827083089274
"CADWELL_ATG16L1_TARGETS_DN",23,"Up",0.602591264660884,0.999827083089274
"BIOCARTA_IL7_PATHWAY",14,"Down",0.603041902329333,0.999827083089274
"GENTILE_UV_RESPONSE_CLUSTER_D1",11,"Down",0.603053386297847,0.999827083089274
"RODRIGUES_DCC_TARGETS_DN",61,"Up",0.603098101006972,0.999827083089274
"ST_INTERFERON_GAMMA_PATHWAY",9,"Down",0.603103274631954,0.999827083089274
"RATTENBACHER_BOUND_BY_CELF1",127,"Up",0.603355399806856,0.999827083089274
"STANELLE_E2F1_TARGETS",20,"Down",0.603356983809373,0.999827083089274
"BIOCARTA_EGFR_SMRTE_PATHWAY",10,"Up",0.603372140758119,0.999827083089274
"GAJATE_RESPONSE_TO_TRABECTEDIN_UP",39,"Up",0.603373598426628,0.999827083089274
"SMITH_LIVER_CANCER",21,"Up",0.60395513049275,0.999827083089274
"REACTOME_FORMATION_OF_THE_HIV1_EARLY_ELONGATION_COMPLEX",15,"Up",0.603969261774061,0.999827083089274
"FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP",47,"Down",0.604079860351449,0.999827083089274
"AUNG_GASTRIC_CANCER",25,"Down",0.604571473655035,0.999827083089274
"ZHAN_MULTIPLE_MYELOMA_CD1_DN",13,"Down",0.604733129832345,0.999827083089274
"HAHTOLA_SEZARY_SYNDROM_UP",50,"Down",0.605199166791148,0.999827083089274
"KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GLOBO_SERIES",11,"Down",0.605223392651811,0.999827083089274
"REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK",18,"Down",0.605247184395302,0.999827083089274
"WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT",39,"Down",0.60528992616673,0.999827083089274
"LEE_LIVER_CANCER_ACOX1_UP",43,"Down",0.60540600852662,0.999827083089274
"REACTOME_REGULATION_OF_IFNA_SIGNALING",20,"Up",0.605429529659649,0.999827083089274
"YIH_RESPONSE_TO_ARSENITE_C2",17,"Up",0.605533112843224,0.999827083089274
"TAVOR_CEBPA_TARGETS_UP",34,"Up",0.605540904428636,0.999827083089274
"REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION",16,"Up",0.605558214849694,0.999827083089274
"REACTOME_RNA_POL_I_TRANSCRIPTION",26,"Down",0.60560710703694,0.999827083089274
"WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_UP",7,"Down",0.605676067809799,0.999827083089274
"REACTOME_SIGNALING_BY_ILS",85,"Down",0.605704917990359,0.999827083089274
"LEE_LIVER_CANCER_CIPROFIBRATE_UP",45,"Down",0.606099158683271,0.999827083089274
"GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP",13,"Up",0.606455536267428,0.999827083089274
"GALLUZZI_PERMEABILIZE_MITOCHONDRIA",29,"Up",0.606587121590077,0.999827083089274
"KIM_GLIS2_TARGETS_DN",2,"Down",0.606668381409426,0.999827083089274
"ZHENG_IL22_SIGNALING_UP",35,"Up",0.606882223777182,0.999827083089274
"MARKEY_RB1_CHRONIC_LOF_UP",79,"Up",0.606884314300684,0.999827083089274
"POOLA_INVASIVE_BREAST_CANCER_DN",73,"Up",0.607057942505796,0.999827083089274
"MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6",20,"Up",0.607140256627671,0.999827083089274
"WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP",54,"Down",0.607225030910337,0.999827083089274
"REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GIP",6,"Up",0.6075905362834,0.999827083089274
"BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN",13,"Up",0.607597666757694,0.999827083089274
"BIOCARTA_CFTR_PATHWAY",10,"Down",0.607655194216257,0.999827083089274
"BIOCARTA_GATA3_PATHWAY",15,"Up",0.607675433756081,0.999827083089274
"SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN",36,"Down",0.607689720947702,0.999827083089274
"RICKMAN_HEAD_AND_NECK_CANCER_B",21,"Down",0.607691791559896,0.999827083089274
"REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21",39,"Down",0.607750469408034,0.999827083089274
"GHANDHI_DIRECT_IRRADIATION_UP",58,"Up",0.607815885600623,0.999827083089274
"BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS",25,"Down",0.607965809106044,0.999827083089274
"KIM_GERMINAL_CENTER_T_HELPER_DN",9,"Up",0.608184838396491,0.999827083089274
"PID_KIT_PATHWAY",44,"Down",0.608461886678263,0.999827083089274
"CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP",87,"Down",0.608541936616327,0.999827083089274
"RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN",171,"Down",0.608961208319526,0.999827083089274
"KRASNOSELSKAYA_ILF3_TARGETS_UP",25,"Down",0.609368150825907,0.999827083089274
"CUI_GLUCOSE_DEPRIVATION",33,"Up",0.609416427212611,0.999827083089274
"JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN",15,"Down",0.609436365803762,0.999827083089274
"SHIN_B_CELL_LYMPHOMA_CLUSTER_8",30,"Down",0.609678052337219,0.999827083089274
"MURAKAMI_UV_RESPONSE_6HR_UP",30,"Down",0.609802302681162,0.999827083089274
"GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP",17,"Down",0.609924551795973,0.999827083089274
"HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP",14,"Up",0.609982945714473,0.999827083089274
"YIH_RESPONSE_TO_ARSENITE_C4",17,"Down",0.610430273760293,0.999827083089274
"TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C",119,"Down",0.61046039950959,0.999827083089274
"PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP",72,"Up",0.610575905470812,0.999827083089274
"GENTLES_LEUKEMIC_STEM_CELL_DN",7,"Up",0.610767130714098,0.999827083089274
"BRUECKNER_TARGETS_OF_MIRLET7A3_DN",40,"Up",0.611122844773967,0.999827083089274
"LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN",52,"Down",0.611541889585366,0.999827083089274
"LINDGREN_BLADDER_CANCER_CLUSTER_1_UP",40,"Up",0.612262916198017,0.999827083089274
"REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS",24,"Down",0.612341367011687,0.999827083089274
"NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON",38,"Down",0.612677431362998,0.999827083089274
"CHANG_CORE_SERUM_RESPONSE_DN",74,"Up",0.612950214607123,0.999827083089274
"ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP",27,"Up",0.613059605261184,0.999827083089274
"FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP",28,"Down",0.613277456539492,0.999827083089274
"LIM_MAMMARY_STEM_CELL_UP",219,"Down",0.61361078347013,0.999827083089274
"FIGUEROA_AML_METHYLATION_CLUSTER_7_UP",37,"Up",0.61378907781152,0.999827083089274
"TIAN_TNF_SIGNALING_NOT_VIA_NFKB",15,"Up",0.613847583879991,0.999827083089274
"OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP",66,"Up",0.613916099628644,0.999827083089274
"DOANE_RESPONSE_TO_ANDROGEN_UP",63,"Up",0.614425132868982,0.999827083089274
"ZEMBUTSU_SENSITIVITY_TO_VINBLASTINE",11,"Up",0.614512602751606,0.999827083089274
"WNT_SIGNALING",65,"Down",0.614530309744736,0.999827083089274
"REACTOME_SYNTHESIS_OF_DNA",60,"Down",0.615179784825101,0.999827083089274
"REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS",12,"Down",0.61530007303319,0.999827083089274
"VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP",9,"Down",0.615539621500398,0.999827083089274
"LY_AGING_OLD_DN",33,"Down",0.615828632867057,0.999827083089274
"REACTOME_PHOSPHOLIPID_METABOLISM",70,"Down",0.61594453665134,0.999827083089274
"KEGG_GLUTATHIONE_METABOLISM",32,"Up",0.615960253440247,0.999827083089274
"PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN",61,"Down",0.616063855710232,0.999827083089274
"REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING",34,"Up",0.616113197455332,0.999827083089274
"SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER",65,"Up",0.616601346919027,0.999827083089274
"YANG_BREAST_CANCER_ESR1_DN",10,"Up",0.616608681088186,0.999827083089274
"KUNINGER_IGF1_VS_PDGFB_TARGETS_DN",23,"Down",0.616845628008678,0.999827083089274
"HILLION_HMGA1B_TARGETS",73,"Up",0.616936866115578,0.999827083089274
"BIOCARTA_SKP2E2F_PATHWAY",9,"Down",0.617624235475932,0.999827083089274
"BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FLI1",7,"Down",0.617626879652592,0.999827083089274
"SERVITJA_LIVER_HNF1A_TARGETS_DN",90,"Down",0.617953433106922,0.999827083089274
"KEGG_PEROXISOME",41,"Up",0.6180682898056,0.999827083089274
"WONG_MITOCHONDRIA_GENE_MODULE",79,"Up",0.618257779410969,0.999827083089274
"PID_HES_HEY_PATHWAY",40,"Down",0.618442319442471,0.999827083089274
"GALE_APL_WITH_FLT3_MUTATED_UP",9,"Down",0.618550882794624,0.999827083089274
"HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN",47,"Up",0.618617013975058,0.999827083089274
"REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE",26,"Down",0.618791981697154,0.999827083089274
"WATANABE_COLON_CANCER_MSI_VS_MSS_UP",15,"Down",0.619014261284716,0.999827083089274
"ZHENG_FOXP3_TARGETS_DN",3,"Down",0.619547588103124,0.999827083089274
"PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2",35,"Down",0.619686683966202,0.999827083089274
"PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_DN",4,"Down",0.619741794412407,0.999827083089274
"ZHAN_EARLY_DIFFERENTIATION_GENES_DN",31,"Up",0.619919927970062,0.999827083089274
"MARKEY_RB1_ACUTE_LOF_UP",143,"Down",0.619949495980745,0.999827083089274
"GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN",3,"Up",0.619971259882712,0.999827083089274
"REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX",34,"Up",0.619972064578864,0.999827083089274
"REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER",7,"Down",0.620071744865945,0.999827083089274
"MAYBURD_RESPONSE_TO_L663536_DN",22,"Down",0.620096313393473,0.999827083089274
"HU_GENOTOXIC_DAMAGE_4HR",21,"Up",0.620170326209083,0.999827083089274
"REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR",21,"Up",0.62043743160066,0.999827083089274
"PENG_GLUTAMINE_DEPRIVATION_UP",25,"Up",0.62081059736773,0.999827083089274
"YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP",12,"Down",0.620934027298232,0.999827083089274
"FARMER_BREAST_CANCER_CLUSTER_8",4,"Down",0.621025186950274,0.999827083089274
"RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP",238,"Down",0.621174660109336,0.999827083089274
"PID_HIV_NEF_PATHWAY",32,"Down",0.621203155983533,0.999827083089274
"GENTILE_UV_RESPONSE_CLUSTER_D6",19,"Down",0.621225314171021,0.999827083089274
"MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30",4,"Up",0.621725775885775,0.999827083089274
"ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP",57,"Down",0.622345949797625,0.999827083089274
"ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP",140,"Up",0.622507749435261,0.999827083089274
"REACTOME_GENERIC_TRANSCRIPTION_PATHWAY",99,"Up",0.622854010883885,0.999827083089274
"REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES",26,"Down",0.623037939701392,0.999827083089274
"JOHNSTONE_PARVB_TARGETS_1_UP",2,"Down",0.623183952717399,0.999827083089274
"KEGG_SELENOAMINO_ACID_METABOLISM",7,"Down",0.623219028390007,0.999827083089274
"CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP",84,"Up",0.623250891162448,0.999827083089274
"REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE",8,"Down",0.623395458352306,0.999827083089274
"RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP",8,"Down",0.623546655666681,0.999827083089274
"BIDUS_METASTASIS_UP",87,"Down",0.62373554713893,0.999827083089274
"XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP",5,"Up",0.623936757196693,0.999827083089274
"PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_5",6,"Up",0.624118551844527,0.999827083089274
"HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_DN",7,"Up",0.624371927973991,0.999827083089274
"REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN",7,"Down",0.624598375131145,0.999827083089274
"SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION",44,"Down",0.624704452442048,0.999827083089274
"LOPEZ_MESOTHELIOMA_SURVIVAL_UP",3,"Up",0.624753874665334,0.999827083089274
"KEGG_RIBOFLAVIN_METABOLISM",5,"Up",0.624822285341734,0.999827083089274
"WANG_TUMOR_INVASIVENESS_DN",133,"Up",0.624894413142203,0.999827083089274
"REICHERT_G1S_REGULATORS_AS_PI3K_TARGETS",8,"Down",0.625409857026476,0.999827083089274
"LANDIS_ERBB2_BREAST_TUMORS_65_DN",23,"Down",0.625764311339425,0.999827083089274
"AUJLA_IL22_AND_IL17A_SIGNALING",3,"Up",0.626223043619293,0.999827083089274
"RIZKI_TUMOR_INVASIVENESS_2D_DN",30,"Down",0.626336648856318,0.999827083089274
"CHOI_ATL_STAGE_PREDICTOR",16,"Down",0.626554841254991,0.999827083089274
"MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP",116,"Up",0.626622947734207,0.999827083089274
"LEE_LIVER_CANCER",26,"Up",0.626899546422008,0.999827083089274
"NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON",42,"Up",0.62712759929833,0.999827083089274
"FIGUEROA_AML_METHYLATION_CLUSTER_4_DN",7,"Down",0.627348221002054,0.999827083089274
"KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY",86,"Down",0.627438886206726,0.999827083089274
"SMIRNOV_RESPONSE_TO_IR_6HR_UP",71,"Down",0.627488607322535,0.999827083089274
"RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2",19,"Down",0.628315242729827,0.999827083089274
"REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE",10,"Down",0.628396363064759,0.999827083089274
"REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS",6,"Up",0.628540605245386,0.999827083089274
"REACTOME_APOPTOTIC_EXECUTION_PHASE",39,"Down",0.629191034949884,0.999827083089274
"HASINA_NOL7_TARGETS_DN",13,"Up",0.629839977693217,0.999827083089274
"REN_ALVEOLAR_RHABDOMYOSARCOMA_DN",223,"Up",0.630766770306855,0.999827083089274
"PARK_HSC_MARKERS",29,"Up",0.630788878397589,0.999827083089274
"KEGG_PANCREATIC_CANCER",60,"Down",0.631063688554196,0.999827083089274
"SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN",25,"Down",0.631208678110362,0.999827083089274
"TERAMOTO_OPN_TARGETS_CLUSTER_7",11,"Up",0.631238516236893,0.999827083089274
"SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN",13,"Up",0.631686441395066,0.999827083089274
"GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP",65,"Down",0.631831304272081,0.999827083089274
"REACTOME_BASE_FREE_SUGAR_PHOSPHATE_REMOVAL_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY",6,"Up",0.63184140907883,0.999827083089274
"GRUETZMANN_PANCREATIC_CANCER_UP",236,"Down",0.631900111136356,0.999827083089274
"REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS",9,"Up",0.632202618881184,0.999827083089274
"REACTOME_CHROMOSOME_MAINTENANCE",37,"Up",0.632242230769564,0.999827083089274
"JI_RESPONSE_TO_FSH_DN",38,"Down",0.632251035293077,0.999827083089274
"COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP",34,"Up",0.632404370634833,0.999827083089274
"FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP",32,"Down",0.632433259981008,0.999827083089274
"ELVIDGE_HYPOXIA_DN",58,"Down",0.632433546706364,0.999827083089274
"DORN_ADENOVIRUS_INFECTION_12HR_DN",23,"Up",0.633119717799851,0.999827083089274
"CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3",214,"Up",0.633151441924934,0.999827083089274
"PID_TXA2PATHWAY",49,"Down",0.633254129792634,0.999827083089274
"BIOCARTA_NO1_PATHWAY",27,"Down",0.63331980374826,0.999827083089274
"REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS",18,"Up",0.633492606563339,0.999827083089274
"KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP",65,"Up",0.633595906717345,0.999827083089274
"REACTOME_SIGNALING_BY_EGFR_IN_CANCER",75,"Down",0.633653195927776,0.999827083089274
"REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS",14,"Up",0.633704267149856,0.999827083089274
"SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES",45,"Down",0.633970981035874,0.999827083089274
"ZHENG_BOUND_BY_FOXP3",193,"Up",0.634022822175668,0.999827083089274
"NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER",19,"Down",0.634417927408621,0.999827083089274
"SHEPARD_BMYB_TARGETS",38,"Down",0.634472217595957,0.999827083089274
"BIOCARTA_MONOCYTE_PATHWAY",11,"Down",0.634618682537719,0.999827083089274
"CORRE_MULTIPLE_MYELOMA_UP",33,"Up",0.63469731399211,0.999827083089274
"NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP",13,"Down",0.634705701840652,0.999827083089274
"YAMASHITA_LIVER_CANCER_STEM_CELL_UP",39,"Up",0.634712000935229,0.999827083089274
"CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN",16,"Down",0.634747674945423,0.999827083089274
"BIOCARTA_RANMS_PATHWAY",6,"Down",0.635011775291941,0.999827083089274
"REACTOME_PHASE_II_CONJUGATION",31,"Down",0.635154417231106,0.999827083089274
"WOOD_EBV_EBNA1_TARGETS_UP",64,"Up",0.635298441965608,0.999827083089274
"WU_HBX_TARGETS_2_DN",12,"Up",0.635386047679493,0.999827083089274
"FEVR_CTNNB1_TARGETS_DN",271,"Down",0.635480308951836,0.999827083089274
"AMIT_SERUM_RESPONSE_20_MCF10A",10,"Down",0.635855318919871,0.999827083089274
"PID_ATF2_PATHWAY",52,"Down",0.635936219054852,0.999827083089274
"MASSARWEH_TAMOXIFEN_RESISTANCE_DN",88,"Up",0.636151898741906,0.999827083089274
"SU_PLACENTA",20,"Down",0.636191059396686,0.999827083089274
"REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS",22,"Down",0.636258330401589,0.999827083089274
"REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS",7,"Down",0.636423170851449,0.999827083089274
"PID_PTP1B_PATHWAY",49,"Down",0.636543485493786,0.999827083089274
"BROWNE_HCMV_INFECTION_4HR_DN",127,"Up",0.636735393610753,0.999827083089274
"CHESLER_BRAIN_QTL_TRANS",2,"Down",0.6372311330694,0.999827083089274
"AMIT_EGF_RESPONSE_40_MCF10A",13,"Down",0.637352086421849,0.999827083089274
"WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP",12,"Up",0.637407666048722,0.999827083089274
"CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP",85,"Down",0.637490597267982,0.999827083089274
"REACTOME_ASSOCIATION_OF_LICENSING_FACTORS_WITH_THE_PRE_REPLICATIVE_COMPLEX",7,"Down",0.637757327120364,0.999827083089274
"REACTOME_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX",7,"Down",0.637757327120364,0.999827083089274
"TAGHAVI_NEOPLASTIC_TRANSFORMATION",6,"Up",0.638109208742268,0.999827083089274
"SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP",41,"Up",0.638335953609516,0.999827083089274
"GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN",36,"Up",0.638369032793895,0.999827083089274
"VERHAAK_GLIOBLASTOMA_PRONEURAL",76,"Up",0.638370061183506,0.999827083089274
"AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN",10,"Down",0.638411397076151,0.999827083089274
"ST_P38_MAPK_PATHWAY",31,"Up",0.638553938477886,0.999827083089274
"MEISSNER_BRAIN_HCP_WITH_H3K4ME2",5,"Down",0.638811488077035,0.999827083089274
"INGRAM_SHH_TARGETS_DN",38,"Up",0.638880109957059,0.999827083089274
"VARELA_ZMPSTE24_TARGETS_UP",24,"Up",0.638955671822614,0.999827083089274
"REACTOME_G1_S_TRANSITION",76,"Down",0.639020708763882,0.999827083089274
"REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1",9,"Up",0.639022562621774,0.999827083089274
"BROWNE_HCMV_INFECTION_2HR_UP",20,"Up",0.639186018321639,0.999827083089274
"BOYLAN_MULTIPLE_MYELOMA_PCA1_UP",55,"Down",0.639367623449232,0.999827083089274
"YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9",49,"Down",0.639540249588106,0.999827083089274
"BIOCARTA_FCER1_PATHWAY",34,"Down",0.639749130199349,0.999827083089274
"JEON_SMAD6_TARGETS_DN",13,"Down",0.639759157575202,0.999827083089274
"PID_PDGFRB_PATHWAY",91,"Down",0.639762419917165,0.999827083089274
"REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX",22,"Up",0.640361930669325,0.999827083089274
"RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP",19,"Down",0.640818169110877,0.999827083089274
"DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP",133,"Down",0.640851713188039,0.999827083089274
"REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES",136,"Down",0.641238223942,0.999827083089274
"LEE_AGING_MUSCLE_DN",37,"Down",0.641585785155905,0.999827083089274
"ABRAMSON_INTERACT_WITH_AIRE",25,"Up",0.641967037126141,0.999827083089274
"ZIRN_TRETINOIN_RESPONSE_WT1_DN",1,"Down",0.642607878858964,0.999827083089274
"JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN",13,"Down",0.64275762716906,0.999827083089274
"KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS",3,"Up",0.642941018788204,0.999827083089274
"VALK_AML_CLUSTER_5",19,"Up",0.643054261612786,0.999827083089274
"LEE_NEURAL_CREST_STEM_CELL_UP",95,"Up",0.643224414973181,0.999827083089274
"KEEN_RESPONSE_TO_ROSIGLITAZONE_UP",14,"Down",0.643306192262356,0.999827083089274
"WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP",13,"Down",0.643389966630325,0.999827083089274
"REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC",17,"Down",0.64361147207662,0.999827083089274
"REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE",55,"Up",0.644190595572482,0.999827083089274
"RAO_BOUND_BY_SALL4_ISOFORM_A",66,"Up",0.644485461022025,0.999827083089274
"PID_FOXM1_PATHWAY",32,"Up",0.644655801941397,0.999827083089274
"KEGG_MELANOGENESIS",80,"Down",0.644680399125635,0.999827083089274
"KIM_GLIS2_TARGETS_UP",70,"Up",0.645076853197374,0.999827083089274
"REACTOME_HIV_LIFE_CYCLE",42,"Down",0.645091846708403,0.999827083089274
"NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_UP",14,"Up",0.645111011563913,0.999827083089274
"RIZKI_TUMOR_INVASIVENESS_2D_UP",40,"Up",0.645149272204167,0.999827083089274
"PID_INTEGRIN5_PATHWAY",16,"Down",0.645540325809583,0.999827083089274
"WONG_ENDMETRIUM_CANCER_UP",18,"Down",0.645629030710593,0.999827083089274
"KONDO_EZH2_TARGETS",102,"Down",0.645672354717449,0.999827083089274
"KEGG_N_GLYCAN_BIOSYNTHESIS",15,"Up",0.645744959506423,0.999827083089274
"VALK_AML_CLUSTER_1",15,"Up",0.645757096675461,0.999827083089274
"KANG_DOXORUBICIN_RESISTANCE_UP",28,"Down",0.645834740438146,0.999827083089274
"BEIER_GLIOMA_STEM_CELL_UP",14,"Down",0.646309267890335,0.999827083089274
"MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP",21,"Up",0.646309527076315,0.999827083089274
"PID_E2F_PATHWAY",53,"Up",0.646467093910277,0.999827083089274
"GENTILE_UV_RESPONSE_CLUSTER_D5",19,"Down",0.646487161841639,0.999827083089274
"ABE_INNER_EAR",28,"Down",0.646515560578354,0.999827083089274
"LIANG_SILENCED_BY_METHYLATION_2",36,"Up",0.64655452928343,0.999827083089274
"AMUNDSON_GAMMA_RADIATION_RESPONSE",24,"Down",0.646786148050725,0.999827083089274
"LINDSTEDT_DENDRITIC_CELL_MATURATION_D",52,"Up",0.646789658462053,0.999827083089274
"DUTTA_APOPTOSIS_VIA_NFKB",29,"Down",0.646908406049548,0.999827083089274
"UDAYAKUMAR_MED1_TARGETS_DN",110,"Up",0.647206638412665,0.999827083089274
"DOUGLAS_BMI1_TARGETS_DN",94,"Down",0.647536279675055,0.999827083089274
"NEBEN_AML_WITH_FLT3_OR_NRAS_UP",5,"Down",0.648196501065346,0.999827083089274
"MOHANKUMAR_TLX1_TARGETS_DN",88,"Up",0.648387290694348,0.999827083089274
"PID_NOTCH_PATHWAY",39,"Down",0.648680778094977,0.999827083089274
"TENEDINI_MEGAKARYOCYTE_MARKERS",58,"Up",0.648952963439358,0.999827083089274
"ZERBINI_RESPONSE_TO_SULINDAC_UP",6,"Up",0.64905166862872,0.999827083089274
"PID_IL23_PATHWAY",30,"Down",0.649185242084493,0.999827083089274
"BIOCARTA_PAR1_PATHWAY",20,"Down",0.649228430585208,0.999827083089274
"PID_ILK_PATHWAY",25,"Down",0.649293515665032,0.999827083089274
"PID_IL8_CXCR2_PATHWAY",25,"Up",0.649317857297814,0.999827083089274
"GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP",10,"Up",0.649550751354978,0.999827083089274
"MARKEY_RB1_ACUTE_LOF_DN",112,"Up",0.649637272817822,0.999827083089274
"BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN",228,"Down",0.650003149504139,0.999827083089274
"STONER_ESOPHAGEAL_CARCINOGENESIS_UP",13,"Down",0.650382517704105,0.999827083089274
"VERRECCHIA_RESPONSE_TO_TGFB1_C1",18,"Down",0.650629032965508,0.999827083089274
"KEGG_FOCAL_ADHESION",146,"Down",0.650880798420745,0.999827083089274
"SA_B_CELL_RECEPTOR_COMPLEXES",20,"Down",0.65113620909558,0.999827083089274
"KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP",36,"Down",0.651258171915741,0.999827083089274
"MORI_PLASMA_CELL_DN",15,"Down",0.651319683646197,0.999827083089274
"LEE_LIVER_CANCER_HEPATOBLAST",14,"Up",0.651359280868329,0.999827083089274
"NAKAMURA_LUNG_CANCER_DIFFERENTIATION_MARKERS",5,"Down",0.65138984544186,0.999827083089274
"RIGGINS_TAMOXIFEN_RESISTANCE_UP",38,"Up",0.651461385289429,0.999827083089274
"ELVIDGE_HIF2A_TARGETS_UP",5,"Down",0.65164668348039,0.999827083089274
"ST_ERK1_ERK2_MAPK_PATHWAY",24,"Down",0.651822810428841,0.999827083089274
"MADAN_DPPA4_TARGETS",16,"Up",0.651827618611733,0.999827083089274
"SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN",11,"Up",0.651835300569687,0.999827083089274
"FARDIN_HYPOXIA_9",4,"Up",0.652358941647414,0.999827083089274
"ZAIDI_OSTEOBLAST_TRANSCRIPTION_FACTORS",12,"Up",0.652716200852103,0.999827083089274
"REACTOME_POTASSIUM_CHANNELS",59,"Down",0.652779857827057,0.999827083089274
"CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP",69,"Up",0.652976859989673,0.999827083089274
"HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN",43,"Up",0.653019968020161,0.999827083089274
"MCBRYAN_PUBERTAL_BREAST_5_6WK_UP",53,"Up",0.653077949501713,0.999827083089274
"UROSEVIC_RESPONSE_TO_IMIQUIMOD",7,"Down",0.653162023222704,0.999827083089274
"FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP",66,"Down",0.653234272718901,0.999827083089274
"TSENG_ADIPOGENIC_POTENTIAL_DN",33,"Down",0.653801661699726,0.999827083089274
"CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP",17,"Up",0.653828634806137,0.999827083089274
"REACTOME_SYNTHESIS_OF_PE",4,"Down",0.653889912454126,0.999827083089274
"PENG_RAPAMYCIN_RESPONSE_UP",102,"Down",0.653941335383063,0.999827083089274
"REACTOME_METABOLISM_OF_CARBOHYDRATES",112,"Down",0.65395480114403,0.999827083089274
"TARTE_PLASMA_CELL_VS_PLASMABLAST_DN",178,"Up",0.654374229421545,0.999827083089274
"IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR",128,"Down",0.654378990020693,0.999827083089274
"GAL_LEUKEMIC_STEM_CELL_UP",45,"Down",0.654398874449314,0.999827083089274
"PHONG_TNF_TARGETS_UP",56,"Up",0.654537658614824,0.999827083089274
"DARWICHE_PAPILLOMA_RISK_LOW_DN",66,"Down",0.654709191188698,0.999827083089274
"DAIRKEE_TERT_TARGETS_UP",142,"Down",0.654714164381288,0.999827083089274
"REACTOME_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE",33,"Down",0.654963534843876,0.999827083089274
"REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS",4,"Up",0.655082345142323,0.999827083089274
"KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450",34,"Up",0.655232978225852,0.999827083089274
"BURTON_ADIPOGENESIS_3",66,"Down",0.655234469064624,0.999827083089274
"REACTOME_SIGNALING_BY_NOTCH4",7,"Down",0.65528177130466,0.999827083089274
"AMIT_EGF_RESPONSE_480_HELA",86,"Up",0.65540372210095,0.999827083089274
"OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_DN",4,"Up",0.655673935879534,0.999827083089274
"WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN",2,"Up",0.655817115364521,0.999827083089274
"YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP",8,"Up",0.65594807032166,0.999827083089274
"SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP",36,"Up",0.656017251649305,0.999827083089274
"DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP",20,"Up",0.656055382039154,0.999827083089274
"PID_CD8_TCR_DOWNSTREAM_PATHWAY",66,"Down",0.656147045139862,0.999827083089274
"ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN",37,"Up",0.656525393706021,0.999827083089274
"ZHOU_PANCREATIC_BETA_CELL",9,"Up",0.656549388964128,0.999827083089274
"PID_RAC1_PATHWAY",34,"Up",0.656584694051742,0.999827083089274
"GU_PDEF_TARGETS_UP",60,"Down",0.656627212994209,0.999827083089274
"BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN",21,"Up",0.656640454667735,0.999827083089274
"OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN",94,"Down",0.656758218389374,0.999827083089274
"PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN",18,"Up",0.657000825719562,0.999827083089274
"SA_PROGRAMMED_CELL_DEATH",11,"Down",0.657003542079718,0.999827083089274
"KIM_WT1_TARGETS_DN",174,"Down",0.657027847345371,0.999827083089274
"STEIN_ESRRA_TARGETS",196,"Up",0.657030096196831,0.999827083089274
"BURTON_ADIPOGENESIS_PEAK_AT_2HR",43,"Down",0.657456656065683,0.999827083089274
"SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN",41,"Down",0.657804242271061,0.999827083089274
"REACTOME_NFKB_ACTIVATION_THROUGH_FADD_RIP1_PATHWAY_MEDIATED_BY_CASPASE_8_AND10",6,"Up",0.657961653641017,0.999827083089274
"REACTOME_SIGNALING_BY_ERBB2",66,"Down",0.657965653339711,0.999827083089274
"BIOCARTA_IGF1MTOR_PATHWAY",15,"Up",0.657974998895424,0.999827083089274
"MOTAMED_RESPONSE_TO_ANDROGEN_DN",3,"Down",0.658685514574827,0.999827083089274
"KEGG_JAK_STAT_SIGNALING_PATHWAY",109,"Down",0.658911212997992,0.999827083089274
"BIOCARTA_CCR5_PATHWAY",17,"Down",0.658923054468974,0.999827083089274
"KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN",10,"Up",0.659264999913395,0.999827083089274
"MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12",5,"Down",0.659371668074482,0.999827083089274
"PID_ATM_PATHWAY",23,"Up",0.659409530626206,0.999827083089274
"KEGG_BUTANOATE_METABOLISM",12,"Down",0.659491733956462,0.999827083089274
"DURAND_STROMA_S_UP",135,"Down",0.659639357977329,0.999827083089274
"KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY",97,"Down",0.659813218350076,0.999827083089274
"YE_METASTATIC_LIVER_CANCER",14,"Down",0.659894132674207,0.999827083089274
"MIKKELSEN_IPS_LCP_WITH_H3K4ME3",58,"Down",0.659988207008594,0.999827083089274
"MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_14",2,"Down",0.660071991885048,0.999827083089274
"REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS",14,"Up",0.660153593983638,0.999827083089274
"KANG_GIST_WITH_PDGFRA_UP",25,"Down",0.660528368831227,0.999827083089274
"CHEOK_RESPONSE_TO_HD_MTX_DN",13,"Up",0.660534274349025,0.999827083089274
"CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP",66,"Down",0.661003943632766,0.999827083089274
"MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP",10,"Down",0.661434628102134,0.999827083089274
"BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS",20,"Down",0.661507133587627,0.999827083089274
"REACTOME_OLFACTORY_SIGNALING_PATHWAY",23,"Down",0.661602874396806,0.999827083089274
"AFFAR_YY1_TARGETS_DN",157,"Down",0.661779205178288,0.999827083089274
"SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN",77,"Down",0.661929679162974,0.999827083089274
"CHYLA_CBFA2T3_TARGETS_UP",153,"Up",0.66206848155841,0.999827083089274
"LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN",42,"Up",0.6627783864573,0.999827083089274
"KEGG_MTOR_SIGNALING_PATHWAY",30,"Down",0.662884115577749,0.999827083089274
"REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING",5,"Up",0.663023411680324,0.999827083089274
"BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN",119,"Down",0.663155513274039,0.999827083089274
"HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP",27,"Up",0.663396341174593,0.999827083089274
"DER_IFN_ALPHA_RESPONSE_DN",2,"Down",0.663763891629432,0.999827083089274
"SCHEIDEREIT_IKK_INTERACTING_PROTEINS",40,"Down",0.664569881901223,0.999827083089274
"FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN",269,"Down",0.66468352736847,0.999827083089274
"IKEDA_MIR133_TARGETS_UP",20,"Down",0.664721480357713,0.999827083089274
"KEGG_BASAL_CELL_CARCINOMA",48,"Down",0.664855067735719,0.999827083089274
"REACTOME_INSULIN_RECEPTOR_RECYCLING",10,"Down",0.665148531948231,0.999827083089274
"REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS",43,"Up",0.665423727178019,0.999827083089274
"AMIT_EGF_RESPONSE_40_HELA",31,"Down",0.665457669663919,0.999827083089274
"SUZUKI_AMPLIFIED_IN_ORAL_CANCER",13,"Down",0.665491763515007,0.999827083089274
"NAGASHIMA_EGF_SIGNALING_UP",46,"Up",0.665926572505182,0.999827083089274
"REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING",26,"Up",0.666004671595627,0.999827083089274
"REACTOME_ACYL_CHAIN_REMODELLING_OF_PI",8,"Up",0.666052807388215,0.999827083089274
"REACTOME_ACYL_CHAIN_REMODELLING_OF_PG",8,"Up",0.666052807388215,0.999827083089274
"YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3",12,"Up",0.666137896201173,0.999827083089274
"ACEVEDO_LIVER_CANCER_DN",225,"Down",0.666307736196045,0.999827083089274
"TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN",45,"Down",0.666689918513143,0.999827083089274
"GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP",21,"Down",0.66670703559637,0.999827083089274
"REACTOME_KERATAN_SULFATE_DEGRADATION",9,"Down",0.66673635227902,0.999827083089274
"HUANG_GATA2_TARGETS_UP",76,"Up",0.666836265840989,0.999827083089274
"ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_2HR",6,"Up",0.666990690223627,0.999827083089274
"WHITESIDE_CISPLATIN_RESISTANCE_DN",8,"Down",0.667043526708962,0.999827083089274
"SIMBULAN_UV_RESPONSE_NORMAL_DN",24,"Up",0.667224544129257,0.999827083089274
"NOJIMA_SFRP2_TARGETS_DN",14,"Up",0.667249832792581,0.999827083089274
"ONO_FOXP3_TARGETS_DN",33,"Down",0.667255505021928,0.999827083089274
"BIOCARTA_CALCINEURIN_PATHWAY",17,"Down",0.667296923451271,0.999827083089274
"ONDER_CDH1_TARGETS_2_UP",128,"Down",0.667387989571584,0.999827083089274
"REACTOME_RORA_ACTIVATES_CIRCADIAN_EXPRESSION",17,"Up",0.667467416469937,0.999827083089274
"BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN",3,"Down",0.667572093979348,0.999827083089274
"NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON",40,"Up",0.667619630926959,0.999827083089274
"BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_UP",4,"Up",0.667790319294501,0.999827083089274
"AMIT_SERUM_RESPONSE_60_MCF10A",33,"Up",0.667855599204265,0.999827083089274
"LEIN_PONS_MARKERS",34,"Down",0.668303132667985,0.999827083089274
"REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS",2,"Down",0.66839134248379,0.999827083089274
"CHYLA_CBFA2T3_TARGETS_DN",91,"Up",0.6685525344995,0.999827083089274
"WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR",7,"Down",0.668730549792014,0.999827083089274
"REACTOME_RNA_POL_I_TRANSCRIPTION_INITIATION",17,"Down",0.668814572476369,0.999827083089274
"ZWANG_EGF_INTERVAL_UP",19,"Up",0.66881589991468,0.999827083089274
"REACTOME_OPSINS",4,"Up",0.669201548510299,0.999827083089274
"EGUCHI_CELL_CYCLE_RB1_TARGETS",16,"Down",0.669232073916035,0.999827083089274
"WORSCHECH_TUMOR_REJECTION_UP",39,"Down",0.669269856084189,0.999827083089274
"ZHANG_BREAST_CANCER_PROGENITORS_UP",147,"Down",0.669320022668871,0.999827083089274
"WIKMAN_ASBESTOS_LUNG_CANCER_UP",6,"Up",0.670062018627517,0.999827083089274
"MIKKELSEN_NPC_WITH_LCP_H3K27ME3",3,"Down",0.670131196175075,0.999827083089274
"SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE",60,"Up",0.670270774690867,0.999827083089274
"WANG_THOC1_TARGETS_DN",17,"Up",0.670445780680725,0.999827083089274
"DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN",196,"Up",0.670495645207257,0.999827083089274
"CERVERA_SDHB_TARGETS_1_UP",38,"Down",0.67055737029999,0.999827083089274
"ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN",15,"Up",0.670573848508349,0.999827083089274
"QI_HYPOXIA",69,"Up",0.670605575205227,0.999827083089274
"WARTERS_RESPONSE_TO_IR_SKIN",28,"Up",0.670772632863987,0.999827083089274
"NUMATA_CSF3_SIGNALING_VIA_STAT3",22,"Up",0.670901434386899,0.999827083089274
"DODD_NASOPHARYNGEAL_CARCINOMA_DN",445,"Down",0.671402247219873,0.999827083089274
"PID_ECADHERIN_KERATINOCYTE_PATHWAY",21,"Up",0.671461459521796,0.999827083089274
"DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN",130,"Up",0.671826594768805,0.999827083089274
"CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_UP",4,"Up",0.671832093913599,0.999827083089274
"WALLACE_PROSTATE_CANCER_UP",13,"Down",0.671869663438109,0.999827083089274
"BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN",52,"Up",0.672046795451676,0.999827083089274
"SCHRAETS_MLL_TARGETS_UP",32,"Down",0.672077646347771,0.999827083089274
"ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER",71,"Down",0.672293669605261,0.999827083089274
"KYNG_RESPONSE_TO_H2O2",44,"Down",0.672389215003703,0.999827083089274
"GILMORE_CORE_NFKB_PATHWAY",12,"Up",0.672761636921653,0.999827083089274
"MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED",12,"Up",0.672900361238096,0.999827083089274
"KEGG_APOPTOSIS",71,"Down",0.673043380499534,0.999827083089274
"NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON",4,"Down",0.673152163876048,0.999827083089274
"REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI",13,"Up",0.673453408762108,0.999827083089274
"PIEPOLI_LGI1_TARGETS_DN",10,"Down",0.673506253081865,0.999827083089274
"KEGG_DNA_REPLICATION",21,"Down",0.673626834174252,0.999827083089274
"KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS",42,"Up",0.673809416601731,0.999827083089274
"MORI_MATURE_B_LYMPHOCYTE_UP",58,"Up",0.673899090324976,0.999827083089274
"CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN",14,"Up",0.674684360977822,0.999827083089274
"BIOCARTA_SET_PATHWAY",9,"Up",0.674757126011117,0.999827083089274
"NADELLA_PRKAR1A_TARGETS_UP",8,"Down",0.675141114390708,0.999827083089274
"REACTOME_ORC1_REMOVAL_FROM_CHROMATIN",46,"Down",0.675233537501961,0.999827083089274
"PUJANA_XPRSS_INT_NETWORK",82,"Down",0.675403350373397,0.999827083089274
"ZHAN_MULTIPLE_MYELOMA_HP_DN",17,"Down",0.675904456052742,0.999827083089274
"VERHAAK_GLIOBLASTOMA_NEURAL",52,"Up",0.675914409706924,0.999827083089274
"FRASOR_TAMOXIFEN_RESPONSE_UP",33,"Down",0.676126816467116,0.999827083089274
"KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_UP",1,"Up",0.676150329636901,0.999827083089274
"IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM",128,"Down",0.676257739664416,0.999827083089274
"REACTOME_AMYLOIDS",25,"Up",0.676339869157414,0.999827083089274
"REACTOME_INNATE_IMMUNE_SYSTEM",138,"Up",0.676496994320063,0.999827083089274
"LI_WILMS_TUMOR_ANAPLASTIC_UP",11,"Down",0.676594701918675,0.999827083089274
"ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN",57,"Down",0.67692152872992,0.999827083089274
"VERHAAK_AML_WITH_NPM1_MUTATED_UP",113,"Up",0.676941135863314,0.999827083089274
"TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_DN",1,"Up",0.677096021178953,0.999827083089274
"MIKKELSEN_MCV6_ICP_WITH_H3K27ME3",33,"Up",0.677125946062238,0.999827083089274
"FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN",49,"Up",0.677455677938079,0.999827083089274
"LINDGREN_BLADDER_CANCER_CLUSTER_3_DN",94,"Up",0.677520133077777,0.999827083089274
"MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP",35,"Up",0.677629496617997,0.999827083089274
"PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_UP",5,"Down",0.677643978181802,0.999827083089274
"BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP",27,"Up",0.677725607360766,0.999827083089274
"STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA",9,"Up",0.67813619045498,0.999827083089274
"REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM",175,"Down",0.678189758706071,0.999827083089274
"REACTOME_MITOTIC_M_M_G1_PHASES",81,"Down",0.678270416782157,0.999827083089274
"WONG_PROTEASOME_GENE_MODULE",25,"Down",0.67853886841851,0.999827083089274
"NATSUME_RESPONSE_TO_INTERFERON_BETA_UP",59,"Down",0.678903236753544,0.999827083089274
"BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP",6,"Up",0.678935658870037,0.999827083089274
"JAZAG_TGFB1_SIGNALING_DN",18,"Up",0.679287943570818,0.999827083089274
"REACTOME_SIGNALING_BY_GPCR",393,"Up",0.679471051734288,0.999827083089274
"PID_TELOMERASE_PATHWAY",53,"Down",0.679547619506356,0.999827083089274
"COATES_MACROPHAGE_M1_VS_M2_UP",35,"Up",0.679696578701046,0.999827083089274
"SENESE_HDAC2_TARGETS_DN",55,"Up",0.679918116980919,0.999827083089274
"YAMANAKA_GLIOBLASTOMA_SURVIVAL_DN",6,"Down",0.680158850151573,0.999827083089274
"KIM_ALL_DISORDERS_CALB1_CORR_DN",21,"Up",0.680233692498937,0.999827083089274
"KEGG_TASTE_TRANSDUCTION",19,"Up",0.680256284613105,0.999827083089274
"MCCABE_HOXC6_TARGETS_CANCER_DN",7,"Up",0.680773268699647,0.999827083089274
"SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4",115,"Down",0.680947730117289,0.999827083089274
"KEGG_ONE_CARBON_POOL_BY_FOLATE",7,"Up",0.680954893797024,0.999827083089274
"NIELSEN_LIPOSARCOMA_DN",10,"Down",0.681045862254624,0.999827083089274
"REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS",3,"Up",0.681201436876635,0.999827083089274
"COATES_MACROPHAGE_M1_VS_M2_DN",38,"Up",0.681365940674395,0.999827083089274
"LI_INDUCED_T_TO_NATURAL_KILLER_UP",145,"Up",0.68149242929418,0.999827083089274
"BECKER_TAMOXIFEN_RESISTANCE_DN",32,"Down",0.682254955732805,0.999827083089274
"HOLLEMAN_DAUNORUBICIN_ALL_UP",4,"Down",0.682265652848634,0.999827083089274
"MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_16",5,"Down",0.682423105120101,0.999827083089274
"RODWELL_AGING_KIDNEY_NO_BLOOD_DN",53,"Up",0.682542170547023,0.999827083089274
"REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS",5,"Down",0.682807568823737,0.999827083089274
"MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN",244,"Down",0.683058611013298,0.999827083089274
"RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP",16,"Down",0.683285967507761,0.999827083089274
"CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN",83,"Down",0.683353891351402,0.999827083089274
"WEBER_METHYLATED_ICP_IN_SPERM_DN",6,"Up",0.683483957480725,0.999827083089274
"WONG_IFNA2_RESISTANCE_DN",19,"Up",0.683990509140634,0.999827083089274
"KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY",76,"Up",0.684255679283342,0.999827083089274
"BASSO_B_LYMPHOCYTE_NETWORK",69,"Up",0.684291721964818,0.999827083089274
"KOBAYASHI_EGFR_SIGNALING_24HR_UP",49,"Down",0.684620289129232,0.999827083089274
"PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6",14,"Down",0.684839390763377,0.999827083089274
"ZHAN_LATE_DIFFERENTIATION_GENES_DN",12,"Up",0.684908591663511,0.999827083089274
"RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN",40,"Up",0.684935893122867,0.999827083089274
"MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH",13,"Up",0.685191012398924,0.999827083089274
"LAU_APOPTOSIS_CDKN2A_DN",5,"Up",0.685445863081292,0.999827083089274
"WIKMAN_ASBESTOS_LUNG_CANCER_DN",14,"Down",0.685547081406278,0.999827083089274
"KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY",62,"Up",0.685742506600271,0.999827083089274
"REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION",72,"Up",0.685816439336222,0.999827083089274
"WEI_MIR34A_TARGETS",46,"Up",0.685985548150419,0.999827083089274
"TONG_INTERACT_WITH_PTTG1",17,"Up",0.686016117549226,0.999827083089274
"BENPORATH_ES_1",182,"Down",0.686097776660865,0.999827083089274
"POS_HISTAMINE_RESPONSE_NETWORK",25,"Down",0.686110017456324,0.999827083089274
"SESTO_RESPONSE_TO_UV_C8",52,"Up",0.686164205195752,0.999827083089274
"ZHU_CMV_24_HR_UP",55,"Down",0.686206177114359,0.999827083089274
"KIM_MYC_AMPLIFICATION_TARGETS_UP",75,"Up",0.686429004877188,0.999827083089274
"DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN",40,"Down",0.686430186772553,0.999827083089274
"KYNG_DNA_DAMAGE_BY_UV",37,"Up",0.686448289353442,0.999827083089274
"REACTOME_LIGAND_GATED_ION_CHANNEL_TRANSPORT",15,"Down",0.686660002670634,0.999827083089274
"HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP",10,"Up",0.686820871997538,0.999827083089274
"KEGG_INSULIN_SIGNALING_PATHWAY",87,"Down",0.686887681997688,0.999827083089274
"CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP",27,"Down",0.68693921110564,0.999827083089274
"ST_STAT3_PATHWAY",10,"Down",0.687170966265522,0.999827083089274
"REACTOME_MRNA_SPLICING",33,"Up",0.68749353558226,0.999827083089274
"ONDER_CDH1_TARGETS_1_DN",78,"Down",0.687656683560324,0.999827083089274
"ZHAN_MULTIPLE_MYELOMA_LB_UP",17,"Down",0.688173448177513,0.999827083089274
"REACTOME_G_PROTEIN_ACTIVATION",25,"Up",0.688190812633938,0.999827083089274
"BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP",13,"Down",0.688694140204301,0.999827083089274
"REACTOME_SMOOTH_MUSCLE_CONTRACTION",14,"Down",0.688812727681711,0.999827083089274
"LINDVALL_IMMORTALIZED_BY_TERT_DN",43,"Up",0.688930950065479,0.999827083089274
"AMIT_EGF_RESPONSE_60_HELA",34,"Up",0.68897582982959,0.999827083089274
"REACTOME_CTLA4_INHIBITORY_SIGNALING",17,"Up",0.689064962198465,0.999827083089274
"KREPPEL_CD99_TARGETS_DN",4,"Down",0.689143608583447,0.999827083089274
"KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION",62,"Up",0.689355209815493,0.999827083089274
"REACTOME_GLUCONEOGENESIS",24,"Up",0.689517375419982,0.999827083089274
"HELLER_SILENCED_BY_METHYLATION_UP",150,"Up",0.689787075322973,0.999827083089274
"BIOCARTA_SRCRPTP_PATHWAY",10,"Up",0.689852577736468,0.999827083089274
"PID_A6B1_A6B4_INTEGRIN_PATHWAY",41,"Up",0.689873268930063,0.999827083089274
"MITSIADES_RESPONSE_TO_APLIDIN_DN",101,"Up",0.689890762881634,0.999827083089274
"LEIN_MEDULLA_MARKERS",38,"Down",0.690032020633891,0.999827083089274
"BROWNE_HCMV_INFECTION_2HR_DN",32,"Down",0.69004677489878,0.999827083089274
"CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP",108,"Down",0.690170389256929,0.999827083089274
"SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP",19,"Down",0.690222788301761,0.999827083089274
"RUAN_RESPONSE_TO_TROGLITAZONE_DN",18,"Down",0.690556811214326,0.999827083089274
"REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES",184,"Down",0.690650960482522,0.999827083089274
"SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN",34,"Up",0.690746999009965,0.999827083089274
"SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5",48,"Down",0.691147587602933,0.999827083089274
"HOSHIDA_LIVER_CANCER_SUBCLASS_S3",162,"Down",0.691196306244581,0.999827083089274
"BIOCARTA_THELPER_PATHWAY",13,"Down",0.69124496515398,0.999827083089274
"NADERI_BREAST_CANCER_PROGNOSIS_DN",11,"Down",0.691366311882694,0.999827083089274
"KIM_WT1_TARGETS_8HR_DN",55,"Down",0.691679105411907,0.999827083089274
"REACTOME_RECEPTOR_LIGAND_BINDING_INITIATES_THE_SECOND_PROTEOLYTIC_CLEAVAGE_OF_NOTCH_RECEPTOR",8,"Down",0.691820205224082,0.999827083089274
"YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8",30,"Up",0.691888072445559,0.999827083089274
"BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP",12,"Down",0.692007698897982,0.999827083089274
"SMID_BREAST_CANCER_NORMAL_LIKE_UP",282,"Up",0.69207124901331,0.999827083089274
"BIOCARTA_ETS_PATHWAY",16,"Up",0.692168542858661,0.999827083089274
"WANG_CLIM2_TARGETS_DN",62,"Up",0.692409525484635,0.999827083089274
"GARY_CD5_TARGETS_UP",200,"Up",0.69257268961833,0.999827083089274
"REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS",28,"Up",0.692581423130036,0.999827083089274
"GRADE_COLON_AND_RECTAL_CANCER_DN",35,"Up",0.692642950776333,0.999827083089274
"HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP",7,"Up",0.692876099536698,0.999827083089274
"GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN",72,"Up",0.693032782853913,0.999827083089274
"PID_BETA_CATENIN_NUC_PATHWAY",59,"Down",0.693051838148254,0.999827083089274
"LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP",16,"Down",0.693271135508032,0.999827083089274
"UEDA_CENTRAL_CLOCK",51,"Down",0.693530529524295,0.999827083089274
"SERVITJA_ISLET_HNF1A_TARGETS_DN",51,"Down",0.693676598640448,0.999827083089274
"PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP",31,"Down",0.693702993813234,0.999827083089274
"TIEN_INTESTINE_PROBIOTICS_2HR_UP",20,"Down",0.693907008233526,0.999827083089274
"GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP",84,"Down",0.693919792266887,0.999827083089274
"REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS",12,"Up",0.693985190617568,0.999827083089274
"PID_TRKR_PATHWAY",44,"Up",0.694025833519347,0.999827083089274
"KEGG_GLYCEROPHOSPHOLIPID_METABOLISM",30,"Up",0.694555870034679,0.999827083089274
"REACTOME_METABOLISM_OF_PROTEINS",163,"Up",0.694633682250554,0.999827083089274
"JAZAG_TGFB1_SIGNALING_UP",55,"Down",0.694886318214052,0.999827083089274
"HUANG_DASATINIB_RESISTANCE_UP",43,"Down",0.695548657196859,0.999827083089274
"KEGG_OXIDATIVE_PHOSPHORYLATION",50,"Up",0.695591159438146,0.999827083089274
"BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP",12,"Up",0.695671004433766,0.999827083089274
"KANG_IMMORTALIZED_BY_TERT_DN",68,"Down",0.695875132180897,0.999827083089274
"ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP",82,"Up",0.695875677094779,0.999827083089274
"GRABARCZYK_BCL11B_TARGETS_DN",18,"Up",0.695968369483162,0.999827083089274
"COLLER_MYC_TARGETS_UP",17,"Down",0.696663367156831,0.999827083089274
"KEGG_GNRH_SIGNALING_PATHWAY",80,"Up",0.697203546389957,0.999827083089274
"WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2",36,"Up",0.697241940412237,0.999827083089274
"ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION",47,"Down",0.697956947638546,0.999827083089274
"SESTO_RESPONSE_TO_UV_C5",24,"Down",0.698066959477931,0.999827083089274
"WANG_METHYLATED_IN_BREAST_CANCER",30,"Up",0.698112702583294,0.999827083089274
"KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS",44,"Down",0.698236990570019,0.999827083089274
"REACTOME_PEPTIDE_HORMONE_BIOSYNTHESIS",11,"Up",0.698280162399296,0.999827083089274
"CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70",38,"Down",0.698294202622184,0.999827083089274
"SERVITJA_LIVER_HNF1A_TARGETS_UP",75,"Up",0.698839361133962,0.999827083089274
"YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP",36,"Down",0.698968063416947,0.999827083089274
"VERHAAK_GLIOBLASTOMA_CLASSICAL",77,"Down",0.699277533537029,0.999827083089274
"GRADE_COLON_VS_RECTAL_CANCER_DN",23,"Down",0.699487556029597,0.999827083089274
"STARK_HYPPOCAMPUS_22Q11_DELETION_DN",17,"Down",0.699692064648883,0.999827083089274
"MOOTHA_TCA",7,"Down",0.699754267076398,0.999827083089274
"CAFFAREL_RESPONSE_TO_THC_24HR_3_UP",5,"Up",0.699971099069346,0.999827083089274
"PID_PRL_SIGNALING_EVENTS_PATHWAY",20,"Down",0.700061882819677,0.999827083089274
"HU_GENOTOXIC_DAMAGE_24HR",19,"Up",0.700114431558429,0.999827083089274
"CHEBOTAEV_GR_TARGETS_DN",51,"Down",0.700280071580401,0.999827083089274
"BIOCARTA_AGR_PATHWAY",29,"Down",0.700545932456778,0.999827083089274
"ZHU_CMV_8_HR_DN",41,"Down",0.700809375178096,0.999827083089274
"BLUM_RESPONSE_TO_SALIRASIB_DN",208,"Down",0.70087533293536,0.999827083089274
"MATZUK_IMPLANTATION_AND_UTERINE",20,"Up",0.701087087058176,0.999827083089274
"VANTVEER_BREAST_CANCER_POOR_PROGNOSIS",19,"Down",0.701110879709182,0.999827083089274
"KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP",103,"Up",0.70119315219515,0.999827083089274
"BYSTROEM_CORRELATED_WITH_IL5_UP",29,"Up",0.701218372958875,0.999827083089274
"WOTTON_RUNX_TARGETS_DN",17,"Up",0.70144570118755,0.999827083089274
"FOSTER_TOLERANT_MACROPHAGE_UP",74,"Down",0.701478846803273,0.999827083089274
"ZHENG_FOXP3_TARGETS_IN_THYMUS_UP",75,"Down",0.702379889607061,0.999827083089274
"TERAO_AOX4_TARGETS_HG_DN",3,"Down",0.702388379861304,0.999827083089274
"LEE_NAIVE_T_LYMPHOCYTE",5,"Down",0.702439110336397,0.999827083089274
"GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN",6,"Up",0.702448302948961,0.999827083089274
"CAIRO_HEPATOBLASTOMA_DN",137,"Down",0.702458813245879,0.999827083089274
"YANG_MUC2_TARGETS_DUODENUM_6MO_UP",8,"Up",0.702768453281588,0.999827083089274
"DING_LUNG_CANCER_MUTATED_RECURRENTLY",6,"Down",0.702897338253543,0.999827083089274
"FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN",15,"Down",0.703017662710941,0.999827083089274
"FINETTI_BREAST_CANCERS_KINOME_GRAY",8,"Up",0.703173787475729,0.999827083089274
"FARDIN_HYPOXIA_11",17,"Up",0.703203760103087,0.999827083089274
"DELACROIX_RARG_BOUND_MEF",166,"Up",0.70335039492757,0.999827083089274
"VERRECCHIA_RESPONSE_TO_TGFB1_C4",9,"Down",0.703383038332206,0.999827083089274
"BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP",5,"Up",0.70345344353602,0.999827083089274
"TURJANSKI_MAPK8_AND_MAPK9_TARGETS",8,"Up",0.703855528362214,0.999827083089274
"RUAN_RESPONSE_TO_TNF_UP",14,"Up",0.703948083464007,0.999827083089274
"GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN",58,"Up",0.704031245322043,0.999827083089274
"GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_DN",4,"Down",0.704300650175978,0.999827083089274
"BROWNE_HCMV_INFECTION_6HR_DN",72,"Up",0.704321272413227,0.999827083089274
"PID_SMAD2_3NUCLEAR_PATHWAY",64,"Up",0.704358444112118,0.999827083089274
"PHONG_TNF_RESPONSE_VIA_P38_PARTIAL",99,"Down",0.704621180076092,0.999827083089274
"BROWN_MYELOID_CELL_DEVELOPMENT_UP",114,"Up",0.70464047625535,0.999827083089274
"HAHTOLA_SEZARY_SYNDROM_DN",23,"Up",0.704654072104539,0.999827083089274
"PID_EPHA2_FWD_PATHWAY",17,"Down",0.704898259935022,0.999827083089274
"PID_TRAIL_PATHWAY",21,"Down",0.705133570480204,0.999827083089274
"SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP",124,"Down",0.705265963096911,0.999827083089274
"GEORGES_TARGETS_OF_MIR192_AND_MIR215",228,"Down",0.705790541081984,0.999827083089274
"NAGY_TFTC_COMPONENTS_HUMAN",4,"Up",0.70586324117263,0.999827083089274
"PID_PLK1_PATHWAY",23,"Up",0.706323357128006,0.999827083089274
"HOEBEKE_LYMPHOID_STEM_CELL_UP",38,"Down",0.706383861649189,0.999827083089274
"TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN",18,"Up",0.706395179898613,0.999827083089274
"SU_SALIVARY_GLAND",7,"Down",0.706465849586602,0.999827083089274
"REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM",80,"Up",0.706741124523864,0.999827083089274
"SENGUPTA_EBNA1_ANTICORRELATED",60,"Up",0.706776750885337,0.999827083089274
"BIOCARTA_ATM_PATHWAY",18,"Down",0.706869456811134,0.999827083089274
"YEGNASUBRAMANIAN_PROSTATE_CANCER",70,"Down",0.706908454384547,0.999827083089274
"CHANDRAN_METASTASIS_UP",67,"Down",0.706997153021978,0.999827083089274
"HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP",43,"Down",0.707187530016634,0.999827083089274
"MORI_IMMATURE_B_LYMPHOCYTE_DN",57,"Down",0.707349115911982,0.999827083089274
"BIOCARTA_CARM1_PATHWAY",10,"Up",0.707385514023356,0.999827083089274
"ZHANG_TLX_TARGETS_DN",58,"Up",0.707512675209696,0.999827083089274
"PENG_LEUCINE_DEPRIVATION_UP",66,"Up",0.707584779849258,0.999827083089274
"STARK_BRAIN_22Q11_DELETION",3,"Up",0.707645628415748,0.999827083089274
"MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN",39,"Down",0.707914847149482,0.999827083089274
"REACTOME_INWARDLY_RECTIFYING_K_CHANNELS",27,"Down",0.708121749063381,0.999827083089274
"SHEPARD_CRUSH_AND_BURN_MUTANT_UP",81,"Up",0.708259468378056,0.999827083089274
"SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN",73,"Up",0.708284927215304,0.999827083089274
"OLSSON_E2F3_TARGETS_DN",21,"Down",0.7082979890916,0.999827083089274
"DAZARD_UV_RESPONSE_CLUSTER_G5",8,"Up",0.708362071455421,0.999827083089274
"STEIN_ESRRA_TARGETS_UP",143,"Up",0.708439609171174,0.999827083089274
"PID_EPHB_FWD_PATHWAY",33,"Down",0.708481102674774,0.999827083089274
"ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY",477,"Up",0.708726813508531,0.999827083089274
"RUTELLA_RESPONSE_TO_HGF_DN",125,"Up",0.708850324946782,0.999827083089274
"WIERENGA_STAT5A_TARGETS_GROUP2",30,"Up",0.708942007403641,0.999827083089274
"BRACHAT_RESPONSE_TO_CISPLATIN",11,"Down",0.70905210068686,0.999827083089274
"GOLUB_ALL_VS_AML_DN",22,"Up",0.709292679615589,0.999827083089274
"KEGG_ARACHIDONIC_ACID_METABOLISM",37,"Up",0.70937346969627,0.999827083089274
"BIOCARTA_BARRESTIN_PATHWAY",8,"Up",0.709490965964871,0.999827083089274
"SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP",47,"Up",0.709554166709914,0.999827083089274
"MACLACHLAN_BRCA1_TARGETS_DN",12,"Down",0.709635262959129,0.999827083089274
"TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP",112,"Down",0.709702149954437,0.999827083089274
"LUI_THYROID_CANCER_CLUSTER_4",8,"Down",0.709977267597994,0.999827083089274
"PUJANA_CHEK2_PCC_NETWORK",344,"Down",0.710305437945677,0.999827083089274
"REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS",18,"Up",0.710337807460614,0.999827083089274
"EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP",116,"Down",0.71043162362411,0.999827083089274
"BENPORATH_PROLIFERATION",63,"Down",0.710503012877784,0.999827083089274
"SASSON_RESPONSE_TO_GONADOTROPHINS_DN",52,"Up",0.710676663966708,0.999827083089274
"BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN",16,"Up",0.710828826813794,0.999827083089274
"DER_IFN_GAMMA_RESPONSE_DN",6,"Up",0.711169044430824,0.999827083089274
"AMUNDSON_GAMMA_RADIATION_RESISTANCE",14,"Up",0.711741863780132,0.999827083089274
"PETRETTO_CARDIAC_HYPERTROPHY",22,"Down",0.711909605698911,0.999827083089274
"BIOCARTA_PS1_PATHWAY",13,"Down",0.712029771635196,0.999827083089274
"DORSAM_HOXA9_TARGETS_UP",21,"Up",0.712040362788425,0.999827083089274
"TAVOR_CEBPA_TARGETS_DN",18,"Up",0.712170525196894,0.999827083089274
"CHEN_LUNG_CANCER_SURVIVAL",29,"Down",0.7122896873714,0.999827083089274
"REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM",21,"Down",0.712415778123742,0.999827083089274
"RIZ_ERYTHROID_DIFFERENTIATION_CCNE1",33,"Up",0.71251017408255,0.999827083089274
"FUJIWARA_PARK2_IN_LIVER_CANCER_UP",7,"Up",0.712909608845283,0.999827083089274
"MIKKELSEN_NPC_LCP_WITH_H3K4ME3",22,"Down",0.712937520524526,0.999827083089274
"TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN",12,"Up",0.712975922205001,0.999827083089274
"LIN_NPAS4_TARGETS_DN",28,"Down",0.713408640468277,0.999827083089274
"MORI_IMMATURE_B_LYMPHOCYTE_UP",34,"Up",0.713531066477654,0.999827083089274
"CAFFAREL_RESPONSE_TO_THC_24HR_5_DN",26,"Up",0.713762267019321,0.999827083089274
"FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP",8,"Up",0.713800196745055,0.999827083089274
"BROWNE_HCMV_INFECTION_20HR_UP",113,"Up",0.71390325020137,0.999827083089274
"CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP",33,"Down",0.714279264007754,0.999827083089274
"DONATO_CELL_CYCLE_TRETINOIN",4,"Down",0.714411898724492,0.999827083089274
"KEGG_ERBB_SIGNALING_PATHWAY",65,"Down",0.714626304411771,0.999827083089274
"REACTOME_SIGNAL_TRANSDUCTION_BY_L1",26,"Down",0.714824230066382,0.999827083089274
"VERHAAK_GLIOBLASTOMA_MESENCHYMAL",136,"Up",0.714857173234188,0.999827083089274
"POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP",43,"Down",0.71486351405549,0.999827083089274
"REACTOME_THE_ROLE_OF_NEF_IN_HIV1_REPLICATION_AND_DISEASE_PATHOGENESIS",26,"Down",0.714951086470824,0.999827083089274
"ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP",219,"Up",0.714976720120073,0.999827083089274
"HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC",24,"Down",0.715148456450166,0.999827083089274
"REACTOME_ANDROGEN_BIOSYNTHESIS",9,"Up",0.715189094936828,0.999827083089274
"REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION",26,"Up",0.71542173907588,0.999827083089274
"KEGG_P53_SIGNALING_PATHWAY",44,"Down",0.715539785092807,0.999827083089274
"BIOCARTA_HCMV_PATHWAY",16,"Down",0.715547480592314,0.999827083089274
"REACTOME_REGULATION_OF_INSULIN_SECRETION",66,"Down",0.715659613248056,0.999827083089274
"SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE",45,"Up",0.715834440345564,0.999827083089274
"VILIMAS_NOTCH1_TARGETS_DN",18,"Down",0.715862177401075,0.999827083089274
"BIOCARTA_SODD_PATHWAY",8,"Down",0.715926553380754,0.999827083089274
"HOOI_ST7_TARGETS_DN",33,"Up",0.716273379633715,0.999827083089274
"GERY_CEBP_TARGETS",88,"Up",0.716283918467795,0.999827083089274
"NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON",44,"Down",0.716341703707571,0.999827083089274
"DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP",72,"Down",0.716377165072722,0.999827083089274
"BIOCARTA_G1_PATHWAY",25,"Up",0.71640196734436,0.999827083089274
"WEST_ADRENOCORTICAL_TUMOR_UP",117,"Down",0.716476842096632,0.999827083089274
"GAL_LEUKEMIC_STEM_CELL_DN",135,"Up",0.716498796357685,0.999827083089274
"SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1",217,"Up",0.716688823644736,0.999827083089274
"DAZARD_UV_RESPONSE_CLUSTER_G6",58,"Up",0.717112937464927,0.999827083089274
"LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN",184,"Down",0.717226989210436,0.999827083089274
"GENTILE_UV_HIGH_DOSE_DN",150,"Up",0.717316750473657,0.999827083089274
"ZHENG_FOXP3_TARGETS_UP",12,"Up",0.717514444928752,0.999827083089274
"GENTILE_UV_RESPONSE_CLUSTER_D2",20,"Down",0.718243942584655,0.999827083089274
"PETRETTO_HEART_MASS_QTL_CIS_UP",12,"Down",0.718385340004989,0.999827083089274
"BILANGES_RAPAMYCIN_SENSITIVE_GENES",13,"Up",0.718537124098867,0.999827083089274
"KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS",10,"Up",0.718572629394338,0.999827083089274
"REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE",22,"Up",0.718719499140485,0.999827083089274
"MISSIAGLIA_REGULATED_BY_METHYLATION_UP",66,"Up",0.718871403517911,0.999827083089274
"KARLSSON_TGFB1_TARGETS_DN",100,"Up",0.718921018579361,0.999827083089274
"CORRADETTI_MTOR_PATHWAY_REGULATORS_DN",2,"Up",0.718977658048801,0.999827083089274
"BRUECKNER_TARGETS_OF_MIRLET7A3_UP",45,"Up",0.719148552817106,0.999827083089274
"SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2",75,"Up",0.719166389115775,0.999827083089274
"WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG",18,"Down",0.71926862438206,0.999827083089274
"VILIMAS_NOTCH1_TARGETS_UP",46,"Down",0.719472740229623,0.999827083089274
"MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3",15,"Up",0.71971124171754,0.999827083089274
"MCGOWAN_RSP6_TARGETS_UP",11,"Up",0.719823867781924,0.999827083089274
"SMIRNOV_RESPONSE_TO_IR_6HR_DN",62,"Up",0.719918355673721,0.999827083089274
"REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION",11,"Up",0.720066446114561,0.999827083089274
"CHIBA_RESPONSE_TO_TSA_UP",49,"Down",0.72015564091473,0.999827083089274
"LEE_LIVER_CANCER_E2F1_DN",43,"Up",0.720428735166458,0.999827083089274
"TESAR_ALK_TARGETS_HUMAN_ES_5D_DN",5,"Down",0.720429645086483,0.999827083089274
"YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6",46,"Up",0.720516858396755,0.999827083089274
"BIOCARTA_SARS_PATHWAY",9,"Down",0.720716900021127,0.999827083089274
"REACTOME_INTERFERON_SIGNALING",89,"Down",0.720781605262838,0.999827083089274
"LENAOUR_DENDRITIC_CELL_MATURATION_DN",97,"Up",0.720877776183444,0.999827083089274
"REACTOME_MITOTIC_PROMETAPHASE",27,"Down",0.721042419156503,0.999827083089274
"GOZGIT_ESR1_TARGETS_UP",61,"Down",0.721080860117787,0.999827083089274
"RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN",252,"Down",0.721160913133301,0.999827083089274
"COWLING_MYCN_TARGETS",20,"Down",0.721229680745017,0.999827083089274
"MARTINELLI_IMMATURE_NEUTROPHIL_UP",7,"Up",0.721317338415595,0.999827083089274
"REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN",4,"Down",0.721473230072828,0.999827083089274
"ISHIKAWA_STING_SIGNALING",5,"Down",0.721587048723039,0.999827083089274
"YANG_MUC2_TARGETS_DUODENUM_6MO_DN",16,"Up",0.72172984154989,0.999827083089274
"WAGSCHAL_EHMT2_TARGETS_UP",5,"Up",0.721760926728618,0.999827083089274
"BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP",237,"Up",0.722447012804618,0.999827083089274
"MIKKELSEN_IPS_LCP_WITH_H3K4ME3_AND_H3K27ME3",1,"Down",0.72249984948279,0.999827083089274
"NIELSEN_SCHWANNOMA_DN",14,"Up",0.722502148361243,0.999827083089274
"REACTOME_INTERFERON_GAMMA_SIGNALING",47,"Down",0.722814143131976,0.999827083089274
"KUWANO_RNA_STABILIZED_BY_NO",6,"Down",0.722834800635625,0.999827083089274
"SAFFORD_T_LYMPHOCYTE_ANERGY",55,"Up",0.722940903939191,0.999827083089274
"PID_IGF1_PATHWAY",27,"Up",0.723081599531647,0.999827083089274
"CHENG_IMPRINTED_BY_ESTRADIOL",43,"Down",0.723117434028694,0.999827083089274
"HOEBEKE_LYMPHOID_STEM_CELL_DN",49,"Up",0.723217265570262,0.999827083089274
"SMITH_TERT_TARGETS_DN",55,"Up",0.723356378130681,0.999827083089274
"BIOCARTA_D4GDI_PATHWAY",12,"Down",0.7235276859021,0.999827083089274
"DAZARD_RESPONSE_TO_UV_NHEK_DN",113,"Up",0.723782771698734,0.999827083089274
"KEGG_DRUG_METABOLISM_CYTOCHROME_P450",37,"Down",0.7237937428649,0.999827083089274
"EHRLICH_ICF_SYNDROM_UP",5,"Down",0.724133025230723,0.999827083089274
"HOEGERKORP_CD44_TARGETS_TEMPORAL_DN",20,"Up",0.724600592161364,0.999827083089274
"KAYO_AGING_MUSCLE_UP",161,"Down",0.724633683479556,0.999827083089274
"REACTOME_NUCLEAR_SIGNALING_BY_ERBB4",25,"Up",0.724774628914229,0.999827083089274
"NABA_PROTEOGLYCANS",18,"Down",0.725057760687873,0.999827083089274
"GROSS_HYPOXIA_VIA_HIF1A_UP",26,"Down",0.725130770127988,0.999827083089274
"REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_",10,"Up",0.725518208723468,0.999827083089274
"GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP",65,"Up",0.725546888592858,0.999827083089274
"VALK_AML_CLUSTER_2",17,"Up",0.725552059280767,0.999827083089274
"BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN",66,"Down",0.72556898390205,0.999827083089274
"BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP",6,"Up",0.725594006181878,0.999827083089274
"FIGUEROA_AML_METHYLATION_CLUSTER_5_DN",19,"Down",0.725617426078905,0.999827083089274
"HEIDENBLAD_AMPLICON_12P11_12_UP",17,"Down",0.725760305986732,0.999827083089274
"DURCHDEWALD_SKIN_CARCINOGENESIS_UP",34,"Down",0.725913629306444,0.999827083089274
"MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_2",3,"Down",0.725931121899659,0.999827083089274
"MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED",7,"Up",0.726163213085287,0.999827083089274
"DAZARD_RESPONSE_TO_UV_SCC_UP",68,"Up",0.726199193251317,0.999827083089274
"LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP",78,"Down",0.726286415080772,0.999827083089274
"ZHANG_ADIPOGENESIS_BY_BMP7",13,"Down",0.726787520158389,0.999827083089274
"XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN",38,"Down",0.726796679756072,0.999827083089274
"KIM_MYC_AMPLIFICATION_TARGETS_DN",29,"Up",0.726876950305737,0.999827083089274
"BORLAK_LIVER_CANCER_EGF_UP",54,"Up",0.727130367399147,0.999827083089274
"STEIN_ESRRA_TARGETS_DN",38,"Up",0.727311836539813,0.999827083089274
"POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP",34,"Up",0.727736680745689,0.999827083089274
"TCGA_GLIOBLASTOMA_MUTATED",8,"Down",0.727755005643164,0.999827083089274
"HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN",12,"Up",0.728023384486187,0.999827083089274
"ZHU_CMV_24_HR_DN",72,"Up",0.728064580953623,0.999827083089274
"GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN",175,"Up",0.728769964637465,0.999827083089274
"HUMMEL_BURKITTS_LYMPHOMA_DN",14,"Up",0.728872465466093,0.999827083089274
"REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA",38,"Up",0.728912453073247,0.999827083089274
"LEE_BMP2_TARGETS_UP",310,"Up",0.728983397618481,0.999827083089274
"YANG_BREAST_CANCER_ESR1_LASER_DN",26,"Down",0.729004689016366,0.999827083089274
"MARTENS_TRETINOIN_RESPONSE_UP",331,"Up",0.729322893094435,0.999827083089274
"CAMPS_COLON_CANCER_COPY_NUMBER_UP",41,"Down",0.729472959143531,0.999827083089274
"VALK_AML_CLUSTER_9",16,"Up",0.729528553305826,0.999827083089274
"CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP",55,"Up",0.729627499267861,0.999827083089274
"LI_PROSTATE_CANCER_EPIGENETIC",24,"Up",0.729925795610854,0.999827083089274
"KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN",271,"Down",0.730182032711649,0.999827083089274
"REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION",48,"Up",0.730199553360905,0.999827083089274
"LI_INDUCED_T_TO_NATURAL_KILLER_DN",61,"Up",0.730202297075463,0.999827083089274
"VANTVEER_BREAST_CANCER_ESR1_UP",63,"Down",0.730350047023039,0.999827083089274
"LU_TUMOR_VASCULATURE_UP",13,"Down",0.730438303244944,0.999827083089274
"TIEN_INTESTINE_PROBIOTICS_6HR_UP",34,"Down",0.730555703319697,0.999827083089274
"PID_WNT_NONCANONICAL_PATHWAY",22,"Up",0.730710005601921,0.999827083089274
"ALFANO_MYC_TARGETS",132,"Down",0.730745379937038,0.999827083089274
"MARTINEZ_RESPONSE_TO_TRABECTEDIN",30,"Up",0.730894202626558,0.999827083089274
"NAKAMURA_ADIPOGENESIS_EARLY_UP",32,"Up",0.731070478456519,0.999827083089274
"BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS",91,"Up",0.731127395297843,0.999827083089274
"NELSON_RESPONSE_TO_ANDROGEN_UP",54,"Up",0.731264869625234,0.999827083089274
"FORTSCHEGGER_PHF8_TARGETS_DN",237,"Up",0.731275100596512,0.999827083089274
"GAVIN_FOXP3_TARGETS_CLUSTER_P4",53,"Down",0.731345689996891,0.999827083089274
"CHEN_PDGF_TARGETS",10,"Down",0.731625965508689,0.999827083089274
"REACTOME_ACTIVATED_TLR4_SIGNALLING",58,"Up",0.73175793551237,0.999827083089274
"BIOCARTA_ARENRF2_PATHWAY",12,"Down",0.732194215018556,0.999827083089274
"ROSS_AML_OF_FAB_M7_TYPE",36,"Up",0.732960893029783,0.999827083089274
"BIOCARTA_MYOSIN_PATHWAY",14,"Down",0.733036217419757,0.999827083089274
"PID_AP1_PATHWAY",72,"Up",0.733126620116879,0.999827083089274
"SMID_BREAST_CANCER_LUMINAL_B_UP",80,"Down",0.733344364719482,0.999827083089274
"GENTILE_UV_LOW_DOSE_DN",34,"Down",0.733467605598068,0.999827083089274
"KIM_WT1_TARGETS_UP",126,"Up",0.733481323947681,0.999827083089274
"MIKKELSEN_DEDIFFERENTIATED_STATE_DN",6,"Up",0.733603465459201,0.999827083089274
"WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2",24,"Down",0.733605607693986,0.999827083089274
"STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP",12,"Down",0.73381711997783,0.999827083089274
"BIOCARTA_GCR_PATHWAY",16,"Up",0.733838075325858,0.999827083089274
"WORSCHECH_TUMOR_REJECTION_DN",6,"Up",0.733846308215441,0.999827083089274
"KIM_ALL_DISORDERS_CALB1_CORR_UP",256,"Up",0.733990101380661,0.999827083089274
"JIANG_HYPOXIA_CANCER",36,"Down",0.734361907924925,0.999827083089274
"AMIT_EGF_RESPONSE_20_MCF10A",12,"Down",0.734570448176747,0.999827083089274
"REACTOME_SYNTHESIS_OF_PC",7,"Down",0.734643546951411,0.999827083089274
"HWANG_PROSTATE_CANCER_MARKERS",25,"Down",0.73468444741345,0.999827083089274
"SHI_SPARC_TARGETS_DN",8,"Down",0.734758530985739,0.999827083089274
"FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP",37,"Up",0.735162264244929,0.999827083089274
"SA_MMP_CYTOKINE_CONNECTION",14,"Down",0.735351250551119,0.999827083089274
"BIOCARTA_AKAPCENTROSOME_PATHWAY",11,"Up",0.735355006215905,0.999827083089274
"REACTOME_REGULATION_OF_AMPK_ACTIVITY_VIA_LKB1",5,"Down",0.735445961601913,0.999827083089274
"AMIT_EGF_RESPONSE_480_MCF10A",22,"Up",0.735747105384022,0.999827083089274
"PARK_TRETINOIN_RESPONSE",7,"Up",0.735747640324241,0.999827083089274
"REACTOME_DESTABILIZATION_OF_MRNA_BY_BRF1",5,"Down",0.735764384202402,0.999827083089274
"REACTOME_COMPLEMENT_CASCADE",23,"Up",0.735775229764857,0.999827083089274
"BIOCARTA_P53HYPOXIA_PATHWAY",16,"Down",0.735814379164329,0.999827083089274
"NICK_RESPONSE_TO_PROC_TREATMENT_DN",11,"Down",0.735838019975908,0.999827083089274
"FERRANDO_TAL1_NEIGHBORS",17,"Up",0.736073822100528,0.999827083089274
"KAUFFMANN_MELANOMA_RELAPSE_DN",3,"Up",0.736155550655179,0.999827083089274
"SCHOEN_NFKB_SIGNALING",34,"Up",0.736171724660711,0.999827083089274
"SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC",56,"Down",0.736335525844811,0.999827083089274
"YUAN_ZNF143_PARTNERS",8,"Up",0.736417602332546,0.999827083089274
"REACTOME_INTEGRATION_OF_ENERGY_METABOLISM",79,"Down",0.736794076036092,0.999827083089274
"BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C",35,"Up",0.736841399459263,0.999827083089274
"REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE",49,"Up",0.736866065638413,0.999827083089274
"PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP",26,"Up",0.737313747911362,0.999827083089274
"NAGASHIMA_NRG1_SIGNALING_UP",111,"Up",0.737386544246041,0.999827083089274
"LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES",23,"Up",0.737413047586291,0.999827083089274
"NAISHIRO_CTNNB1_TARGETS_WITH_LEF1_MOTIF",7,"Up",0.737454678777219,0.999827083089274
"ALONSO_METASTASIS_UP",98,"Up",0.737577207533165,0.999827083089274
"TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP",15,"Down",0.737751136128693,0.999827083089274
"NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_DN",12,"Up",0.737807464631461,0.999827083089274
"LEE_LIVER_CANCER_CIPROFIBRATE_DN",51,"Down",0.737807897064956,0.999827083089274
"VALK_AML_CLUSTER_11",23,"Up",0.737817617420375,0.999827083089274
"VANTVEER_BREAST_CANCER_METASTASIS_DN",46,"Up",0.737866286452097,0.999827083089274
"TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP",12,"Down",0.737882937227262,0.999827083089274
"CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN",87,"Up",0.738765047627611,0.999827083089274
"BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING",83,"Down",0.738796471391134,0.999827083089274
"PID_SYNDECAN_1_PATHWAY",41,"Down",0.738825802899362,0.999827083089274
"SENESE_HDAC1_AND_HDAC2_TARGETS_UP",118,"Up",0.739407201217322,0.999827083089274
"REN_MIF_TARGETS_DN",4,"Down",0.739552164747234,0.999827083089274
"BIOCARTA_CELLCYCLE_PATHWAY",21,"Up",0.739850274055682,0.999827083089274
"FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL",135,"Up",0.739936557505186,0.999827083089274
"HATADA_METHYLATED_IN_LUNG_CANCER_DN",8,"Down",0.740350473661232,0.999827083089274
"PID_TCR_PATHWAY",53,"Down",0.740400879257177,0.999827083089274
"DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN",14,"Down",0.740727090830464,0.999827083089274
"HUMMERICH_BENIGN_SKIN_TUMOR_DN",16,"Up",0.740733309789861,0.999827083089274
"REACTOME_ELONGATION_ARREST_AND_RECOVERY",13,"Down",0.740841365128312,0.999827083089274
"PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP",108,"Up",0.740966212423314,0.999827083089274
"GAVIN_FOXP3_TARGETS_CLUSTER_T7",52,"Down",0.741128906458222,0.999827083089274
"MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER",25,"Down",0.742248956426038,0.999827083089274
"REACTOME_INTEGRATION_OF_PROVIRUS",4,"Up",0.742669735893885,0.999827083089274
"REACTOME_M_G1_TRANSITION",53,"Down",0.742706455880961,0.999827083089274
"GRATIAS_RETINOBLASTOMA_16Q24",5,"Up",0.742761932266736,0.999827083089274
"HILLION_HMGA1_TARGETS",72,"Down",0.742907761149438,0.999827083089274
"LU_AGING_BRAIN_DN",92,"Down",0.742921550445486,0.999827083089274
"REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS",16,"Down",0.742947978515816,0.999827083089274
"ZEMBUTSU_SENSITIVITY_TO_METHOTREXATE",8,"Down",0.743049405317493,0.999827083089274
"DURAND_STROMA_NS_UP",56,"Up",0.743097238499813,0.999827083089274
"CLIMENT_BREAST_CANCER_COPY_NUMBER_UP",17,"Down",0.743106334897415,0.999827083089274
"KIM_WT1_TARGETS_8HR_UP",96,"Up",0.743149243154219,0.999827083089274
"SAGIV_CD24_TARGETS_UP",7,"Up",0.743256632274151,0.999827083089274
"ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN",15,"Down",0.743406708902817,0.999827083089274
"KIM_GASTRIC_CANCER_CHEMOSENSITIVITY",34,"Up",0.743539096944892,0.999827083089274
"PID_AURORA_A_PATHWAY",19,"Down",0.743816070139657,0.999827083089274
"ST_PAC1_RECEPTOR_PATHWAY",5,"Down",0.744077314738673,0.999827083089274
"TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA",44,"Down",0.744307478306178,0.999827083089274
"ZHAN_MULTIPLE_MYELOMA_DN",30,"Up",0.744474369619961,0.999827083089274
"MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN",6,"Up",0.74500710835063,0.999827083089274
"THUM_SYSTOLIC_HEART_FAILURE_UP",199,"Up",0.745029654607569,0.999827083089274
"KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION",11,"Up",0.745165057053735,0.999827083089274
"SHANK_TAL1_TARGETS_DN",10,"Down",0.745428936690866,0.999827083089274
"MARSON_FOXP3_CORE_DIRECT_TARGETS",16,"Down",0.745457152776758,0.999827083089274
"SCHLOSSER_SERUM_RESPONSE_DN",322,"Up",0.745559155630393,0.999827083089274
"TARTE_PLASMA_CELL_VS_PLASMABLAST_UP",295,"Up",0.745587046939115,0.999827083089274
"HOFMANN_CELL_LYMPHOMA_DN",27,"Down",0.745929295028842,0.999827083089274
"IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_DN",6,"Up",0.745990827745396,0.999827083089274
"LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN",18,"Up",0.746027983438897,0.999827083089274
"KEEN_RESPONSE_TO_ROSIGLITAZONE_DN",88,"Up",0.74617465921592,0.999827083089274
"HOELZEL_NF1_TARGETS_UP",52,"Down",0.746221149030151,0.999827083089274
"PETROVA_PROX1_TARGETS_DN",40,"Down",0.74623201181197,0.999827083089274
"DORSAM_HOXA9_TARGETS_DN",21,"Up",0.746378737762115,0.999827083089274
"KORKOLA_YOLK_SAC_TUMOR_UP",11,"Down",0.746392008095538,0.999827083089274
"PID_HIF1A_PATHWAY",8,"Up",0.746521134396371,0.999827083089274
"NUYTTEN_EZH2_TARGETS_DN",280,"Down",0.746537241637415,0.999827083089274
"TIEN_INTESTINE_PROBIOTICS_6HR_DN",55,"Down",0.746569862155753,0.999827083089274
"LIEN_BREAST_CARCINOMA_METAPLASTIC",24,"Down",0.746785521268885,0.999827083089274
"ST_INTEGRIN_SIGNALING_PATHWAY",50,"Down",0.746885942809003,0.999827083089274
"CAIRO_LIVER_DEVELOPMENT_DN",130,"Down",0.746925635215985,0.999827083089274
"SANA_RESPONSE_TO_IFNG_DN",50,"Up",0.746973871317912,0.999827083089274
"BROWNE_HCMV_INFECTION_10HR_DN",25,"Down",0.747228403261461,0.999827083089274
"PRAMOONJAGO_SOX4_TARGETS_UP",36,"Up",0.747615738300276,0.999827083089274
"BIOCARTA_EIF_PATHWAY",12,"Down",0.748103052328167,0.999827083089274
"CASTELLANO_NRAS_TARGETS_UP",45,"Down",0.748114320840972,0.999827083089274
"PID_INTEGRIN2_PATHWAY",22,"Down",0.748172311239,0.999827083089274
"NUTT_GBM_VS_AO_GLIOMA_UP",22,"Up",0.748297749874038,0.999827083089274
"VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN",8,"Down",0.748502719007459,0.999827083089274
"HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN",51,"Up",0.748647984589721,0.999827083089274
"WILLERT_WNT_SIGNALING",15,"Down",0.748692158889477,0.999827083089274
"DANG_REGULATED_BY_MYC_DN",175,"Down",0.74932738007058,0.999827083089274
"REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6",31,"Down",0.749343465560512,0.999827083089274
"STEGER_ADIPOGENESIS_DN",17,"Up",0.749432944914171,0.999827083089274
"MATZUK_SPERMATOCYTE",47,"Up",0.749443169249189,0.999827083089274
"WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC",13,"Down",0.749456574548122,0.999827083089274
"MULLIGHAN_MLL_SIGNATURE_1_DN",110,"Up",0.749767016186109,0.999827083089274
"KEGG_DILATED_CARDIOMYOPATHY",65,"Up",0.749947302954385,0.999827083089274
"REACTOME_G2_M_CHECKPOINTS",28,"Up",0.750167667981905,0.999827083089274
"KOINUMA_COLON_CANCER_MSI_UP",11,"Up",0.750198501811395,0.999827083089274
"LY_AGING_MIDDLE_UP",11,"Up",0.750476375740036,0.999827083089274
"ABDELMOHSEN_ELAVL4_TARGETS",13,"Down",0.750574605675113,0.999827083089274
"RICKMAN_HEAD_AND_NECK_CANCER_E",34,"Down",0.750690534955764,0.999827083089274
"BURTON_ADIPOGENESIS_1",24,"Down",0.751194461208942,0.999827083089274
"CHOI_ATL_CHRONIC_VS_ACUTE_DN",7,"Down",0.751253853256778,0.999827083089274
"OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP",33,"Up",0.75148762954107,0.999827083089274
"FARMER_BREAST_CANCER_CLUSTER_6",2,"Up",0.751906981550672,0.999827083089274
"KARLSSON_TGFB1_TARGETS_UP",51,"Up",0.752607430846467,0.999827083089274
"SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP",102,"Down",0.75261226227632,0.999827083089274
"ODONNELL_TFRC_TARGETS_UP",169,"Down",0.752642868950575,0.999827083089274
"SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP",209,"Up",0.752648808145605,0.999827083089274
"NABA_CORE_MATRISOME",135,"Down",0.752679291479197,0.999827083089274
"LIAN_LIPA_TARGETS_3M",43,"Up",0.752772458530052,0.999827083089274
"CAFFAREL_RESPONSE_TO_THC_8HR_5_UP",6,"Up",0.753266521340066,0.999827083089274
"ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP",255,"Down",0.753376504079637,0.999827083089274
"STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP",20,"Up",0.753432636531026,0.999827083089274
"PUJANA_BRCA_CENTERED_NETWORK",59,"Down",0.753482717760221,0.999827083089274
"MIKKELSEN_IPS_WITH_HCP_H3K27ME3",63,"Down",0.753738715639839,0.999827083089274
"WOO_LIVER_CANCER_RECURRENCE_UP",79,"Up",0.753892823566616,0.999827083089274
"CAIRO_PML_TARGETS_BOUND_BY_MYC_UP",17,"Down",0.753902473972886,0.999827083089274
"ZHANG_PROLIFERATING_VS_QUIESCENT",47,"Up",0.754036594018496,0.999827083089274
"BIOCARTA_GABA_PATHWAY",7,"Down",0.754124551687694,0.999827083089274
"REACTOME_TIE2_SIGNALING",15,"Down",0.754236126267597,0.999827083089274
"KEGG_TIGHT_JUNCTION",73,"Down",0.754431279571866,0.999827083089274
"SIG_CD40PATHWAYMAP",29,"Up",0.754464652399825,0.999827083089274
"MATTHEWS_AP1_TARGETS",13,"Down",0.754487477396717,0.999827083089274
"MAHADEVAN_IMATINIB_RESISTANCE_UP",11,"Up",0.754540039201779,0.999827083089274
"BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP",336,"Up",0.754669090934741,0.999827083089274
"BOYLAN_MULTIPLE_MYELOMA_C_UP",19,"Up",0.754700645861162,0.999827083089274
"BOYAULT_LIVER_CANCER_SUBCLASS_G2",8,"Down",0.7548274952182,0.999827083089274
"ROY_WOUND_BLOOD_VESSEL_UP",29,"Up",0.754911106031432,0.999827083089274
"REACTOME_ENOS_ACTIVATION_AND_REGULATION",14,"Up",0.754949599014503,0.999827083089274
"KEGG_BLADDER_CANCER",34,"Down",0.75541203513129,0.999827083089274
"YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN",7,"Up",0.755418997269963,0.999827083089274
"CHIBA_RESPONSE_TO_TSA_DN",17,"Down",0.755421354550567,0.999827083089274
"ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN",92,"Down",0.755563007589144,0.999827083089274
"SENESE_HDAC1_TARGETS_UP",184,"Up",0.755692014936739,0.999827083089274
"RODWELL_AGING_KIDNEY_NO_BLOOD_UP",107,"Down",0.756049146726715,0.999827083089274
"REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES",8,"Down",0.756107042774612,0.999827083089274
"DORN_ADENOVIRUS_INFECTION_24HR_UP",7,"Up",0.756409257415541,0.999827083089274
"CHEN_ETV5_TARGETS_TESTIS",15,"Up",0.756633890702376,0.999827083089274
"DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN",19,"Down",0.756863559504576,0.999827083089274
"KEGG_OLFACTORY_TRANSDUCTION",38,"Down",0.757304830280671,0.999827083089274
"REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION",25,"Up",0.757464611060358,0.999827083089274
"BROWNE_HCMV_INFECTION_14HR_DN",163,"Down",0.757752527642865,0.999827083089274
"WINTER_HYPOXIA_UP",46,"Up",0.757754157958671,0.999827083089274
"SU_KIDNEY",12,"Up",0.757854984915071,0.999827083089274
"RAMALHO_STEMNESS_DN",53,"Up",0.757884364242528,0.999827083089274
"GALIE_TUMOR_STEMNESS_GENES",6,"Down",0.757891335952622,0.999827083089274
"HOLLEMAN_DAUNORUBICIN_ALL_DN",3,"Down",0.758323851248969,0.999827083089274
"VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP",90,"Down",0.75836525155771,0.999827083089274
"CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN",67,"Down",0.758377058334666,0.999827083089274
"WU_CELL_MIGRATION",105,"Up",0.75852483545393,0.999827083089274
"FARMER_BREAST_CANCER_CLUSTER_7",10,"Down",0.75858294951205,0.999827083089274
"BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN",20,"Up",0.75867435097202,0.999827083089274
"RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN",37,"Down",0.758740436614671,0.999827083089274
"MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN",35,"Up",0.758868683617845,0.999827083089274
"KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN",284,"Down",0.758876953549285,0.999827083089274
"RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN",175,"Down",0.759039447527327,0.999827083089274
"LIN_NPAS4_TARGETS_UP",42,"Up",0.759118494336773,0.999827083089274
"LU_IL4_SIGNALING",56,"Down",0.759322966691831,0.999827083089274
"MARZEC_IL2_SIGNALING_UP",76,"Down",0.759693540139205,0.999827083089274
"MIKKELSEN_MEF_ICP_WITH_H3K27ME3",79,"Up",0.759907789119338,0.999827083089274
"DIRMEIER_LMP1_RESPONSE_LATE_UP",33,"Down",0.75996077241738,0.999827083089274
"NIELSEN_LEIOMYOSARCOMA_DN",9,"Up",0.759973596502417,0.999827083089274
"BHAT_ESR1_TARGETS_VIA_AKT1_UP",102,"Up",0.760095457043224,0.999827083089274
"REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING",24,"Down",0.760298016593602,0.999827083089274
"CAFFAREL_RESPONSE_TO_THC_8HR_5_DN",8,"Down",0.760421049411924,0.999827083089274
"LEE_NEURAL_CREST_STEM_CELL_DN",59,"Down",0.761303239630168,0.999827083089274
"REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM",13,"Down",0.761480196354212,0.999827083089274
"WINZEN_DEGRADED_VIA_KHSRP",58,"Down",0.762060888380563,0.999827083089274
"REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE",24,"Up",0.762195974111137,0.999827083089274
"REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE",3,"Down",0.762288518256371,0.999827083089274
"CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1",169,"Down",0.76243263280517,0.999827083089274
"CHICAS_RB1_TARGETS_CONFLUENT",251,"Up",0.762631315106357,0.999827083089274
"RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP",23,"Up",0.762674587228966,0.999827083089274
"NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON",18,"Down",0.762874024094321,0.999827083089274
"AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G",80,"Up",0.763265699855673,0.999827083089274
"HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN",15,"Down",0.763300253642153,0.999827083089274
"BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP",22,"Down",0.763572518407781,0.999827083089274
"REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS",15,"Down",0.76358186001038,0.999827083089274
"MUNSHI_MULTIPLE_MYELOMA_UP",63,"Up",0.763642131655744,0.999827083089274
"REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES",2,"Down",0.763677585822381,0.999827083089274
"BECKER_TAMOXIFEN_RESISTANCE_UP",30,"Up",0.764094846508665,0.999827083089274
"CHENG_RESPONSE_TO_NICKEL_ACETATE",23,"Up",0.764134381912379,0.999827083089274
"BIOCARTA_MTA3_PATHWAY",12,"Down",0.764189211822248,0.999827083089274
"VANDESLUIS_NORMAL_EMBRYOS_UP",2,"Down",0.764366860878949,0.999827083089274
"BRUNO_HEMATOPOIESIS",53,"Down",0.764495811102526,0.999827083089274
"REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY",40,"Down",0.764805759550964,0.999827083089274
"FRIDMAN_SENESCENCE_DN",9,"Down",0.764838384740324,0.999827083089274
"REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES",106,"Down",0.764896962399409,0.999827083089274
"GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN",21,"Down",0.764942964293049,0.999827083089274
"MCBRYAN_PUBERTAL_BREAST_6_7WK_UP",121,"Down",0.765071847315093,0.999827083089274
"BIOCARTA_EXTRINSIC_PATHWAY",11,"Down",0.765124502480564,0.999827083089274
"DARWICHE_PAPILLOMA_RISK_HIGH_DN",70,"Down",0.765376830999386,0.999827083089274
"HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP",220,"Up",0.765450657837424,0.999827083089274
"BOYLAN_MULTIPLE_MYELOMA_C_D_DN",120,"Up",0.765639860319212,0.999827083089274
"STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN",8,"Down",0.765701027542721,0.999827083089274
"MANN_RESPONSE_TO_AMIFOSTINE_UP",16,"Up",0.765707147396669,0.999827083089274
"SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_DN",5,"Up",0.765791949727052,0.999827083089274
"VANOEVELEN_MYOGENESIS_SIN3A_TARGETS",71,"Down",0.765837076168657,0.999827083089274
"FOSTER_KDM1A_TARGETS_UP",94,"Down",0.765884508255744,0.999827083089274
"BIOCARTA_NGF_PATHWAY",16,"Down",0.766229918211768,0.999827083089274
"VECCHI_GASTRIC_CANCER_EARLY_UP",155,"Up",0.767054278851175,0.999827083089274
"VECCHI_GASTRIC_CANCER_EARLY_DN",149,"Up",0.767168231955113,0.999827083089274
"MARTINELLI_IMMATURE_NEUTROPHIL_DN",10,"Down",0.767337229971889,0.999827083089274
"MA_MYELOID_DIFFERENTIATION_UP",35,"Up",0.767419562185069,0.999827083089274
"NABA_ECM_REGULATORS",126,"Down",0.76745337427394,0.999827083089274
"SHEN_SMARCA2_TARGETS_UP",131,"Up",0.767534558695173,0.999827083089274
"BIOCARTA_STATHMIN_PATHWAY",16,"Up",0.767592600398724,0.999827083089274
"HALMOS_CEBPA_TARGETS_DN",32,"Down",0.767806215706558,0.999827083089274
"ST_TUMOR_NECROSIS_FACTOR_PATHWAY",26,"Up",0.768020977555577,0.999827083089274
"LEE_BMP2_TARGETS_DN",271,"Down",0.768483863788792,0.999827083089274
"HEIDENBLAD_AMPLICON_8Q24_DN",14,"Down",0.768529044301271,0.999827083089274
"FIGUEROA_AML_METHYLATION_CLUSTER_1_UP",33,"Up",0.768542252670445,0.999827083089274
"BIOCARTA_MAPK_PATHWAY",65,"Up",0.768547928934089,0.999827083089274
"LOPEZ_MBD_TARGETS",463,"Down",0.768604256605388,0.999827083089274
"REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION",91,"Down",0.768761967237229,0.999827083089274
"HUANG_GATA2_TARGETS_DN",32,"Down",0.768808161547709,0.999827083089274
"JOHNSTONE_PARVB_TARGETS_3_DN",255,"Down",0.768913965782275,0.999827083089274
"GRADE_COLON_AND_RECTAL_CANCER_UP",132,"Up",0.768979306626436,0.999827083089274
"REACTOME_DESTABILIZATION_OF_MRNA_BY_TRISTETRAPROLIN_TTP",4,"Down",0.769295628606977,0.999827083089274
"HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP",48,"Up",0.769504997213481,0.999827083089274
"DANG_REGULATED_BY_MYC_UP",48,"Down",0.769756975097207,0.999827083089274
"OKUMURA_INFLAMMATORY_RESPONSE_LPS",89,"Up",0.769861979050346,0.999827083089274
"REACTOME_AMINE_LIGAND_BINDING_RECEPTORS",27,"Down",0.770039382048431,0.999827083089274
"MODY_HIPPOCAMPUS_NEONATAL",30,"Up",0.770898955343704,0.999827083089274
"WANG_LSD1_TARGETS_UP",22,"Down",0.771013302795946,0.999827083089274
"VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN",114,"Up",0.771247801233376,0.999827083089274
"DELACROIX_RAR_TARGETS_DN",17,"Up",0.77150594188611,0.999827083089274
"WANG_TUMOR_INVASIVENESS_UP",215,"Down",0.771864738989464,0.999827083089274
"GUO_HEX_TARGETS_DN",42,"Up",0.771950557298372,0.999827083089274
"WENG_POR_DOSAGE",13,"Down",0.772039780439356,0.999827083089274
"KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION",14,"Up",0.772231410571146,0.999827083089274
"PLASARI_TGFB1_TARGETS_10HR_DN",120,"Down",0.772476086895534,0.999827083089274
"KUMAR_AUTOPHAGY_NETWORK",18,"Up",0.772562621175941,0.999827083089274
"RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP",8,"Down",0.77304260420672,0.999827083089274
"KEGG_NITROGEN_METABOLISM",14,"Down",0.773268920466791,0.999827083089274
"BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3",7,"Down",0.77351137314828,0.999827083089274
"LIM_MAMMARY_LUMINAL_MATURE_DN",55,"Down",0.773699601651322,0.999827083089274
"PYEON_HPV_POSITIVE_TUMORS_DN",6,"Up",0.77390645770032,0.999827083089274
"PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN",61,"Down",0.77399016083666,0.999827083089274
"WIELAND_UP_BY_HBV_INFECTION",72,"Down",0.774177805536428,0.999827083089274
"XU_GH1_EXOGENOUS_TARGETS_UP",33,"Up",0.774227042041266,0.999827083089274
"REACTOME_DNA_STRAND_ELONGATION",18,"Down",0.774325658322368,0.999827083089274
"MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_21",5,"Up",0.774451290116779,0.999827083089274
"TSAI_RESPONSE_TO_IONIZING_RADIATION",106,"Up",0.774564807432132,0.999827083089274
"PID_ECADHERIN_NASCENT_AJ_PATHWAY",31,"Up",0.774565056282935,0.999827083089274
"REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE",5,"Down",0.774742649688288,0.999827083089274
"NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON",98,"Down",0.774944752866971,0.999827083089274
"LASTOWSKA_COAMPLIFIED_WITH_MYCN",12,"Down",0.775026378383249,0.999827083089274
"LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP",24,"Up",0.775163846588538,0.999827083089274
"SENESE_HDAC3_TARGETS_DN",171,"Down",0.775371841235505,0.999827083089274
"WU_HBX_TARGETS_1_DN",17,"Up",0.775497222525636,0.999827083089274
"CROMER_TUMORIGENESIS_DN",34,"Up",0.775663283077377,0.999827083089274
"SCHURINGA_STAT5A_TARGETS_DN",13,"Up",0.775671684878147,0.999827083089274
"INAMURA_LUNG_CANCER_SCC_SUBTYPES_DN",1,"Down",0.775686190988555,0.999827083089274
"OUYANG_PROSTATE_CANCER_MARKERS",16,"Up",0.775713419667317,0.999827083089274
"REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1",9,"Down",0.775872546542673,0.999827083089274
"REACTOME_ABORTIVE_ELONGATION_OF_HIV1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT",8,"Up",0.77602932696044,0.999827083089274
"BERENJENO_TRANSFORMED_BY_RHOA_UP",279,"Down",0.77608969012723,0.999827083089274
"REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS",5,"Up",0.77614756740712,0.999827083089274
"WEBER_METHYLATED_ICP_IN_FIBROBLAST",9,"Down",0.77679223998507,0.999827083089274
"PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN",12,"Up",0.777212950754773,0.999827083089274
"RASHI_NFKB1_TARGETS",14,"Down",0.777245738226926,0.999827083089274
"LENAOUR_DENDRITIC_CELL_MATURATION_UP",81,"Up",0.777260337616124,0.999827083089274
"RIZ_ERYTHROID_DIFFERENTIATION_HBZ",35,"Up",0.777333379157224,0.999827083089274
"PID_SHP2_PATHWAY",52,"Down",0.777559563210451,0.999827083089274
"KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS",45,"Down",0.777579301571327,0.999827083089274
"PID_IL4_2PATHWAY",56,"Up",0.777763211809364,0.999827083089274
"PID_BARD1_PATHWAY",19,"Down",0.777784846054764,0.999827083089274
"REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION",23,"Down",0.777906016229048,0.999827083089274
"KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY",63,"Down",0.777926416847484,0.999827083089274
"ZWANG_EGF_PERSISTENTLY_UP",10,"Down",0.778394388381883,0.999827083089274
"REACTOME_TRYPTOPHAN_CATABOLISM",2,"Up",0.778631702108764,0.999827083089274
"BYSTRYKH_HEMATOPOIESIS_STEM_CELL_RUNX1",10,"Up",0.778881362262147,0.999827083089274
"REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX",27,"Up",0.779674508927292,0.999827083089274
"RAO_BOUND_BY_SALL4",92,"Down",0.779855486085883,0.999827083089274
"HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN",38,"Up",0.779864507918626,0.999827083089274
"REACTOME_ETHANOL_OXIDATION",5,"Down",0.780128316181656,0.999827083089274
"WOO_LIVER_CANCER_RECURRENCE_DN",41,"Down",0.780244163076946,0.999827083089274
"BIERIE_INFLAMMATORY_RESPONSE_TGFB1",4,"Down",0.780908215100475,0.999827083089274
"REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT",58,"Down",0.780970319730338,0.999827083089274
"LABBE_WNT3A_TARGETS_DN",86,"Down",0.780971961699786,0.999827083089274
"ENK_UV_RESPONSE_KERATINOCYTE_DN",222,"Down",0.781103896749049,0.999827083089274
"GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP",10,"Up",0.781512084027367,0.999827083089274
"UEDA_PERIFERAL_CLOCK",88,"Down",0.781529569984164,0.999827083089274
"BURTON_ADIPOGENESIS_2",45,"Up",0.781745992577977,0.999827083089274
"SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP",209,"Up",0.781934997389892,0.999827083089274
"KAAB_FAILED_HEART_VENTRICLE_DN",27,"Up",0.782051244299262,0.999827083089274
"LIU_CDX2_TARGETS_UP",32,"Down",0.782316982772212,0.999827083089274
"DOANE_RESPONSE_TO_ANDROGEN_DN",125,"Down",0.782424736869279,0.999827083089274
"TIEN_INTESTINE_PROBIOTICS_24HR_UP",193,"Down",0.782634297414892,0.999827083089274
"CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN",83,"Down",0.782862994598501,0.999827083089274
"TESAR_JAK_TARGETS_MOUSE_ES_D3_UP",7,"Up",0.783015374814741,0.999827083089274
"BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP",12,"Down",0.783314956857606,0.999827083089274
"VALK_AML_WITH_CEBPA",21,"Up",0.783626647197858,0.999827083089274
"MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER",15,"Down",0.783985477041951,0.999827083089274
"REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION",47,"Up",0.784267624559319,0.999827083089274
"LINDSTEDT_DENDRITIC_CELL_MATURATION_A",47,"Down",0.784418270660645,0.999827083089274
"BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN",24,"Down",0.784712673195333,0.999827083089274
"SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1",110,"Up",0.784870838391251,0.999827083089274
"ST_JAK_STAT_PATHWAY",7,"Down",0.785405699680548,0.999827083089274
"VANASSE_BCL2_TARGETS_DN",38,"Up",0.78566313483325,0.999827083089274
"LIU_SOX4_TARGETS_UP",61,"Up",0.785913943372219,0.999827083089274
"RODRIGUES_DCC_TARGETS_UP",5,"Down",0.786911500211323,0.999827083089274
"REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS",7,"Up",0.786941378919069,0.999827083089274
"MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3",61,"Up",0.787115838374498,0.999827083089274
"REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLP1",8,"Up",0.787174536954057,0.999827083089274
"KEGG_ENDOCYTOSIS",91,"Down",0.787292789213704,0.999827083089274
"MIZUKAMI_HYPOXIA_UP",12,"Up",0.787403438369966,0.999827083089274
"HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN",16,"Down",0.787533161909352,0.999827083089274
"ABE_VEGFA_TARGETS_30MIN",20,"Down",0.787657431377432,0.999827083089274
"GAVIN_PDE3B_TARGETS",15,"Up",0.787821439432898,0.999827083089274
"REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM",28,"Down",0.788064482050406,0.999827083089274
"WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN",147,"Down",0.788099028011,0.999827083089274
"CHIN_BREAST_CANCER_COPY_NUMBER_UP",23,"Down",0.788323160386863,0.999827083089274
"REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS",22,"Down",0.788474417258532,0.999827083089274
"PID_NFAT_TFPATHWAY",43,"Up",0.788631883014075,0.999827083089274
"SCHRAETS_MLL_TARGETS_DN",30,"Up",0.788769799378167,0.999827083089274
"SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_UP",3,"Up",0.788779422861395,0.999827083089274
"GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP",86,"Down",0.789008739451256,0.999827083089274
"OXFORD_RALA_OR_RALB_TARGETS_UP",27,"Down",0.789116580030884,0.999827083089274
"LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER",90,"Down",0.789123593547605,0.999827083089274
"NAKAMURA_ADIPOGENESIS_LATE_DN",29,"Up",0.789132937059337,0.999827083089274
"KAMIKUBO_MYELOID_MN1_NETWORK",5,"Up",0.789145076009608,0.999827083089274
"MENSE_HYPOXIA_UP",40,"Up",0.789443087562811,0.999827083089274
"HARRIS_HYPOXIA",75,"Up",0.789530140679309,0.999827083089274
"REACTOME_CELL_CYCLE_CHECKPOINTS",69,"Down",0.7896296197748,0.999827083089274
"OUILLETTE_CLL_13Q14_DELETION_DN",26,"Up",0.789749376032733,0.999827083089274
"WHITEHURST_PACLITAXEL_SENSITIVITY",5,"Down",0.789868627685484,0.999827083089274
"BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN",27,"Down",0.789985740693467,0.999827083089274
"GALE_APL_WITH_FLT3_MUTATED_DN",8,"Down",0.789995595541439,0.999827083089274
"NADERI_BREAST_CANCER_PROGNOSIS_UP",22,"Down",0.790004231384387,0.999827083089274
"LIU_BREAST_CANCER",12,"Up",0.790013161793245,0.999827083089274
"REACTOME_KERATAN_SULFATE_BIOSYNTHESIS",10,"Down",0.790210707271105,0.999827083089274
"MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3",108,"Up",0.790400265103059,0.999827083089274
"KEGG_SPLICEOSOME",33,"Up",0.790606440694518,0.999827083089274
"NEMETH_INFLAMMATORY_RESPONSE_LPS_UP",77,"Down",0.790753611560263,0.999827083089274
"ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF",108,"Up",0.790860212480159,0.999827083089274
"LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q",25,"Down",0.790945491012133,0.999827083089274
"LIU_TARGETS_OF_VMYB_VS_CMYB_DN",24,"Up",0.790980432793936,0.999827083089274
"XU_GH1_AUTOCRINE_TARGETS_UP",99,"Down",0.790998666467968,0.999827083089274
"GAURNIER_PSMD4_TARGETS",61,"Up",0.791215331946883,0.999827083089274
"LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP",7,"Down",0.791423575750876,0.999827083089274
"LEE_EARLY_T_LYMPHOCYTE_UP",40,"Down",0.791494244431442,0.999827083089274
"LEE_LIVER_CANCER_SURVIVAL_UP",92,"Down",0.7915544546482,0.999827083089274
"HAN_JNK_SINGALING_UP",25,"Down",0.791689882880699,0.999827083089274
"RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP",39,"Up",0.791715844761123,0.999827083089274
"DANG_MYC_TARGETS_UP",92,"Down",0.791850136568604,0.999827083089274
"LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK",10,"Up",0.791938711013916,0.999827083089274
"KEGG_CHRONIC_MYELOID_LEUKEMIA",61,"Up",0.792015269623834,0.999827083089274
"JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN",47,"Up",0.79205590240409,0.999827083089274
"CAIRO_HEPATOBLASTOMA_UP",87,"Up",0.792068955921215,0.999827083089274
"ENGELMANN_CANCER_PROGENITORS_UP",29,"Down",0.792142349432123,0.999827083089274
"REACTOME_PEPTIDE_CHAIN_ELONGATION",44,"Up",0.792179668280282,0.999827083089274
"WANG_LMO4_TARGETS_DN",95,"Up",0.792203691221898,0.999827083089274
"REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM",8,"Down",0.792266073968489,0.999827083089274
"MULLIGHAN_NPM1_SIGNATURE_3_DN",78,"Up",0.792295821263365,0.999827083089274
"JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN",42,"Down",0.792372931710285,0.999827083089274
"BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS",7,"Up",0.792534991062151,0.999827083089274
"TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN",112,"Up",0.792692146626114,0.999827083089274
"WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP",43,"Down",0.792875766277646,0.999827083089274
"MAHAJAN_RESPONSE_TO_IL1A_UP",65,"Down",0.793006636573322,0.999827083089274
"CHO_NR4A1_TARGETS",19,"Down",0.793423415930036,0.999827083089274
"SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12",130,"Down",0.793445425613103,0.999827083089274
"DEMAGALHAES_AGING_DN",10,"Down",0.793679530192699,0.999827083089274
"ZHAN_MULTIPLE_MYELOMA_CD2_UP",23,"Up",0.793801575554349,0.999827083089274
"WANG_LMO4_TARGETS_UP",117,"Up",0.79382739990389,0.999827083089274
"BAELDE_DIABETIC_NEPHROPATHY_DN",220,"Down",0.793880930544457,0.999827083089274
"HATADA_METHYLATED_IN_LUNG_CANCER_UP",150,"Up",0.794170821844252,0.999827083089274
"FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP",9,"Down",0.794312988334094,0.999827083089274
"ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF",182,"Down",0.794530912855824,0.999827083089274
"SESTO_RESPONSE_TO_UV_C7",41,"Down",0.794815336270672,0.999827083089274
"VERRECCHIA_RESPONSE_TO_TGFB1_C3",10,"Up",0.794879034353458,0.999827083089274
"BIOCARTA_LECTIN_PATHWAY",9,"Up",0.795021894346597,0.999827083089274
"PEREZ_TP53_AND_TP63_TARGETS",83,"Up",0.795215473027551,0.999827083089274
"MOOTHA_HUMAN_MITODB_6_2002",186,"Up",0.795274301877628,0.999827083089274
"HINATA_NFKB_TARGETS_KERATINOCYTE_DN",13,"Down",0.795533599844589,0.999827083089274
"HASEGAWA_TUMORIGENESIS_BY_RET_C634R",3,"Down",0.795579183345196,0.999827083089274
"REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY",8,"Up",0.79579360109095,0.999827083089274
"BAKKER_FOXO3_TARGETS_DN",73,"Down",0.795819752120342,0.999827083089274
"WANG_BARRETTS_ESOPHAGUS_DN",18,"Up",0.79582848108302,0.999827083089274
"PHESSE_TARGETS_OF_APC_AND_MBD2_DN",8,"Down",0.795875709217065,0.999827083089274
"REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS",8,"Down",0.795884683211773,0.999827083089274
"KRIEG_HYPOXIA_NOT_VIA_KDM3A",263,"Down",0.795902562460446,0.999827083089274
"PID_IL2_PI3K_PATHWAY",30,"Down",0.796142522485042,0.999827083089274
"KEGG_PROTEIN_EXPORT",6,"Up",0.796196930482394,0.999827083089274
"HOSHIDA_LIVER_CANCER_SUBCLASS_S2",62,"Up",0.796289248115921,0.999827083089274
"MORI_LARGE_PRE_BII_LYMPHOCYTE_DN",43,"Up",0.796305299871882,0.999827083089274
"BIOCARTA_NDKDYNAMIN_PATHWAY",14,"Down",0.7964611335056,0.999827083089274
"WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR",53,"Up",0.796524632197327,0.999827083089274
"GOERING_BLOOD_HDL_CHOLESTEROL_QTL_CIS",5,"Down",0.796601575133401,0.999827083089274
"PID_AURORA_B_PATHWAY",23,"Down",0.796818688604357,0.999827083089274
"KANG_AR_TARGETS_UP",17,"Down",0.796890184615264,0.999827083089274
"REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM",12,"Down",0.796978673443792,0.999827083089274
"SEIDEN_ONCOGENESIS_BY_MET",41,"Down",0.797061710185999,0.999827083089274
"PID_FCER1_PATHWAY",55,"Up",0.797143013407807,0.999827083089274
"GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN",89,"Down",0.797197019274952,0.999827083089274
"ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP",17,"Down",0.797577389349382,0.999827083089274
"SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP",140,"Down",0.79783882131997,0.999827083089274
"REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS",8,"Up",0.798062938856132,0.999827083089274
"NELSON_RESPONSE_TO_ANDROGEN_DN",14,"Up",0.798064809646164,0.999827083089274
"BURTON_ADIPOGENESIS_6",101,"Down",0.798412856729366,0.999827083089274
"KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS",5,"Down",0.798433930814403,0.999827083089274
"YAMAZAKI_TCEB3_TARGETS_UP",109,"Down",0.798545260821339,0.999827083089274
"CHANG_POU5F1_TARGETS_UP",12,"Down",0.798576195763917,0.999827083089274
"BURTON_ADIPOGENESIS_4",24,"Down",0.798635554992371,0.999827083089274
"KEGG_NON_SMALL_CELL_LUNG_CANCER",42,"Down",0.798709488165265,0.999827083089274
"XU_GH1_EXOGENOUS_TARGETS_DN",48,"Down",0.798950804148543,0.999827083089274
"BROWNE_HCMV_INFECTION_4HR_UP",29,"Up",0.79901964262214,0.999827083089274
"NIKOLSKY_BREAST_CANCER_16P13_AMPLICON",26,"Down",0.799082418841972,0.999827083089274
"GOZGIT_ESR1_TARGETS_DN",300,"Down",0.799204270386008,0.999827083089274
"WANG_RESPONSE_TO_BEXAROTENE_UP",19,"Up",0.799248082829752,0.999827083089274
"RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP",36,"Up",0.799588413951833,0.999827083089274
"BIOCARTA_GLYCOLYSIS_PATHWAY",9,"Down",0.799875307772208,0.999827083089274
"BAKER_HEMATOPOESIS_STAT5_TARGETS",7,"Down",0.79999928550042,0.999827083089274
"BIOCARTA_WNT_PATHWAY",21,"Down",0.800074411447232,0.999827083089274
"PILON_KLF1_TARGETS_UP",237,"Down",0.80069295626903,0.999827083089274
"KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP",251,"Down",0.801606942255176,0.999827083089274
"HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_DN",8,"Down",0.802065192149903,0.999827083089274
"INAMURA_LUNG_CANCER_SCC_UP",6,"Down",0.802431022331884,0.999827083089274
"DACOSTA_UV_RESPONSE_VIA_ERCC3_UP",176,"Up",0.802596233297342,0.999827083089274
"DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP",11,"Down",0.802808284766848,0.999827083089274
"SCHUHMACHER_MYC_TARGETS_UP",38,"Down",0.802929831092552,0.999827083089274
"FIRESTEIN_PROLIFERATION",80,"Down",0.802974523506636,0.999827083089274
"REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE",22,"Down",0.803048477477061,0.999827083089274
"SU_TESTIS",30,"Up",0.803329167738164,0.999827083089274
"ZHAN_MULTIPLE_MYELOMA_PR_UP",16,"Up",0.803729811494526,0.999827083089274
"RODWELL_AGING_KIDNEY_DN",51,"Up",0.803878228906501,0.999827083089274
"PLASARI_NFIC_TARGETS_BASAL_DN",13,"Down",0.803897612056508,0.999827083089274
"KEGG_ETHER_LIPID_METABOLISM",17,"Down",0.804125890295891,0.999827083089274
"PID_THROMBIN_PAR1_PATHWAY",36,"Down",0.804290050150518,0.999827083089274
"LIAO_METASTASIS",191,"Up",0.804306244253331,0.999827083089274
"ONDER_CDH1_TARGETS_3_DN",28,"Down",0.804428698661012,0.999827083089274
"LINDSTEDT_DENDRITIC_CELL_MATURATION_B",41,"Up",0.804504457519877,0.999827083089274
"REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING",40,"Down",0.804581955496037,0.999827083089274
"KOYAMA_SEMA3B_TARGETS_UP",108,"Down",0.80469920686895,0.999827083089274
"MALONEY_RESPONSE_TO_17AAG_UP",26,"Up",0.804818378938188,0.999827083089274
"ZHAN_MULTIPLE_MYELOMA_MF_UP",19,"Down",0.804917163540653,0.999827083089274
"MANN_RESPONSE_TO_AMIFOSTINE_DN",6,"Down",0.805205793866927,0.999827083089274
"ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR",36,"Up",0.805350500824452,0.999827083089274
"FOURNIER_ACINAR_DEVELOPMENT_LATE_2",116,"Down",0.80550679067975,0.999827083089274
"HAN_SATB1_TARGETS_UP",192,"Up",0.805571517663233,0.999827083089274
"JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN",30,"Up",0.805704901283637,0.999827083089274
"REACTOME_IL_6_SIGNALING",9,"Down",0.805747674438077,0.999827083089274
"BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP",29,"Down",0.80588241916465,0.999827083089274
"MOOTHA_GLUCONEOGENESIS",25,"Down",0.805961837455133,0.999827083089274
"KANG_GIST_WITH_PDGFRA_DN",1,"Down",0.806463155172684,0.999827083089274
"SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX3",3,"Down",0.806632530512605,0.999827083089274
"RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP",184,"Up",0.806635506437556,0.999827083089274
"DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP",129,"Up",0.807194561815172,0.999827083089274
"DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN",80,"Up",0.807347561812047,0.999827083089274
"MILI_PSEUDOPODIA_HAPTOTAXIS_DN",247,"Up",0.807385213274242,0.999827083089274
"GRADE_COLON_CANCER_UP",333,"Up",0.807607411519496,0.999827083089274
"GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP",83,"Up",0.807778747714894,0.999827083089274
"TSENG_ADIPOGENIC_POTENTIAL_UP",23,"Up",0.80793637421726,0.999827083089274
"BENPORATH_ES_WITH_H3K27ME3",547,"Up",0.807967783806925,0.999827083089274
"BOCHKIS_FOXA2_TARGETS",208,"Down",0.807981842705218,0.999827083089274
"MIKKELSEN_IPS_ICP_WITH_H3K27ME3",24,"Down",0.808028283588544,0.999827083089274
"LANDIS_BREAST_CANCER_PROGRESSION_DN",50,"Up",0.808200213820562,0.999827083089274
"MARTINEZ_RB1_TARGETS_DN",256,"Up",0.808386032398825,0.999827083089274
"BIOCARTA_CASPASE_PATHWAY",22,"Down",0.808467364943304,0.999827083089274
"CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN",207,"Down",0.808535201735781,0.999827083089274
"FUJII_YBX1_TARGETS_UP",20,"Down",0.808578904354374,0.999827083089274
"RIGGI_EWING_SARCOMA_PROGENITOR_DN",87,"Down",0.808690021993569,0.999827083089274
"PID_RHOA_PATHWAY",38,"Up",0.809112768042877,0.999827083089274
"OHGUCHI_LIVER_HNF4A_TARGETS_DN",63,"Down",0.809250641884246,0.999827083089274
"NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON",4,"Down",0.809302193711398,0.999827083089274
"SPIRA_SMOKERS_LUNG_CANCER_DN",4,"Down",0.809612171948224,0.999827083089274
"REACTOME_GAB1_SIGNALOSOME",22,"Up",0.810140668097608,0.999827083089274
"KAAB_HEART_ATRIUM_VS_VENTRICLE_DN",129,"Up",0.810279647722868,0.999827083089274
"PID_SYNDECAN_2_PATHWAY",28,"Down",0.810295505822549,0.999827083089274
"DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN",33,"Down",0.811074027635262,0.999827083089274
"REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE",15,"Up",0.811251134287101,0.999827083089274
"REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL",99,"Down",0.811907277130795,0.999827083089274
"HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN",9,"Up",0.812077329595796,0.999827083089274
"GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN",357,"Down",0.812913457735178,0.999827083089274
"PUJANA_BRCA2_PCC_NETWORK",197,"Down",0.813146080739315,0.999827083089274
"REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS",33,"Up",0.813508621617408,0.999827083089274
"KEGG_NOTCH_SIGNALING_PATHWAY",32,"Up",0.813528077974526,0.999827083089274
"REACTOME_MEIOTIC_RECOMBINATION",21,"Up",0.813551041395936,0.999827083089274
"YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13",54,"Down",0.813557464323315,0.999827083089274
"JIANG_AGING_HYPOTHALAMUS_UP",35,"Up",0.813765237012974,0.999827083089274
"TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN",4,"Down",0.813915756822838,0.999827083089274
"AMUNDSON_GENOTOXIC_SIGNATURE",61,"Up",0.813971887603458,0.999827083089274
"ROVERSI_GLIOMA_COPY_NUMBER_UP",39,"Up",0.814324086818299,0.999827083089274
"RODRIGUES_NTN1_TARGETS_DN",85,"Down",0.814457529428301,0.999827083089274
"ROY_WOUND_BLOOD_VESSEL_DN",10,"Up",0.814647486103169,0.999827083089274
"REACTOME_SIGNALLING_BY_NGF",127,"Down",0.814685285129216,0.999827083089274
"SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP",61,"Up",0.814917881593647,0.999827083089274
"BENPORATH_SUZ12_TARGETS",502,"Up",0.81501602939032,0.999827083089274
"CAIRO_LIVER_DEVELOPMENT_UP",84,"Up",0.81512314793072,0.999827083089274
"SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_DN",4,"Up",0.815568854400702,0.999827083089274
"CROMER_TUMORIGENESIS_UP",43,"Up",0.8157774000409,0.999827083089274
"KIM_HYPOXIA",21,"Up",0.816013044188722,0.999827083089274
"VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP",43,"Down",0.816028416773697,0.999827083089274
"PUJANA_BRCA1_PCC_NETWORK",744,"Down",0.816183255857975,0.999827083089274
"PUJANA_BREAST_CANCER_LIT_INT_NETWORK",76,"Down",0.816187796402649,0.999827083089274
"SIMBULAN_PARP1_TARGETS_DN",12,"Up",0.816339864177271,0.999827083089274
"SASSON_RESPONSE_TO_FORSKOLIN_UP",63,"Up",0.816403750137969,0.999827083089274
"SHEPARD_BMYB_MORPHOLINO_DN",111,"Down",0.816630383529822,0.999827083089274
"GROSS_HYPOXIA_VIA_ELK3_DN",90,"Down",0.81672264028578,0.999827083089274
"PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION",14,"Up",0.816893545547624,0.999827083089274
"NIELSEN_SCHWANNOMA_UP",13,"Down",0.816967743722453,0.999827083089274
"BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2",38,"Up",0.817663556009954,0.999827083089274
"ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN",23,"Up",0.817828525125321,0.999827083089274
"REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS",12,"Up",0.817849893168947,0.999827083089274
"KEGG_VIBRIO_CHOLERAE_INFECTION",29,"Up",0.817912647226745,0.999827083089274
"ACEVEDO_LIVER_CANCER_UP",269,"Down",0.818007020590529,0.999827083089274
"DELACROIX_RAR_BOUND_ES",203,"Up",0.818251408736516,0.999827083089274
"REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE",33,"Down",0.818388630550804,0.999827083089274
"KAMMINGA_EZH2_TARGETS",23,"Down",0.818636708128888,0.999827083089274
"WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN",51,"Up",0.818701439698424,0.999827083089274
"ZHOU_TNF_SIGNALING_4HR",30,"Down",0.818738635242205,0.999827083089274
"SHIPP_DLBCL_CURED_VS_FATAL_DN",27,"Down",0.818834517249653,0.999827083089274
"REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING",26,"Up",0.818920635101275,0.999827083089274
"JOHNSTONE_PARVB_TARGETS_2_UP",82,"Down",0.819036072422937,0.999827083089274
"REACTOME_TRIF_MEDIATED_TLR3_SIGNALING",46,"Up",0.81940821103394,0.999827083089274
"BALLIF_DEVELOPMENTAL_DISABILITY_P16_P12_DELETION",8,"Down",0.819725452454044,0.999827083089274
"LI_AMPLIFIED_IN_LUNG_CANCER",115,"Down",0.820320821958627,0.999827083089274
"LU_AGING_BRAIN_UP",126,"Down",0.820415013249681,0.999827083089274
"REACTOME_MEMBRANE_TRAFFICKING",62,"Down",0.820782499057869,0.999827083089274
"MOREIRA_RESPONSE_TO_TSA_UP",25,"Up",0.821215257382339,0.999827083089274
"BOYLAN_MULTIPLE_MYELOMA_PCA1_DN",4,"Down",0.821360325549078,0.999827083089274
"PID_FAS_PATHWAY",34,"Down",0.821439785763319,0.999827083089274
"ZHAN_MULTIPLE_MYELOMA_SUBGROUPS",21,"Up",0.821533316794493,0.999827083089274
"HELLER_HDAC_TARGETS_DN",146,"Up",0.821581668436121,0.999827083089274
"BIOCARTA_AKAP13_PATHWAY",8,"Up",0.821646830943913,0.999827083089274
"WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP",35,"Up",0.821706380000373,0.999827083089274
"HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP",26,"Up",0.821721609448647,0.999827083089274
"KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3",40,"Down",0.82189935335704,0.999827083089274
"KAYO_CALORIE_RESTRICTION_MUSCLE_DN",47,"Down",0.821980493119694,0.999827083089274
"DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY",23,"Up",0.821997625304904,0.999827083089274
"RAY_ALZHEIMERS_DISEASE",10,"Down",0.822002124346576,0.999827083089274
"BIOCARTA_HIF_PATHWAY",13,"Down",0.822057908137049,0.999827083089274
"REACTOME_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS",10,"Down",0.822091825918229,0.999827083089274
"LEE_EARLY_T_LYMPHOCYTE_DN",29,"Up",0.822128001078503,0.999827083089274
"TSENG_IRS1_TARGETS_UP",67,"Down",0.822322280181636,0.999827083089274
"CASORELLI_APL_SECONDARY_VS_DE_NOVO_DN",2,"Down",0.822485760872247,0.999827083089274
"REACTOME_GLUTATHIONE_CONJUGATION",15,"Up",0.822545373335887,0.999827083089274
"LIN_MELANOMA_COPY_NUMBER_DN",17,"Up",0.822637830600645,0.999827083089274
"RICKMAN_METASTASIS_DN",109,"Down",0.822639753061678,0.999827083089274
"KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES",12,"Down",0.822655061399069,0.999827083089274
"SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_UP",5,"Up",0.822691832568634,0.999827083089274
"MCLACHLAN_DENTAL_CARIES_DN",174,"Up",0.822800770965689,0.999827083089274
"SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS",30,"Up",0.823010593566864,0.999827083089274
"REACTOME_DOWNSTREAM_TCR_SIGNALING",23,"Up",0.823256522148438,0.999827083089274
"FALVELLA_SMOKERS_WITH_LUNG_CANCER",44,"Up",0.823442955049245,0.999827083089274
"SHIPP_DLBCL_CURED_VS_FATAL_UP",27,"Up",0.823504416152078,0.999827083089274
"MOOTHA_PGC",224,"Up",0.823512519308619,0.999827083089274
"LUCAS_HNF4A_TARGETS_DN",5,"Up",0.823512678725079,0.999827083089274
"WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH",50,"Up",0.823526825413379,0.999827083089274
"WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D",292,"Down",0.823620339436909,0.999827083089274
"THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN",140,"Down",0.823774620327353,0.999827083089274
"ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM",54,"Down",0.823784335582977,0.999827083089274
"MEISSNER_NPC_HCP_WITH_H3K4ME2",200,"Up",0.823876957179888,0.999827083089274
"REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS",43,"Down",0.824023641566388,0.999827083089274
"KOBAYASHI_EGFR_SIGNALING_24HR_DN",121,"Down",0.824049704082063,0.999827083089274
"AFFAR_YY1_TARGETS_UP",142,"Up",0.824145651431487,0.999827083089274
"HOWLIN_CITED1_TARGETS_2_DN",9,"Up",0.824180207156004,0.999827083089274
"BLALOCK_ALZHEIMERS_DISEASE_DN",566,"Up",0.824244801543258,0.999827083089274
"REACTOME_INTRINSIC_PATHWAY",12,"Down",0.82436103484435,0.999827083089274
"REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR",84,"Down",0.824528250215934,0.999827083089274
"BIOCARTA_EPONFKB_PATHWAY",11,"Down",0.82466510562558,0.999827083089274
"STANHILL_HRAS_TRANSFROMATION_UP",6,"Down",0.824757487189332,0.999827083089274
"YANG_BCL3_TARGETS_UP",164,"Down",0.824962619827485,0.999827083089274
"CAIRO_PML_TARGETS_BOUND_BY_MYC_DN",13,"Up",0.825158821247566,0.999827083089274
"RHODES_UNDIFFERENTIATED_CANCER",38,"Up",0.825800502044359,0.999827083089274
"BROWNE_HCMV_INFECTION_10HR_UP",52,"Up",0.825868360212579,0.999827083089274
"LIU_SOX4_TARGETS_DN",130,"Up",0.826153386462169,0.999827083089274
"MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP",117,"Up",0.826161578754144,0.999827083089274
"OXFORD_RALA_AND_RALB_TARGETS_DN",6,"Up",0.826197499252183,0.999827083089274
"LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_UP",3,"Down",0.826243730005788,0.999827083089274
"BUDHU_LIVER_CANCER_METASTASIS_UP",9,"Down",0.826397057424463,0.999827083089274
"SASAKI_ADULT_T_CELL_LEUKEMIA",84,"Up",0.826456772851031,0.999827083089274
"REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES",27,"Down",0.826678783300665,0.999827083089274
"REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES",27,"Down",0.826678783300665,0.999827083089274
"YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12",39,"Down",0.826740151548632,0.999827083089274
"WILENSKY_RESPONSE_TO_DARAPLADIB",23,"Up",0.826750178012339,0.999827083089274
"REACTOME_PLATELET_SENSITIZATION_BY_LDL",11,"Up",0.826977576241158,0.999827083089274
"COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP",48,"Down",0.827002871585043,0.999827083089274
"BIOCARTA_STEM_PATHWAY",15,"Down",0.827065078601717,0.999827083089274
"BILANGES_SERUM_SENSITIVE_GENES",39,"Down",0.827090243241133,0.999827083089274
"REACTOME_ACYL_CHAIN_REMODELLING_OF_PC",9,"Up",0.827222417186786,0.999827083089274
"REACTOME_ACYL_CHAIN_REMODELLING_OF_PE",9,"Up",0.827222417186786,0.999827083089274
"REACTOME_ACYL_CHAIN_REMODELLING_OF_PS",9,"Up",0.827222417186786,0.999827083089274
"WINNEPENNINCKX_MELANOMA_METASTASIS_UP",56,"Down",0.827369618867071,0.999827083089274
"ZWANG_EGF_INTERVAL_DN",66,"Up",0.827423848430741,0.999827083089274
"SCHLOSSER_SERUM_RESPONSE_UP",81,"Up",0.827587471119202,0.999827083089274
"PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN",11,"Up",0.827897201006995,0.999827083089274
"MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP",14,"Down",0.828161077413633,0.999827083089274
"BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP",12,"Up",0.828322489251126,0.999827083089274
"ALCALAY_AML_BY_NPM1_LOCALIZATION_DN",89,"Up",0.828436106473574,0.999827083089274
"ALCALA_APOPTOSIS",53,"Up",0.828489020384282,0.999827083089274
"IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP",59,"Up",0.82869232182165,0.999827083089274
"KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION",43,"Up",0.828834142797674,0.999827083089274
"REACTOME_BOTULINUM_NEUROTOXICITY",9,"Up",0.828941042444165,0.999827083089274
"GALIE_TUMOR_ANGIOGENESIS",8,"Down",0.828991136384874,0.999827083089274
"NIKOLSKY_BREAST_CANCER_20P13_AMPLICON",4,"Up",0.829159712574064,0.999827083089274
"MCCLUNG_DELTA_FOSB_TARGETS_8WK",31,"Up",0.829250737560084,0.999827083089274
"KEGG_OOCYTE_MEIOSIS",61,"Up",0.829390958440793,0.999827083089274
"REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT",29,"Down",0.82943536338974,0.999827083089274
"AMIT_EGF_RESPONSE_60_MCF10A",24,"Down",0.829467262712863,0.999827083089274
"REACTOME_TCR_SIGNALING",38,"Down",0.830010264249447,0.999827083089274
"BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN",10,"Down",0.8300639313857,0.999827083089274
"REACTOME_GAP_JUNCTION_TRAFFICKING",20,"Down",0.830152671518943,0.999827083089274
"ONDER_CDH1_TARGETS_1_UP",61,"Down",0.83054548259997,0.999827083089274
"GOLDRATH_IMMUNE_MEMORY",37,"Down",0.830730404654395,0.999827083089274
"SANA_TNF_SIGNALING_UP",53,"Up",0.830734764534113,0.999827083089274
"DASU_IL6_SIGNALING_UP",42,"Up",0.830813102035619,0.999827083089274
"CLAUS_PGR_POSITIVE_MENINGIOMA_UP",1,"Down",0.831175208705285,0.999827083089274
"YAN_ESCAPE_FROM_ANOIKIS",23,"Down",0.83135906379697,0.999827083089274
"FERNANDEZ_BOUND_BY_MYC",147,"Up",0.831374494069413,0.999827083089274
"PHONG_TNF_RESPONSE_NOT_VIA_P38",171,"Up",0.831462802609056,0.999827083089274
"VERRECCHIA_EARLY_RESPONSE_TO_TGFB1",49,"Up",0.831775510924279,0.999827083089274
"HAHTOLA_CTCL_CUTANEOUS",13,"Down",0.831837199736332,0.999827083089274
"OUYANG_PROSTATE_CANCER_PROGRESSION_UP",14,"Down",0.831859270643354,0.999827083089274
"KEGG_HUNTINGTONS_DISEASE",80,"Up",0.831874319375424,0.999827083089274
"ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP",30,"Up",0.831916454128469,0.999827083089274
"PID_ECADHERIN_STABILIZATION_PATHWAY",33,"Down",0.83208939557978,0.999827083089274
"WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2",32,"Up",0.832507741001809,0.999827083089274
"BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A",365,"Up",0.832614584104108,0.999827083089274
"DAZARD_RESPONSE_TO_UV_NHEK_UP",156,"Up",0.832772782633432,0.999827083089274
"REACTOME_TRANSCRIPTION_COUPLED_NER_TC_NER",22,"Down",0.833080430252634,0.999827083089274
"TSAI_DNAJB4_TARGETS_UP",6,"Up",0.833247243041993,0.999827083089274
"BIOCARTA_IL1R_PATHWAY",27,"Up",0.833320513120509,0.999827083089274
"NADELLA_PRKAR1A_TARGETS_DN",7,"Down",0.833983248054426,0.999827083089274
"TSUNODA_CISPLATIN_RESISTANCE_DN",30,"Up",0.834078050078731,0.999827083089274
"NAKAYAMA_FGF2_TARGETS",13,"Down",0.834194479240503,0.999827083089274
"KRIGE_AMINO_ACID_DEPRIVATION",18,"Up",0.834650249942292,0.999827083089274
"YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN",116,"Down",0.834695066823533,0.999827083089274
"HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP",40,"Up",0.834786845537518,0.999827083089274
"REACTOME_ACTIVATED_AMPK_STIMULATES_FATTY_ACID_OXIDATION_IN_MUSCLE",8,"Down",0.834867839810477,0.999827083089274
"PID_P75_NTR_PATHWAY",53,"Down",0.834891815174102,0.999827083089274
"KANG_IMMORTALIZED_BY_TERT_UP",52,"Up",0.835001995963586,0.999827083089274
"KORKOLA_YOLK_SAC_TUMOR",33,"Down",0.835247899135057,0.999827083089274
"KAAB_HEART_ATRIUM_VS_VENTRICLE_UP",152,"Down",0.835281321443161,0.999827083089274
"CHANG_POU5F1_TARGETS_DN",4,"Down",0.835393475305546,0.999827083089274
"ASTON_MAJOR_DEPRESSIVE_DISORDER_DN",91,"Down",0.835409767100466,0.999827083089274
"GUO_HEX_TARGETS_UP",56,"Up",0.835678210740446,0.999827083089274
"MCBRYAN_PUBERTAL_BREAST_3_4WK_DN",22,"Down",0.835796808272711,0.999827083089274
"MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP",44,"Up",0.836028693835274,0.999827083089274
"KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN",126,"Up",0.836127739395654,0.999827083089274
"IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN",20,"Down",0.836139400220097,0.999827083089274
"LU_EZH2_TARGETS_DN",118,"Up",0.836204833873857,0.999827083089274
"MARSON_BOUND_BY_E2F4_UNSTIMULATED",202,"Down",0.836286286096385,0.999827083089274
"MARZEC_IL2_SIGNALING_DN",23,"Up",0.836352836873743,0.999827083089274
"SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN",10,"Up",0.836380656849416,0.999827083089274
"BILD_HRAS_ONCOGENIC_SIGNATURE",130,"Down",0.836500107459324,0.999827083089274
"BROWNE_HCMV_INFECTION_12HR_DN",47,"Up",0.836583349587319,0.999827083089274
"MORI_LARGE_PRE_BII_LYMPHOCYTE_UP",56,"Up",0.836751671585734,0.999827083089274
"TSENG_IRS1_TARGETS_DN",81,"Down",0.836791357138436,0.999827083089274
"BAUS_TFF2_TARGETS_DN",8,"Up",0.836834870297212,0.999827083089274
"WEBER_METHYLATED_LCP_IN_FIBROBLAST_DN",3,"Up",0.836847024190874,0.999827083089274
"LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES",7,"Down",0.836926077802063,0.999827083089274
"TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP",77,"Up",0.836968883109831,0.999827083089274
"BENPORATH_ES_2",19,"Up",0.83701592643327,0.999827083089274
"CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY",14,"Up",0.837124970467024,0.999827083089274
"REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS",8,"Down",0.83715053066512,0.999827083089274
"CHANDRAN_METASTASIS_DN",112,"Up",0.837179569076127,0.999827083089274
"REACTOME_N_GLYCAN_ANTENNAE_ELONGATION",4,"Up",0.83728786869293,0.999827083089274
"ROZANOV_MMP14_TARGETS_SUBSET",23,"Up",0.837384405587342,0.999827083089274
"GREENBAUM_E2A_TARGETS_UP",25,"Down",0.837714843215851,0.999827083089274
"GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP",11,"Up",0.837870359345125,0.999827083089274
"REACTOME_CTNNB1_PHOSPHORYLATION_CASCADE",9,"Up",0.837884853831064,0.999827083089274
"BIDUS_METASTASIS_DN",46,"Down",0.837900279809685,0.999827083089274
"OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP",140,"Up",0.838136464197933,0.999827083089274
"LANDEMAINE_LUNG_METASTASIS",6,"Down",0.838276652393076,0.999827083089274
"JIANG_HYPOXIA_NORMAL",145,"Down",0.838605047419908,0.999827083089274
"XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP",14,"Up",0.838702611375767,0.999827083089274
"REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS",6,"Down",0.838770600623496,0.999827083089274
"ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR",52,"Down",0.838811440406803,0.999827083089274
"TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP",84,"Up",0.838952957214575,0.999827083089274
"DELASERNA_MYOD_TARGETS_DN",27,"Down",0.839048421792434,0.999827083089274
"VALK_AML_CLUSTER_15",16,"Down",0.839311474143494,0.999827083089274
"ZHENG_RESPONSE_TO_ARSENITE_DN",11,"Down",0.839426716286916,0.999827083089274
"REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS",24,"Up",0.839453741287441,0.999827083089274
"BASAKI_YBX1_TARGETS_UP",115,"Down",0.839557621036992,0.999827083089274
"DE_YY1_TARGETS_DN",58,"Down",0.839568220017127,0.999827083089274
"KEGG_PROSTATE_CANCER",86,"Up",0.839604192560062,0.999827083089274
"TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN",100,"Up",0.839795908214376,0.999827083089274
"FORTSCHEGGER_PHF8_TARGETS_UP",97,"Up",0.839863377877718,0.999827083089274
"YAMAZAKI_TCEB3_TARGETS_DN",130,"Down",0.83989790429374,0.999827083089274
"MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP",141,"Down",0.839909761289259,0.999827083089274
"SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN",11,"Up",0.840477059654192,0.999827083089274
"LEE_RECENT_THYMIC_EMIGRANT",69,"Down",0.840603029347836,0.999827083089274
"AMIT_EGF_RESPONSE_20_HELA",8,"Down",0.840672822953125,0.999827083089274
"KOYAMA_SEMA3B_TARGETS_DN",134,"Up",0.840770462389086,0.999827083089274
"FUJII_YBX1_TARGETS_DN",92,"Down",0.840900523287064,0.999827083089274
"ABE_VEGFA_TARGETS_2HR",22,"Down",0.840948980056499,0.999827083089274
"REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS",8,"Down",0.841129123046378,0.999827083089274
"POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN",40,"Up",0.841309276339615,0.999827083089274
"PID_PDGFRA_PATHWAY",19,"Up",0.841426071874785,0.999827083089274
"BIOCARTA_CK1_PATHWAY",15,"Down",0.841427802418261,0.999827083089274
"REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS",223,"Up",0.84145631342545,0.999827083089274
"PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP",45,"Up",0.841491062512621,0.999827083089274
"DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP",103,"Down",0.841565888800069,0.999827083089274
"DOANE_BREAST_CANCER_ESR1_DN",32,"Down",0.841757433516832,0.999827083089274
"IGLESIAS_E2F_TARGETS_DN",15,"Up",0.841934009198594,0.999827083089274
"MEISSNER_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3",5,"Down",0.842001462174819,0.999827083089274
"CHEN_METABOLIC_SYNDROM_NETWORK",508,"Down",0.84217652949091,0.999827083089274
"REACTOME_IRON_UPTAKE_AND_TRANSPORT",17,"Up",0.842359468593423,0.999827083089274
"ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP",26,"Down",0.842454995411525,0.999827083089274
"ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST",100,"Down",0.842457856978278,0.999827083089274
"BIOCARTA_TOB1_PATHWAY",19,"Down",0.842556208249591,0.999827083089274
"DITTMER_PTHLH_TARGETS_UP",66,"Down",0.842686412948835,0.999827083089274
"KANG_DOXORUBICIN_RESISTANCE_DN",6,"Up",0.842839806718341,0.999827083089274
"REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS",68,"Up",0.842948380146845,0.999827083089274
"RIZ_ERYTHROID_DIFFERENTIATION",63,"Down",0.843097208402986,0.999827083089274
"WEST_ADRENOCORTICAL_TUMOR_DN",268,"Up",0.843117842428806,0.999827083089274
"KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE",7,"Down",0.843224554053427,0.999827083089274
"KEGG_ACUTE_MYELOID_LEUKEMIA",48,"Down",0.843250166634204,0.999827083089274
"NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON",7,"Up",0.843337479594835,0.999827083089274
"BENPORATH_PRC2_TARGETS",339,"Up",0.843519229689414,0.999827083089274
"LEE_TARGETS_OF_PTCH1_AND_SUFU_DN",48,"Down",0.843601649516031,0.999827083089274
"MCCLUNG_CREB1_TARGETS_UP",59,"Up",0.843775634325643,0.999827083089274
"KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP",288,"Down",0.84380927461729,0.999827083089274
"PACHER_TARGETS_OF_IGF1_AND_IGF2_UP",20,"Down",0.843864943399132,0.999827083089274
"MURATA_VIRULENCE_OF_H_PILORI",17,"Up",0.843966565107928,0.999827083089274
"FU_INTERACT_WITH_ALKBH8",11,"Down",0.843971399055539,0.999827083089274
"HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR",32,"Up",0.844039821167788,0.999827083089274
"DELASERNA_MYOD_TARGETS_UP",54,"Up",0.844056048318195,0.999827083089274
"NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP",23,"Down",0.844119800910758,0.999827083089274
"REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION",11,"Up",0.844218325221621,0.999827083089274
"BAE_BRCA1_TARGETS_DN",22,"Up",0.844743421127739,0.999827083089274
"GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP",100,"Down",0.844930126842493,0.999827083089274
"OXFORD_RALA_OR_RALB_TARGETS_DN",13,"Down",0.845265318644359,0.999827083089274
"CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN",87,"Up",0.845528742070771,0.999827083089274
"REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB",11,"Down",0.845531353496603,0.999827083089274
"FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN",32,"Up",0.845614316715347,0.999827083089274
"BIOCARTA_TNFR1_PATHWAY",25,"Down",0.84564336012585,0.999827083089274
"HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2",16,"Down",0.845801481019404,0.999827083089274
"GALI_TP53_TARGETS_APOPTOTIC_UP",8,"Down",0.846023800702201,0.999827083089274
"BIOCARTA_RB_PATHWAY",13,"Down",0.846171494349592,0.999827083089274
"NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN",227,"Down",0.84624444195117,0.999827083089274
"SUNG_METASTASIS_STROMA_DN",23,"Down",0.846621636813408,0.999827083089274
"LIU_IL13_MEMORY_MODEL_UP",9,"Up",0.846637802787906,0.999827083089274
"TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP",105,"Down",0.846815163476751,0.999827083089274
"HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP",14,"Down",0.846998874598329,0.999827083089274
"CHIBA_RESPONSE_TO_TSA",28,"Up",0.847044943907104,0.999827083089274
"GROSS_HYPOXIA_VIA_HIF1A_DN",63,"Up",0.847088611099049,0.999827083089274
"ENGELMANN_CANCER_PROGENITORS_DN",31,"Down",0.847165730215742,0.999827083089274
"IVANOVA_HEMATOPOIESIS_STEM_CELL",104,"Up",0.847271864034801,0.999827083089274
"SIMBULAN_PARP1_TARGETS_UP",29,"Up",0.847335624471977,0.999827083089274
"MILI_PSEUDOPODIA_CHEMOTAXIS_DN",192,"Down",0.847772425460203,0.999827083089274
"HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY",6,"Up",0.847885589967542,0.999827083089274
"REACTOME_GLUCOSE_METABOLISM",40,"Up",0.847886905409633,0.999827083089274
"LIN_MELANOMA_COPY_NUMBER_UP",26,"Up",0.848074461401401,0.999827083089274
"PID_TGFBR_PATHWAY",37,"Up",0.848508852001216,0.999827083089274
"REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM",17,"Up",0.848764101684568,0.999827083089274
"FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP",78,"Up",0.848992080965098,0.999827083089274
"HORIUCHI_WTAP_TARGETS_DN",120,"Up",0.849194838680122,0.999827083089274
"FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN",37,"Up",0.849356668746517,0.999827083089274
"PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN",103,"Down",0.849556976885331,0.999827083089274
"COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN",21,"Down",0.849809387778509,0.999827083089274
"DAIRKEE_CANCER_PRONE_RESPONSE_BPA",30,"Down",0.849821723786135,0.999827083089274
"REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION",53,"Down",0.850052281552201,0.999827083089274
"WELCSH_BRCA1_TARGETS_DN",72,"Up",0.850322197133459,0.999827083089274
"REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT",24,"Down",0.850522750402881,0.999827083089274
"SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN",25,"Up",0.850580884384726,0.999827083089274
"WANG_METASTASIS_OF_BREAST_CANCER",4,"Up",0.850679119350435,0.999827083089274
"REACTOME_BASIGIN_INTERACTIONS",15,"Up",0.85085402655382,0.999827083089274
"SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6",186,"Up",0.850956037549024,0.999827083089274
"TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_DN",1,"Down",0.851075954882606,0.999827083089274
"REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE",38,"Down",0.85109178303797,0.999827083089274
"NAKAMURA_CANCER_MICROENVIRONMENT_DN",16,"Up",0.851163041140539,0.999827083089274
"ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_DN",141,"Up",0.851411825662954,0.999827083089274
"ENK_UV_RESPONSE_EPIDERMIS_DN",274,"Down",0.851481699025788,0.999827083089274
"REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION",7,"Up",0.851494048522223,0.999827083089274
"REACTOME_RNA_POL_II_TRANSCRIPTION",34,"Up",0.851774331072902,0.999827083089274
"SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_UP",6,"Down",0.851864918906832,0.999827083089274
"REACTOME_METABOLISM_OF_NUCLEOTIDES",34,"Down",0.852166888180956,0.999827083089274
"BENPORATH_SOX2_TARGETS",284,"Down",0.852223194751885,0.999827083089274
"POOLA_INVASIVE_BREAST_CANCER_UP",163,"Up",0.852377263016757,0.999827083089274
"VALK_AML_WITH_T_8_21_TRANSLOCATION",5,"Down",0.85246047773136,0.999827083089274
"TANG_SENESCENCE_TP53_TARGETS_DN",32,"Up",0.85248565775689,0.999827083089274
"KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION",75,"Down",0.852718651692275,0.999827083089274
"TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN",65,"Up",0.852723724956172,0.999827083089274
"CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN",31,"Down",0.852804172526169,0.999827083089274
"ELVIDGE_HIF1A_TARGETS_DN",48,"Down",0.852902999092932,0.999827083089274
"SEKI_INFLAMMATORY_RESPONSE_LPS_UP",47,"Down",0.852929125016676,0.999827083089274
"BILANGES_SERUM_SENSITIVE_VIA_TSC1",13,"Up",0.853034098822176,0.999827083089274
"PID_RAC1_REG_PATHWAY",14,"Down",0.853109380929822,0.999827083089274
"ROZANOV_MMP14_TARGETS_DN",14,"Up",0.853164075721041,0.999827083089274
"EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN",16,"Down",0.853305142572615,0.999827083089274
"FRIDMAN_SENESCENCE_UP",52,"Down",0.853320824458845,0.999827083089274
"GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP",38,"Up",0.853451095259463,0.999827083089274
"WILCOX_RESPONSE_TO_PROGESTERONE_UP",60,"Up",0.853647631200822,0.999827083089274
"PID_CMYB_PATHWAY",71,"Up",0.8537265943191,0.999827083089274
"KANNAN_TP53_TARGETS_DN",16,"Up",0.853757545395788,0.999827083089274
"HUI_MAPK14_TARGETS_UP",13,"Up",0.853908955050252,0.999827083089274
"BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_AND_PAX3",6,"Down",0.853966802705467,0.999827083089274
"HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN",18,"Down",0.854315175093802,0.999827083089274
"SAMOLS_TARGETS_OF_KHSV_MIRNAS_UP",6,"Down",0.85456079920238,0.999827083089274
"TIEN_INTESTINE_PROBIOTICS_24HR_DN",107,"Up",0.854568052520357,0.999827083089274
"BIOCARTA_TEL_PATHWAY",18,"Down",0.854752498587626,0.999827083089274
"MOHANKUMAR_TLX1_TARGETS_UP",170,"Up",0.854973517191799,0.999827083089274
"WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN",75,"Up",0.854990211209508,0.999827083089274
"CAMPS_COLON_CANCER_COPY_NUMBER_DN",11,"Down",0.854991315984252,0.999827083089274
"BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN",29,"Up",0.855030407737875,0.999827083089274
"JAATINEN_HEMATOPOIETIC_STEM_CELL_UP",100,"Down",0.855599927059069,0.999827083089274
"SMIRNOV_RESPONSE_TO_IR_2HR_DN",17,"Down",0.855701541474351,0.999827083089274
"REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES",6,"Up",0.855888575728105,0.999827083089274
"BROWNE_HCMV_INFECTION_30MIN_DN",72,"Up",0.856090367172291,0.999827083089274
"GREENBAUM_E2A_TARGETS_DN",14,"Down",0.856296527745134,0.999827083089274
"MCCLUNG_CREB1_TARGETS_DN",36,"Up",0.856371404222711,0.999827083089274
"JAEGER_METASTASIS_DN",138,"Up",0.856671863656803,0.999827083089274
"IKEDA_MIR30_TARGETS_UP",51,"Up",0.856742298640815,0.999827083089274
"BRUINS_UVC_RESPONSE_EARLY_LATE",93,"Up",0.856781973770978,0.999827083089274
"NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN",47,"Down",0.857022920523056,0.999827083089274
"VANTVEER_BREAST_CANCER_BRCA1_DN",18,"Up",0.857042098761392,0.999827083089274
"ST_INTERLEUKIN_13_PATHWAY",6,"Up",0.857207053424037,0.999827083089274
"ST_IL_13_PATHWAY",6,"Up",0.857207053424037,0.999827083089274
"ZHOU_PANCREATIC_EXOCRINE_PROGENITOR",11,"Down",0.857363733669049,0.999827083089274
"GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP",6,"Up",0.857395444121412,0.999827083089274
"SASSON_RESPONSE_TO_GONADOTROPHINS_UP",60,"Down",0.857444257157876,0.999827083089274
"REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION",62,"Down",0.857589978299698,0.999827083089274
"ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN",30,"Down",0.857675094394901,0.999827083089274
"CAFFAREL_RESPONSE_TO_THC_24HR_5_UP",16,"Up",0.857789459025103,0.999827083089274
"SILIGAN_BOUND_BY_EWS_FLT1_FUSION",22,"Down",0.857829600335231,0.999827083089274
"BIOCARTA_AKT_PATHWAY",17,"Up",0.858265415112742,0.999827083089274
"NIELSEN_SYNOVIAL_SARCOMA_DN",10,"Down",0.85826963936032,0.999827083089274
"TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN",34,"Down",0.858431068686768,0.999827083089274
"SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP",68,"Up",0.858472661980096,0.999827083089274
"LIAN_LIPA_TARGETS_6M",54,"Down",0.858857133255902,0.999827083089274
"GAVIN_FOXP3_TARGETS_CLUSTER_T4",45,"Down",0.858989013934457,0.999827083089274
"TRAYNOR_RETT_SYNDROM_DN",13,"Down",0.859115966661883,0.999827083089274
"BOQUEST_STEM_CELL_DN",113,"Up",0.859348403496027,0.999827083089274
"JAATINEN_HEMATOPOIETIC_STEM_CELL_DN",136,"Up",0.859466441413577,0.999827083089274
"TOMLINS_PROSTATE_CANCER_DN",21,"Up",0.859559024505819,0.999827083089274
"KASLER_HDAC7_TARGETS_1_UP",83,"Up",0.859743173189361,0.999827083089274
"LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP",105,"Up",0.859872425859371,0.999827083089274
"CAIRO_HEPATOBLASTOMA_CLASSES_DN",103,"Down",0.860233604269858,0.999827083089274
"LUI_TARGETS_OF_PAX8_PPARG_FUSION",21,"Up",0.860238713555621,0.999827083089274
"PID_INTEGRIN1_PATHWAY",52,"Down",0.860284717173735,0.999827083089274
"ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN",26,"Down",0.860316954012359,0.999827083089274
"NAKAMURA_METASTASIS_MODEL_DN",25,"Up",0.86058297407581,0.999827083089274
"WANG_CLIM2_TARGETS_UP",74,"Up",0.860730867335467,0.999827083089274
"CAFFAREL_RESPONSE_TO_THC_DN",21,"Down",0.860958714777531,0.999827083089274
"KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC",53,"Down",0.861219735283407,0.999827083089274
"LINSLEY_MIR16_TARGETS",64,"Up",0.861317574373819,0.999827083089274
"MCCLUNG_DELTA_FOSB_TARGETS_2WK",33,"Up",0.86135291871935,0.999827083089274
"HELLER_SILENCED_BY_METHYLATION_DN",51,"Up",0.861807672624297,0.999827083089274
"MCGOWAN_RSP6_TARGETS_DN",2,"Down",0.862016473491722,0.999827083089274
"HUPER_BREAST_BASAL_VS_LUMINAL_DN",34,"Down",0.862120334674749,0.999827083089274
"REACTOME_CELL_CELL_COMMUNICATION",64,"Down",0.862124948198195,0.999827083089274
"BIOCARTA_NO2IL12_PATHWAY",16,"Down",0.862140547903419,0.999827083089274
"WONG_ENDMETRIUM_CANCER_DN",39,"Up",0.862217973340189,0.999827083089274
"PID_INTEGRIN3_PATHWAY",38,"Down",0.862297022850165,0.999827083089274
"PYEON_HPV_POSITIVE_TUMORS_UP",23,"Up",0.862306492951433,0.999827083089274
"KASLER_HDAC7_TARGETS_2_DN",15,"Down",0.86237180456314,0.999827083089274
"KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION",73,"Up",0.862404277567822,0.999827083089274
"CHANG_CORE_SERUM_RESPONSE_UP",80,"Up",0.862409929470616,0.999827083089274
"REACTOME_DARPP_32_EVENTS",19,"Down",0.862798617178184,0.999827083089274
"MOOTHA_MITOCHONDRIA",188,"Up",0.863130669695787,0.999827083089274
"KRIEG_HYPOXIA_VIA_KDM3A",29,"Up",0.863208454366771,0.999827083089274
"REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE",12,"Down",0.863361260915939,0.999827083089274
"GENTLES_LEUKEMIC_STEM_CELL_UP",11,"Up",0.863429674170749,0.999827083089274
"HUMMERICH_MALIGNANT_SKIN_TUMOR_UP",12,"Down",0.863626541897212,0.999827083089274
"BIOCARTA_RACCYCD_PATHWAY",25,"Up",0.863661865853041,0.999827083089274
"KHETCHOUMIAN_TRIM24_TARGETS_UP",45,"Down",0.86397891225873,0.999827083089274
"BIOCARTA_CARM_ER_PATHWAY",18,"Up",0.864045157219353,0.999827083089274
"WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP",117,"Up",0.86436451705843,0.999827083089274
"REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY",3,"Up",0.864799093682946,0.999827083089274
"GAVIN_FOXP3_TARGETS_CLUSTER_P7",36,"Up",0.865019071062277,0.999827083089274
"VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1",30,"Up",0.865085410243958,0.999827083089274
"HASINA_NOL7_TARGETS_UP",10,"Up",0.865459680033412,0.999827083089274
"MUELLER_METHYLATED_IN_GLIOBLASTOMA",23,"Up",0.865460556855822,0.999827083089274
"STEIN_ESR1_TARGETS",42,"Down",0.865526413381703,0.999827083089274
"GAZIN_EPIGENETIC_SILENCING_BY_KRAS",11,"Up",0.865534607233436,0.999827083089274
"GAVIN_FOXP3_TARGETS_CLUSTER_P6",40,"Down",0.865787817260096,0.999827083089274
"DANG_BOUND_BY_MYC",547,"Down",0.865991933057877,0.999827083089274
"RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_DN",5,"Down",0.866038269497128,0.999827083089274
"HASLINGER_B_CLL_WITH_MUTATED_VH_GENES",9,"Down",0.866172544618444,0.999827083089274
"MARSHALL_VIRAL_INFECTION_RESPONSE_DN",23,"Down",0.866243932542173,0.999827083089274
"BASAKI_YBX1_TARGETS_DN",142,"Down",0.86626426515782,0.999827083089274
"ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP",15,"Down",0.866323370539679,0.999827083089274
"PODAR_RESPONSE_TO_ADAPHOSTIN_UP",69,"Down",0.866628669234288,0.999827083089274
"BIOCARTA_RHO_PATHWAY",16,"Down",0.866666695892007,0.999827083089274
"PID_IL8_CXCR1_PATHWAY",21,"Up",0.866835027819799,0.999827083089274
"KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP",18,"Down",0.86704927374434,0.999827083089274
"YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP",71,"Up",0.867114956792487,0.999827083089274
"ODONNELL_TFRC_TARGETS_DN",58,"Down",0.867117464995627,0.999827083089274
"LEE_LIVER_CANCER_MYC_UP",33,"Down",0.867341180207787,0.999827083089274
"SU_PANCREAS",21,"Down",0.867415742454395,0.999827083089274
"REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS",10,"Down",0.86743263138024,0.999827083089274
"MASSARWEH_TAMOXIFEN_RESISTANCE_UP",189,"Down",0.867565595906011,0.999827083089274
"HOSHIDA_LIVER_CANCER_SUBCLASS_S1",176,"Up",0.867759466965121,0.999827083089274
"REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS",8,"Down",0.867858392730819,0.999827083089274
"ZHENG_IL22_SIGNALING_DN",19,"Down",0.867999341743822,0.999827083089274
"MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN",92,"Down",0.868168897450661,0.999827083089274
"ELVIDGE_HYPOXIA_BY_DMOG_UP",70,"Down",0.86829878617065,0.999827083089274
"BAELDE_DIABETIC_NEPHROPATHY_UP",52,"Up",0.868332002820796,0.999827083089274
"LINDGREN_BLADDER_CANCER_CLUSTER_3_UP",126,"Down",0.868359993555238,0.999827083089274
"FARMER_BREAST_CANCER_BASAL_VS_LULMINAL",163,"Up",0.86872915361485,0.999827083089274
"KEGG_PRION_DISEASES",28,"Down",0.868829767723163,0.999827083089274
"NEWMAN_ERCC6_TARGETS_UP",11,"Down",0.868864333186438,0.999827083089274
"NAKAMURA_METASTASIS",21,"Down",0.868968890007008,0.999827083089274
"HOLLMANN_APOPTOSIS_VIA_CD40_DN",99,"Down",0.869084903119889,0.999827083089274
"VALK_AML_WITH_FLT3_ITD",23,"Down",0.869356166373264,0.999827083089274
"FARMER_BREAST_CANCER_CLUSTER_1",22,"Down",0.86936792527215,0.999827083089274
"REACTOME_G_ALPHA_S_SIGNALLING_EVENTS",82,"Down",0.869415363867543,0.999827083089274
"PID_HIF2PATHWAY",26,"Down",0.869476804821409,0.999827083089274
"TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN",27,"Up",0.869497915871,0.999827083089274
"NGUYEN_NOTCH1_TARGETS_UP",23,"Down",0.869582928170616,0.999827083089274
"MUNSHI_MULTIPLE_MYELOMA_DN",5,"Down",0.869758104192946,0.999827083089274
"IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS",8,"Up",0.869979153823313,0.999827083089274
"PID_AJDISS_2PATHWAY",40,"Down",0.870063524644108,0.999827083089274
"GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP",253,"Up",0.870166251876677,0.999827083089274
"KEGG_NEUROTROPHIN_SIGNALING_PATHWAY",90,"Down",0.870349733010043,0.999827083089274
"ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY",27,"Down",0.870526426397032,0.999827083089274
"LUND_SILENCED_BY_METHYLATION",14,"Down",0.870702798111463,0.999827083089274
"NIELSEN_SYNOVIAL_SARCOMA_UP",12,"Down",0.870728650145309,0.999827083089274
"BOYLAN_MULTIPLE_MYELOMA_PCA3_DN",35,"Up",0.871106632739453,0.999827083089274
"BIOCARTA_IGF1_PATHWAY",18,"Down",0.871236340874028,0.999827083089274
"REACTOME_STRIATED_MUSCLE_CONTRACTION",23,"Down",0.871272998535275,0.999827083089274
"BIOCARTA_DREAM_PATHWAY",12,"Up",0.871316896991639,0.999827083089274
"SCHRAMM_INHBA_TARGETS_UP",6,"Up",0.871321227587925,0.999827083089274
"ALONSO_METASTASIS_EMT_UP",29,"Up",0.871381755404967,0.999827083089274
"REACTOME_REGULATION_OF_IFNG_SIGNALING",12,"Down",0.871640092731441,0.999827083089274
"TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP",38,"Up",0.871662448443642,0.999827083089274
"MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3",496,"Up",0.871728052099929,0.999827083089274
"BENPORATH_MYC_TARGETS_WITH_EBOX",176,"Down",0.871892875804086,0.999827083089274
"SUBTIL_PROGESTIN_TARGETS",26,"Up",0.871998410998747,0.999827083089274
"ZHENG_GLIOBLASTOMA_PLASTICITY_UP",132,"Down",0.872165872550731,0.999827083089274
"WANG_MLL_TARGETS",154,"Up",0.872202717132457,0.999827083089274
"KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP",96,"Up",0.872245354084529,0.999827083089274
"CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN",84,"Down",0.872329426309166,0.999827083089274
"LE_EGR2_TARGETS_UP",61,"Down",0.872690530326796,0.999827083089274
"NUYTTEN_NIPP1_TARGETS_DN",290,"Up",0.873027155305124,0.999827083089274
"HUANG_FOXA2_TARGETS_UP",26,"Up",0.873255103645566,0.999827083089274
"MIKKELSEN_MEF_LCP_WITH_H3K4ME3",58,"Down",0.874245792279372,0.999827083089274
"KEGG_RNA_DEGRADATION",12,"Up",0.874276316369772,0.999827083089274
"REACTOME_RNA_POL_I_TRANSCRIPTION_TERMINATION",17,"Down",0.874381811818714,0.999827083089274
"CUI_TCF21_TARGETS_2_UP",191,"Up",0.874517643581303,0.999827083089274
"MATZUK_CUMULUS_EXPANSION",9,"Down",0.875014201646994,0.999827083089274
"BROCKE_APOPTOSIS_REVERSED_BY_IL6",83,"Up",0.87502251072389,0.999827083089274
"REACTOME_COPI_MEDIATED_TRANSPORT",2,"Down",0.87526236356735,0.999827083089274
"MANTOVANI_VIRAL_GPCR_SIGNALING_DN",26,"Down",0.875434991237275,0.999827083089274
"DELLA_RESPONSE_TO_TSA_AND_BUTYRATE",16,"Up",0.875465132240392,0.999827083089274
"KONDO_COLON_CANCER_HCP_WITH_H3K27ME1",9,"Down",0.875615388577703,0.999827083089274
"KEGG_AXON_GUIDANCE",93,"Up",0.875638726190464,0.999827083089274
"GOLDRATH_ANTIGEN_RESPONSE",223,"Down",0.876058066236294,0.999827083089274
"SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN",36,"Down",0.876236331262608,0.999827083089274
"ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN",16,"Down",0.876368480861623,0.999827083089274
"TIAN_TNF_SIGNALING_VIA_NFKB",26,"Down",0.876686850184589,0.999827083089274
"KEGG_ADHERENS_JUNCTION",55,"Down",0.877104919346411,0.999827083089274
"PID_P53_DOWNSTREAM_PATHWAY",96,"Down",0.877379086983676,0.999827083089274
"REACTOME_TRIGLYCERIDE_BIOSYNTHESIS",10,"Down",0.877478775023685,0.999827083089274
"IKEDA_MIR1_TARGETS_UP",25,"Up",0.878000674885671,0.999827083089274
"BURTON_ADIPOGENESIS_PEAK_AT_8HR",24,"Down",0.878025770028666,0.999827083089274
"BIOCARTA_MTOR_PATHWAY",17,"Up",0.878178909634683,0.999827083089274
"MARSON_BOUND_BY_FOXP3_STIMULATED",335,"Up",0.878831295216771,0.999827083089274
"BIOCARTA_P27_PATHWAY",11,"Down",0.879004284380155,0.999827083089274
"CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN",76,"Down",0.879010300079486,0.999827083089274
"HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP",87,"Down",0.879135269777716,0.999827083089274
"NOUZOVA_TRETINOIN_AND_H4_ACETYLATION",29,"Down",0.879208729814046,0.999827083089274
"AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP",79,"Down",0.88021143216807,0.999827083089274
"ZHAN_MULTIPLE_MYELOMA_HP_UP",15,"Up",0.880566962805603,0.999827083089274
"MCCABE_BOUND_BY_HOXC6",129,"Up",0.880579993371374,0.999827083089274
"KORKOLA_EMBRYONAL_CARCINOMA_UP",26,"Down",0.880897153012726,0.999827083089274
"REACTOME_HS_GAG_BIOSYNTHESIS",17,"Down",0.881019317861889,0.999827083089274
"TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN",89,"Up",0.881093642491474,0.999827083089274
"ONDER_CDH1_TARGETS_3_UP",9,"Down",0.881220578940284,0.999827083089274
"ROESSLER_LIVER_CANCER_METASTASIS_UP",69,"Up",0.881279011144289,0.999827083089274
"BIOCARTA_TPO_PATHWAY",21,"Down",0.881334550915622,0.999827083089274
"SENESE_HDAC3_TARGETS_UP",220,"Up",0.88142451103908,0.999827083089274
"ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY",439,"Up",0.881802105169342,0.999827083089274
"REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS",7,"Down",0.882027436054369,0.999827083089274
"REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS",34,"Up",0.882055258976526,0.999827083089274
"ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP",198,"Down",0.882157843831556,0.999827083089274
"SWEET_KRAS_ONCOGENIC_SIGNATURE",70,"Down",0.882392909562941,0.999827083089274
"ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION",94,"Down",0.882754050818759,0.999827083089274
"PEDRIOLI_MIR31_TARGETS_DN",156,"Up",0.882774448296476,0.999827083089274
"TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP",38,"Up",0.882924337963067,0.999827083089274
"DACOSTA_UV_RESPONSE_VIA_ERCC3_DN",351,"Down",0.882936348318586,0.999827083089274
"THUM_MIR21_TARGETS_HEART_DISEASE_UP",12,"Down",0.883032919095642,0.999827083089274
"MURAKAMI_UV_RESPONSE_24HR",16,"Down",0.883111821903819,0.999827083089274
"ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP",35,"Up",0.883285011912106,0.999827083089274
"RIZKI_TUMOR_INVASIVENESS_3D_UP",114,"Up",0.883658358217598,0.999827083089274
"PATIL_LIVER_CANCER",277,"Down",0.883728886090044,0.999827083089274
"REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE",88,"Down",0.8838305028007,0.999827083089274
"WHITFIELD_CELL_CYCLE_G2_M",85,"Down",0.883870913360019,0.999827083089274
"CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS",27,"Down",0.883926254601814,0.999827083089274
"STARK_HYPPOCAMPUS_22Q11_DELETION_UP",20,"Down",0.883959778275244,0.999827083089274
"NAKAJIMA_EOSINOPHIL",18,"Down",0.884060023641515,0.999827083089274
"BIOCARTA_PPARA_PATHWAY",49,"Up",0.884277168632507,0.999827083089274
"SCHURINGA_STAT5A_TARGETS_UP",16,"Up",0.884277905540477,0.999827083089274
"CROONQUIST_STROMAL_STIMULATION_UP",44,"Down",0.88431879022296,0.999827083089274
"DAIRKEE_TERT_TARGETS_DN",28,"Down",0.884501433576395,0.999827083089274
"PID_RANBP2_PATHWAY",6,"Down",0.884538588485106,0.999827083089274
"ANASTASSIOU_CANCER_MESENCHYMAL_TRANSITION_SIGNATURE",44,"Down",0.884867260510013,0.999827083089274
"GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP",39,"Up",0.884878223907958,0.999827083089274
"AKL_HTLV1_INFECTION_DN",33,"Down",0.885016211817431,0.999827083089274
"KIM_WT1_TARGETS_12HR_UP",79,"Up",0.885024073932178,0.999827083089274
"PID_IL5_PATHWAY",14,"Down",0.885114326130974,0.999827083089274
"VANTVEER_BREAST_CANCER_ESR1_DN",121,"Up",0.885456433764301,0.999827083089274
"LEE_AGING_CEREBELLUM_DN",59,"Down",0.885477818167018,0.999827083089274
"KEGG_VEGF_SIGNALING_PATHWAY",55,"Down",0.885612509386454,0.999827083089274
"IVANOV_MUTATED_IN_COLON_CANCER",7,"Down",0.885844116743418,0.999827083089274
"CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP",133,"Down",0.886010319114385,0.999827083089274
"KANG_CISPLATIN_RESISTANCE_UP",11,"Up",0.886039884151368,0.999827083089274
"OSMAN_BLADDER_CANCER_UP",134,"Down",0.886363387086624,0.999827083089274
"TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN",44,"Down",0.886365289308501,0.999827083089274
"REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS",11,"Down",0.886705387628925,0.999827083089274
"PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1",26,"Down",0.886718306867847,0.999827083089274
"JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_UP",5,"Up",0.886725041128741,0.999827083089274
"PUJANA_ATM_PCC_NETWORK",649,"Down",0.886993405230996,0.999827083089274
"CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL",10,"Down",0.887470242421189,0.999827083089274
"RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_UP",5,"Up",0.887589607436623,0.999827083089274
"ONDER_CDH1_TARGETS_2_DN",245,"Down",0.887989112421148,0.999827083089274
"KESHELAVA_MULTIPLE_DRUG_RESISTANCE",28,"Down",0.888301013264569,0.999827083089274
"REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL",46,"Up",0.888340743475613,0.999827083089274
"HAN_SATB1_TARGETS_DN",212,"Down",0.888392923975411,0.999827083089274
"BROWNE_HCMV_INFECTION_20HR_DN",40,"Down",0.888447393556389,0.999827083089274
"MATSUDA_NATURAL_KILLER_DIFFERENTIATION",253,"Up",0.888521028949338,0.999827083089274
"CHESLER_BRAIN_HIGHEST_EXPRESSION",19,"Down",0.88873108134034,0.999827083089274
"KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3",342,"Up",0.888840900973422,0.999827083089274
"IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN",55,"Down",0.88886092154026,0.999827083089274
"WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN",18,"Up",0.888897297621602,0.999827083089274
"AMIT_SERUM_RESPONSE_480_MCF10A",13,"Down",0.888929301641484,0.999827083089274
"MIKKELSEN_NPC_ICP_WITH_H3K4ME3",135,"Up",0.8891270020344,0.999827083089274
"KHETCHOUMIAN_TRIM24_TARGETS_DN",8,"Up",0.88917703099302,0.999827083089274
"LIU_PROSTATE_CANCER_DN",211,"Up",0.889205587274065,0.999827083089274
"REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL",62,"Down",0.889555611918213,0.999827083089274
"KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP",328,"Up",0.889594861549635,0.999827083089274
"CERVERA_SDHB_TARGETS_2",54,"Down",0.889643999322447,0.999827083089274
"BAFNA_MUC4_TARGETS_UP",4,"Down",0.889875491097714,0.999827083089274
"MIKKELSEN_ES_HCP_WITH_H3K27ME3",19,"Down",0.889917772242376,0.999827083089274
"REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK",128,"Up",0.890218428980326,0.999827083089274
"REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS",11,"Up",0.890383702888772,0.999827083089274
"KORKOLA_TERATOMA",23,"Down",0.890485100913775,0.999827083089274
"FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP",303,"Up",0.890700652570609,0.999827083089274
"LI_CYTIDINE_ANALOGS_CYCTOTOXICITY",9,"Down",0.890719626823165,0.999827083089274
"SANA_RESPONSE_TO_IFNG_UP",38,"Up",0.890772115665141,0.999827083089274
"YAMASHITA_SILENCED_BY_METHYLATION",5,"Down",0.890803933274835,0.999827083089274
"MAHADEVAN_IMATINIB_RESISTANCE_DN",15,"Up",0.890855951115126,0.999827083089274
"WILLIAMS_ESR2_TARGETS_DN",5,"Up",0.890865437851839,0.999827083089274
"WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN",9,"Up",0.89094805987082,0.999827083089274
"BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP",169,"Up",0.890984340101165,0.999827083089274
"KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION",51,"Down",0.891253675320951,0.999827083089274
"GRADE_COLON_VS_RECTAL_CANCER_UP",11,"Up",0.891350474099732,0.999827083089274
"SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN",173,"Up",0.89137030269277,0.999827083089274
"PLASARI_TGFB1_TARGETS_10HR_UP",110,"Up",0.89173121261037,0.999827083089274
"HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER",10,"Down",0.891758457142975,0.999827083089274
"MAHAJAN_RESPONSE_TO_IL1A_DN",46,"Down",0.891911013713522,0.999827083089274
"LEE_CALORIE_RESTRICTION_MUSCLE_DN",44,"Up",0.892212912635172,0.999827083089274
"REACTOME_NETRIN1_SIGNALING",26,"Up",0.892219127999602,0.999827083089274
"MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP",54,"Down",0.892254328609116,0.999827083089274
"REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT",8,"Down",0.892369471743756,0.999827083089274
"LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED",13,"Down",0.892598085251416,0.999827083089274
"MARCHINI_TRABECTEDIN_RESISTANCE_DN",29,"Up",0.893154133981958,0.999827083089274
"YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5",23,"Down",0.893236769160371,0.999827083089274
"GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP",7,"Down",0.893348160375029,0.999827083089274
"KASLER_HDAC7_TARGETS_1_DN",10,"Up",0.893438821309196,0.999827083089274
"THILLAINADESAN_ZNF217_TARGETS_UP",9,"Down",0.893579038154053,0.999827083089274
"DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP",140,"Up",0.893737959772212,0.999827083089274
"HASLINGER_B_CLL_WITH_17P13_DELETION",8,"Down",0.893842556774754,0.999827083089274
"CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4",112,"Up",0.893952697693706,0.999827083089274
"DASU_IL6_SIGNALING_DN",3,"Up",0.893955766740734,0.999827083089274
"HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN",137,"Up",0.894053483956288,0.999827083089274
"FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP",229,"Down",0.894449196626797,0.999827083089274
"PENG_LEUCINE_DEPRIVATION_DN",101,"Up",0.894485373895577,0.999827083089274
"REACTOME_G_ALPHA1213_SIGNALLING_EVENTS",46,"Up",0.894835226921818,0.999827083089274
"DOANE_BREAST_CANCER_ESR1_UP",53,"Down",0.894863813958648,0.999827083089274
"WAESCH_ANAPHASE_PROMOTING_COMPLEX",4,"Down",0.895081114779196,0.999827083089274
"SCHMIDT_POR_TARGETS_IN_LIMB_BUD_DN",5,"Up",0.895467422622618,0.999827083089274
"RICKMAN_HEAD_AND_NECK_CANCER_F",36,"Up",0.89557221254552,0.999827083089274
"SENESE_HDAC1_TARGETS_DN",104,"Up",0.895613485155492,0.999827083089274
"MIKKELSEN_ES_ICP_WITH_H3K4ME3",210,"Up",0.895747594209309,0.999827083089274
"ODONNELL_METASTASIS_UP",42,"Up",0.895909048182995,0.999827083089274
"GRESHOCK_CANCER_COPY_NUMBER_UP",203,"Down",0.895931348774385,0.999827083089274
"SCIBETTA_KDM5B_TARGETS_DN",33,"Down",0.896173455915411,0.999827083089274
"KEGG_GLYCEROLIPID_METABOLISM",18,"Down",0.896543116715738,0.999827083089274
"MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP",16,"Down",0.896656070018986,0.999827083089274
"KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN",5,"Down",0.896688298506587,0.999827083089274
"DODD_NASOPHARYNGEAL_CARCINOMA_UP",427,"Up",0.896728895077363,0.999827083089274
"STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN",190,"Up",0.896902608738064,0.999827083089274
"YU_MYC_TARGETS_DN",40,"Up",0.897084906378581,0.999827083089274
"MULLIGHAN_NPM1_SIGNATURE_3_UP",143,"Up",0.897116366137191,0.999827083089274
"DOANE_BREAST_CANCER_CLASSES_DN",18,"Down",0.897222819882772,0.999827083089274
"FOSTER_KDM1A_TARGETS_DN",61,"Down",0.89724538822097,0.999827083089274
"IVANOVA_HEMATOPOIESIS_MATURE_CELL",91,"Up",0.897328788271714,0.999827083089274
"WIERENGA_STAT5A_TARGETS_GROUP1",59,"Up",0.897343380540294,0.999827083089274
"ENK_UV_RESPONSE_KERATINOCYTE_UP",337,"Up",0.89736271910168,0.999827083089274
"TOMLINS_METASTASIS_DN",6,"Up",0.897461320161165,0.999827083089274
"LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN",48,"Up",0.897500394166242,0.999827083089274
"WALLACE_JAK2_TARGETS_UP",12,"Up",0.897737612101962,0.999827083089274
"MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_6",3,"Up",0.897745737239177,0.999827083089274
"GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN",2,"Up",0.89784432875141,0.999827083089274
"REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S",33,"Down",0.898030871887692,0.999827083089274
"CROONQUIST_IL6_DEPRIVATION_DN",56,"Down",0.898077018385735,0.999827083089274
"REACTOME_ADP_SIGNALLING_THROUGH_P2RY1",23,"Up",0.898079355763765,0.999827083089274
"HINATA_NFKB_TARGETS_KERATINOCYTE_UP",76,"Up",0.898139541526626,0.999827083089274
"ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP",74,"Down",0.898392145380528,0.999827083089274
"KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION",26,"Down",0.898459392453595,0.999827083089274
"IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM",10,"Down",0.899146177819773,0.999827083089274
"PID_ARF6_TRAFFICKING_PATHWAY",31,"Down",0.89916212746352,0.999827083089274
"BRACHAT_RESPONSE_TO_METHOTREXATE_DN",13,"Up",0.899247455240949,0.999827083089274
"LIU_VAV3_PROSTATE_CARCINOGENESIS_DN",10,"Up",0.89942906401814,0.999827083089274
"PID_ALK2_PATHWAY",9,"Down",0.899494434638027,0.999827083089274
"CHICAS_RB1_TARGETS_SENESCENT",230,"Down",0.899516542182191,0.999827083089274
"MARTENS_TRETINOIN_RESPONSE_DN",258,"Down",0.899565753785265,0.999827083089274
"XU_RESPONSE_TO_TRETINOIN_DN",8,"Down",0.899620242571854,0.999827083089274
"GEORGANTAS_HSC_MARKERS",28,"Down",0.899683870512588,0.999827083089274
"WEBER_METHYLATED_IN_COLON_CANCER",7,"Down",0.899688940663059,0.999827083089274
"REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY",8,"Up",0.89983606168744,0.999827083089274
"KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION",29,"Up",0.899855657038606,0.999827083089274
"DING_LUNG_CANCER_BY_MUTATION_RATE",14,"Up",0.900035559295213,0.999827083089274
"BRUINS_UVC_RESPONSE_MIDDLE",35,"Down",0.900151467684567,0.999827083089274
"BROWNE_HCMV_INFECTION_1HR_DN",115,"Up",0.900465905148309,0.999827083089274
"MUELLER_PLURINET",169,"Down",0.900656879547205,0.999827083089274
"PASINI_SUZ12_TARGETS_DN",169,"Up",0.900674887829676,0.999827083089274
"REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER",14,"Down",0.900784277616618,0.999827083089274
"NOUSHMEHR_GBM_SOMATIC_MUTATED",7,"Down",0.900809215225037,0.999827083089274
"LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN",33,"Down",0.900822568427706,0.999827083089274
"REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY",11,"Up",0.901054987854194,0.999827083089274
"NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER",27,"Down",0.90136739793194,0.999827083089274
"BIOCARTA_ETC_PATHWAY",6,"Down",0.901479509124331,0.999827083089274
"RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN",69,"Up",0.901553963548999,0.999827083089274
"REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN",11,"Down",0.901659653567082,0.999827083089274
"REACTOME_GABA_B_RECEPTOR_ACTIVATION",31,"Up",0.901790272147202,0.999827083089274
"ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN",132,"Up",0.901846226056769,0.999827083089274
"FOSTER_TOLERANT_MACROPHAGE_DN",178,"Down",0.901920923970418,0.999827083089274
"YAGI_AML_FAB_MARKERS",103,"Down",0.902258064196999,0.999827083089274
"KASLER_HDAC7_TARGETS_2_UP",4,"Up",0.902441925658564,0.999827083089274
"RASHI_RESPONSE_TO_IONIZING_RADIATION_6",50,"Up",0.902458299686545,0.999827083089274
"BOYLAN_MULTIPLE_MYELOMA_C_DN",20,"Down",0.902524627279923,0.999827083089274
"KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION",51,"Up",0.902723508515342,0.999827083089274
"SWEET_LUNG_CANCER_KRAS_DN",296,"Down",0.90296673645129,0.999827083089274
"REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING",14,"Down",0.903116036839742,0.999827083089274
"REACTOME_CELL_CELL_JUNCTION_ORGANIZATION",25,"Up",0.903181846603944,0.999827083089274
"REACTOME_PROTEIN_FOLDING",25,"Up",0.903285079990021,0.999827083089274
"SHEPARD_BMYB_MORPHOLINO_UP",83,"Up",0.903330615072392,0.999827083089274
"LOPEZ_MESOTHELIOMA_SURVIVAL_DN",8,"Down",0.903412365786434,0.999827083089274
"PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN",62,"Up",0.90344423008796,0.999827083089274
"RIZ_ERYTHROID_DIFFERENTIATION_12HR",34,"Up",0.903596272815935,0.999827083089274
"LEE_LIVER_CANCER_MYC_TGFA_UP",49,"Up",0.903636876237708,0.999827083089274
"ZAMORA_NOS2_TARGETS_UP",56,"Down",0.90385860402943,0.999827083089274
"REACTOME_ENDOGENOUS_STEROLS",12,"Up",0.903898506173098,0.999827083089274
"KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT",13,"Up",0.904227442834987,0.999827083089274
"NGUYEN_NOTCH1_TARGETS_DN",57,"Up",0.90429163208134,0.999827083089274
"LEIN_CEREBELLUM_MARKERS",36,"Up",0.904332293900673,0.999827083089274
"JI_RESPONSE_TO_FSH_UP",36,"Up",0.904498568618783,0.999827083089274
"REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS",59,"Down",0.904595059358573,0.999827083089274
"KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM",59,"Up",0.904670743540766,0.999827083089274
"JOHNSTONE_PARVB_TARGETS_3_UP",188,"Up",0.904800411560483,0.999827083089274
"HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP",80,"Up",0.905303314447384,0.999827083089274
"MARKS_ACETYLATED_NON_HISTONE_PROTEINS",15,"Down",0.905419503749575,0.999827083089274
"SCIBETTA_KDM5B_TARGETS_UP",5,"Up",0.905535232439318,0.999827083089274
"LINDGREN_BLADDER_CANCER_CLUSTER_2B",210,"Down",0.905587229561928,0.999827083089274
"LEE_CALORIE_RESTRICTION_NEOCORTEX_DN",66,"Down",0.905708927262375,0.999827083089274
"RODRIGUES_NTN1_AND_DCC_TARGETS",18,"Down",0.906004486262904,0.999827083089274
"RASHI_RESPONSE_TO_IONIZING_RADIATION_1",34,"Up",0.906048414912874,0.999827083089274
"ZWANG_DOWN_BY_2ND_EGF_PULSE",42,"Up",0.906193109116428,0.999827083089274
"MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP",132,"Down",0.906452925075808,0.999827083089274
"KAYO_CALORIE_RESTRICTION_MUSCLE_UP",67,"Up",0.90655642996562,0.999827083089274
"KEGG_GALACTOSE_METABOLISM",14,"Down",0.906666549821038,0.999827083089274
"LIN_APC_TARGETS",41,"Down",0.906829523735837,0.999827083089274
"REACTOME_ERKS_ARE_INACTIVATED",6,"Down",0.90692007375615,0.999827083089274
"REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING",19,"Down",0.907073232043597,0.999827083089274
"REACTOME_DIABETES_PATHWAYS",76,"Up",0.907173672155027,0.999827083089274
"ROME_INSULIN_TARGETS_IN_MUSCLE_UP",189,"Up",0.907173802124658,0.999827083089274
"LEE_DIFFERENTIATING_T_LYMPHOCYTE",78,"Down",0.907410624990808,0.999827083089274
"SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6",25,"Up",0.907463433982406,0.999827083089274
"YAMASHITA_METHYLATED_IN_PROSTATE_CANCER",36,"Up",0.907638782150117,0.999827083089274
"JISON_SICKLE_CELL_DISEASE_DN",76,"Up",0.908514831376121,0.999827083089274
"REACTOME_PI3K_AKT_ACTIVATION",21,"Up",0.908606714285545,0.999827083089274
"GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP",16,"Down",0.908743868021393,0.999827083089274
"MARSON_BOUND_BY_FOXP3_UNSTIMULATED",404,"Down",0.908856472605363,0.999827083089274
"PROVENZANI_METASTASIS_DN",67,"Up",0.909065430968787,0.999827083089274
"VALK_AML_CLUSTER_6",13,"Down",0.909128900633887,0.999827083089274
"ZHOU_INFLAMMATORY_RESPONSE_LPS_UP",164,"Down",0.909202813395879,0.999827083089274
"ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP",22,"Down",0.909300352675544,0.999827083089274
"SEMENZA_HIF1_TARGETS",34,"Down",0.909318512113609,0.999827083089274
"YIH_RESPONSE_TO_ARSENITE_C5",10,"Up",0.909509018667762,0.999827083089274
"PID_DNA_PK_PATHWAY",7,"Up",0.909883705282434,0.999827083089274
"DARWICHE_PAPILLOMA_RISK_LOW_UP",78,"Up",0.909959495423558,0.999827083089274
"BOSCO_TH1_CYTOTOXIC_MODULE",59,"Up",0.910040526156883,0.999827083089274
"LABBE_TGFB1_TARGETS_DN",89,"Down",0.910051222970728,0.999827083089274
"MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP",17,"Down",0.910589975365131,0.999827083089274
"YAGUE_PRETUMOR_DRUG_RESISTANCE_DN",6,"Down",0.910648001628733,0.999827083089274
"IWANAGA_CARCINOGENESIS_BY_KRAS_DN",48,"Down",0.910754045355877,0.999827083089274
"FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN",185,"Down",0.910824327923019,0.999827083089274
"IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP",4,"Up",0.910835944525866,0.999827083089274
"MARTINEZ_RB1_AND_TP53_TARGETS_DN",284,"Up",0.910846619837931,0.999827083089274
"BASSO_CD40_SIGNALING_UP",73,"Up",0.910949012489364,0.999827083089274
"LOPEZ_TRANSLATION_VIA_FN1_SIGNALING",20,"Down",0.911049671116672,0.999827083089274
"BLUM_RESPONSE_TO_SALIRASIB_UP",131,"Down",0.911136717750451,0.999827083089274
"FUNG_IL2_SIGNALING_1",6,"Up",0.911549952936081,0.999827083089274
"FERRARI_RESPONSE_TO_FENRETINIDE_UP",14,"Up",0.911774191811621,0.999827083089274
"KEGG_ECM_RECEPTOR_INTERACTION",65,"Up",0.911855007207867,0.999827083089274
"KEGG_MAPK_SIGNALING_PATHWAY",188,"Down",0.911960598539323,0.999827083089274
"BILD_E2F3_ONCOGENIC_SIGNATURE",82,"Down",0.912144640435137,0.999827083089274
"NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON",42,"Up",0.912234000618003,0.999827083089274
"BARIS_THYROID_CANCER_DN",43,"Down",0.912347703922187,0.999827083089274
"MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED",181,"Up",0.91263467629294,0.999827083089274
"LINDGREN_BLADDER_CANCER_CLUSTER_1_DN",181,"Down",0.912962751429808,0.999827083089274
"REACTOME_G1_PHASE",25,"Up",0.9130477261785,0.999827083089274
"REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS",13,"Up",0.913323100647936,0.999827083089274
"BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP",76,"Up",0.913330919808629,0.999827083089274
"GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP",46,"Up",0.913354078996159,0.999827083089274
"DELYS_THYROID_CANCER_UP",286,"Up",0.913449585831843,0.999827083089274
"URS_ADIPOCYTE_DIFFERENTIATION_UP",45,"Down",0.913762835002076,0.999827083089274
"CHIARETTI_T_ALL_RELAPSE_PROGNOSIS",11,"Up",0.913781312278081,0.999827083089274
"MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN",16,"Down",0.91382131699479,0.999827083089274
"HUPER_BREAST_BASAL_VS_LUMINAL_UP",30,"Down",0.913902676565715,0.999827083089274
"OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN",8,"Up",0.91442540663101,0.999827083089274
"MULLIGHAN_MLL_SIGNATURE_2_UP",175,"Up",0.914473549246954,0.999827083089274
"SMID_BREAST_CANCER_LUMINAL_B_DN",328,"Up",0.914657444493601,0.999827083089274
"WANG_CISPLATIN_RESPONSE_AND_XPC_DN",112,"Down",0.914847170964088,0.999827083089274
"ELLWOOD_MYC_TARGETS_DN",16,"Down",0.915335465694774,0.999827083089274
"SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN",201,"Down",0.915352133047166,0.999827083089274
"MA_MYELOID_DIFFERENTIATION_DN",43,"Up",0.915376940380156,0.999827083089274
"SANSOM_APC_TARGETS_REQUIRE_MYC",68,"Up",0.915378094656616,0.999827083089274
"JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP",42,"Down",0.915496099055453,0.999827083089274
"BENPORATH_NANOG_TARGETS",359,"Down",0.915514664840592,0.999827083089274
"GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP",199,"Down",0.915530347278221,0.999827083089274
"MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN",131,"Down",0.915918610498228,0.999827083089274
"GENTILE_UV_LOW_DOSE_UP",14,"Down",0.915930505754001,0.999827083089274
"KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP",404,"Up",0.91597458191611,0.999827083089274
"GRADE_METASTASIS_DN",22,"Down",0.916047254307195,0.999827083089274
"MIKKELSEN_MCV6_LCP_WITH_H3K4ME3",58,"Up",0.916544894101659,0.999827083089274
"REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT",12,"Up",0.916945347885896,0.999827083089274
"FOURNIER_ACINAR_DEVELOPMENT_LATE_UP",11,"Down",0.917093360564628,0.999827083089274
"MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_29",7,"Down",0.917134101132265,0.999827083089274
"NAGY_PCAF_COMPONENTS_HUMAN",2,"Down",0.917587414782884,0.999827083089274
"SU_LIVER",26,"Up",0.917601991533227,0.999827083089274
"CROONQUIST_NRAS_SIGNALING_DN",37,"Up",0.917646190770147,0.999827083089274
"BIOCARTA_COMP_PATHWAY",14,"Up",0.917785875773463,0.999827083089274
"STEARMAN_TUMOR_FIELD_EFFECT_UP",29,"Up",0.917909077795944,0.999827083089274
"CHEN_HOXA5_TARGETS_6HR_DN",3,"Down",0.917950735535149,0.999827083089274
"REACTOME_GABA_RECEPTOR_ACTIVATION",43,"Down",0.918070660089744,0.999827083089274
"CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP",141,"Up",0.918126089450176,0.999827083089274
"INAMURA_LUNG_CANCER_SCC_SUBTYPES_UP",6,"Down",0.918261311984767,0.999827083089274
"YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP",59,"Up",0.918262925766858,0.999827083089274
"LI_LUNG_CANCER",38,"Down",0.918307184277368,0.999827083089274
"LEE_LIVER_CANCER_MYC_TGFA_DN",50,"Down",0.918356908775196,0.999827083089274
"GROSS_HIF1A_TARGETS_UP",7,"Up",0.918656097513569,0.999827083089274
"MALONEY_RESPONSE_TO_17AAG_DN",47,"Down",0.918803360102688,0.999827083089274
"GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB",71,"Down",0.91882549498255,0.999827083089274
"ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN",47,"Down",0.918953874904073,0.999827083089274
"PETRETTO_BLOOD_PRESSURE_UP",6,"Down",0.919062254349312,0.999827083089274
"SMITH_TERT_TARGETS_UP",81,"Up",0.919062466154343,0.999827083089274
"GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN",8,"Down",0.919166518300689,0.999827083089274
"SERVITJA_ISLET_HNF1A_TARGETS_UP",109,"Up",0.919564538835206,0.999827083089274
"SANSOM_APC_TARGETS_DN",239,"Up",0.919590965555225,0.999827083089274
"CAIRO_HEPATOBLASTOMA_CLASSES_UP",231,"Down",0.919613163433518,0.999827083089274
"LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN",95,"Up",0.91974836086237,0.999827083089274
"BIOCARTA_P53_PATHWAY",16,"Down",0.919923609142764,0.999827083089274
"MOOTHA_GLYCOLYSIS",18,"Up",0.91998566174449,0.999827083089274
"GRABARCZYK_BCL11B_TARGETS_UP",32,"Down",0.920014164604358,0.999827083089274
"MATZUK_CENTRAL_FOR_FEMALE_FERTILITY",25,"Up",0.920069735443072,0.999827083089274
"LIM_MAMMARY_LUMINAL_PROGENITOR_UP",32,"Up",0.92035111980216,0.999827083089274
"KEGG_PATHWAYS_IN_CANCER",284,"Down",0.920579142802863,0.999827083089274
"BENPORATH_EED_TARGETS",497,"Up",0.920634715185,0.999827083089274
"KAAB_FAILED_HEART_ATRIUM_DN",85,"Down",0.920761298945068,0.999827083089274
"GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN",54,"Up",0.920801457220612,0.999827083089274
"BROWNE_HCMV_INFECTION_24HR_UP",81,"Up",0.920851502945122,0.999827083089274
"ST_GA13_PATHWAY",29,"Up",0.921191242811846,0.999827083089274
"KOBAYASHI_RESPONSE_TO_ROMIDEPSIN",10,"Down",0.921312324279519,0.999827083089274
"BROWNE_HCMV_INFECTION_8HR_UP",58,"Down",0.921393121395913,0.999827083089274
"RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN",133,"Up",0.921735468418507,0.999827083089274
"RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN",164,"Down",0.922042661263224,0.999827083089274
"BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP",82,"Up",0.922376222097908,0.999827083089274
"ST_TYPE_I_INTERFERON_PATHWAY",8,"Up",0.922423779712846,0.999827083089274
"PID_CD40_PATHWAY",27,"Down",0.922502510500718,0.999827083089274
"BROWNE_HCMV_INFECTION_48HR_DN",261,"Up",0.922539779718859,0.999827083089274
"ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN",8,"Down",0.922717886272237,0.999827083089274
"REACTOME_INHIBITION_OF_VOLTAGE_GATED_CA2_CHANNELS_VIA_GBETA_GAMMA_SUBUNITS",23,"Up",0.922941121726805,0.999827083089274
"BIOCARTA_PLCE_PATHWAY",8,"Down",0.922991964671458,0.999827083089274
"WACKER_HYPOXIA_TARGETS_OF_VHL",10,"Up",0.923059858353626,0.999827083089274
"NUYTTEN_EZH2_TARGETS_UP",396,"Down",0.923249077894216,0.999827083089274
"KAUFFMANN_DNA_REPLICATION_GENES",76,"Up",0.92343382028415,0.999827083089274
"HOOI_ST7_TARGETS_UP",28,"Down",0.923911460514511,0.999827083089274
"BROWNE_HCMV_INFECTION_18HR_DN",94,"Down",0.923941049643804,0.999827083089274
"MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP",5,"Up",0.924075684454649,0.999827083089274
"PAL_PRMT5_TARGETS_UP",106,"Down",0.924302171065597,0.999827083089274
"RUNNE_GENDER_EFFECT_UP",4,"Down",0.924691666593098,0.999827083089274
"PID_RB_1PATHWAY",57,"Down",0.924702616374401,0.999827083089274
"YOSHIMURA_MAPK8_TARGETS_DN",219,"Up",0.924845323296284,0.999827083089274
"CARD_MIR302A_TARGETS",50,"Up",0.924958699320455,0.999827083089274
"DELYS_THYROID_CANCER_DN",140,"Up",0.925066153676335,0.999827083089274
"GRUETZMANN_PANCREATIC_CANCER_DN",136,"Down",0.92508170792162,0.999827083089274
"MARTINEZ_TP53_TARGETS_UP",321,"Up",0.925098025318574,0.999827083089274
"FINAK_BREAST_CANCER_SDPP_SIGNATURE",16,"Up",0.925704581954669,0.999827083089274
"NIKOLSKY_BREAST_CANCER_7P22_AMPLICON",9,"Down",0.92573132715856,0.999827083089274
"DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_DN",15,"Up",0.925862365974889,0.999827083089274
"EHLERS_ANEUPLOIDY_UP",15,"Up",0.926393443312039,0.999827083089274
"REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION",17,"Down",0.926463070637951,0.999827083089274
"REACTOME_SEMAPHORIN_INTERACTIONS",45,"Up",0.926479959695912,0.999827083089274
"NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON",5,"Down",0.927459513901956,0.999827083089274
"BENPORATH_MYC_MAX_TARGETS",344,"Down",0.927461425485356,0.999827083089274
"WANG_CISPLATIN_RESPONSE_AND_XPC_UP",119,"Down",0.927466279053494,0.999827083089274
"BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS",511,"Down",0.927495441088961,0.999827083089274
"LEE_LIVER_CANCER_MYC_E2F1_UP",46,"Down",0.927801545860539,0.999827083089274
"NAM_FXYD5_TARGETS_DN",9,"Down",0.927814633177097,0.999827083089274
"WALLACE_PROSTATE_CANCER_RACE_UP",164,"Up",0.928081300900157,0.999827083089274
"NIELSEN_LEIOMYOSARCOMA_CNN1_DN",13,"Down",0.928811327328533,0.999827083089274
"TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP",21,"Down",0.928986638550222,0.999827083089274
"JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN",48,"Up",0.929085626516455,0.999827083089274
"KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_KERATAN_SULFATE",5,"Down",0.929180879627535,0.999827083089274
"GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN",264,"Up",0.929469731348078,0.999827083089274
"YOKOE_CANCER_TESTIS_ANTIGENS",17,"Down",0.929602514345854,0.999827083089274
"SUNG_METASTASIS_STROMA_UP",58,"Down",0.929777068409314,0.999827083089274
"YANAGIHARA_ESX1_TARGETS",11,"Up",0.930563152791364,0.999827083089274
"REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION",12,"Down",0.930568163135666,0.999827083089274
"RAGHAVACHARI_PLATELET_SPECIFIC_GENES",37,"Down",0.930937584166247,0.999827083089274
"KEGG_PRIMARY_IMMUNODEFICIENCY",29,"Up",0.931025734492987,0.999827083089274
"MEISSNER_BRAIN_HCP_WITH_H3K27ME3",168,"Up",0.931043170642896,0.999827083089274
"SANSOM_APC_MYC_TARGETS",81,"Down",0.931202080196828,0.999827083089274
"CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP",28,"Down",0.931247948332787,0.999827083089274
"PID_PI3KCI_PATHWAY",38,"Down",0.931289700464141,0.999827083089274
"MCLACHLAN_DENTAL_CARIES_UP",185,"Up",0.931386480887137,0.999827083089274
"RODWELL_AGING_KIDNEY_UP",239,"Down",0.931411064190931,0.999827083089274
"RUTELLA_RESPONSE_TO_HGF_UP",223,"Down",0.931796158245293,0.999827083089274
"KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION",39,"Up",0.931842913724411,0.999827083089274
"DEN_INTERACT_WITH_LCA5",17,"Up",0.931876786621099,0.999827083089274
"HOELZEL_NF1_TARGETS_DN",44,"Up",0.931887229025507,0.999827083089274
"CROMER_METASTASIS_UP",36,"Up",0.931919047167157,0.999827083089274
"CUI_TCF21_TARGETS_UP",26,"Up",0.931976902387647,0.999827083089274
"SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP",36,"Up",0.932292983415033,0.999827083089274
"FARMER_BREAST_CANCER_APOCRINE_VS_BASAL",145,"Down",0.932367332848914,0.999827083089274
"BROWNE_HCMV_INFECTION_18HR_UP",98,"Down",0.932460981022712,0.999827083089274
"HSIAO_HOUSEKEEPING_GENES",274,"Up",0.932879189579917,0.999827083089274
"MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP",182,"Up",0.932903640010453,0.999827083089274
"REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION",61,"Down",0.933017947185995,0.999827083089274
"NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP",72,"Up",0.933075172647351,0.999827083089274
"RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN",6,"Down",0.933102036567147,0.999827083089274
"MANALO_HYPOXIA_UP",103,"Up",0.933223845086012,0.999827083089274
"YANG_BCL3_TARGETS_DN",3,"Down",0.933535034560919,0.999827083089274
"RASHI_RESPONSE_TO_IONIZING_RADIATION_2",92,"Up",0.933569061383525,0.999827083089274
"LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP",49,"Down",0.933588851281184,0.999827083089274
"REACTOME_AQUAPORIN_MEDIATED_TRANSPORT",38,"Up",0.933790836993661,0.999827083089274
"BRUINS_UVC_RESPONSE_LATE",420,"Down",0.933836141791265,0.999827083089274
"REACTOME_CIRCADIAN_REPRESSION_OF_EXPRESSION_BY_REV_ERBA",16,"Up",0.934344746098986,0.999827083089274
"VISALA_AGING_LYMPHOCYTE_DN",15,"Down",0.934399207360288,0.999827083089274
"RIGGI_EWING_SARCOMA_PROGENITOR_UP",176,"Up",0.934426071266709,0.999827083089274
"JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP",56,"Up",0.934535717769687,0.999827083089274
"KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP",367,"Down",0.934776890282679,0.999827083089274
"YAGI_AML_WITH_T_8_21_TRANSLOCATION",190,"Up",0.934904255638427,0.999827083089274
"SHEPARD_CRUSH_AND_BURN_MUTANT_DN",91,"Down",0.934939854142786,0.999827083089274
"BIOCARTA_HIVNEF_PATHWAY",50,"Up",0.934963110187563,0.999827083089274
"REACTOME_SIGNALING_BY_BMP",16,"Down",0.93498152973249,0.999827083089274
"PID_CD8_TCR_PATHWAY",52,"Down",0.935033303231428,0.999827083089274
"WINTER_HYPOXIA_METAGENE",181,"Up",0.935285016514716,0.999827083089274
"MARTINEZ_TP53_TARGETS_DN",294,"Up",0.935334463009646,0.999827083089274
"PETROVA_PROX1_TARGETS_UP",16,"Up",0.935518323309211,0.999827083089274
"LIANG_SILENCED_BY_METHYLATION_UP",21,"Down",0.935531110206418,0.999827083089274
"XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN",10,"Down",0.935823894265482,0.999827083089274
"NABA_ECM_GLYCOPROTEINS",88,"Down",0.936120588395266,0.999827083089274
"PID_ERA_GENOMIC_PATHWAY",44,"Up",0.936159783944092,0.999827083089274
"AMIT_SERUM_RESPONSE_120_MCF10A",35,"Up",0.936203480654851,0.999827083089274
"FEVR_CTNNB1_TARGETS_UP",353,"Up",0.936271981796365,0.999827083089274
"LOPEZ_EPITHELIOID_MESOTHELIOMA",9,"Down",0.936281197579741,0.999827083089274
"REACTOME_AXON_GUIDANCE",174,"Down",0.93636760756837,0.999827083089274
"RODRIGUES_THYROID_CARCINOMA_UP",3,"Up",0.936382171777254,0.999827083089274
"SHI_SPARC_TARGETS_UP",13,"Down",0.936427400358112,0.999827083089274
"TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA",31,"Up",0.93646914981649,0.999827083089274
"NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON",15,"Down",0.93661487853599,0.999827083089274
"PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN",56,"Up",0.936658415077602,0.999827083089274
"REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES",10,"Down",0.936882858939542,0.999827083089274
"PID_RETINOIC_ACID_PATHWAY",25,"Up",0.937068420985566,0.999827083089274
"PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP",122,"Up",0.937104473162493,0.999827083089274
"CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN",222,"Up",0.937134242786567,0.999827083089274
"SASSON_RESPONSE_TO_FORSKOLIN_DN",49,"Up",0.937217739519228,0.999827083089274
"KEGG_AMINOACYL_TRNA_BIOSYNTHESIS",6,"Up",0.937219208555101,0.999827083089274
"KAPOSI_LIVER_CANCER_MET_DN",5,"Up",0.937404416936596,0.999827083089274
"MODY_HIPPOCAMPUS_POSTNATAL",48,"Up",0.937686007707271,0.999827083089274
"BIOCARTA_IL5_PATHWAY",8,"Up",0.937845512413019,0.999827083089274
"MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN",19,"Down",0.938217546309325,0.999827083089274
"PID_VEGFR1_2_PATHWAY",59,"Down",0.938231073806983,0.999827083089274
"KENNY_CTNNB1_TARGETS_DN",25,"Down",0.938480362968213,0.999827083089274
"KEGG_RIBOSOME",41,"Up",0.938825354965803,0.999827083089274
"KANG_AR_TARGETS_DN",17,"Up",0.938843431280256,0.999827083089274
"SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_UP",5,"Down",0.938917948280874,0.999827083089274
"KORKOLA_SEMINOMA_UP",24,"Up",0.939153616665258,0.999827083089274
"OXFORD_RALA_TARGETS_DN",5,"Down",0.939266614661307,0.999827083089274
"KEGG_ASTHMA",25,"Down",0.939277142213818,0.999827083089274
"HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP",124,"Down",0.939359959475709,0.999827083089274
"ASTIER_INTEGRIN_SIGNALING",34,"Down",0.939361134018538,0.999827083089274
"PID_SYNDECAN_3_PATHWAY",13,"Down",0.939530938860886,0.999827083089274
"DOUGLAS_BMI1_TARGETS_UP",223,"Up",0.939693380715523,0.999827083089274
"KIM_PTEN_TARGETS_DN",3,"Down",0.939952156702082,0.999827083089274
"WHITESIDE_CISPLATIN_RESISTANCE_UP",8,"Down",0.94013915764339,0.999827083089274
"BENPORATH_ES_CORE_NINE_CORRELATED",62,"Down",0.940512445985944,0.999827083089274
"LE_EGR2_TARGETS_DN",70,"Up",0.940514505684606,0.999827083089274
"OUYANG_PROSTATE_CANCER_PROGRESSION_DN",10,"Down",0.940519593226671,0.999827083089274
"MILI_PSEUDOPODIA_HAPTOTAXIS_UP",137,"Down",0.940535437291721,0.999827083089274
"GROSS_HYPOXIA_VIA_ELK3_UP",115,"Up",0.940605668063796,0.999827083089274
"REACTOME_ADAPTIVE_IMMUNE_SYSTEM",269,"Up",0.940841233794898,0.999827083089274
"KATSANOU_ELAVL1_TARGETS_UP",83,"Down",0.941209340972905,0.999827083089274
"TOMIDA_METASTASIS_UP",12,"Down",0.941214735860544,0.999827083089274
"PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP",25,"Down",0.941518328630161,0.999827083089274
"DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN",81,"Down",0.941655012400955,0.999827083089274
"CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN",294,"Down",0.941676720588293,0.999827083089274
"LEE_LIVER_CANCER_DENA_DN",57,"Up",0.94180993367913,0.999827083089274
"RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP",215,"Up",0.94183995893427,0.999827083089274
"LI_ADIPOGENESIS_BY_ACTIVATED_PPARG",16,"Up",0.942070484892183,0.999827083089274
"CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5",161,"Down",0.942112752417405,0.999827083089274
"MATZUK_STEROIDOGENESIS",6,"Up",0.942441498733614,0.999827083089274
"REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS",28,"Down",0.942456704083349,0.999827083089274
"KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN",15,"Up",0.942557261753191,0.999827083089274
"FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN",61,"Up",0.942669651611093,0.999827083089274
"REACTOME_CELL_CYCLE_MITOTIC",153,"Down",0.942855603039185,0.999827083089274
"LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP",29,"Down",0.943003247807226,0.999827083089274
"PETRETTO_BLOOD_PRESSURE_DN",3,"Up",0.943069173534818,0.999827083089274
"TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN",122,"Down",0.943105451864225,0.999827083089274
"KYNG_NORMAL_AGING_DN",11,"Up",0.943206415382859,0.999827083089274
"REACTOME_PROTEOLYTIC_CLEAVAGE_OF_SNARE_COMPLEX_PROTEINS",7,"Down",0.943400366424896,0.999827083089274
"DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN",72,"Up",0.943482554709022,0.999827083089274
"SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP",9,"Down",0.943774148309758,0.999827083089274
"LEIN_ASTROCYTE_MARKERS",31,"Down",0.943795655902013,0.999827083089274
"ELVIDGE_HYPOXIA_UP",88,"Down",0.944382128074678,0.999827083089274
"WANG_TARGETS_OF_MLL_CBP_FUSION_DN",19,"Up",0.9444975480044,0.999827083089274
"MORI_MATURE_B_LYMPHOCYTE_DN",51,"Up",0.944648964291719,0.999827083089274
"PID_NECTIN_PATHWAY",22,"Down",0.944784826810038,0.999827083089274
"KAYO_AGING_MUSCLE_DN",74,"Up",0.944829944829519,0.999827083089274
"HEDENFALK_BREAST_CANCER_BRACX_UP",11,"Down",0.944923965502096,0.999827083089274
"LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN",74,"Down",0.944975173073951,0.999827083089274
"KRASNOSELSKAYA_ILF3_TARGETS_DN",33,"Down",0.945211921826846,0.999827083089274
"GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN",195,"Down",0.945261471079392,0.999827083089274
"BIOCARTA_LEPTIN_PATHWAY",5,"Down",0.945337768403128,0.999827083089274
"SESTO_RESPONSE_TO_UV_C6",22,"Down",0.94534140751323,0.999827083089274
"KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN",103,"Up",0.945499870532313,0.999827083089274
"PEREZ_TP53_TARGETS",371,"Down",0.945562757395831,0.999827083089274
"BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS",19,"Down",0.945564224993494,0.999827083089274
"HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS",54,"Up",0.945761261805066,0.999827083089274
"PAL_PRMT5_TARGETS_DN",22,"Up",0.945934015687137,0.999827083089274
"BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING",207,"Up",0.946137789557906,0.999827083089274
"AIYAR_COBRA1_TARGETS_UP",24,"Up",0.946172402183454,0.999827083089274
"VERNOCHET_ADIPOGENESIS",14,"Up",0.946286451213989,0.999827083089274
"DIRMEIER_LMP1_RESPONSE_LATE_DN",25,"Down",0.946622615036873,0.999827083089274
"PEREZ_TP63_TARGETS",140,"Up",0.946755763907108,0.999827083089274
"WU_ALZHEIMER_DISEASE_DN",12,"Up",0.946901814839387,0.999827083089274
"GAVIN_FOXP3_TARGETS_CLUSTER_P2",34,"Up",0.946913093947306,0.999827083089274
"WIERENGA_STAT5A_TARGETS_UP",104,"Up",0.947328491308665,0.999827083089274
"WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D",245,"Down",0.947384006296365,0.999827083089274
"REACTOME_SIGNALING_BY_RHO_GTPASES",32,"Down",0.947450540988188,0.999827083089274
"REACTOME_BILE_SALT_AND_ORGANIC_ANION_SLC_TRANSPORTERS",3,"Down",0.947473516409157,0.999827083089274
"KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN",39,"Up",0.947537967994601,0.999827083089274
"REACTOME_HEMOSTASIS",312,"Down",0.947644906846141,0.999827083089274
"DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN",196,"Up",0.947654979582628,0.999827083089274
"TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN",27,"Up",0.947675792548108,0.999827083089274
"BIOCARTA_KREB_PATHWAY",6,"Up",0.94809415843288,0.999827083089274
"PID_ER_NONGENOMIC_PATHWAY",39,"Up",0.948133934921897,0.999827083089274
"PID_LPA4_PATHWAY",8,"Down",0.948189410426969,0.999827083089274
"ZHAN_V2_LATE_DIFFERENTIATION_GENES",33,"Up",0.948245847656822,0.999827083089274
"GROSS_HIF1A_TARGETS_DN",14,"Down",0.948313841333063,0.999827083089274
"ONKEN_UVEAL_MELANOMA_DN",229,"Up",0.9485663185388,0.999827083089274
"NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP",121,"Up",0.948568199471289,0.999827083089274
"PENG_GLUCOSE_DEPRIVATION_DN",83,"Up",0.948712270100134,0.999827083089274
"TAVAZOIE_METASTASIS",43,"Up",0.948814847787169,0.999827083089274
"ST_ADRENERGIC",29,"Down",0.949020825457654,0.999827083089274
"SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4",77,"Down",0.949412485382092,0.999827083089274
"YAGI_AML_WITH_INV_16_TRANSLOCATION",210,"Down",0.949924480744032,0.999827083089274
"REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR",60,"Down",0.950081130364386,0.999827083089274
"GOUYER_TATI_TARGETS_UP",9,"Up",0.950373777948339,0.999827083089274
"WU_HBX_TARGETS_2_UP",13,"Down",0.950386006822133,0.999827083089274
"WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP",25,"Down",0.950657159013134,0.999827083089274
"AMUNDSON_DNA_DAMAGE_RESPONSE_TP53",11,"Down",0.950725906612428,0.999827083089274
"PID_PI3KCI_AKT_PATHWAY",22,"Down",0.950767432087914,0.999827083089274
"MARCHINI_TRABECTEDIN_RESISTANCE_UP",10,"Up",0.950780891800121,0.999827083089274
"REACTOME_RNA_POL_III_CHAIN_ELONGATION",4,"Down",0.950879534941195,0.999827083089274
"BROWNE_HCMV_INFECTION_48HR_UP",88,"Down",0.950882184072162,0.999827083089274
"MULLIGHAN_MLL_SIGNATURE_2_DN",131,"Up",0.951212904495421,0.999827083089274
"RUIZ_TNC_TARGETS_DN",68,"Up",0.951303656282065,0.999827083089274
"LI_CYTIDINE_ANALOG_PATHWAY",4,"Up",0.951366648920781,0.999827083089274
"TOOKER_GEMCITABINE_RESISTANCE_DN",60,"Down",0.951367924586017,0.999827083089274
"GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP",74,"Up",0.951798566089192,0.999827083089274
"REACTOME_BIOLOGICAL_OXIDATIONS",73,"Up",0.952058191592682,0.999827083089274
"PID_NFKAPPAB_ATYPICAL_PATHWAY",15,"Up",0.952096650841527,0.999827083089274
"THUM_MIR21_TARGETS_HEART_DISEASE_DN",4,"Down",0.952222708558866,0.999827083089274
"NABA_MATRISOME",546,"Down",0.952470680707164,0.999827083089274
"JAEGER_METASTASIS_UP",24,"Up",0.952608535787212,0.999827083089274
"WANG_SMARCE1_TARGETS_UP",125,"Up",0.9526261022281,0.999827083089274
"MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23",10,"Up",0.953213731979976,0.999827083089274
"NAKAMURA_CANCER_MICROENVIRONMENT_UP",14,"Down",0.953501636939549,0.999827083089274
"REACTOME_SIGNALING_BY_NOTCH",55,"Down",0.953980782807269,0.999827083089274
"PID_LYSOPHOSPHOLIPID_PATHWAY",54,"Up",0.953986531444923,0.999827083089274
"ST_G_ALPHA_I_PATHWAY",27,"Down",0.954302628476831,0.999827083089274
"ISSAEVA_MLL2_TARGETS",37,"Down",0.954348366738954,0.999827083089274
"KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN",26,"Down",0.954679211952627,0.999827083089274
"DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP",164,"Down",0.954845710273465,0.999827083089274
"PID_MET_PATHWAY",60,"Down",0.954991706966436,0.999827083089274
"MCBRYAN_PUBERTAL_BREAST_4_5WK_UP",159,"Up",0.955093387107272,0.999827083089274
"WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN",18,"Down",0.955110100431456,0.999827083089274
"PID_HDAC_CLASSIII_PATHWAY",13,"Down",0.955166143416617,0.999827083089274
"REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM",1,"Up",0.955249783841052,0.999827083089274
"SMID_BREAST_CANCER_LUMINAL_A_UP",51,"Down",0.955359100749985,0.999827083089274
"WU_HBX_TARGETS_1_UP",8,"Up",0.955406529318435,0.999827083089274
"BASSO_HAIRY_CELL_LEUKEMIA_DN",41,"Down",0.95546725309493,0.999827083089274
"AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP",100,"Up",0.95546840685881,0.999827083089274
"REACTOME_HS_GAG_DEGRADATION",16,"Down",0.955480699614718,0.999827083089274
"HADDAD_B_LYMPHOCYTE_PROGENITOR",136,"Down",0.955509360209456,0.999827083089274
"SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN",46,"Down",0.955799599406443,0.999827083089274
"SENESE_HDAC1_AND_HDAC2_TARGETS_DN",87,"Up",0.955826959041878,0.999827083089274
"QI_PLASMACYTOMA_UP",185,"Up",0.956041641959248,0.999827083089274
"IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN",8,"Up",0.956214829054988,0.999827083089274
"HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP",46,"Up",0.956451736515287,0.999827083089274
"CHUANG_OXIDATIVE_STRESS_RESPONSE_UP",17,"Down",0.957011079515597,0.999827083089274
"WHITFIELD_CELL_CYCLE_G2",66,"Down",0.957214277227912,0.999827083089274
"KEGG_ALZHEIMERS_DISEASE",93,"Down",0.957261885986185,0.999827083089274
"REN_ALVEOLAR_RHABDOMYOSARCOMA_UP",58,"Up",0.957300780783924,0.999827083089274
"SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP",11,"Down",0.957342636163706,0.999827083089274
"BERENJENO_TRANSFORMED_BY_RHOA_DN",236,"Up",0.957467257295134,0.999827083089274
"OZANNE_AP1_TARGETS_DN",2,"Up",0.957523119891879,0.999827083089274
"OHGUCHI_LIVER_HNF4A_TARGETS_UP",25,"Up",0.957540751328332,0.999827083089274
"CERVERA_SDHB_TARGETS_1_DN",20,"Up",0.957622106329604,0.999827083089274
"MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS",20,"Up",0.957634245204077,0.999827083089274
"IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN",144,"Up",0.957659062093039,0.999827083089274
"MULLIGHAN_MLL_SIGNATURE_1_UP",164,"Up",0.957754546088842,0.999827083089274
"GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN",635,"Down",0.958278902470689,0.999827083089274
"KEGG_CELL_CYCLE",85,"Up",0.958298677010908,0.999827083089274
"XU_AKT1_TARGETS_6HR",13,"Up",0.958354657813412,0.999827083089274
"STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP",62,"Down",0.958393875581442,0.999827083089274
"GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_DN",8,"Up",0.958405699570742,0.999827083089274
"SHIRAISHI_PLZF_TARGETS_DN",4,"Down",0.958525496135138,0.999827083089274
"LEE_TARGETS_OF_PTCH1_AND_SUFU_UP",32,"Down",0.958562943553259,0.999827083089274
"FURUKAWA_DUSP6_TARGETS_PCI35_UP",24,"Up",0.958894294470516,0.999827083089274
"MMS_MOUSE_LYMPH_HIGH_4HRS_UP",27,"Down",0.958898369896535,0.999827083089274
"HOSHIDA_LIVER_CANCER_SURVIVAL_DN",59,"Down",0.958967485770228,0.999827083089274
"RICKMAN_HEAD_AND_NECK_CANCER_D",22,"Down",0.958982004249133,0.999827083089274
"BYSTROEM_CORRELATED_WITH_IL5_DN",50,"Up",0.959086901409779,0.999827083089274
"BIOCARTA_P35ALZHEIMERS_PATHWAY",7,"Down",0.959240826122348,0.999827083089274
"NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_DN",10,"Up",0.959311267725723,0.999827083089274
"LANDIS_ERBB2_BREAST_TUMORS_324_DN",97,"Up",0.959596948694902,0.999827083089274
"BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP",23,"Down",0.959754566396826,0.999827083089274
"SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN",172,"Up",0.959834443571153,0.999827083089274
"HOLLEMAN_DAUNORUBICIN_B_ALL_UP",6,"Down",0.960021546320135,0.999827083089274
"REACTOME_G1_S_SPECIFIC_TRANSCRIPTION",14,"Down",0.960093016868171,0.999827083089274
"SMID_BREAST_CANCER_BASAL_DN",289,"Down",0.960234955446089,0.999827083089274
"NIKOLSKY_BREAST_CANCER_10Q22_AMPLICON",2,"Up",0.960318515096283,0.999827083089274
"CONRAD_STEM_CELL",24,"Up",0.960645581444094,0.999827083089274
"BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D",106,"Down",0.960736815840013,0.999827083089274
"VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP",135,"Up",0.960865652797381,0.999827083089274
"KEGG_PARKINSONS_DISEASE",55,"Down",0.960927324277141,0.999827083089274
"IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR",220,"Up",0.961160862030939,0.999827083089274
"ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP",107,"Up",0.96123525388015,0.999827083089274
"KORKOLA_EMBRYONAL_CARCINOMA_DN",5,"Down",0.961249494111796,0.999827083089274
"KORKOLA_CHORIOCARCINOMA_DN",5,"Down",0.961249494111796,0.999827083089274
"AMUNDSON_RESPONSE_TO_ARSENITE",126,"Up",0.961771979582168,0.999827083089274
"CHASSOT_SKIN_WOUND",10,"Up",0.96180630608644,0.999827083089274
"ONKEN_UVEAL_MELANOMA_UP",299,"Up",0.961869247675398,0.999827083089274
"SEMBA_FHIT_TARGETS_DN",6,"Down",0.962135932171138,0.999827083089274
"REACTOME_MRNA_3_END_PROCESSING",8,"Down",0.962401547215564,0.999827083089274
"SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP",236,"Down",0.962541574599698,0.999827083089274
"STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN",41,"Down",0.96256751402881,0.999827083089274
"AMIT_SERUM_RESPONSE_240_MCF10A",33,"Down",0.962866598450651,0.999827083089274
"MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_UP",3,"Down",0.962927848016569,0.999827083089274
"GUO_TARGETS_OF_IRS1_AND_IRS2",53,"Up",0.962968712620904,0.999827083089274
"CHEBOTAEV_GR_TARGETS_UP",31,"Up",0.963160691940884,0.999827083089274
"KUMAMOTO_RESPONSE_TO_NUTLIN_3A_UP",5,"Up",0.963183120853173,0.999827083089274
"MARTENS_BOUND_BY_PML_RARA_FUSION",173,"Up",0.963658476673834,0.999827083089274
"REACTOME_DEVELOPMENTAL_BIOLOGY",271,"Up",0.963837507923232,0.999827083089274
"TERAO_AOX4_TARGETS_SKIN_UP",11,"Down",0.964075466501862,0.999827083089274
"YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0",40,"Up",0.964080644672653,0.999827083089274
"HALMOS_CEBPA_TARGETS_UP",40,"Down",0.964328202332927,0.999827083089274
"ROPERO_HDAC2_TARGETS",50,"Up",0.964361406856349,0.999827083089274
"VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP",9,"Up",0.964387849964175,0.999827083089274
"GNATENKO_PLATELET_SIGNATURE",29,"Up",0.964446677645902,0.999827083089274
"PID_ATR_PATHWAY",22,"Down",0.964793316928151,0.999827083089274
"DAZARD_UV_RESPONSE_CLUSTER_G1",40,"Up",0.964959347513304,0.999827083089274
"BILBAN_B_CLL_LPL_UP",24,"Up",0.96496457127579,0.999827083089274
"BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN",25,"Down",0.965012582284373,0.999827083089274
"WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN",21,"Up",0.965034729478709,0.999827083089274
"TAKAO_RESPONSE_TO_UVB_RADIATION_DN",56,"Down",0.96515197668683,0.999827083089274
"KEGG_TGF_BETA_SIGNALING_PATHWAY",67,"Up",0.96528645609654,0.999827083089274
"ROETH_TERT_TARGETS_UP",4,"Up",0.965475941811823,0.999827083089274
"PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY",32,"Up",0.965538842787232,0.999827083089274
"GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP",459,"Down",0.965905771391161,0.999827083089274
"CHAN_INTERFERON_PRODUCING_DENDRITIC_CELL",10,"Up",0.965946238709136,0.999827083089274
"LA_MEN1_TARGETS",20,"Up",0.966153026165547,0.999827083089274
"GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN",25,"Up",0.966167868141442,0.999827083089274
"HORIUCHI_WTAP_TARGETS_UP",117,"Up",0.966236800448563,0.999827083089274
"ROZANOV_MMP14_TARGETS_UP",110,"Down",0.966574911038588,0.999827083089274
"BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP",7,"Down",0.966832004943965,0.999827083089274
"MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN",22,"Up",0.967169243061767,0.999827083089274
"RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN",139,"Down",0.967201968590529,0.999827083089274
"DER_IFN_BETA_RESPONSE_DN",4,"Up",0.967288606440897,0.999827083089274
"WALLACE_PROSTATE_CANCER_DN",4,"Up",0.967315460894808,0.999827083089274
"MIKKELSEN_MCV6_HCP_WITH_H3K27ME3",198,"Down",0.967391165055968,0.999827083089274
"KEGG_STARCH_AND_SUCROSE_METABOLISM",13,"Up",0.967820539133273,0.999827083089274
"REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX",47,"Up",0.967896072871108,0.999827083089274
"RADMACHER_AML_PROGNOSIS",45,"Up",0.967928364758383,0.999827083089274
"KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM",14,"Down",0.967996728748484,0.999827083089274
"REACTOME_INFLUENZA_LIFE_CYCLE",56,"Down",0.968032609659074,0.999827083089274
"HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN",26,"Up",0.968156098171512,0.999827083089274
"CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP",53,"Up",0.968443078394468,0.999827083089274
"PID_CASPASE_PATHWAY",45,"Down",0.968486381448032,0.999827083089274
"MARTINEZ_RB1_AND_TP53_TARGETS_UP",330,"Up",0.968532646833858,0.999827083089274
"APPIERTO_RESPONSE_TO_FENRETINIDE_UP",25,"Down",0.968583538354687,0.999827083089274
"IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP",80,"Down",0.968639187872163,0.999827083089274
"ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN",228,"Down",0.968904188354435,0.999827083089274
"GAVIN_FOXP3_TARGETS_CLUSTER_P3",79,"Up",0.969107682429941,0.999827083089274
"WIERENGA_STAT5A_TARGETS_DN",77,"Down",0.96927534783063,0.999827083089274
"REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER",5,"Up",0.969328457210669,0.999827083089274
"ZHANG_TLX_TARGETS_60HR_UP",139,"Up",0.969474770112022,0.999827083089274
"REACTOME_TRANSPORT_OF_ORGANIC_ANIONS",4,"Down",0.969539963147706,0.999827083089274
"BIOCARTA_IL6_PATHWAY",20,"Down",0.969558034429988,0.999827083089274
"WANG_LSD1_TARGETS_DN",27,"Up",0.969762369019153,0.999827083089274
"HELLER_HDAC_TARGETS_UP",135,"Down",0.969894364432042,0.999827083089274
"MCBRYAN_PUBERTAL_BREAST_4_5WK_DN",109,"Up",0.970000934985754,0.999827083089274
"BURTON_ADIPOGENESIS_12",15,"Down",0.970090228429572,0.999827083089274
"WANG_SMARCE1_TARGETS_DN",156,"Up",0.970101644074264,0.999827083089274
"BIOCARTA_KERATINOCYTE_PATHWAY",44,"Up",0.970122791135219,0.999827083089274
"BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES",35,"Up",0.97018203016613,0.999827083089274
"MISSIAGLIA_REGULATED_BY_METHYLATION_DN",56,"Down",0.970318922306045,0.999827083089274
"REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS",23,"Up",0.970381930756226,0.999827083089274
"BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP",12,"Down",0.97044927208763,0.999827083089274
"BILBAN_B_CLL_LPL_DN",20,"Down",0.970681557234033,0.999827083089274
"SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN",275,"Down",0.970779026715658,0.999827083089274
"BHATTACHARYA_EMBRYONIC_STEM_CELL",50,"Up",0.970869449006219,0.999827083089274
"PID_INSULIN_PATHWAY",31,"Down",0.970870884686117,0.999827083089274
"YOSHIMURA_MAPK8_TARGETS_UP",856,"Down",0.970966375796803,0.999827083089274
"BURTON_ADIPOGENESIS_PEAK_AT_0HR",48,"Up",0.971231238622755,0.999827083089274
"PARENT_MTOR_SIGNALING_DN",25,"Down",0.971451159799443,0.999827083089274
"KARAKAS_TGFB1_SIGNALING",15,"Up",0.971785687612949,0.999827083089274
"ONDER_CDH1_SIGNALING_VIA_CTNNB1",51,"Down",0.971929519486002,0.999827083089274
"REACTOME_MITOTIC_G1_G1_S_PHASES",92,"Down",0.971937957117093,0.999827083089274
"DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP",37,"Up",0.972293860992065,0.999827083089274
"KIM_MYCL1_AMPLIFICATION_TARGETS_DN",7,"Up",0.972515644852676,0.999827083089274
"CUI_TCF21_TARGETS_2_DN",292,"Down",0.972518782824198,0.999827083089274
"KEGG_HEMATOPOIETIC_CELL_LINEAGE",76,"Down",0.972749203409231,0.999827083089274
"DITTMER_PTHLH_TARGETS_DN",34,"Up",0.972982554784715,0.999827083089274
"KEGG_WNT_SIGNALING_PATHWAY",109,"Up",0.973000850424964,0.999827083089274
"CHEN_HOXA5_TARGETS_9HR_UP",83,"Up",0.973216745230544,0.999827083089274
"ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN",22,"Down",0.973278905143826,0.999827083089274
"BIOCARTA_CXCR4_PATHWAY",23,"Down",0.973288714600403,0.999827083089274
"BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN",10,"Up",0.973432695142628,0.999827083089274
"FINETTI_BREAST_CANCER_KINOME_GREEN",14,"Up",0.973504198200506,0.999827083089274
"BIOCARTA_DEATH_PATHWAY",28,"Up",0.973781962572489,0.999827083089274
"KEGG_SULFUR_METABOLISM",5,"Down",0.973915911255184,0.999827083089274
"WONG_ADULT_TISSUE_STEM_MODULE",434,"Down",0.973937455701004,0.999827083089274
"BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B",259,"Up",0.974043369473942,0.999827083089274
"REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE",50,"Down",0.974191064091604,0.999827083089274
"MCDOWELL_ACUTE_LUNG_INJURY_UP",32,"Up",0.974298831549257,0.999827083089274
"BIOCARTA_NUCLEARRS_PATHWAY",13,"Up",0.974312453375504,0.999827083089274
"TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN",9,"Down",0.97436265471251,0.999827083089274
"AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN",79,"Down",0.974363418720107,0.999827083089274
"KYNG_WERNER_SYNDROM_DN",10,"Down",0.974389023626334,0.999827083089274
"OXFORD_RALA_TARGETS_UP",3,"Down",0.974427245106912,0.999827083089274
"HINATA_NFKB_TARGETS_FIBROBLAST_UP",59,"Down",0.974481735337185,0.999827083089274
"VERRECCHIA_RESPONSE_TO_TGFB1_C5",17,"Up",0.974524027406093,0.999827083089274
"TSUDA_ALVEOLAR_SOFT_PART_SARCOMA",7,"Up",0.974565863498223,0.999827083089274
"BIOCARTA_GRANULOCYTES_PATHWAY",14,"Down",0.974757750410065,0.999827083089274
"WU_APOPTOSIS_BY_CDKN1A_VIA_TP53",31,"Up",0.974777081665329,0.999827083089274
"BIOCARTA_GSK3_PATHWAY",24,"Down",0.974800366740924,0.999827083089274
"KOBAYASHI_EGFR_SIGNALING_6HR_DN",15,"Up",0.974951307713215,0.999827083089274
"RHODES_CANCER_META_SIGNATURE",34,"Down",0.975096607027387,0.999827083089274
"BOQUEST_STEM_CELL_UP",156,"Up",0.975314118175726,0.999827083089274
"SHIN_B_CELL_LYMPHOMA_CLUSTER_5",17,"Up",0.975371670461648,0.999827083089274
"DAZARD_UV_RESPONSE_CLUSTER_G3",12,"Down",0.975458110754684,0.999827083089274
"NABA_MATRISOME_ASSOCIATED",411,"Up",0.975501174349983,0.999827083089274
"MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN",18,"Up",0.975582002578884,0.999827083089274
"JIANG_TIP30_TARGETS_UP",28,"Down",0.975619637952627,0.999827083089274
"CASTELLANO_NRAS_TARGETS_DN",8,"Up",0.97590106987596,0.999827083089274
"HECKER_IFNB1_TARGETS",38,"Down",0.97635892315972,0.999827083089274
"NOUSHMEHR_GBM_SILENCED_BY_METHYLATION",22,"Up",0.976505776943524,0.999827083089274
"ZHANG_RESPONSE_TO_CANTHARIDIN_UP",13,"Down",0.976541097795764,0.999827083089274
"BAUS_TFF2_TARGETS_UP",25,"Up",0.976629076500772,0.999827083089274
"GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP",46,"Down",0.976832909083805,0.999827083089274
"WELCSH_BRCA1_TARGETS_UP",120,"Down",0.976925662684948,0.999827083089274
"MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7",6,"Down",0.977108145106907,0.999827083089274
"REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX_",20,"Up",0.977553542849319,0.999827083089274
"SMID_BREAST_CANCER_BASAL_UP",347,"Down",0.977793969527784,0.999827083089274
"SHEN_SMARCA2_TARGETS_DN",183,"Down",0.97806470291239,0.999827083089274
"GROSS_ELK3_TARGETS_UP",19,"Up",0.97809648685358,0.999827083089274
"RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP",212,"Up",0.978098085620968,0.999827083089274
"LEE_CALORIE_RESTRICTION_NEOCORTEX_UP",60,"Down",0.978129385162957,0.999827083089274
"XU_AKT1_TARGETS_48HR",4,"Up",0.978227328465616,0.999827083089274
"REACTOME_SIGNALING_BY_NOTCH1",35,"Down",0.978426356745166,0.999827083089274
"KEGG_PHENYLALANINE_METABOLISM",11,"Up",0.978454247854749,0.999827083089274
"BARRIER_COLON_CANCER_RECURRENCE_DN",10,"Up",0.978787652075752,0.999827083089274
"MIKKELSEN_NPC_ICP_WITH_H3K27ME3",4,"Up",0.978855980250701,0.999827083089274
"SWEET_LUNG_CANCER_KRAS_UP",312,"Up",0.979105509016449,0.999827083089274
"REACTOME_MYOGENESIS",23,"Up",0.979374018861276,0.999827083089274
"FINETTI_BREAST_CANCERS_KINOME_BLUE",11,"Down",0.979522943209111,0.999827083089274
"PID_HNF3A_PATHWAY",53,"Down",0.979580486825505,0.999827083089274
"MCCLUNG_COCAINE_REWARD_5D",45,"Up",0.979590367987694,0.999827083089274
"REACTOME_CELL_CYCLE",178,"Up",0.979907442486929,0.999827083089274
"MIKKELSEN_ES_LCP_WITH_H3K4ME3",42,"Down",0.980389806109182,0.999827083089274
"VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP",22,"Up",0.980514825418594,0.999827083089274
"IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP",13,"Down",0.980797961742066,0.999827083089274
"GYORFFY_MITOXANTRONE_RESISTANCE",19,"Down",0.981135786252305,0.999827083089274
"WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN",58,"Down",0.981353003554065,0.999827083089274
"MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN",47,"Up",0.981928958079321,0.999827083089274
"DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP",663,"Down",0.982152392042936,0.999827083089274
"KEGG_RETINOL_METABOLISM",29,"Down",0.982209821336024,0.999827083089274
"RASHI_RESPONSE_TO_IONIZING_RADIATION_4",30,"Down",0.982259512757017,0.999827083089274
"MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN",19,"Down",0.982305431037221,0.999827083089274
"GOLUB_ALL_VS_AML_UP",17,"Down",0.982356771812107,0.999827083089274
"YIH_RESPONSE_TO_ARSENITE_C3",21,"Up",0.982599277838218,0.999827083089274
"REACTOME_OPIOID_SIGNALLING",64,"Down",0.98269651273977,0.999827083089274
"BROWNE_HCMV_INFECTION_12HR_UP",49,"Down",0.982955442972482,0.999827083089274
"KEGG_PURINE_METABOLISM",73,"Down",0.98375847612038,0.999827083089274
"MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED",77,"Up",0.984038119019469,0.999827083089274
"JU_AGING_TERC_TARGETS_UP",8,"Up",0.984045877226178,0.999827083089274
"BLALOCK_ALZHEIMERS_DISEASE_UP",746,"Down",0.984053908028989,0.999827083089274
"GHANDHI_BYSTANDER_IRRADIATION_DN",5,"Down",0.984212124369487,0.999827083089274
"PID_ERB_GENOMIC_PATHWAY",12,"Down",0.984215647352686,0.999827083089274
"REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION",23,"Up",0.984247735435097,0.999827083089274
"MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN",20,"Up",0.984364839079876,0.999827083089274
"KEGG_REGULATION_OF_AUTOPHAGY",13,"Up",0.984675883126437,0.999827083089274
"MCDOWELL_ACUTE_LUNG_INJURY_DN",32,"Down",0.984953849299976,0.999827083089274
"LEE_CALORIE_RESTRICTION_MUSCLE_UP",34,"Up",0.985121725882541,0.999827083089274
"KEGG_PYRIMIDINE_METABOLISM",35,"Up",0.985268172532677,0.999827083089274
"SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES",19,"Down",0.985292768189388,0.999827083089274
"MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP",15,"Down",0.985352590511566,0.999827083089274
"LAMB_CCND1_TARGETS",15,"Up",0.985441165972456,0.999827083089274
"LEE_LIVER_CANCER_MYC_E2F1_DN",47,"Down",0.985730232089203,0.999827083089274
"BIOCARTA_CHREBP2_PATHWAY",21,"Up",0.985835389014842,0.999827083089274
"MAEKAWA_ATF2_TARGETS",17,"Down",0.986036152541651,0.999827083089274
"KUNINGER_IGF1_VS_PDGFB_TARGETS_UP",43,"Down",0.986063302134302,0.999827083089274
"REACTOME_CIRCADIAN_CLOCK",38,"Down",0.986081522026356,0.999827083089274
"DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN",21,"Down",0.986087727260343,0.999827083089274
"ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN",59,"Up",0.986156033870848,0.999827083089274
"EINAV_INTERFERON_SIGNATURE_IN_CANCER",12,"Down",0.98616195921252,0.999827083089274
"AMIT_EGF_RESPONSE_120_MCF10A",26,"Down",0.986168299283935,0.999827083089274
"PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP",92,"Down",0.986179210618574,0.999827083089274
"JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER",10,"Down",0.986183892441419,0.999827083089274
"LEE_LIVER_CANCER_SURVIVAL_DN",84,"Down",0.986243060334406,0.999827083089274
"KEGG_CYSTEINE_AND_METHIONINE_METABOLISM",17,"Down",0.986308988405343,0.999827083089274
"WOTTON_RUNX_TARGETS_UP",10,"Up",0.986313597003183,0.999827083089274
"ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR",12,"Up",0.9867673264011,0.999827083089274
"REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS",10,"Down",0.986775763956027,0.999827083089274
"KORKOLA_SEMINOMA_DN",4,"Up",0.986977800792912,0.999827083089274
"MIKI_COEXPRESSED_WITH_CYP19A1",7,"Down",0.987043273063421,0.999827083089274
"HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR",27,"Down",0.987160749129608,0.999827083089274
"REACTOME_IMMUNE_SYSTEM",482,"Up",0.987237389735884,0.999827083089274
"ZHANG_TLX_TARGETS_36HR_UP",113,"Up",0.987331522642105,0.999827083089274
"LUI_THYROID_CANCER_PAX8_PPARG_DN",25,"Down",0.987483285208151,0.999827083089274
"PID_HIF1_TFPATHWAY",57,"Up",0.987598317610086,0.999827083089274
"KUMAR_TARGETS_OF_MLL_AF9_FUSION",233,"Up",0.987744217058432,0.999827083089274
"PILON_KLF1_TARGETS_DN",635,"Up",0.987832063586457,0.999827083089274
"KEGG_LONG_TERM_POTENTIATION",51,"Down",0.98784628707149,0.999827083089274
"SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP",94,"Up",0.987894377940635,0.999827083089274
"ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE",59,"Down",0.987956477055316,0.999827083089274
"CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP",18,"Up",0.988013978685005,0.999827083089274
"HUMMERICH_SKIN_CANCER_PROGRESSION_DN",74,"Up",0.988114972737626,0.999827083089274
"HUMMERICH_SKIN_CANCER_PROGRESSION_UP",72,"Up",0.988129906233884,0.999827083089274
"REACTOME_MITOTIC_G2_G2_M_PHASES",39,"Up",0.988539043207474,0.999827083089274
"PID_AVB3_OPN_PATHWAY",28,"Up",0.988745277313325,0.999827083089274
"MURAKAMI_UV_RESPONSE_1HR_UP",13,"Up",0.988755691172476,0.999827083089274
"KINNEY_DNMT1_METHYLATION_TARGETS",7,"Down",0.989182525034314,0.999827083089274
"IKEDA_MIR1_TARGETS_DN",3,"Up",0.989513031151993,0.999827083089274
"TAKAO_RESPONSE_TO_UVB_RADIATION_UP",50,"Down",0.989600921403265,0.999827083089274
"INGRAM_SHH_TARGETS_UP",78,"Down",0.98969656185565,0.999827083089274
"REACTOME_P75NTR_SIGNALS_VIA_NFKB",10,"Down",0.989756240584083,0.999827083089274
"MIKKELSEN_ES_ICP_WITH_H3K27ME3",22,"Up",0.989802700106926,0.999827083089274
"IGLESIAS_E2F_TARGETS_UP",130,"Up",0.989814467439035,0.999827083089274
"PID_CERAMIDE_PATHWAY",40,"Down",0.990477636662998,0.999827083089274
"MOREIRA_RESPONSE_TO_TSA_DN",16,"Up",0.991274330620947,0.999827083089274
"BIOCARTA_LAIR_PATHWAY",16,"Up",0.991545063688739,0.999827083089274
"CONRAD_GERMLINE_STEM_CELL",7,"Up",0.991794124118915,0.999827083089274
"NABA_SECRETED_FACTORS",211,"Up",0.991915653235712,0.999827083089274
"HORTON_SREBF_TARGETS",11,"Down",0.992008949392791,0.999827083089274
"LIU_SMARCA4_TARGETS",26,"Up",0.992163215367762,0.999827083089274
"PID_WNT_CANONICAL_PATHWAY",12,"Up",0.992201536222371,0.999827083089274
"PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN",175,"Down",0.992382990207785,0.999827083089274
"NADLER_HYPERGLYCEMIA_AT_OBESITY",37,"Down",0.992592376225189,0.999827083089274
"PEDRIOLI_MIR31_TARGETS_UP",72,"Up",0.99279352422233,0.999827083089274
"BIOCARTA_TCYTOTOXIC_PATHWAY",13,"Down",0.993222669777379,0.999827083089274
"TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP",76,"Down",0.99371146755809,0.999827083089274
"REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_",39,"Up",0.993939862273159,0.999827083089274
"PID_AR_PATHWAY",44,"Down",0.994164043670702,0.999827083089274
"KEGG_PPAR_SIGNALING_PATHWAY",50,"Down",0.99427385173868,0.999827083089274
"BIOCARTA_LONGEVITY_PATHWAY",12,"Up",0.994919540356255,0.999827083089274
"BAE_BRCA1_TARGETS_UP",50,"Down",0.99496085652943,0.999827083089274
"SIG_BCR_SIGNALING_PATHWAY",40,"Up",0.994974285806022,0.999827083089274
"DAZARD_RESPONSE_TO_UV_SCC_DN",55,"Up",0.995260814975341,0.999827083089274
"CHUNG_BLISTER_CYTOTOXICITY_UP",42,"Down",0.995342866638946,0.999827083089274
"SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL",27,"Up",0.995459408596824,0.999827083089274
"BILD_MYC_ONCOGENIC_SIGNATURE",71,"Down",0.995541447542373,0.999827083089274
"CUI_TCF21_TARGETS_DN",19,"Down",0.995547608110942,0.999827083089274
"KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION",190,"Up",0.995550889322942,0.999827083089274
"MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN",51,"Up",0.995712153282916,0.999827083089274
"GU_PDEF_TARGETS_DN",21,"Down",0.995981112351864,0.999827083089274
"MORI_PRE_BI_LYMPHOCYTE_UP",52,"Up",0.996104041514534,0.999827083089274
"GARY_CD5_TARGETS_DN",136,"Up",0.996141298584219,0.999827083089274
"SABATES_COLORECTAL_ADENOMA_SIZE_DN",1,"Up",0.996196865165712,0.999827083089274
"ZHU_CMV_ALL_DN",100,"Down",0.996369996657028,0.999827083089274
"ZIRN_TRETINOIN_RESPONSE_DN",4,"Up",0.996420270559759,0.999827083089274
"MCBRYAN_PUBERTAL_BREAST_6_7WK_DN",50,"Down",0.996517702460533,0.999827083089274
"NAKAMURA_ADIPOGENESIS_EARLY_DN",28,"Down",0.996663956837663,0.999827083089274
"REACTOME_SIGNAL_AMPLIFICATION",28,"Up",0.996716285824362,0.999827083089274
"MCBRYAN_PUBERTAL_BREAST_5_6WK_DN",71,"Down",0.996841798133392,0.999827083089274
"PID_S1P_META_PATHWAY",18,"Up",0.997072610969056,0.999827083089274
"AMIT_EGF_RESPONSE_240_MCF10A",9,"Down",0.997168598993095,0.999827083089274
"DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN",15,"Up",0.997764375415238,0.999827083089274
"KYNG_RESPONSE_TO_H2O2_VIA_ERCC6",10,"Down",0.998115411975613,0.999827083089274
"REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT",5,"Down",0.998579297061604,0.999827083089274
"REACTOME_SIGNALING_BY_ERBB4",56,"Down",0.998652482267545,0.999827083089274
"REACTOME_GABA_A_RECEPTOR_ACTIVATION",10,"Down",0.998653024377457,0.999827083089274
"WOOD_EBV_EBNA1_TARGETS_DN",21,"Down",0.998663126878329,0.999827083089274
"MARTINEZ_RB1_TARGETS_UP",371,"Up",0.99867835481126,0.999827083089274
"DARWICHE_PAPILLOMA_RISK_HIGH_UP",74,"Down",0.998918892721627,0.999827083089274
"BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP",22,"Down",0.999008707313906,0.999827083089274
"SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP",53,"Down",0.999049744789009,0.999827083089274
"REACTOME_UNBLOCKING_OF_NMDA_RECEPTOR_GLUTAMATE_BINDING_AND_ACTIVATION",12,"Down",0.999088959394557,0.999827083089274
"REACTOME_TRANSLATION",66,"Up",0.999137283053974,0.999827083089274
"REACTOME_OTHER_SEMAPHORIN_INTERACTIONS",9,"Up",0.999436166241831,0.999827083089274
"GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP",10,"Up",0.999469655728997,0.999827083089274
"LIU_TOPBP1_TARGETS",10,"Down",0.999491018678931,0.999827083089274
"HUTTMANN_B_CLL_POOR_SURVIVAL_DN",22,"Down",0.999576387954727,0.999827083089274
"ROVERSI_GLIOMA_LOH_REGIONS",16,"Down",0.999643705963615,0.999827083089274
"REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS",32,"Down",0.999731587094879,0.999827083089274
"ZWANG_EGF_PERSISTENTLY_DN",13,"Down",0.999738699477211,0.999827083089274
"BIOCARTA_AGPCR_PATHWAY",11,"Up",0.999827083089274,0.999827083089274
